[
  {
    "patient_name": "John Marsten",
    "patient_profile": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTevUwZJM2JzUarw4SPkl4wRqfDwG7-McWSpg&s",
    "patient_id": "TEST_PT_001",
    "archetype": "Archetype_1_Uncontrolled_Diabetic",
    "demographics": {
      "age": 58,
      "sex": "M",
      "race_ethnicity": "Hispanic/Latino"
    },
    "allergies": [
      {
        "allergen": "Sulfa drugs (Sulfamethoxazole)",
        "reaction": "Rash, itching",
        "severity": "moderate",
        "onset": "2015"
      },
      {
        "allergen": "Contrast dye (iodinated)",
        "reaction": "Hives, concern for nephropathy",
        "severity": "moderate",
        "onset": "documented 2019"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_001_A",
        "type": "lab_trend",
        "description": "Progressive HbA1c elevation from 8.2% to 10.8% over 7 months despite medication escalation",
        "entities_involved": [
          "HbA1c",
          "Metformin",
          "Glipizide",
          "Insulin Glargine"
        ],
        "visits_involved": ["V1", "V3", "V5", "V6"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_001_B",
        "type": "lab_trend",
        "description": "Declining renal function with GFR drop from 68 to 48 mL/min and rising creatinine",
        "entities_involved": ["GFR", "Creatinine", "Diabetic nephropathy"],
        "visits_involved": ["V1", "V3", "V5", "V6"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.9
      },
      {
        "correlation_id": "CORR_001_C",
        "type": "symptom_lab_correlation",
        "description": "Persistent fatigue correlating with worsening anemia (Hgb 13.2 to 10.1 g/dL)",
        "entities_involved": ["Fatigue", "Hemoglobin", "Ferritin"],
        "visits_involved": ["V2", "V4", "V5", "V6"],
        "expected_severity": "medium",
        "minimum_confidence_threshold": 0.82
      },
      {
        "correlation_id": "CORR_001_D",
        "type": "care_gap",
        "description": "No retinal examination performed despite diabetic retinopathy risk and duration of diabetes >10 years",
        "entities_involved": [
          "Ophthalmology referral",
          "Retinal exam",
          "Diabetes duration"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4", "V5", "V6"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.85
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-03-15",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up for diabetes, feeling more tired lately",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 78,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 210.5,
          "height_inches": 68.0,
          "bmi": 32.0
        },
        "labs": {
          "hba1c": 8.2,
          "glucose_mg_dl": 178,
          "creatinine_mg_dl": 1.3,
          "gfr_ml_min": 68,
          "hemoglobin_g_dl": 13.2,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 245,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "cholesterol_total_mg_dl": 198,
          "ldl_mg_dl": 118,
          "hdl_mg_dl": 42,
          "triglycerides_mg_dl": 190,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 145.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg twice daily",
            "Lisinopril 10mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily"
          ],
          "started": ["Glipizide 5mg daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "HbA1c recheck in 3 months",
          "Basic metabolic panel in 3 months"
        ],
        "referrals": [],
        "provider_note_snippet": "A1c elevated at 8.2%, adding glipizide to regimen. Discussed diet and exercise. Patient reports difficulty with portion control. RTC 3 months.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": "former",
          "alcohol": "social",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-05-10",
        "visit_type": "office_visit",
        "chief_complaint": "Still feeling tired all the time, some tingling in feet",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 138,
          "bp_diastolic": 86,
          "hr_bpm": 82,
          "rr_bpm": 15,
          "spo2_percent": 98.0,
          "weight_lbs": 212.0,
          "height_inches": 68.0,
          "bmi": 32.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 195,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 12.4,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": 285,
          "folate_ng_ml": 8.2,
          "ferritin_ng_ml": 98.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg twice daily",
            "Glipizide 5mg daily",
            "Lisinopril 10mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": ["Glipizide increased to 10mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)"
          ],
          "new_acute": ["Peripheral neuropathy, likely diabetic (E11.42)"],
          "differential": []
        },
        "procedures_ordered": [
          "Monofilament foot exam",
          "Gabapentin trial for neuropathy"
        ],
        "referrals": [],
        "provider_note_snippet": "Patient reports persistent fatigue and paresthesias in feet. Hemoglobin slightly down at 12.4. B12 and folate normal. Starting gabapentin 300mg for neuropathy. Increased glipizide dose.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-28",
        "visit_type": "office_visit",
        "chief_complaint": "Diabetes check, foot numbness not much better",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 145,
          "bp_diastolic": 92,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 214.8,
          "height_inches": 68.0,
          "bmi": 32.6
        },
        "labs": {
          "hba1c": 9.1,
          "glucose_mg_dl": 215,
          "creatinine_mg_dl": 1.5,
          "gfr_ml_min": 58,
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 238,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.5,
          "alt_u_l": 35,
          "ast_u_l": 30,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg twice daily",
            "Glipizide 10mg daily",
            "Lisinopril 10mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily",
            "Gabapentin 300mg three times daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": ["Metformin increased to 1000mg three times daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus, uncontrolled (E11.65)",
            "Diabetic peripheral neuropathy (E11.42)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Diabetic nephropathy (E11.21)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": ["Urine microalbumin", "Nephrology referral"],
        "referrals": ["Nephrology for diabetic kidney disease"],
        "provider_note_snippet": "A1c worsened to 9.1% despite medication increases. Creatinine now 1.5, GFR 58 - concerning for progressive nephropathy. Hemoglobin trending down. Referred to nephrology. Discussed insulin initiation if A1c not improved at next visit.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": "insecure"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-08-16",
        "visit_type": "office_visit",
        "chief_complaint": "Fatigue getting worse, some swelling in ankles",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 148,
          "bp_diastolic": 90,
          "hr_bpm": 84,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 218.2,
          "height_inches": 68.0,
          "bmi": 33.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 228,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 7.5,
          "platelets_k_ul": 242,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.7,
          "alt_u_l": null,
          "ast_u_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 72.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg three times daily",
            "Glipizide 10mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily",
            "Gabapentin 300mg three times daily"
          ],
          "started": ["Ferrous sulfate 325mg daily"],
          "stopped": [],
          "dose_changed": ["Lisinopril increased to 20mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus, uncontrolled (E11.65)",
            "Diabetic peripheral neuropathy (E11.42)",
            "Diabetic nephropathy (E11.21)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)"
          ],
          "new_acute": ["Anemia, likely multifactorial (D63.1)"],
          "differential": []
        },
        "procedures_ordered": ["Complete iron panel"],
        "referrals": [],
        "provider_note_snippet": "Hemoglobin continues to decline, now 10.8. Ferritin low at 72. Started iron supplementation. Patient missed nephrology appointment - will reschedule. Fatigue likely related to anemia and poor glucose control. Weight gain of 4 lbs, some pedal edema noted.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-09-20",
        "visit_type": "office_visit",
        "chief_complaint": "Diabetes follow-up, tired all the time, can barely get through work day",
        "vitals": {
          "temp_f": 98.5,
          "bp_systolic": 152,
          "bp_diastolic": 94,
          "hr_bpm": 88,
          "rr_bpm": 17,
          "spo2_percent": 96.0,
          "weight_lbs": 220.5,
          "height_inches": 68.0,
          "bmi": 33.5
        },
        "labs": {
          "hba1c": 10.2,
          "glucose_mg_dl": 248,
          "creatinine_mg_dl": 1.7,
          "gfr_ml_min": 52,
          "hemoglobin_g_dl": 10.3,
          "wbc_k_ul": 8.1,
          "platelets_k_ul": 235,
          "sodium_meq_l": 137,
          "potassium_meq_l": 4.9,
          "alt_u_l": 38,
          "ast_u_l": 33,
          "cholesterol_total_mg_dl": 212,
          "ldl_mg_dl": 128,
          "hdl_mg_dl": 38,
          "triglycerides_mg_dl": 230,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 85.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg three times daily",
            "Glipizide 10mg daily",
            "Lisinopril 20mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily",
            "Gabapentin 300mg three times daily",
            "Ferrous sulfate 325mg daily"
          ],
          "started": ["Insulin glargine 10 units at bedtime"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus, uncontrolled (E11.65)",
            "Diabetic peripheral neuropathy (E11.42)",
            "Diabetic nephropathy, Stage 3 CKD (E11.21, N18.3)",
            "Hypertension, uncontrolled (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Anemia of chronic disease (D63.1)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Diabetes education referral",
          "HbA1c recheck in 6 weeks"
        ],
        "referrals": ["Diabetes education", "Endocrinology consult"],
        "provider_note_snippet": "A1c now 10.2% - significantly elevated. Renal function worsening with GFR 52, creatinine 1.7. Anemia persistent despite iron supplementation. Starting basal insulin. Long discussion about medication adherence - patient reports financial barriers to medications and healthy food. Connected with social work.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "insecure"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-10-25",
        "visit_type": "office_visit",
        "chief_complaint": "Insulin follow-up, still very fatigued",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 156,
          "bp_diastolic": 96,
          "hr_bpm": 90,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 222.0,
          "height_inches": 68.0,
          "bmi": 33.7
        },
        "labs": {
          "hba1c": 10.8,
          "glucose_mg_dl": 265,
          "creatinine_mg_dl": 1.8,
          "gfr_ml_min": 48,
          "hemoglobin_g_dl": 10.1,
          "wbc_k_ul": 8.4,
          "platelets_k_ul": 228,
          "sodium_meq_l": 136,
          "potassium_meq_l": 5.1,
          "alt_u_l": null,
          "ast_u_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Metformin 1000mg three times daily",
            "Glipizide 10mg daily",
            "Lisinopril 20mg daily",
            "Atorvastatin 40mg daily",
            "Aspirin 81mg daily",
            "Gabapentin 300mg three times daily",
            "Ferrous sulfate 325mg daily"
          ],
          "started": ["Amlodipine 5mg daily"],
          "stopped": [],
          "dose_changed": ["Insulin glargine increased to 20 units at bedtime"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus, uncontrolled (E11.65)",
            "Diabetic peripheral neuropathy (E11.42)",
            "Diabetic nephropathy, Stage 3b CKD (E11.21, N18.32)",
            "Hypertension, uncontrolled (I10)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Anemia of chronic disease (D63.1)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": ["EPO level", "Nephrology urgent referral"],
        "referrals": [],
        "provider_note_snippet": "Diabetes control continues to deteriorate despite insulin initiation - A1c 10.8%. Patient admits not taking insulin consistently due to cost. GFR now 48, concerning for progression to Stage 3b CKD. Anemia worsening. NO RETINAL EXAM DOCUMENTED IN 18+ MONTHS - critical gap. Discussed urgent need for ophthalmology. Increased insulin dose and added amlodipine for BP control.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": "insecure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Distinguishing medication non-adherence from treatment resistance",
      "Connecting multiple organ system complications to underlying diabetes",
      "Recognizing the interaction between anemia and fatigue in context of CKD",
      "Detecting the critical care gap (missed retinal exam) amidst multiple other issues",
      "Understanding social determinants (food insecurity, medication costs) as contributors to poor control"
    ],
    "evaluation_notes": "This case tests ability to: (1) track multiple lab trends simultaneously, (2) recognize progressive multi-organ diabetic complications, (3) identify medication non-response patterns, (4) detect preventive care gaps, and (5) incorporate social determinants into clinical reasoning. The LLM should flag the missing ophthalmology referral as high priority given duration and severity of diabetes."
  },

  {
    "patient_name": "Samantha Jones",
    "patient_profile": "https://st2.depositphotos.com/2783505/9427/i/950/depositphotos_94278920-stock-photo-passport-picture-of-a-blonde.jpg",
    "patient_id": "TEST_PT_009",
    "archetype": "Archetype_5_CHF_Acute_Exacerbation",
    "demographics": {
      "age": 73,
      "sex": "F",
      "race_ethnicity": "Caucasian"
    },
    "allergies": [
      {
        "allergen": "ACE inhibitors (Lisinopril)",
        "reaction": "Angioedema - facial swelling, difficulty breathing",
        "severity": "severe",
        "onset": "2018"
      },
      {
        "allergen": "Shellfish",
        "reaction": "Hives, throat tightness",
        "severity": "moderate",
        "onset": "adult"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_009_A",
        "type": "symptom_lab_correlation",
        "description": "Rapid weight gain (12 lbs in 10 days) correlating with worsening dyspnea and edema in CHF patient",
        "entities_involved": ["Weight", "Dyspnea", "Edema", "BNP elevation"],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_009_B",
        "type": "lab_trend",
        "description": "Dramatically elevated BNP from baseline 450 to 2800 pg/mL indicating acute decompensated heart failure",
        "entities_involved": ["BNP", "Weight gain", "Crackles on exam"],
        "visits_involved": ["V1", "V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_009_C",
        "type": "persistent_symptom",
        "description": "Progressive orthopnea and paroxysmal nocturnal dyspnea signaling volume overload",
        "entities_involved": [
          "Orthopnea",
          "PND",
          "Shortness of breath",
          "Weight gain"
        ],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_009_D",
        "type": "medication_nonresponse",
        "description": "Inadequate diuretic dosing for acute volume overload requiring IV diuretics and hospitalization",
        "entities_involved": [
          "Furosemide dose",
          "Weight",
          "Urine output",
          "IV diuretics"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.85
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-06-14",
        "visit_type": "office_visit",
        "chief_complaint": "Heart failure follow-up, doing well",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 68,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 152.0,
          "height_inches": 64.0,
          "bmi": 26.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 102,
          "creatinine_mg_dl": 1.1,
          "gfr_ml_min": 68,
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 6.5,
          "platelets_k_ul": 235,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Sacubitril-valsartan 97-103mg twice daily",
            "Metoprolol succinate 100mg daily",
            "Furosemide 40mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, EF 30% (I50.22)",
            "Coronary artery disease, history of CABG 2020 (I25.10, Z95.1)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.3)",
            "Atrial fibrillation, rate controlled (I48.91)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": ["Echo in 6 months", "BNP baseline"],
        "referrals": [],
        "provider_note_snippet": "Stable CHF visit. EF 30% on last echo 3 months ago. Patient doing well on GDMT (guideline-directed medical therapy). No dyspnea at rest, able to walk 2 blocks without symptoms. Dry weight 152 lbs. No edema on exam. Lungs clear. JVP not elevated. BNP 450 (stable from prior). Continue current medications. Reinforced daily weights and low-sodium diet.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "never",
          "alcohol": "none",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-08-02",
        "visit_type": "office_visit",
        "chief_complaint": "Noticed some ankle swelling past few days, feeling a bit more winded",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 132,
          "bp_diastolic": 78,
          "hr_bpm": 76,
          "rr_bpm": 18,
          "spo2_percent": 95.0,
          "weight_lbs": 157.0,
          "height_inches": 64.0,
          "bmi": 27.0
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 64,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.4,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Sacubitril-valsartan 97-103mg twice daily",
            "Metoprolol succinate 100mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": ["Furosemide increased to 60mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, EF 30% (I50.22)",
            "Coronary artery disease, history of CABG 2020 (I25.10, Z95.1)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.3)",
            "Atrial fibrillation, rate controlled (I48.91)"
          ],
          "new_acute": ["Volume overload, mild (E87.70)"],
          "differential": []
        },
        "procedures_ordered": ["Daily weights at home", "Recheck in 5-7 days"],
        "referrals": [],
        "provider_note_snippet": "Patient with 5 lb weight gain from dry weight (152 to 157 lbs). Reports increased ankle swelling and mild dyspnea with usual activities. 1+ pitting edema bilateral ankles. Lungs still clear. Patient admits eating more salty foods at family gathering last weekend. Increased furosemide to 60mg daily. Reinforced strict low-sodium diet. Daily weights. RTC if weight increases further or dyspnea worsens.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-08-12",
        "visit_type": "urgent_care",
        "chief_complaint": "Much more short of breath, can't sleep lying flat, legs very swollen",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 148,
          "bp_diastolic": 86,
          "hr_bpm": 88,
          "rr_bpm": 24,
          "spo2_percent": 91.0,
          "weight_lbs": 164.0,
          "height_inches": 64.0,
          "bmi": 28.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 115,
          "creatinine_mg_dl": 1.5,
          "gfr_ml_min": 52,
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 242,
          "sodium_meq_l": 135,
          "potassium_meq_l": 4.6,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Sacubitril-valsartan 97-103mg twice daily",
            "Metoprolol succinate 100mg daily",
            "Furosemide 60mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": ["Furosemide 80mg IV x1 dose given in urgent care"],
          "stopped": [],
          "dose_changed": ["Furosemide increased to 80mg PO twice daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, EF 30% (I50.22)",
            "Coronary artery disease, history of CABG 2020 (I25.10, Z95.1)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.3)",
            "Atrial fibrillation, rate controlled (I48.91)"
          ],
          "new_acute": [
            "Acute decompensated heart failure (I50.23)",
            "Volume overload, severe (E87.70)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Chest X-ray - shows pulmonary edema, cardiomegaly",
          "BNP - pending",
          "EKG - atrial fibrillation, rate 88"
        ],
        "referrals": [],
        "provider_note_snippet": "ACUTE CHF EXACERBATION. Patient with 12 lb weight gain in 10 days (152 to 164 lbs). Significant respiratory distress with orthopnea (sleeps on 3 pillows now vs usual 1), PND x3 nights. 3+ pitting edema to knees bilaterally. Crackles bilateral bases. JVP elevated to 12cm. SpO2 91% on room air. CXR shows pulmonary edema. Patient admits dietary indiscretion - eating restaurant meals daily. Given furosemide 80mg IV with good response (urinated 800cc in 2 hours). Increased PO furosemide to 80mg BID. Patient stable for outpatient management but needs close follow-up. If no improvement in 24-48 hours, will need hospital admission.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-08-14",
        "visit_type": "emergency",
        "chief_complaint": "Worse shortness of breath, can't breathe lying down at all, coughing up pink frothy sputum",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 162,
          "bp_diastolic": 94,
          "hr_bpm": 102,
          "rr_bpm": 28,
          "spo2_percent": 86.0,
          "weight_lbs": 166.0,
          "height_inches": 64.0,
          "bmi": 28.5
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 128,
          "creatinine_mg_dl": 1.7,
          "gfr_ml_min": 46,
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 8.5,
          "platelets_k_ul": 245,
          "sodium_meq_l": 133,
          "potassium_meq_l": 4.8,
          "alt_u_l": 52,
          "ast_u_l": 48,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Sacubitril-valsartan 97-103mg twice daily",
            "Metoprolol succinate 100mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [
            "Furosemide 80mg IV every 8 hours",
            "Metolazone 5mg daily",
            "BiPAP therapy",
            "Oxygen 4L nasal cannula"
          ],
          "stopped": ["Oral furosemide switched to IV"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, EF 30% (I50.22)",
            "Coronary artery disease, history of CABG 2020 (I25.10, Z95.1)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3b (N18.32)",
            "Atrial fibrillation, rate controlled (I48.91)"
          ],
          "new_acute": [
            "Acute decompensated heart failure with pulmonary edema (I50.23)",
            "Acute hypoxemic respiratory failure (J96.01)",
            "Cardiorenal syndrome (N17.9, I50.23)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Chest X-ray - severe pulmonary edema, bilateral pleural effusions",
          "BNP 2800 pg/mL (was 450 at baseline)",
          "Troponin - negative",
          "Echo - EF 25% (decreased from 30%), severe volume overload",
          "Admitted to CCU"
        ],
        "referrals": ["Cardiology consult", "Heart failure team"],
        "provider_note_snippet": "SEVERE ACUTE DECOMPENSATED HEART FAILURE. Patient failed outpatient diuresis, continued to gain weight (now 166 lbs, 14 lbs above dry weight). Presenting with acute pulmonary edema - pink frothy sputum, severe respiratory distress, SpO2 86% on room air. Tachypneic at 28/min, tachycardic to 102. Diffuse crackles throughout lung fields, large pleural effusions on CXR. JVP >15cm. 3+ edema to thighs. BNP critically elevated at 2800 (baseline 450). Echo shows EF declined to 25%, severe volume overload. Cardiorenal syndrome developing (Cr 1.7, Na 133). Started on BiPAP with improvement in work of breathing. IV furosemide 80mg Q8H + metolazone 5mg for aggressive diuresis. ADMITTED TO CCU. Patient needs intensive monitoring, possible ultrafiltration if diuretics inadequate.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-09-06",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up after hospital discharge, breathing much better now",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 122,
          "bp_diastolic": 74,
          "hr_bpm": 70,
          "rr_bpm": 16,
          "spo2_percent": 96.0,
          "weight_lbs": 150.0,
          "height_inches": 64.0,
          "bmi": 25.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 64,
          "hemoglobin_g_dl": 12.4,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 238,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.3,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Sacubitril-valsartan 97-103mg twice daily",
            "Metoprolol succinate 100mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [
            "Furosemide 80mg twice daily (continuing higher dose)",
            "Metolazone 2.5mg three times weekly (Mon-Wed-Fri)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, EF 25% (I50.22)",
            "Coronary artery disease, history of CABG 2020 (I25.10, Z95.1)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.3)",
            "Atrial fibrillation, rate controlled (I48.91)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Weekly weights to clinic for 1 month",
          "Echo in 3 months",
          "Cardiology follow-up in 2 weeks",
          "Dietary consult - strict 2g sodium diet",
          "Home health nursing for medication reconciliation and education"
        ],
        "referrals": [
          "Registered dietitian",
          "Home health nursing",
          "Cardiac rehabilitation"
        ],
        "provider_note_snippet": "Post-discharge follow-up after 7-day CCU admission. Patient received aggressive IV diuresis (total net negative 18 liters), ultimately required single session of ultrafiltration. Discharged on increased diuretic regimen. Currently at NEW dry weight of 150 lbs (2 lbs below previous dry weight of 152). No dyspnea at rest, no orthopnea. Trace edema only. Lungs clear. EF declined from 30% to 25% on discharge echo - concerning progression. Long discussion about dietary sodium restriction, medication adherence, and daily weight monitoring. Patient very motivated after this hospitalization. Enrolled in home health for close monitoring and education. Weekly weight checks in clinic x1 month. Considering ICD/CRT evaluation given EF decline.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing rapid weight gain as the critical early warning sign of CHF decompensation",
      "Connecting orthopnea and PND with volume overload before overt pulmonary edema",
      "Understanding the significance of BNP elevation from 450 to 2800 pg/mL",
      "Distinguishing inadequate outpatient diuresis from true diuretic resistance",
      "Recognizing cardiorenal syndrome (worsening kidney function despite diuresis need)",
      "Understanding the escalation from oral to IV diuretics to ultrafiltration"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize acute-on-chronic heart failure exacerbation through weight and symptom tracking, (2) understand the clinical significance of orthopnea, PND, and progressive edema, (3) correlate laboratory values (BNP, creatinine) with clinical deterioration, (4) recognize treatment failure requiring escalation of care, (5) understand cardiorenal syndrome complicating diuresis, and (6) appreciate the importance of medication adherence and dietary factors in CHF management. The LLM should flag early warning signs at V2 with 5 lb weight gain, recognize acute decompensation by V3, identify critical status requiring hospitalization at V4, and understand the long-term implications of EF decline by V5."
  },

  {
    "patient_name": "Prateek Patidar",
    "patient_profile": "data:image/jpeg;base64,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",
    "patient_id": "TEST_PT_010",
    "archetype": "Archetype_6_Occult_Cancer_Colon",
    "demographics": {
      "age": 71,
      "sex": "M",
      "race_ethnicity": "Caucasian"
    },
    "allergies": [
      {
        "allergen": "Codeine",
        "reaction": "Severe nausea, vomiting",
        "severity": "moderate",
        "onset": "2010"
      },
      {
        "allergen": "Latex",
        "reaction": "Contact dermatitis, skin irritation",
        "severity": "mild",
        "onset": "2005"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_010_A",
        "type": "persistent_symptom",
        "description": "Progressive unintentional weight loss (22 lbs over 6 months) without clear benign etiology",
        "entities_involved": ["Weight loss", "Appetite", "BMI decline"],
        "visits_involved": ["V1", "V2", "V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_010_B",
        "type": "symptom_lab_correlation",
        "description": "Progressive iron deficiency anemia despite supplementation, concerning for GI blood loss",
        "entities_involved": [
          "Hemoglobin",
          "Ferritin",
          "Iron saturation",
          "Occult blood"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_010_C",
        "type": "persistent_symptom",
        "description": "Intermittent abdominal pain and change in bowel habits persisting across multiple visits",
        "entities_involved": [
          "Abdominal pain",
          "Constipation",
          "Bowel habit changes"
        ],
        "visits_involved": ["V2", "V3", "V4", "V5"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_010_D",
        "type": "care_gap",
        "description": "Delayed colonoscopy despite red flag symptoms (weight loss, anemia, age >70, bowel changes) - 4+ month delay",
        "entities_involved": [
          "Colonoscopy",
          "Weight loss",
          "Anemia",
          "Age",
          "Symptoms"
        ],
        "visits_involved": ["V2", "V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.9
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-03-28",
        "visit_type": "office_visit",
        "chief_complaint": "Annual physical, also noticed losing some weight without trying",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 138,
          "bp_diastolic": 82,
          "hr_bpm": 74,
          "rr_bpm": 15,
          "spo2_percent": 98.0,
          "weight_lbs": 182.0,
          "height_inches": 70.0,
          "bmi": 26.1
        },
        "labs": {
          "hba1c": 5.8,
          "glucose_mg_dl": 102,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 7.5,
          "platelets_k_ul": 385,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": 2.4,
          "cholesterol_total_mg_dl": 198,
          "ldl_mg_dl": 118,
          "hdl_mg_dl": 48,
          "triglycerides_mg_dl": 160,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 38.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Atorvastatin 20mg daily",
            "Aspirin 81mg daily"
          ],
          "started": ["Ferrous sulfate 325mg daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Hyperlipidemia (E78.5)"],
          "new_acute": ["Anemia, unspecified (D64.9)", "Weight loss (R63.4)"],
          "differential": []
        },
        "procedures_ordered": ["Stool guaiac test"],
        "referrals": [],
        "provider_note_snippet": "Annual physical. Patient reports 8 lb unintentional weight loss over past 3 months (was 190 lbs, now 182 lbs). Attributes to 'eating less' but no clear reason. Hemoglobin slightly low at 12.8, ferritin low at 38 suggesting iron deficiency. No obvious bleeding source. Stool guaiac ordered. Started iron supplementation. Patient last colonoscopy was 12 years ago (age 59) - overdue for screening. Will schedule if stool guaiac positive.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "former (quit 10 years ago, 20 pack-year history)",
          "alcohol": "moderate",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-05-17",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up on weight loss and anemia, now having some belly discomfort",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 134,
          "bp_diastolic": 80,
          "hr_bpm": 76,
          "rr_bpm": 15,
          "spo2_percent": 98.0,
          "weight_lbs": 178.0,
          "height_inches": 70.0,
          "bmi": 25.5
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 398,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": 385,
          "folate_ng_ml": 10.2,
          "ferritin_ng_ml": 42.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Atorvastatin 20mg daily",
            "Aspirin 81mg daily",
            "Ferrous sulfate 325mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Anemia, iron deficiency (D50.9)"
          ],
          "new_acute": ["Weight loss (R63.4)", "Abdominal pain (R10.9)"],
          "differential": ["Gastritis", "Peptic ulcer", "Malabsorption"]
        },
        "procedures_ordered": ["Upper endoscopy", "Celiac panel"],
        "referrals": ["GI for EGD"],
        "provider_note_snippet": "Patient with continued weight loss - now down to 178 lbs (12 lbs total over 4 months). Hemoglobin declining despite iron supplementation (12.8 to 12.2). Ferritin minimally improved. Stool guaiac was negative. Now reports vague intermittent lower abdominal cramping and notes stools sometimes harder to pass. B12 and folate normal. Referred for upper endoscopy to evaluate for gastric source of bleeding/malabsorption. Patient hesitant about colonoscopy, wants to 'see what EGD shows first.'",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-28",
        "visit_type": "office_visit",
        "chief_complaint": "EGD results follow-up, weight still dropping, constipation worse",
        "vitals": {
          "temp_f": 98.0,
          "bp_systolic": 130,
          "bp_diastolic": 78,
          "hr_bpm": 78,
          "rr_bpm": 15,
          "spo2_percent": 98.0,
          "weight_lbs": 172.0,
          "height_inches": 70.0,
          "bmi": 24.7
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 11.4,
          "wbc_k_ul": 8.2,
          "platelets_k_ul": 412,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.1,
          "alt_u_l": 35,
          "ast_u_l": 32,
          "crp_mg_l": 18.5,
          "esr_mm_hr": 42,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 35.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Atorvastatin 20mg daily",
            "Aspirin 81mg daily",
            "Ferrous sulfate 325mg daily"
          ],
          "started": ["Polyethylene glycol 3350 17g daily for constipation"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Anemia, iron deficiency (D50.9)"
          ],
          "new_acute": [
            "Weight loss, progressive (R63.4)",
            "Constipation (K59.00)",
            "Abdominal pain (R10.9)"
          ],
          "differential": ["Inflammatory bowel disease", "Malignancy", "IBS"]
        },
        "procedures_ordered": ["Colonoscopy ordered - patient to schedule"],
        "referrals": [],
        "provider_note_snippet": "EGD results: mild gastritis, no ulcers, biopsies benign. This does NOT explain progressive weight loss and anemia. Patient now down 18 lbs total (190 to 172 lbs over 5 months). Hemoglobin continues to decline (11.4). Ferritin not improving despite iron therapy. New complaints of worsening constipation and crampy abdominal pain. CRP and ESR elevated suggesting inflammation. NEED COLONOSCOPY - this could be colon cancer, IBD, or other colonic pathology. Strongly recommended colonoscopy. Patient agrees but wants to wait until after daughter's wedding in 6 weeks.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-08-09",
        "visit_type": "office_visit",
        "chief_complaint": "Weight loss continues, very fatigued, noticed blood on toilet paper few times",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 126,
          "bp_diastolic": 76,
          "hr_bpm": 82,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 168.0,
          "height_inches": 70.0,
          "bmi": 24.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 8.8,
          "platelets_k_ul": 445,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "alt_u_l": 38,
          "ast_u_l": 35,
          "crp_mg_l": 28.4,
          "esr_mm_hr": 58,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": 28.0,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Atorvastatin 20mg daily",
            "Aspirin 81mg daily",
            "Ferrous sulfate 325mg daily",
            "Polyethylene glycol 3350 17g daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Anemia, iron deficiency (D50.9)"
          ],
          "new_acute": [
            "Weight loss, severe (R63.4)",
            "Hematochezia (K62.5)",
            "Fatigue (R53.83)"
          ],
          "differential": ["Colorectal cancer", "IBD", "Colonic polyps"]
        },
        "procedures_ordered": [
          "Colonoscopy URGENT - called GI to expedite",
          "CEA level"
        ],
        "referrals": ["GI urgent colonoscopy"],
        "provider_note_snippet": "ALARMING PROGRESSION. Patient now 22 lbs below baseline weight (190 to 168 lbs over 6 months). Hemoglobin 10.2 - moderate anemia worsening despite iron. Now reports visible blood on toilet paper with bowel movements. Severe fatigue limiting activities. Platelets elevated at 445 (reactive thrombocytosis - concerning for malignancy). CRP and ESR markedly elevated. This is RED FLAG constellation: age >70 + progressive weight loss + worsening anemia + GI bleeding + inflammatory markers. HIGH SUSPICION FOR COLORECTAL CANCER. Called GI to expedite colonoscopy - scheduled for next week. Ordered CEA tumor marker.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-08-23",
        "visit_type": "office_visit",
        "chief_complaint": "Colonoscopy results discussion",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 132,
          "bp_diastolic": 80,
          "hr_bpm": 80,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 166.0,
          "height_inches": 70.0,
          "bmi": 23.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 9.8,
          "wbc_k_ul": 9.2,
          "platelets_k_ul": 468,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.1,
          "alt_u_l": 42,
          "ast_u_l": 38,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Atorvastatin 20mg daily",
            "Aspirin 81mg daily",
            "Ferrous sulfate 325mg daily"
          ],
          "started": [],
          "stopped": ["Polyethylene glycol discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Hyperlipidemia (E78.5)"],
          "new_acute": [
            "Adenocarcinoma of sigmoid colon, Stage II (C18.7)",
            "Anemia secondary to malignancy (D63.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "CT chest/abdomen/pelvis for staging",
          "PET scan",
          "Surgical oncology consultation",
          "Nutritional support consultation"
        ],
        "referrals": ["Surgical oncology", "Medical oncology", "Nutrition"],
        "provider_note_snippet": "COLONOSCOPY RESULTS: Large, partially obstructing mass in sigmoid colon (5cm). Biopsies confirm moderately differentiated adenocarcinoma. CEA elevated at 42 ng/mL (normal <5). This explains entire clinical picture - progressive weight loss, iron deficiency anemia, bowel changes, bleeding, inflammatory markers. CT staging pending but no obvious metastases on initial imaging. Likely Stage II or III. Referred urgently to surgical oncology for resection. Patient and family devastated but also relieved to have diagnosis. In retrospect, colonoscopy should have been done 4-5 months ago when red flags first appeared. Delay may have allowed progression. Important lesson about acting quickly on alarm symptoms.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing the constellation of alarm symptoms (weight loss + anemia + age >70) early in the timeline",
      "Understanding that negative stool guaiac does NOT rule out GI malignancy",
      "Identifying the pattern of progressive anemia despite iron supplementation as highly concerning",
      "Recognizing reactive thrombocytosis and elevated inflammatory markers as potential cancer signals",
      "Understanding the critical delay in performing colonoscopy despite multiple red flags",
      "Connecting seemingly disparate symptoms (weight loss, anemia, constipation, fatigue) to a unifying diagnosis"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize occult cancer presentation through progressive symptoms over time, (2) identify alarm symptoms requiring urgent investigation, (3) understand that normal or minimally helpful initial tests do not exclude serious pathology, (4) track multiple converging clinical indicators (weight loss, anemia, bleeding, inflammatory markers), (5) recognize critical diagnostic delays as care gaps, and (6) appreciate the urgency needed when multiple red flags are present. The LLM should flag concern by V1-V2 with weight loss and anemia in elderly patient, recognize high suspicion for malignancy by V3 with progressive symptoms and normal EGD, identify critical urgency by V4 with overt bleeding and severe anemia, and understand that the 4-5 month delay to colonoscopy was a significant care gap that may have affected outcomes."
  },

  {
    "patient_id": "TEST_PT_011",
    "patient_name": "Barbara Chen",
    "patient_profile": "https://plus.unsplash.com/premium_photo-1664298528358-790433ba0815?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=1170",
    "archetype": "Anticoagulation failure leading to preventable stroke",
    "age": 74,
    "sex": "F",
    "race_ethnicity": "Asian",
    "allergies": [
      {
        "allergen": "Amiodarone",
        "reaction": "Thyroid dysfunction, pulmonary toxicity",
        "severity": "severe",
        "onset": "2021"
      },
      {
        "allergen": "Sulfa drugs",
        "reaction": "Rash, itching",
        "severity": "moderate",
        "onset": "1990s"
      }
    ],

    "chief_complaint": "Palpitations, irregular heartbeat, fatigue x3 weeks",
    "first_visit_date": "2024-02-20",
    "last_visit_date": "2024-09-25",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_020_A",
        "type": "symptom_lab_correlation",
        "description": "New-onset atrial fibrillation with high stroke risk requiring anticoagulation",
        "entities_involved": [
          "Atrial fibrillation",
          "Irregular pulse",
          "ECG findings",
          "CHA2DS2-VASc score",
          "Anticoagulation"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_020_B",
        "type": "persistent_symptom",
        "description": "Acute ischemic stroke while on inadequate anticoagulation demonstrating importance of INR monitoring",
        "entities_involved": [
          "Stroke symptoms",
          "Brain imaging",
          "Subtherapeutic INR",
          "Warfarin failure"
        ],
        "visits_involved": ["V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_020_C",
        "type": "lab_trend",
        "description": "Transition from warfarin to DOAC with improved anticoagulation stability and quality of life",
        "entities_involved": [
          "INR variability",
          "Warfarin discontinuation",
          "Apixaban initiation",
          "Stable anticoagulation"
        ],
        "visits_involved": ["V4", "V5", "V6"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_020_D",
        "type": "persistent_symptom",
        "description": "Successful rate control and anticoagulation management preventing recurrent stroke",
        "entities_involved": [
          "Heart rate control",
          "Symptom improvement",
          "No bleeding complications",
          "Stroke prevention"
        ],
        "visits_involved": ["V6", "V7", "V8", "V9", "V10"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.88
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-02-20",
        "visit_type": "office_visit",
        "chief_complaint": "Palpitations, irregular heartbeat, fatigue x3 weeks",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 142,
          "bp_diastolic": 86,
          "hr_bpm": 115,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 128.0,
          "height_inches": 62.0,
          "bmi": 23.4
        },
        "labs": {
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 245,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 58,
          "tsh_miu_l": 2.8,
          "bnp_pg_ml": 180
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 20mg daily"
          ],
          "started": ["Metoprolol tartrate 25mg BID"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [
            "Atrial fibrillation, new onset (I48.91)",
            "Palpitations (R00.2)"
          ],
          "differential": [
            "Atrial fibrillation",
            "Atrial flutter",
            "Supraventricular tachycardia",
            "Hyperthyroidism",
            "Anxiety"
          ]
        },
        "procedures_ordered": [
          "12-lead ECG",
          "Thyroid function tests",
          "Echocardiogram",
          "24-hour Holter monitor",
          "Chest X-ray",
          "Cardiology referral"
        ],
        "referrals": ["Cardiology for AFib management"],
        "provider_note_snippet": "74F retired teacher presents with 3-week history of palpitations, sensation of 'irregular heartbeat,' and increased fatigue. SYMPTOM DETAILS: Palpitations intermittent but occurring daily, lasting minutes to hours. Describes heart as 'fluttering' or 'racing.' Associated with mild lightheadedness but no syncope, no chest pain, no dyspnea at rest (mild dyspnea with exertion - new). Fatigue more pronounced - 'don't have energy I used to.' PAST MEDICAL HISTORY: Hypertension x 15 years, controlled on amlodipine. Hypothyroidism x 10 years on levothyroxine. Hyperlipidemia on statin. Stage 3a CKD (baseline creatinine 1.0, GFR 58). History of amiodarone intolerance in 2021 (developed thyroid toxicity and interstitial lung disease, discontinued after 6 months). No prior cardiac history - no MI, no heart failure, no valvular disease. SOCIAL HISTORY: Retired elementary school teacher. Widowed 5 years ago. Lives alone in apartment, 2 adult children nearby (daughter age 48, son age 45). Independent with ADLs. Never smoker, no alcohol. PHYSICAL EXAM: Alert, well-appearing elderly Asian female. BP 142/86, HR 115 (tachycardic), irregularly irregular rhythm (classic for AFib). No JVP elevation. Lungs clear. Cardiac: Irregularly irregular rhythm, no murmurs, no S3/S4. Abdomen soft. Extremities: No edema. Neurologic: Grossly intact. ECG (performed in office): ATRIAL FIBRILLATION with rapid ventricular response, rate 110-120 bpm, No P waves visible, irregularly irregular R-R intervals, No acute ST-T changes, QRS narrow. ASSESSMENT: NEW-ONSET ATRIAL FIBRILLATION. This is most common sustained arrhythmia, especially in elderly. Affects 10-15% of people >80 years old. Patient is 74 with multiple risk factors: age, hypertension, possible structural heart disease (need echo). STROKE RISK ASSESSMENT - CHA2DS2-VASc SCORE: C - Congestive heart failure: 0 (no HF history, but need echo) H - Hypertension: 1 (yes, on medication) A - Age 75: 0 (age 74, just under cutoff) D - Diabetes: 0 (no diabetes) S - Prior Stroke/TIA: 0 (no prior stroke) V - Vascular disease: 0 (no CAD/PAD/aortic disease) A - Age 65-74: 1 (yes) Sc - Sex category (female): 1 (yes) TOTAL CHA2DS2-VASc: 3 points = HIGH STROKE RISK (4-6% annual stroke risk without anticoagulation). ANTICOAGULATION STRONGLY RECOMMENDED (reduces stroke risk by ~60-70%). MANAGEMENT PLAN: (1) RATE CONTROL: Started metoprolol 25mg BID to slow heart rate (target <110 bpm at rest). (2) RHYTHM vs RATE CONTROL: Will defer to cardiology, but given age and likely will pursue rate control strategy (maintain AFib, control rate) rather than rhythm control (cardioversion, antiarrhythmic drugs). Rhythm control doesn't improve outcomes in elderly with persistent AFib, and patient cannot take amiodarone (prior toxicity). (3) ANTICOAGULATION: Patient requires anticoagulation given CHA2DS2-VASc 3. Options: Warfarin (vitamin K antagonist, requires INR monitoring), DOACs (direct oral anticoagulants - apixaban, rivaroxaban, edoxaban, dabigatran - no monitoring required, but more expensive). Will discuss with cardiology and patient. Patient has Medicare Part D but concerned about medication costs. (4) ECHOCARDIOGRAM: Need to assess LV function, valvular disease, atrial size, rule out structural abnormalities. (5) THYROID CHECK: TSH normal (2.8), so AFib not from hyperthyroidism. Patient explained: Atrial fibrillation means top chambers of heart quivering instead of beating normally. Most concerning risk is STROKE - blood can pool in atria and form clots, clots can travel to brain. MUST have anticoagulation (blood thinner) to prevent stroke. Will need this lifelong. Patient anxious about 'blood thinners' - worried about bleeding. Explained benefits outweigh risks given high stroke risk. Cardiology referral placed, appointment in 2 weeks.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "occupation": "Retired elementary school teacher",
          "living_situation": "Lives alone, widowed 5 years, 2 adult children nearby",
          "insurance": "Medicare Part A+B, Part D prescription coverage with co-pays",
          "smoking": "Never smoker",
          "alcohol": "None",
          "functional_status": "Independent with ADLs, lives alone",
          "support": "Daughter visits weekly, son helps with errands"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-03-05",
        "visit_type": "cardiology_consultation",
        "chief_complaint": "New-onset atrial fibrillation, anticoagulation planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 135,
          "bp_diastolic": 82,
          "hr_bpm": 92,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 127.0
        },
        "labs": {
          "inr": 1.0,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 58,
          "has_bled_score": 1
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 20mg daily",
            "Metoprolol tartrate 25mg BID"
          ],
          "started": ["Warfarin 5mg daily (with INR monitoring plan)"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": ["Atrial fibrillation, persistent (I48.1)"],
          "differential": []
        },
        "procedures_ordered": [
          "INR monitoring (check in 5 days, then weekly until therapeutic, then monthly)",
          "Repeat echo in 1 year",
          "Cardiology follow-up in 3 months"
        ],
        "referrals": [],
        "provider_note_snippet": "CARDIOLOGY CONSULTATION for new-onset AFib, anticoagulation decision. ECHOCARDIOGRAM RESULTS (2/28): LV size normal, LV function normal (EF 60-65%), No regional wall motion abnormalities, Mild left atrial enlargement (LA diameter 4.2cm), Mild mitral regurgitation (trace-mild), No other valvular disease, No LV thrombus, No pericardial effusion. INTERPRETATION: Structurally normal heart except mild LA enlargement (consistent with AFib). Normal LV function. HOLTER MONITOR (48 hours, 2/25-2/27): Atrial fibrillation throughout entire recording (persistent AFib, not paroxysmal). Average heart rate 85 bpm (improved on metoprolol from 115 bpm). Maximum heart rate 125 bpm. Minimum heart rate 62 bpm. No significant pauses. ASSESSMENT: PERSISTENT ATRIAL FIBRILLATION. Likely has been in AFib longer than 3 weeks (patient may not have noticed initially). With persistent AFib and age 74, RATE CONTROL strategy is appropriate (not pursuing rhythm control/cardioversion). RATE CONTROL: Metoprolol 25mg BID providing adequate rate control (HR 92 at rest, average 85 on Holter). Will continue current dose. Goal <110 bpm at rest (lenient rate control, appropriate for elderly). ANTICOAGULATION DECISION: CHA2DS2-VASc 3 = MUST anticoagulate. BLEEDING RISK ASSESSMENT - HAS-BLED SCORE: H - Hypertension: 1 (yes) A - Abnormal renal/liver function: 0 (GFR 58, mild CKD but not dialysis; liver function normal) S - Stroke: 0 (no prior stroke) B - Bleeding: 0 (no prior bleeding) L - Labile INR: 0 (not on warfarin yet) E - Elderly (>65): 1 (age 74) D - Drugs/alcohol: 0 (no NSAIDs, no alcohol) HAS-BLED: 2 = MODERATE bleeding risk (but stroke risk still outweighs bleeding risk, anticoagulation indicated). WARFARIN vs DOAC DISCUSSION: DOACs (apixaban, rivaroxaban, edoxaban): Pros: No INR monitoring, more stable anticoagulation, lower intracranial bleeding risk, fewer drug/food interactions. Cons: More expensive ($400-600/month), no reversal agent for some (though now available for some DOACs), require good renal function (patient has GFR 58 - acceptable for most DOACs with dose adjustment). Warfarin: Pros: Inexpensive ($4-10/month generic), long track record, reversible with vitamin K/FFP, Medicare covers. Cons: Requires frequent INR monitoring (blood draws), many drug and food interactions (vitamin K in greens), narrow therapeutic window, variable dosing. PATIENT PREFERENCE: Patient chose WARFARIN primarily for cost reasons. On fixed income (Social Security + small pension), concerned about DOAC co-pays even with Medicare Part D ($50-100/month co-pay). Warfarin essentially free with Medicare. WARFARIN INITIATION: Starting dose 5mg daily (standard for elderly Asian female - typically require lower doses). INR goal 2-3 (standard for AFib). INR monitoring: Check in 5 days, then adjust dose, then weekly until stable in therapeutic range x2 weeks, then every 2 weeks x1 month, then monthly if stable. WARFARIN EDUCATION: Must take same time daily, avoid large fluctuations in vitamin K intake (can eat greens but be consistent), many drug interactions (told to check before starting any new medications), watch for bleeding signs (easy bruising, blood in urine/stool, unusual bleeding). Patient understanding but appears anxious about monitoring requirements. Daughter will help with appointments. Fall risk assessment: Patient stable on feet, no fall history, but at age 74 with anticoagulation, fall with head trauma could be catastrophic (intracranial hemorrhage). Educated on fall prevention. PROGNOSIS: With rate control and anticoagulation, excellent prognosis. Stroke risk reduced from 4-6%/year to <1%/year with warfarin. Quality of life should improve as heart rate controlled and symptoms diminish.",
        "patient_reported_adherence": "good - daughter helping with medication management and appointment scheduling",
        "social_history_updates": {
          "finances": "On fixed income (Social Security + pension), medication costs a concern"
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-04-22",
        "visit_type": "emergency_department",
        "chief_complaint": "Sudden onset right arm weakness, difficulty speaking x2 hours",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 168,
          "bp_diastolic": 92,
          "hr_bpm": 98,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 127.0
        },
        "labs": {
          "inr": 1.4,
          "hemoglobin_g_dl": 12.6,
          "platelets_k_ul": 238,
          "glucose_mg_dl": 142,
          "creatinine_mg_dl": 1.0,
          "troponin_i_ng_ml": 0.02
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 20mg daily",
            "Metoprolol tartrate 25mg BID"
          ],
          "started": ["Aspirin 325mg x1 dose in ED"],
          "stopped": [],
          "dose_changed": ["Warfarin held (acute stroke)"]
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [
            "Acute ischemic stroke, left MCA territory (I63.512)",
            "Right hemiparesis (G81.91)",
            "Expressive aphasia (R47.01)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "STAT CT head non-contrast",
          "CT angiography head/neck",
          "MRI brain with DWI",
          "Carotid ultrasound",
          "Echocardiogram with bubble study",
          "Neurology consultation",
          "Stroke team activation"
        ],
        "referrals": [
          "Neurology - stroke service",
          "Speech therapy",
          "Physical therapy",
          "Occupational therapy"
        ],
        "provider_note_snippet": "74F with known AFib on warfarin presents via EMS with ACUTE STROKE. ONSET: 12:15pm today (arrived ED 2:05pm = 1 hour 50 minutes from symptom onset). Patient was at home, daughter visiting for lunch. At 12:15pm, patient suddenly unable to lift right arm, face drooping on right side, speech garbled. Daughter called 911 immediately. LAST KNOWN WELL: 12:15pm today. SYMPTOMS: Right arm weakness (unable to lift against gravity), Right facial droop, Expressive aphasia (difficulty speaking, word-finding difficulty), Alert and following commands with left arm. NO seizure activity, NO loss of consciousness, NO headache. NIHSS (NIH Stroke Scale): 8 points (moderate stroke) - Right arm: 3 (drift, cannot lift), Right face: 2 (partial paralysis), Language: 2 (aphasia, some meaningful speech), Sensory: 1 (mild sensory loss right side). PAST MEDICAL HISTORY: ATRIAL FIBRILLATION - diagnosed 2 months ago, on warfarin for stroke prevention. INR goal 2-3. Last INR check 2 weeks ago was 2.1 (therapeutic). Patient reports taking warfarin daily as prescribed. No recent medication changes, no dietary changes, no new medications. PHYSICAL EXAM: Alert, oriented to self and place (not to time), following commands. BP 168/92 (hypertensive, common in acute stroke). HR 98, irregularly irregular (AFib). Neurologic: Right facial droop, right arm 1/5 strength (no movement against gravity), right leg 3/5 strength, expressive aphasia (understands but cannot speak fluently). CT HEAD NON-CONTRAST (2:15pm): NO acute hemorrhage, NO large territorial infarct (early ischemic changes not always visible on CT), NO mass effect, NO midline shift. Negative CT does NOT rule out acute ischemic stroke. CT ANGIOGRAPHY: Left middle cerebral artery (MCA) M2 segment occlusion. Proximal vessels patent. INR: 1.4 (SUBTHERAPEUTIC - goal 2-3). Patient supposedly taking warfarin daily. This is WARFARIN FAILURE or NON-ADHERENCE or interaction. ASSESSMENT: ACUTE ISCHEMIC STROKE - LEFT MCA TERRITORY from CARDIOEMBOLIC source (AFib with inadequate anticoagulation). This is exactly what we try to prevent with anticoagulation. INR 1.4 is subtherapeutic - patient NOT adequately anticoagulated despite reported adherence. THROMBOLYSIS CONSIDERATION: Patient within 4.5-hour window for tPA (tissue plasminogen activator - clot-busting drug). However, INR 1.4 and on warfarin = RELATIVE CONTRAINDICATION. Neurology consulted - decision: Given small vessel occlusion (M2, not M1), moderate deficit (NIHSS 8), and risk of hemorrhagic transformation with warfarin on board, will NOT give tPA. Will pursue supportive care. THROMBECTOMY CONSIDERATION: M2 occlusion is small for mechanical thrombectomy. Typically done for large vessel occlusion (M1, ICA, basilar). Interventional neuro consulted - patient NOT candidate for thrombectomy given small vessel and moderate deficit. MANAGEMENT: Supportive care, blood pressure management (permissive hypertension in acute stroke to maintain penumbra perfusion - goal SBP 140-180), monitor for hemorrhagic transformation, ASA 325mg given (antiplatelet), warfarin held acutely (will resume in 24-48 hours once hemorrhage ruled out on repeat imaging), neurology admission. MRI BRAIN (4/22 evening): Acute infarct left MCA territory (insular cortex, inferior frontal gyrus), restricted diffusion on DWI, approximately 2cm territory, No hemorrhage. INTERPRETATION: Small cortical infarct from left MCA M2 branch occlusion. Cardioembolic stroke from AFib. PATIENT/FAMILY DISCUSSION: Daughter devastated. 'But she was taking her blood thinner! How did this happen?' Reviewed INR 1.4 (subtherapeutic). Possible explanations: (1) NON-ADHERENCE - patient missing doses (possible - elderly, lives alone, may forget), (2) DRUG INTERACTION - new medication or supplement interfering with warfarin (patient denies), (3) DIETARY CHANGES - increased vitamin K intake (patient denies), (4) WARFARIN VARIABILITY - INR can fluctuate even with perfect adherence. Daughter feels guilty - 'I should have been checking on her medications more carefully.' Explained stroke risk remains even with anticoagulation (warfarin reduces risk 60-70%, but not 100%). However, subtherapeutic INR increases risk substantially.",
        "patient_reported_adherence": "patient states taking warfarin daily, but INR subtherapeutic - suggests non-adherence or interaction",
        "social_history_updates": {
          "functional_status": "Baseline independent, now with right hemiparesis and aphasia"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-04-28",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Stroke service Day 6, preparing for acute rehab discharge",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 142,
          "bp_diastolic": 84,
          "hr_bpm": 88,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 125.0
        },
        "labs": {
          "inr": 2.5,
          "hemoglobin_g_dl": 12.2,
          "creatinine_mg_dl": 1.0
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin increased to 80mg daily (high-intensity statin post-stroke)",
            "Metoprolol tartrate 25mg BID"
          ],
          "started": ["Apixaban 5mg BID (DOAC, replacing warfarin)"],
          "stopped": [
            "Warfarin discontinued (switching to DOAC)",
            "Aspirin discontinued after 24 hours (now on apixaban)"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [
            "Acute ischemic stroke, left MCA territory, with residual deficits (I63.512)",
            "Right hemiparesis, improving (G81.91)",
            "Expressive aphasia, improving (R47.01)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Transfer to acute inpatient rehabilitation",
          "Speech therapy 5x/week",
          "Physical therapy 5x/week",
          "Occupational therapy 5x/week",
          "Follow-up neurology in 1 month",
          "Follow-up cardiology in 2 weeks"
        ],
        "referrals": [
          "Acute inpatient rehabilitation facility",
          "Outpatient neurology",
          "Home health after rehab discharge"
        ],
        "provider_note_snippet": "STROKE DAY 6 - PREPARING FOR REHAB DISCHARGE. CLINICAL COURSE: Patient admitted 4/22 with left MCA stroke. Initial NIHSS 8 (moderate). Received supportive care, no tPA or thrombectomy. Warfarin restarted 4/24 (48 hours post-stroke, after repeat CT showed no hemorrhage). MRI (4/23): Confirmed small cortical infarct, no hemorrhagic transformation. CURRENT NEUROLOGIC STATUS: Significant improvement over 6 days. Right arm: 3/5 strength (was 1/5 on admission) - can lift against gravity, some resistance. Right leg: 4/5 strength (was 3/5) - nearly normal. Facial droop: Minimal residual weakness. Aphasia: Improved - speaking in short sentences, some word-finding difficulty but communicating needs. NIHSS now 4 (mild stroke) - improved from 8. FUNCTIONAL STATUS: Requires assistance with ADLs (dressing, bathing due to right arm weakness). Can ambulate with walker and supervision. Swallowing evaluation: Passed - tolerating regular diet. THERAPY ASSESSMENTS: Physical therapy: Recommends acute inpatient rehab - patient has rehab potential, motivated, medically stable. Speech therapy: Recommends continued intensive speech therapy for aphasia. Occupational therapy: Needs ADL retraining with dominant right hand weakness. ANTICOAGULATION CHANGE - WARFARIN TO DOAC: DISCUSSION: Patient's stroke occurred while on warfarin with SUBTHERAPEUTIC INR (1.4). Reviewed medication adherence with patient and daughter. Patient admits sometimes forgets whether she took warfarin (lives alone, no pill organizer, relies on memory). Daughter states she only checks medications weekly, did not realize mother was missing doses. INR HISTORY REVIEW: 3/10: INR 2.2 (therapeutic), 3/24: INR 2.1 (therapeutic), 4/8: INR 1.8 (low-therapeutic), 4/22: INR 1.4 (subtherapeutic, day of stroke). PATTERN: INR trending down despite reported adherence - suggests intermittent non-adherence. DECISION: SWITCH FROM WARFARIN TO DOAC (apixaban). Rationale: (1) No INR monitoring required - removes burden of frequent blood draws, (2) More predictable anticoagulation - less variable response, (3) Twice-daily dosing may help with adherence (patient remembers morning/evening pills better than once-daily), (4) Lower intracranial hemorrhage risk if future falls. COST DISCUSSION: Major barrier previously was cost. However, post-stroke, daughter willing to help cover co-pays. Medicare Part D covers DOACs with typical co-pay $50-100/month. Daughter will pay co-pay difference. Additionally, manufacturer assistance program may reduce cost. APIXABAN DOSING: Standard dose 5mg BID. (Would use 2.5mg BID reduced dose if met 2 of 3 criteria: age 80, weight 60kg, creatinine 1.5. Patient is 74yo, 127 lbs (58kg), creatinine 1.0 = meets 1 criterion only, so STANDARD dose 5mg BID appropriate). GFR 58 = safe for apixaban (can use down to GFR 15). Overlap: Warfarin discontinued, apixaban started immediately (no bridging needed). INR will decline over next few days as warfarin wears off. DISCHARGE PLAN: ACUTE INPATIENT REHABILITATION for 2-3 weeks. Intensive therapy (3 hours/day, 5-6 days/week). Goal: Maximize functional recovery, improve right arm function, improve speech, train for ADL independence. After rehab: Home with home health services (PT, OT, speech therapy continuation). May need some assistance - daughter plans to increase visits to daily initially, considering home health aide. SECONDARY STROKE PREVENTION: (1) ANTICOAGULATION: Apixaban 5mg BID lifelong (AFib stroke prevention). (2) BLOOD PRESSURE: Continue antihypertensives, goal <140/90 post-stroke. (3) HIGH-INTENSITY STATIN: Atorvastatin increased from 20mg to 80mg (reduces recurrent stroke risk even with cardioembolic stroke). (4) RATE CONTROL: Continue metoprolol for AFib. PROGNOSIS: Favorable. Young stroke (age 74, relatively young for stroke patients), small infarct, significant early improvement (NIHSS 84 in 6 days), motivated patient, good family support. Expect continued recovery over 3-6 months. May recover near-complete function, though some residual aphasia and right hand fine motor deficits likely. Key is preventing RECURRENT stroke - with adequate anticoagulation on DOAC, risk substantially reduced.",
        "patient_reported_adherence": "poor with warfarin (admitted forgetting doses), hoping for better adherence with apixaban BID dosing",
        "social_history_updates": {
          "living_situation": "Will need increased support at home - daughter planning daily visits initially",
          "functional_status": "Requiring assistance with ADLs, using walker",
          "medications": "Daughter now managing medication administration and monitoring"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-05-20",
        "visit_type": "cardiology_office_visit",
        "chief_complaint": "Post-stroke follow-up, assess anticoagulation on apixaban",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 138,
          "bp_diastolic": 80,
          "hr_bpm": 84,
          "r_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 124.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.4,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 58,
          "alt_u_l": 28,
          "ast_u_l": 32
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "History of ischemic stroke (Z86.73)",
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Renal function monitoring every 6 months (for DOAC dosing)",
          "CBC annually (monitor for bleeding)",
          "Liver function annually",
          "Cardiology follow-up in 6 months"
        ],
        "referrals": [],
        "provider_note_snippet": "POST-STROKE 4 WEEKS - CARDIOLOGY FOLLOW-UP. Patient completed 3 weeks acute inpatient rehabilitation (4/28-5/18), discharged home 2 days ago with home health services. REHABILITATION OUTCOMES: Excellent progress. Right arm strength: 4+/5 (nearly normal, can perform most tasks). Right leg strength: 5/5 (normal). Gait: Independent with cane (no longer needs walker). Speech: Mild residual word-finding difficulty but functional communication. ADLs: Independent with dressing, bathing (uses adaptive equipment). Cooking: Independent with supervision initially. FIM score improved from 68 (admission rehab) to 105 (discharge rehab) = significant functional gain. CURRENT SYMPTOMS: Patient reports feeling 'much better.' No palpitations (AFib still present but rate controlled, asymptomatic). No chest pain, no dyspnea. No neurologic symptoms. No falls. PHYSICAL EXAM: Alert, oriented x3. Speech fluent with occasional word-finding pauses. BP 138/80 (well-controlled), HR 84 irregularly irregular (AFib). Right arm: Minimal residual weakness. Gait: Steady with cane. APIXABAN TOLERANCE: Patient tolerating apixaban 5mg BID well. NO bleeding complications - no bruising, no blood in urine/stool, no gum bleeding, no nosebleeds. Daughter managing medications - using pill organizer with AM/PM compartments. Patient takes medications at 8am and 8pm daily. Daughter checks pill box daily via phone video call. MUCH better adherence than with warfarin. ADHERENCE DISCUSSION: Daughter reports patient taking ALL doses of apixaban without missing. Using smartphone alarm reminders. Daughter states 'this is so much easier than warfarin - no blood draws, no clinic visits, no worrying about what she eats.' Patient agrees: 'I feel more confident now. I don't have to remember if I took my pill - I just check the box. And no more needles every week.' RENAL FUNCTION: Stable GFR 58 (unchanged from baseline). Important to monitor with DOAC - if GFR drops <30, would need dose adjustment or switch to warfarin. Will check every 6 months. BLEEDING RISK MONITORING: No signs of bleeding currently. Educated on warning signs: dark/tarry stools, blood in urine, excessive bruising, severe headache, prolonged bleeding from cuts. Fall prevention emphasized - patient using cane, home safety evaluation completed by OT (removed throw rugs, installed grab bars). RATE CONTROL: HR 84 at rest (goal <110), well-controlled on metoprolol 25mg BID. Patient asymptomatic from AFib. Will continue current dose. STROKE PREVENTION: This is why we're here. Patient had stroke 4 weeks ago due to inadequate anticoagulation on warfarin. Now on apixaban with better adherence. Apixaban reduces stroke risk ~60-70% compared to no anticoagulation. With proper adherence, patient's stroke risk now <1%/year (compared to 4-6%/year without anticoagulation). PATIENT PERSPECTIVE: Patient tearful during visit. 'The stroke was terrifying. I couldn't talk, couldn't move my arm. I thought my life was over. I'm so grateful I recovered. I will never miss my blood thinner again. Never.' Daughter also emotional: 'I feel responsible - I should have been monitoring her medications better. Now I check every single day. I won't let this happen again.' PROGNOSIS: Excellent. Patient recovered well from stroke, on appropriate anticoagulation with good adherence, rate controlled, all risk factors managed. Risk of recurrent stroke now very low with adherence to apixaban. Patient may live many more years with good quality of life if continues current management.",
        "patient_reported_adherence": "excellent - daughter managing medications daily with pill organizer and phone check-ins",
        "social_history_updates": {
          "living_situation": "Home with daily daughter visits initially, now transitioning to 3-4x/week",
          "functional_status": "Independent with ADLs, using cane for ambulation",
          "medication_management": "Daughter supervising daily via phone video calls"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-06-28",
        "visit_type": "neurology_office_visit",
        "chief_complaint": "Post-stroke 2-month follow-up, assess neurologic recovery",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 132,
          "bp_diastolic": 78,
          "hr_bpm": 80,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 126.0
        },
        "labs": {},
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "History of ischemic stroke with residual mild deficits (Z86.73)",
            "Atrial fibrillation, persistent (I48.1)",
            "Hypertension (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Continue outpatient speech therapy 2x/week x 6 more weeks",
          "MRI brain in 6 months (routine post-stroke surveillance)",
          "Neurology follow-up in 6 months"
        ],
        "referrals": ["Continue outpatient speech therapy"],
        "provider_note_snippet": "POST-STROKE 2 MONTHS - NEUROLOGY FOLLOW-UP. NEUROLOGIC EXAMINATION: Mental status: Alert, oriented x3, follows complex commands. Speech: Fluent conversational speech, minimal word-finding difficulty (significant improvement from initial moderate aphasia). Able to name objects, repeat phrases, follow 3-step commands. Cranial nerves: Right facial weakness resolved (was present initially). Motor: Right upper extremity 5/5 strength all muscle groups (full recovery from initial 1/5), Right lower extremity 5/5 strength (full recovery), Left side 5/5 strength. Sensation: Intact to light touch, pinprick bilateral. Coordination: Finger-to-nose, heel-to-shin intact bilaterally. Gait: Normal gait without assistive device (patient brought cane but not using during exam). FUNCTIONAL STATUS: Patient reports 'back to normal' for most activities. Independent with all ADLs, cooking, light housework. Driving: Not yet resumed - will need driving evaluation (occupational therapy) given history of stroke. Patient cautious about driving, 'don't want to hurt anyone.' Social activities: Resumed church attendance, seeing friends, daughter visits 2-3x/week now (decreased from daily). Reading: Back to reading books (had difficulty initially with focus/fatigue). RESIDUAL DEFICITS: Minimal. Occasional word-finding difficulty (anomia) - notices when trying to recall names or specific words, usually can circumlocute. Mild fine motor deficit right hand - difficulty with small buttons, threading needles (not functionally limiting). Fatigue: More fatigued than pre-stroke, needs afternoon rest (common post-stroke, improves over time). STROKE RECOVERY TIMELINE: Patient is 2 months post-stroke. Most recovery occurs in first 3-6 months. Patient has recovered remarkably well - NIHSS went from 8 (moderate) acutely to ~1 (minimal residual deficit) now. This is EXCELLENT outcome. Small cortical stroke + young age (74) + intensive rehab = good recovery potential, which patient achieved. SECONDARY PREVENTION: Anticoagulation: Apixaban 5mg BID - excellent adherence per patient and daughter. No bleeding complications. Blood pressure: Well-controlled <140/90. Statin: High-intensity, appropriate. Rate control: Adequate. Lifestyle: Patient walking daily 20-30 minutes, eating heart-healthy diet. RECURRENT STROKE RISK: With proper anticoagulation (apixaban), blood pressure control, statin, patient's annual stroke risk now <1%. Without anticoagulation, risk would be 4-6%/year. Critical that patient continues apixaban LIFELONG. Explained that stopping anticoagulation would put her at high risk for another stroke, which might be more severe/disabling. Patient understanding: 'I will take this medication forever. I never want to go through that again.' PROGNOSIS: Excellent. Patient has achieved near-complete recovery with minimal residual deficits. Should continue to improve gradually over next 3-6 months. Can resume most normal activities. Main limitation is cannot drive yet (will reassess after driving evaluation). Otherwise functionally independent. Will follow annually unless new symptoms develop.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Independent with ADLs, walking without assistive device",
          "activities": "Resumed church, social activities, reading",
          "driving": "Not yet resumed, will need formal driving evaluation"
        }
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-07-30",
        "visit_type": "primary_care_visit",
        "chief_complaint": "Routine follow-up, medication refills, health maintenance",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 128,
          "bp_diastolic": 76,
          "hr_bpm": 78,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 127.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 6.5,
          "platelets_k_ul": 245,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 58,
          "tsh_miu_l": 2.2,
          "hba1c": 5.6,
          "lipid_panel": {
            "total_cholesterol_mg_dl": 142,
            "ldl_mg_dl": 58,
            "hdl_mg_dl": 52,
            "triglycerides_mg_dl": 160
          }
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "History of ischemic stroke (Z86.73)",
            "Hypertension, controlled (I10)",
            "Hypothyroidism, controlled (E03.9)",
            "Hyperlipidemia, controlled (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Mammogram (due for screening)",
          "Bone density scan (osteoporosis screening)",
          "Colonoscopy (due - last one 2018)",
          "Annual influenza vaccine (will give in September)",
          "Continue current medications",
          "Follow-up in 6 months"
        ],
        "referrals": ["Mammography", "GI for colonoscopy", "DEXA scan"],
        "provider_note_snippet": "74F for routine health maintenance and chronic disease management. Patient doing very well 3.5 months post-stroke. INTERVAL HISTORY: No new symptoms, no chest pain, no palpitations, no neurologic symptoms, no falls, no bleeding episodes. Feeling 'back to normal' per patient. Completed outpatient speech therapy 2 weeks ago - discharged at maximum benefit. PHYSICAL EXAM: Well-appearing, alert, conversing fluently. BP 128/76, HR 78 irregularly irregular (AFib). Cardiovascular: Irregularly irregular rhythm, no murmurs. Neurologic: Speech fluent, strength 5/5 all extremities, gait normal. CHRONIC DISEASE MANAGEMENT: (1) ATRIAL FIBRILLATION: Rate controlled (HR 78), anticoagulated on apixaban. No symptoms. Adherence excellent per daughter's supervision. No bleeding complications. (2) HYPERTENSION: Well-controlled on amlodipine 5mg + metoprolol. BP 128/76 (goal <140/90 for age, achieved). (3) HYPOTHYROIDISM: TSH 2.2 (normal range), well-controlled on levothyroxine 75mcg. (4) HYPERLIPIDEMIA: On high-intensity statin post-stroke. LDL 58 (goal <70, achieved). HDL 52 (good). (5) CHRONIC KIDNEY DISEASE: Stage 3a, stable GFR 58. Monitoring for DOAC dosing. MEDICATION ADHERENCE: Daughter reports patient taking ALL medications as prescribed without missing doses. Using pill organizer, phone reminders, daily check-ins. Patient states 'medications are my lifeline now.' FALL RISK: Patient ambulating normally without assistive device. Home safety measures in place (grab bars, removed rugs). No falls since stroke. On anticoagulation, falls would be high-risk for intracranial bleeding - emphasized continued fall prevention. HEALTH MAINTENANCE: Age 74 female - due for several screening tests: (1) MAMMOGRAM: Last one 2 years ago (2022) - due for screening. Ordered. (2) COLONOSCOPY: Last one 2018 (6 years ago) - due for repeat (every 10 years if normal, but patient now 74, may consider if life expectancy >10 years). Patient interested in screening. Referred to GI. (3) BONE DENSITY: Never had DEXA scan. Age 74, female, Asian (lower peak bone mass), on no estrogen - should screen for osteoporosis. Ordered. (4) VACCINATIONS: Influenza vaccine due in September (will give at next visit). Pneumococcal vaccine up to date. COVID vaccine - patient had bivalent booster 1 year ago, will offer updated vaccine when available. (5) CANCER SCREENING: Up to date with Pap smears (stopped at age 65 after normal screens). FUNCTIONAL STATUS: Independent with all ADLs and IADLs. Cooking, cleaning, managing finances (with daughter's oversight). Walking 30 minutes daily. Attending church weekly. Resumed volunteer work at church (helping with Sunday school materials). DRIVING: Completed driving evaluation last week - PASSED. Occupational therapist cleared patient for driving. Patient resumed driving short distances (church, grocery store). Not driving long distances or highways yet (daughter still takes her for medical appointments). QUALITY OF LIFE: Patient reports excellent quality of life. 'I'm grateful every day that I survived the stroke and recovered so well. I know it could have been much worse. I don't take anything for granted. I'm living my life fully, seeing my grandchildren (daughter just had first baby 2 weeks ago!), enjoying my retirement. The medications are a small price to pay for being able to live independently.' PROGNOSIS: Excellent. Patient has multiple chronic conditions (AFib, HTN, HLD, CKD, hypothyroidism, history of stroke) but ALL are well-controlled on medications. Excellent adherence. Good functional status. Strong family support. Should live many more years with good quality of life as long as continues current management.",
        "patient_reported_adherence": "excellent - exemplary adherence with daughter's supervision",
        "social_history_updates": {
          "activities": "Resumed driving (short distances), volunteer work at church",
          "family": "Daughter had first baby - patient now grandmother, very engaged"
        }
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-08-26",
        "visit_type": "cardiology_office_visit",
        "chief_complaint": "6-month post-stroke cardiology follow-up",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 125,
          "bp_diastolic": 74,
          "hr_bpm": 76,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 128.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.0,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 62,
          "bnp_pg_ml": 165
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "History of ischemic stroke, recovered (Z86.73)",
            "Hypertension, controlled (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "ECG",
          "Repeat echocardiogram in 1 year",
          "Continue current medications",
          "Cardiology follow-up annually"
        ],
        "referrals": [],
        "provider_note_snippet": "6-MONTH POST-STROKE CARDIOLOGY FOLLOW-UP. Patient doing exceptionally well. Fully recovered from stroke, independent, excellent quality of life. INTERVAL HISTORY: No cardiovascular symptoms - no chest pain, no palpitations (AFib asymptomatic), no dyspnea, no edema, no syncope/presyncope. No neurologic symptoms - no weakness, numbness, visual changes, speech changes. No bleeding episodes on apixaban. PHYSICAL EXAM: Well-appearing elderly Asian female. BP 125/74 (excellent), HR 76 irregularly irregular (AFib). JVP normal. Lungs clear. Cardiac: Irregularly irregular rhythm, normal S1/S2, no murmurs. Extremities: No edema. ECG: Atrial fibrillation, ventricular rate 76 bpm, No acute ST-T changes, QRS narrow, QTc 420ms (normal). ATRIAL FIBRILLATION MANAGEMENT: (1) RATE CONTROL: Excellent - resting HR 76 (goal <110), asymptomatic. Metoprolol 25mg BID adequate. Patient tolerating well, no side effects. (2) ANTICOAGULATION: Apixaban 5mg BID - patient taking religiously. Daughter confirms zero missed doses over past 6 months. NO bleeding complications: No bruising, no blood in urine/stool, no gum bleeding, no epistaxis, No falls. This is IDEAL outcome on anticoagulation. GFR improved slightly to 62 (was 58) - still safe for apixaban standard dosing. (3) RHYTHM CONTROL: Not pursuing. Patient is 74, asymptomatic in AFib, rate controlled. Rhythm control (cardioversion, antiarrhythmic drugs) not indicated. Patient cannot take amiodarone (prior toxicity). Will continue rate control + anticoagulation strategy. STROKE PREVENTION: Patient is 6 months post-stroke. With apixaban and excellent adherence, stroke risk reduced from ~5%/year to <1%/year. NO recurrent strokes or TIAs in past 6 months (excellent). BNP 165 (normal, indicates no heart failure from chronic AFib). Echocardiogram from 2/28 showed normal LV function, mild LA enlargement. Will repeat in 1 year to ensure no progression. MEDICATION REVIEW: All 5 daily medications appropriate: Amlodipine (BP control), Metoprolol (rate control), Atorvastatin (stroke prevention), Levothyroxine (hypothyroidism), Apixaban (stroke prevention). All tolerated well. Patient not experiencing polypharmacy burden - states 'these pills keep me alive and healthy.' PATIENT SATISFACTION WITH DOAC: Patient very satisfied with switch from warfarin to apixaban. 'Best decision we made. No more blood draws every week, no more worrying about what I eat, no more adjusting doses. I just take my pills twice a day and I'm protected. So much simpler.' Daughter agrees: 'Much easier to manage. We know exactly what she needs to take every day. The peace of mind is worth the extra cost.' COST: Daughter paying $75/month co-pay for apixaban (Medicare Part D). Family considers this worthwhile investment given stroke prevention and improved quality of life vs. warfarin. FALL PREVENTION: Still emphasized. On anticoagulation, fall with head trauma = high risk intracranial bleed. Patient using handrails on stairs, removed throw rugs, wears sturdy shoes, avoids icy conditions. No falls in 6 months. PROGNOSIS: Excellent. Patient has permanent atrial fibrillation but well-rate-controlled and anticoagulated. Stroke risk minimized with apixaban adherence. Should continue to do well indefinitely with current management. PLAN: Continue all medications. Annual cardiology follow-up. Contact sooner if symptoms develop (palpitations with rapid rate, chest pain, dyspnea, neurologic symptoms, bleeding). Patient and family very pleased with care and outcomes.",
        "patient_reported_adherence": "excellent - zero missed doses of apixaban in 6 months per daughter",
        "social_history_updates": {}
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-09-15",
        "visit_type": "primary_care_visit",
        "chief_complaint": "Routine follow-up, complete health maintenance screening",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 130,
          "bp_diastolic": 78,
          "hr_bpm": 80,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 127.0
        },
        "labs": {},
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID"
          ],
          "started": [
            "Calcium 600mg + Vitamin D 800 IU BID (osteoporosis prevention)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Atrial fibrillation, persistent (I48.1)",
            "History of ischemic stroke (Z86.73)",
            "Hypertension, controlled (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)",
            "Osteopenia (M85.80)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Influenza vaccine given today",
          "Updated COVID-19 vaccine given today",
          "Follow-up in 4 months"
        ],
        "referrals": [],
        "provider_note_snippet": "HEALTH MAINTENANCE VISIT. Patient continues to do very well 7 months post-stroke. SCREENING RESULTS: (1) MAMMOGRAM (8/5): NEGATIVE - no masses, no calcifications, BI-RADS 1 (normal). Repeat in 1 year. (2) DEXA SCAN (8/12): Lumbar spine T-score: -1.8 (osteopenia), Femoral neck T-score: -1.5 (osteopenia), 10-year fracture risk (FRAX): 8% major osteoporotic fracture, 1.2% hip fracture. INTERPRETATION: OSTEOPENIA (not quite osteoporosis which is T-score <-2.5). Expected for age 74, Asian female, post-menopausal. Fracture risk moderate. RECOMMENDATIONS: Calcium + Vitamin D supplementation (started today), Weight-bearing exercise (patient already walking daily), Repeat DEXA in 2 years, Consider bisphosphonate if progresses to osteoporosis. (3) COLONOSCOPY: Scheduled for next month (10/15). Patient completed bowel prep instructions, family member will accompany for procedure. VACCINATIONS: Influenza vaccine 2024-2025 strain given today. COVID-19 updated vaccine (2024-2025 formulation) given today. Patient tolerating well, no immediate reactions. OVERALL HEALTH STATUS: All chronic conditions well-controlled. Patient independent, active, excellent quality of life. No new concerns. Patient stating 'I feel better now than I did before my stroke - I'm taking better care of myself, seeing doctors regularly, taking my medications. The stroke was a blessing in disguise - it made me prioritize my health.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "activities": "Very active - walking daily, volunteering at church, babysitting new grandchild weekly"
        }
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-09-25",
        "visit_type": "neurology_office_visit",
        "chief_complaint": "6-month post-stroke neurology follow-up",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 128,
          "bp_diastolic": 76,
          "hr_bpm": 78,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 128.0
        },
        "labs": {},
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Levothyroxine 75mcg daily",
            "Atorvastatin 80mg daily",
            "Metoprolol tartrate 25mg BID",
            "Apixaban 5mg BID",
            "Calcium + Vitamin D BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "History of ischemic stroke, fully recovered (Z86.73)",
            "Atrial fibrillation, persistent (I48.1)",
            "Hypertension, controlled (I10)",
            "Hypothyroidism (E03.9)",
            "Hyperlipidemia (E78.5)",
            "Chronic kidney disease Stage 3a (N18.31)",
            "Osteopenia (M85.80)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "MRI brain (surveillance) - scheduled for next week",
          "Neurology follow-up in 1 year (transition to annual surveillance)"
        ],
        "referrals": [],
        "provider_note_snippet": "6-MONTH POST-STROKE NEUROLOGY SURVEILLANCE. NEUROLOGIC EXAMINATION: Completely normal. Mental status: Alert, oriented x3, fluent speech, no aphasia. Cranial nerves: Intact, symmetric facial movements. Motor: 5/5 strength all extremities bilateral. Sensory: Intact. Coordination: Normal. Gait: Normal, no assistive device needed. FUNCTIONAL STATUS: Patient reports COMPLETE RECOVERY. No residual neurologic deficits. Independent with all activities. Driving without restrictions. Working as church volunteer regularly. Babysitting grandchild weekly. Reading, cooking, managing household independently. Quality of life 'excellent.' COGNITIVE STATUS: Patient passed Montreal Cognitive Assessment (MoCA) with score 28/30 (normal, >26). No cognitive deficits from stroke. Memory, attention, executive function all intact. RECURRENT STROKE PREVENTION: Apixaban adherence perfect per patient and daughter. No strokes or TIAs since index event in April. Blood pressure well-controlled. All risk factors optimized. MRI BRAIN: Will obtain surveillance MRI next week to assess: (1) Infarct evolution (should see chronic infarct, well-demarcated), (2) New silent infarcts (sometimes see small new infarcts on imaging despite no clinical symptoms), (3) Cerebral small vessel disease burden, (4) Baseline for future comparison. PROGNOSIS: EXCELLENT. Patient has achieved complete functional recovery from stroke 6 months ago. With excellent anticoagulation adherence on apixaban, risk of recurrent stroke <1%/year (vs 5%/year without anticoagulation). Patient should do well long-term. TRANSITION TO ANNUAL SURVEILLANCE: Given complete recovery and stable course, will transition from q6-month to annual neurology follow-up. Patient understands to call immediately if any new neurologic symptoms (weakness, numbness, vision changes, speech changes, severe headache). PATIENT REFLECTION: 'Six months ago I had a stroke and thought my life was over. I couldn't move my right arm, I couldn't speak. It was terrifying. But with the amazing care I received - the rehab, the therapy, the doctors, my daughter's support - I made a complete recovery. I'm back to my normal life. The only difference is I'm more careful about my health now. I take my medications every single day without fail. I see my doctors regularly. I know how lucky I am. Many stroke patients don't recover like I did. I'm grateful every day.' This patient represents OPTIMAL POST-STROKE OUTCOME: Early recognition and treatment, comprehensive rehabilitation, excellent family support, transition from warfarin (with poor adherence) to DOAC (with excellent adherence), aggressive secondary prevention, complete functional recovery.",
        "patient_reported_adherence": "excellent - continues exemplary adherence 6+ months post-stroke",
        "social_history_updates": {
          "functional_status": "Complete recovery, independent in all domains",
          "activities": "Church volunteer, babysitting grandchild weekly, driving independently",
          "quality_of_life": "Excellent per patient report"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_012",
    "patient_name": "Margaret Chen",
    "patient_profile": "https://images.unsplash.com/photo-1619895862022-09114b41f16f?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=1170",
    "archetype": "Breast Cancer with Chemotherapy Complications",
    "age": 52,
    "sex": "F",
    "race_ethnicity": "Asian",
    "allergies": [
      {
        "allergen": "Ondansetron",
        "reaction": "Severe QT prolongation on EKG",
        "severity": "severe",
        "onset": "documented 2023"
      },
      {
        "allergen": "Adhesive tape",
        "reaction": "Contact dermatitis, blistering",
        "severity": "moderate",
        "onset": "childhood"
      }
    ],

    "chief_complaint": "New lump in right breast, noticed 2 months ago while showering",
    "first_visit_date": "2024-01-15",
    "last_visit_date": "2024-10-18",
    "total_visits": 12,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_012_A",
        "type": "symptom_lab_correlation",
        "description": "Hypersensitivity reaction to paclitaxel requiring treatment discontinuation and protocol change",
        "entities_involved": [
          "Paclitaxel",
          "Hypersensitivity",
          "Treatment modification",
          "Alternative chemotherapy"
        ],
        "visits_involved": ["V9", "V10"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_012_B",
        "type": "lab_trend",
        "description": "Recurrent febrile neutropenia requiring dose reduction and treatment delays",
        "entities_involved": [
          "ANC",
          "Fever",
          "Chemotherapy delays",
          "Dose reduction"
        ],
        "visits_involved": ["V6", "V7", "V8"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_012_C",
        "type": "symptom_lab_correlation",
        "description": "Excellent tumor response to neoadjuvant chemotherapy (>40% reduction) guiding surgical approach",
        "entities_involved": [
          "Tumor size reduction",
          "Lymph node resolution",
          "Surgical planning"
        ],
        "visits_involved": ["V3", "V8", "V11"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_012_D",
        "type": "persistent_symptom",
        "description": "Progressive peripheral neuropathy from chemotherapy requiring dose adjustments",
        "entities_involved": [
          "Peripheral neuropathy",
          "Paclitaxel",
          "Dose modification",
          "Quality of life"
        ],
        "visits_involved": ["V8", "V9", "V10", "V11"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.85
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-01-15",
        "visit_type": "office_visit",
        "chief_complaint": "Lump in right breast x2 months",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 128,
          "bp_diastolic": 82,
          "hr_bpm": 88,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 145.0,
          "height_inches": 64.0,
          "bmi": 24.9
        },
        "labs": {},
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)"
          ],
          "new_acute": [
            "Right breast mass, suspicious for malignancy (N63.10)"
          ],
          "differential": ["Breast cancer", "Fibroadenoma", "Cyst"]
        },
        "procedures_ordered": [
          "STAT diagnostic mammogram",
          "Ultrasound right breast and axilla"
        ],
        "referrals": ["Surgical oncology"],
        "provider_note_snippet": "52F elementary school teacher presents with 2.5cm firm, irregular, non-tender mass in right breast upper outer quadrant at 10 o'clock, 3cm from nipple. No skin retraction, no nipple discharge. No palpable axillary lymphadenopathy. SIGNIFICANT FAMILY HISTORY: Mother had breast cancer diagnosed at age 58 (ER/PR positive, died at 64), maternal aunt had ovarian cancer at 62, father had colon cancer at 71. Given family history and mass characteristics, highly suspicious for malignancy. Patient very anxious - understandable given mother's death from breast cancer. Husband present, supportive. Ordered STAT imaging. Will see back in 3 days to discuss results. Patient on sertraline for anxiety, may need dose increase. Former smoker (quit 10 years ago). Married with 2 adult children local.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-01-18",
        "visit_type": "office_visit",
        "chief_complaint": "Return for imaging results",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 135,
          "bp_diastolic": 88,
          "hr_bpm": 92,
          "weight_lbs": 144.0
        },
        "labs": {},
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)"
          ],
          "new_acute": [
            "BI-RADS 5 right breast mass (C50.911)",
            "Suspicious right axillary lymphadenopathy (C77.3)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Core needle biopsy right breast mass - scheduled 2024-01-22",
          "FNA right axillary lymph node"
        ],
        "referrals": ["Surgical oncology appointment 2024-01-25"],
        "provider_note_snippet": "Imaging results: Mammogram shows 2.8cm irregular, spiculated mass with microcalcifications - BI-RADS 5 (highly suggestive of malignancy). Ultrasound confirms 2.8 x 2.1 x 2.3cm irregular hypoechoic mass with posterior shadowing. RIGHT AXILLA: One enlarged 1.8cm lymph node with loss of fatty hilum - suspicious for metastatic involvement. Patient anxious but composed, husband present. Discussed high suspicion for breast cancer with likely lymph node spread. Core biopsy scheduled Monday. Provided written materials. Emphasized importance of both attending surgical oncology appointment together. Patient declined increasing sertraline for now - wants to 'get through the diagnosis first.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-01-25",
        "visit_type": "surgical_oncology_consultation",
        "chief_complaint": "Biopsy results discussion",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 132,
          "bp_diastolic": 84,
          "hr_bpm": 86,
          "weight_lbs": 143.0
        },
        "labs": {},
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)"
          ],
          "new_acute": [
            "Invasive ductal carcinoma, right breast, Grade 2, ER+/PR+/HER2-, Stage IIA (T2N1M0) (C50.911)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Breast MRI",
          "CT chest/abdomen/pelvis",
          "Bone scan",
          "Echocardiogram",
          "PFTs",
          "Genetic testing (BRCA1/BRCA2)",
          "Port placement (scheduled prior to chemo)"
        ],
        "referrals": ["Medical oncology for chemotherapy planning"],
        "provider_note_snippet": "PATHOLOGY CONFIRMED: Invasive ductal carcinoma, Grade 2. Immunohistochemistry: ER 90% positive, PR 75% positive, HER2 negative (IHC 1+), Ki-67 18%. FNA of axillary lymph node positive for metastatic carcinoma. STAGING: T2N1M0 - Stage IIA breast cancer. Treatment plan discussed: NEOADJUVANT CHEMOTHERAPY first (to shrink tumor and treat micrometastatic disease), followed by surgery (likely mastectomy given 3cm tumor and node-positive disease), then radiation and long-term endocrine therapy (tamoxifen or aromatase inhibitor). Rationale for neoadjuvant approach: tumor >2cm, node-positive, may allow breast conservation if excellent response, allows assessment of chemo sensitivity. Ordered staging scans to rule out distant metastases. Echo and PFTs for chemo clearance. GENETIC TESTING given strong family history - mother breast ca age 58, aunt ovarian ca, father colon ca. If BRCA positive, may influence surgical decision (bilateral mastectomy). Patient and husband asking excellent questions. Fertility preservation discussed - patient completed childbearing (children ages 26 and 24). Medical oncology referral for chemo protocol selection.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-02-08",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Chemotherapy treatment planning",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 126,
          "bp_diastolic": 78,
          "hr_bpm": 82,
          "weight_lbs": 142.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.4,
          "wbc_k_ul": 7.2,
          "anc": 4.8,
          "platelets_k_ul": 268,
          "creatinine_mg_dl": 0.9,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.1,
          "alt_u_l": 18,
          "ast_u_l": 22,
          "alk_phos_u_l": 68,
          "total_bilirubin_mg_dl": 0.6,
          "albumin_g_dl": 4.2
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)"
          ],
          "new_acute": [
            "Stage IIA (cT2N1M0) invasive ductal carcinoma, ER+/PR+/HER2- (C50.911)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Port placement scheduled 2024-02-12",
          "First chemotherapy 2024-02-15"
        ],
        "referrals": [],
        "provider_note_snippet": "ALL STAGING NEGATIVE for distant metastases. Breast MRI: 3.2cm right breast mass, no additional lesions, no chest wall invasion, left breast normal. CT chest/abd/pelvis: No metastases, right axillary adenopathy as expected. Bone scan: negative. Echo: Normal LV function EF 62%, no valvular abnormalities - CLEARED FOR ANTHRACYCLINE. PFTs: Normal spirometry. GENETIC TESTING: BRCA1 and BRCA2 NEGATIVE. Variant of uncertain significance in CHEK2 gene - will discuss bilateral mastectomy vs lumpectomy after assessing chemo response. TREATMENT PLAN: Dose-dense AC-T protocol: (1) Adriamycin (doxorubicin) 60mg/m + Cytoxan (cyclophosphamide) 600mg/m every 2 weeks x 4 cycles, (2) followed by Taxol (paclitaxel) 80mg/m weekly x 12 weeks. Supportive meds: Dexamethasone pre-med, granisetron for nausea (AVOIDING ONDANSETRON due to documented QT prolongation allergy), Neulasta on-body injector day after chemo for neutropenia prevention. SIDE EFFECTS COUNSELED: Hair loss will occur (complete alopecia expected by cycle 2), nausea (though well-managed with meds), fatigue, infection risk (nadir days 10-14), possible neuropathy from Taxol. Patient doing better emotionally - connected with breast cancer support group through hospital. Short-term disability paperwork completed - will take medical leave from teaching. Patient asked about scalp cooling to prevent hair loss - discussed limited efficacy, offered doxycycline scalp prophylaxis. Port placement Monday, first chemo Thursday.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-02-15",
        "visit_type": "chemotherapy_infusion",
        "chief_complaint": "Cycle 1 Day 1 of AC chemotherapy",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 122,
          "bp_diastolic": 76,
          "hr_bpm": 78,
          "weight_lbs": 141.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.2,
          "wbc_k_ul": 6.8,
          "anc": 4.5,
          "platelets_k_ul": 255,
          "creatinine_mg_dl": 0.9,
          "potassium_meq_l": 4.0
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [
            "Dexamethasone 8mg PO BID x3 days",
            "Granisetron 1mg PO daily PRN nausea",
            "Prochlorperazine 10mg PO q6h PRN breakthrough nausea",
            "Loperamide PRN diarrhea"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)"
          ],
          "new_acute": [
            "Stage IIA invasive ductal carcinoma on active chemotherapy (C50.911)"
          ],
          "differential": []
        },
        "procedures_ordered": ["Return Cycle 2 Day 1: 2024-02-29"],
        "referrals": [],
        "provider_note_snippet": "C1D1 AC chemotherapy administered. Port placed 2024-02-12 without complications - site clean, dry, intact. PREMEDICATIONS: Dexamethasone 12mg IV, Granisetron 1mg IV (avoiding ondansetron per allergy), Famotidine 20mg IV, Diphenhydramine 25mg IV. CHEMOTHERAPY: Doxorubicin 60mg/m IV push (102mg total, BSA 1.7m), Cyclophosphamide 600mg/m IV over 30min (1020mg total). Tolerated well, no acute reactions. Neulasta Onpro device applied to abdomen - will auto-deliver pegfilgrastim 24 hours post-chemo. DISCHARGE INSTRUCTIONS: Take dexamethasone as prescribed x3 days (reduces delayed nausea). Use granisetron and prochlorperazine PRN nausea. NEUTROPENIC PRECAUTIONS: No gardening, avoid crowds, wash hands frequently, check temp if feeling unwell, NO FRESH FLOWERS OR PLANTS. Nadir (lowest blood counts) expected days 10-14. CALL IMMEDIATELY FOR: Fever 100.4F, severe nausea/vomiting despite meds, chest pain, severe shortness of breath, signs of infection. Patient nervous but tolerated first infusion well. Husband present throughout. Reinforced infection precautions.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-02-26",
        "visit_type": "urgent_care_visit",
        "chief_complaint": "Fever 101.8F at home, Day 11 post-chemo",
        "vitals": {
          "temp_f": 101.8,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 102,
          "rr_bpm": 18,
          "spo2_percent": 97.0,
          "weight_lbs": 139.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.2,
          "wbc_k_ul": 0.8,
          "anc": 0.3,
          "lymphocytes": 0.4,
          "monocytes": 0.1,
          "platelets_k_ul": 156,
          "creatinine_mg_dl": 0.9,
          "sodium_meq_l": 138,
          "potassium_meq_l": 3.9,
          "lactate_mmol_l": 1.2
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": ["Cefepime 2g IV q8h", "Granisetron PRN"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer on chemotherapy (C50.911)"
          ],
          "new_acute": [
            "Febrile neutropenia (D70.1)",
            "Post-chemotherapy nadir"
          ],
          "differential": ["Occult bacterial infection", "Viral syndrome"]
        },
        "procedures_ordered": [
          "Blood cultures x2 sets",
          "Urinalysis",
          "Chest X-ray",
          "Daily CBC and BMP monitoring",
          "ADMISSION to oncology floor"
        ],
        "referrals": [],
        "provider_note_snippet": "FEBRILE NEUTROPENIA - oncologic emergency. Patient presents Day 11 post-AC chemo with fever 101.8F, ANC 0.3 (critically low). Feeling fatigued, mild chills, body aches. Denies cough, SOB, chest pain, abdominal pain, diarrhea, urinary symptoms, new rash. Exam: Ill-appearing, flushed, but alert and oriented. Lungs clear, heart tachycardic but regular, abdomen soft/non-tender. Port site clean without erythema or drainage. No oral mucositis. No CVA tenderness. LABS: Severe neutropenia ANC 0.3 (normal >1.5), hemoglobin dropped to 11.2, platelets adequate at 156. Lactate normal 1.2 (not septic). NO CLEAR SOURCE IDENTIFIED. Blood cultures drawn from 2 peripheral sites (not through port). Urinalysis negative. CXR clear - no infiltrates. MANAGEMENT: ADMITTED to oncology floor for IV broad-spectrum antibiotics. Started cefepime 2g IV q8h immediately (covers pseudomonas and gram-negatives). Strict neutropenic precautions: private room, no fresh flowers/plants, cooked food only, masks for all visitors. NPO except ice chips until afebrile and stable. HOLD Cycle 2 chemotherapy (scheduled 2024-02-29) - will reassess count recovery. Educated patient and husband on seriousness of neutropenic fever - can become life-threatening rapidly if untreated.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-02-29",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Hospital Day 3, febrile neutropenia improving",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 120,
          "bp_diastolic": 74,
          "hr_bpm": 76,
          "weight_lbs": 138.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 3.2,
          "anc": 1.8,
          "platelets_k_ul": 142
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [
            "Cefpodoxime 200mg PO BID x5 days (completion of antibiotic course at home)"
          ],
          "stopped": ["Cefepime IV (switching to oral)"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer on chemotherapy (C50.911)"
          ],
          "new_acute": ["Febrile neutropenia, resolved"],
          "differential": []
        },
        "procedures_ordered": [
          "Pre-chemo labs 2024-03-06",
          "Cycle 2 AC rescheduled to 2024-03-07"
        ],
        "referrals": [],
        "provider_note_snippet": "Excellent response to antibiotics. Afebrile x48 hours (last fever 2/27 at 6am). ANC recovered to 1.8 (>1.5 threshold). Feeling much better, appetite improving, ambulating well. Blood cultures: NO GROWTH at 72 hours (final) - presumed viral vs occult bacterial infection that cleared. DISCHARGE HOME today. Complete oral cefpodoxime x5 more days. Resume baseline medications. CHEMOTHERAPY ADJUSTMENT: Cycle 2 DELAYED by 1 week (from 2/29 to 3/7) to allow better count recovery. Close monitoring going forward - if recurrent febrile neutropenia, will need dose reduction per protocol (reduce to 75% dose). Patient relieved to go home, anxious about next chemo cycle. Reassured this is common complication, we'll monitor closely. RTC 3/6 for pre-chemo evaluation.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-04-18",
        "visit_type": "post_ac_evaluation",
        "chief_complaint": "Completed 4 cycles AC chemotherapy, evaluate for Taxol initiation",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 124,
          "bp_diastolic": 78,
          "hr_bpm": 74,
          "weight_lbs": 136.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 4.8,
          "anc": 2.8,
          "platelets_k_ul": 198,
          "creatinine_mg_dl": 0.9,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.1,
          "alt_u_l": 22,
          "ast_u_l": 25
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer, partial response to chemotherapy (C50.911)"
          ],
          "new_acute": [
            "Chemotherapy-induced peripheral neuropathy, Grade 1 (G62.0)",
            "Chemotherapy-induced alopecia (L65.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Breast ultrasound - tumor reassessment",
          "First Taxol infusion scheduled 2024-04-25",
          "Surgical oncology consultation in 3 weeks"
        ],
        "referrals": ["Surgical oncology for surgical planning"],
        "provider_note_snippet": "AC CHEMOTHERAPY COMPLETED: 4 cycles total (last dose 2024-04-04). COMPLICATIONS: Had SECOND episode of febrile neutropenia during Cycle 3 (Day 11, ANC 0.4, admitted 24 hours). Required dose reduction to 75% for Cycles 3 and 4 per protocol. Tolerated reduced-dose cycles well without further neutropenic episodes. CURRENT STATUS: Cachectic-appearing, wearing wig (complete alopecia as expected). PHYSICAL EXAM: Right breast tumor NOW PALPABLE AS 1.5cm firm area (was 3cm at baseline) - SIGNIFICANT REDUCTION IN SIZE. No palpable axillary lymph nodes (previously had 1.8cm node). NEUROPATHY ASSESSMENT: Mild tingling/numbness in fingertips bilaterally (Grade 1 peripheral neuropathy). Can still button clothes, write, type. No motor weakness. TUMOR RESPONSE: Ultrasound shows right breast mass now 1.6 x 1.2cm (decreased from 2.8 x 2.1cm) - 43% reduction in largest diameter. No abnormal axillary lymph nodes visualized. EXCELLENT PARTIAL RESPONSE to AC chemotherapy. PLAN: Proceed with weekly Paclitaxel 80mg/m x12 weeks (standard dose to start). Pre-meds: Dexamethasone 10mg IV, diphenhydramine 25mg IV, famotidine 20mg IV (standard hypersensitivity prophylaxis - taxanes have high reaction risk). Monitor neuropathy closely - may need dose adjustment if worsens. No Neulasta with weekly Taxol (lower myelosuppression than AC). Given excellent response, surgical planning to begin - meeting with surgeon in 3 weeks to discuss lumpectomy + radiation vs mastectomy. Lumpectomy may now be possible given dramatic tumor shrinkage. Patient tolerating treatment well emotionally, support system strong.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-04-25",
        "visit_type": "chemotherapy_infusion",
        "chief_complaint": "Taxol Week 1 - HYPERSENSITIVITY REACTION",
        "vitals": {
          "temp_f": 98.0,
          "bp_systolic": 126,
          "bp_diastolic": 80,
          "hr_bpm": 80,
          "weight_lbs": 136.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.4,
          "wbc_k_ul": 5.1,
          "anc": 3.2,
          "platelets_k_ul": 205
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [
            "Diphenhydramine 50mg IV STAT",
            "Hydrocortisone 100mg IV STAT",
            "Albuterol nebulizer",
            "Famotidine 20mg IV",
            "Methylprednisolone 125mg IV"
          ],
          "stopped": ["Paclitaxel (discontinued due to hypersensitivity)"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer on chemotherapy (C50.911)"
          ],
          "new_acute": [
            "Hypersensitivity reaction to paclitaxel, Grade 3 (T88.6)",
            "Chemotherapy-induced bronchospasm (J45.990)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Observation in infusion center x2 hours",
          "Pulmonary function monitoring",
          "Medical oncology urgent consultation for alternative regimen"
        ],
        "referrals": [],
        "provider_note_snippet": "ACUTE HYPERSENSITIVITY REACTION TO PACLITAXEL - Code initiated. TIMELINE: Infusion started 15:00 with standard pre-medications (dexamethasone 10mg IV, diphenhydramine 25mg IV, famotidine 20mg IV). At 15:45 (45 minutes into planned 60-minute infusion, ~75% dose delivered), patient developed: ACUTE ONSET flushing, chest tightness, difficulty breathing, severe anxiety. VITALS AT ONSET: BP 156/92 (hypertensive), HR 112 (tachycardic), O2 sat 94% on room air (hypoxic), audible wheezing. IMMEDIATE MANAGEMENT: (1) INFUSION STOPPED immediately, (2) IV access maintained, (3) Diphenhydramine 50mg IV STAT, (4) Hydrocortisone 100mg IV STAT, (5) Albuterol nebulizer for bronchospasm, (6) O2 2L nasal cannula. RESPONSE: Within 20 minutes, symptoms began improving. Wheezing resolved after second albuterol treatment. BP normalized to 128/78, HR 88, O2 sat 98% on 2L. Patient calmer after reassurance. DIAGNOSIS: Grade 3 hypersensitivity reaction to paclitaxel (moderate-severe, requiring treatment discontinuation). PLAN: (1) PACLITAXEL DISCONTINUED - cannot rechallenge, (2) Observed x2 hours in infusion center - stable, (3) Methylprednisolone 125mg IV before discharge, (4) Prednisone taper: 40mg daily x3 days, then 20mg x2 days, (5) Diphenhydramine 25mg PO q6h PRN, (6) URGENT medical oncology consultation to discuss alternative taxane options. OPTIONS: (a) Docetaxel (different taxane, lower cross-reactivity), (b) Paclitaxel desensitization protocol (prolonged infusion with intensive monitoring), (c) Capecitabine (oral chemo, different mechanism). Patient shaken by experience but recovering well. Husband present. Extensive counseling on what happened and next steps.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-05-02",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Alternative chemotherapy planning after paclitaxel hypersensitivity",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 124,
          "bp_diastolic": 76,
          "hr_bpm": 78,
          "weight_lbs": 135.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.3,
          "wbc_k_ul": 5.3,
          "anc": 3.1,
          "platelets_k_ul": 212,
          "creatinine_mg_dl": 0.9
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer, partial response to neoadjuvant chemotherapy (C50.911)"
          ],
          "new_acute": [
            "Paclitaxel hypersensitivity (T88.6)",
            "Chemotherapy-induced peripheral neuropathy, Grade 1 (G62.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "First dose nab-paclitaxel scheduled 2024-05-09"
        ],
        "referrals": [],
        "provider_note_snippet": "Reviewed paclitaxel hypersensitivity reaction - classic presentation. Discussed treatment options: OPTION 1: Docetaxel (Taxotere) - different taxane formulation, less hypersensitivity but more myelosuppression, fluid retention. OPTION 2: Nab-paclitaxel (Abraxane) - albumin-bound paclitaxel, NO SOLVENT (solvent causes most reactions), much lower hypersensitivity risk (~2% vs 10% for standard paclitaxel), NO PREMEDICATIONS NEEDED. OPTION 3: Capecitabine oral chemotherapy - completely different class, but less data in neoadjuvant setting. DECISION: Nab-paclitaxel (Abraxane) 100mg/m weekly x12 weeks. RATIONALE: (1) Same active drug (paclitaxel) so maintains efficacy, (2) Cremophor-free formulation eliminates primary allergen, (3) Minimal cross-reactivity, (4) No premedications needed (though we'll give famotidine as precaution), (5) Well-tolerated, (6) Can complete intended taxane-based regimen. RISKS: Still small chance of reaction (~2%), neuropathy risk similar to paclitaxel, myelosuppression. Will monitor closely during first infusion - have emergency meds ready, slower infusion rate initially. Patient and husband understand risks vs benefits, willing to proceed. PERIPHERAL NEUROPATHY UPDATE: Grade 1 fingertip numbness unchanged, not interfering with function. Will monitor - if worsens to Grade 2 (moderate interference with ADLs), will reduce nab-paclitaxel dose to 75mg/m. Patient anxious about another reaction but reassured by different formulation.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V11",
        "visit_date": "2024-07-25",
        "visit_type": "post_chemotherapy_evaluation",
        "chief_complaint": "Completed nab-paclitaxel, surgical planning",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 122,
          "bp_diastolic": 74,
          "hr_bpm": 72,
          "weight_lbs": 133.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 5.6,
          "anc": 3.4,
          "platelets_k_ul": 225,
          "creatinine_mg_dl": 0.9
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Stage IIA breast cancer, excellent response to neoadjuvant chemotherapy (C50.911)"
          ],
          "new_acute": [
            "Chemotherapy-induced peripheral neuropathy, Grade 2 (G62.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Breast MRI for surgical planning",
          "Surgical oncology consultation 2024-08-01",
          "Pre-operative labs and EKG"
        ],
        "referrals": [
          "Surgical oncology",
          "Radiation oncology consultation post-surgery"
        ],
        "provider_note_snippet": "NAB-PACLITAXEL COMPLETED: 12 weekly doses total (last dose 2024-07-18). NO HYPERSENSITIVITY REACTIONS - tolerated much better than standard paclitaxel. Required dose reduction to 75mg/m at week 8 due to progressive neuropathy (Grade 12). FINAL TUMOR ASSESSMENT: Breast MRI shows right breast residual mass 0.9cm (started at 3.2cm) - 72% REDUCTION from baseline, 44% further reduction from post-AC assessment. OUTSTANDING RESPONSE to neoadjuvant chemotherapy overall. No abnormal lymph nodes visualized on MRI. PHYSICAL EXAM: Right breast - palpable 1cm firm area upper outer quadrant, significantly smaller. No palpable axillary nodes. PERIPHERAL NEUROPATHY: Now Grade 2 - numbness and tingling in fingers and toes bilaterally, some difficulty with fine motor tasks (buttoning small buttons, picking up coins). Can still perform most ADLs but with difficulty. Symptoms expected to slowly improve over 3-6 months after stopping chemo, though may have some permanent residual neuropathy. SURGICAL PLANNING: Given excellent response (>70% reduction), patient is NOW CANDIDATE FOR BREAST-CONSERVING SURGERY (lumpectomy). Initial tumor was 3.2cm making mastectomy likely, but dramatic response allows lumpectomy. Will discuss options: (1) Lumpectomy + sentinel lymph node biopsy + radiation, vs (2) Mastectomy (with or without reconstruction). CHEK2 VUS complicates decision - uncertain significance for contralateral breast cancer risk. Genetic counselor involved. Patient leaning toward lumpectomy - wants to preserve breast if oncologically safe. Surgery scheduled for mid-August after MRI surgical planning. Post-surgery: radiation therapy 6 weeks, then long-term endocrine therapy (likely aromatase inhibitor given post-menopausal) for 5-10 years. OVERALL: Excellent response to neoadjuvant chemotherapy despite complications (2 episodes febrile neutropenia requiring dose reduction, paclitaxel hypersensitivity requiring switch to nab-paclitaxel, progressive neuropathy). Demonstrates importance of completing treatment despite toxicities. Patient and family pleased with tumor response, hopeful about breast conservation.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V12",
        "visit_date": "2024-10-18",
        "visit_type": "post_surgical_follow_up",
        "chief_complaint": "Post-lumpectomy pathology review, radiation planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 120,
          "bp_diastolic": 72,
          "hr_bpm": 70,
          "weight_lbs": 137.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.4,
          "wbc_k_ul": 6.2,
          "platelets_k_ul": 245
        },
        "medications": {
          "continued": ["Levothyroxine 100mcg daily", "Sertraline 50mg daily"],
          "started": [
            "Anastrozole 1mg daily (aromatase inhibitor)",
            "Gabapentin 300mg TID for neuropathy"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypothyroidism (E03.9)",
            "Anxiety disorder (F41.9)",
            "Breast cancer, status post neoadjuvant chemotherapy and lumpectomy, ypT1N0 (C50.911)"
          ],
          "new_acute": [
            "Chemotherapy-induced peripheral neuropathy, Grade 2, improving (G62.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Radiation therapy simulation appointment",
          "Bone density scan (baseline before aromatase inhibitor)",
          "Follow-up in 3 months"
        ],
        "referrals": [
          "Radiation oncology",
          "Physical therapy for lymphedema prevention"
        ],
        "provider_note_snippet": "SURGERY COMPLETED 2024-08-15: Right breast lumpectomy with sentinel lymph node biopsy. SURGICAL PATHOLOGY: PATHOLOGIC COMPLETE RESPONSE in lymph nodes - all 3 sentinel nodes NEGATIVE. Residual invasive carcinoma in breast 0.8cm (ypT1), Grade 2, ER+/PR+/HER2-, margins negative (>5mm all margins). FINAL STAGING: ypT1N0 - downstaged from initial cT2N1 (Stage IIA  Stage IA). OUTSTANDING RESPONSE to neoadjuvant chemotherapy. Surgical site healing well, no complications. NEUROPATHY UPDATE: Grade 2 peripheral neuropathy SLOWLY IMPROVING. Started gabapentin 300mg TID with some benefit. Still has numbness/tingling but fine motor function better. Physical therapy helping with hand exercises. May take 6-12 months for maximal recovery, likely some permanent residual symptoms. RADIATION THERAPY: Starting in 2 weeks. Plan: Whole breast radiation 50 Gy in 25 fractions over 5 weeks, with boost to tumor bed 10-16 Gy (5-8 fractions). ENDOCRINE THERAPY: Started anastrozole 1mg daily (aromatase inhibitor - patient post-menopausal, superior to tamoxifen). Will continue for 5-10 years. Baseline bone density ordered (aromatase inhibitors increase osteoporosis risk). SIDE EFFECTS COUNSELED: Joint pain/stiffness (arthralgias), hot flashes, bone density loss. Will monitor bone density annually, consider bisphosphonates if needed. PROGNOSIS: Excellent given pathologic downstaging and node-negative status. Estimated 5-year disease-free survival >90%, 10-year overall survival >85%. Patient and family relieved to have completed chemotherapy and surgery. Emotional about journey - from diagnosis to now 9 months later. Plans to return to teaching part-time in January after completing radiation. Hair regrowing (short pixie cut emerging). Support group has been invaluable. Discussed survivorship care plan: annual mammograms, clinical exams every 3-6 months for 3 years then annually, endocrine therapy adherence critical. GENETICS: BRCA negative, CHEK2 VUS - annual screening bilateral mammograms, no additional surgery recommended. Family history significant but genetic testing negative for high-penetrance mutations.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "employment": "On medical leave from teaching, planning part-time return January 2025"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_013",
    "patient_name": "Robert Sullivan",
    "patient_profile": "https://images.unsplash.com/photo-1560250097-0b93528c311a?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=687",
    "achetype": "Non-Small Cell Lung Cancer with Brain Metastases",
    "age": 64,
    "sex": "M",
    "race_ethnicity": "Caucasian",
    "allergies": [
      {
        "allergen": "Morphine",
        "reaction": "Severe hallucinations, agitation",
        "severity": "severe",
        "onset": "2018"
      },
      {
        "allergen": "Sulfa antibiotics",
        "reaction": "Rash, hives",
        "severity": "moderate",
        "onset": "1995"
      }
    ],

    "chief_complaint": "Persistent cough x3 months, now coughing up blood",
    "first_visit_date": "2024-02-12",
    "last_visit_date": "2024-09-20",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_013_A",
        "type": "symptom_lab_correlation",
        "description": "Progressive respiratory symptoms with weight loss revealing advanced lung cancer with brain metastases",
        "entities_involved": [
          "Persistent cough",
          "Hemoptysis",
          "Weight loss",
          "Lung mass",
          "Brain metastases"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_013_B",
        "type": "symptom_lab_correlation",
        "description": "New neurological symptoms (headaches, confusion) correlating with brain metastases progression",
        "entities_involved": [
          "Headaches",
          "Confusion",
          "Brain MRI",
          "Multiple brain lesions"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_013_C",
        "type": "lab_trend",
        "description": "EGFR mutation positive tumor allowing targeted therapy with dramatic initial response",
        "entities_involved": [
          "EGFR mutation",
          "Osimertinib",
          "Tumor shrinkage",
          "Symptom improvement"
        ],
        "visits_involved": ["V4", "V5", "V6", "V7"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_013_D",
        "type": "persistent_symptom",
        "description": "Disease progression on targeted therapy with development of resistance requiring treatment change",
        "entities_involved": [
          "Progressive disease",
          "New liver metastases",
          "Treatment resistance",
          "Chemotherapy switch"
        ],
        "visits_involved": ["V8", "V9", "V10"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.9
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-02-12",
        "visit_type": "office_visit",
        "chief_complaint": "Persistent cough x3 months, worsening, now with some blood",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 84,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 172.0,
          "height_inches": 70.0,
          "bmi": 24.7
        },
        "labs": {
          "hemoglobin_g_dl": 13.8,
          "wbc_k_ul": 9.2,
          "platelets_k_ul": 312,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.2,
          "creatinine_mg_dl": 1.1,
          "glucose_mg_dl": 108,
          "albumin_g_dl": 3.9
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily"
          ],
          "started": ["Benzonatate 100mg TID PRN cough"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Former smoker (Z87.891)"
          ],
          "new_acute": ["Persistent cough (R05.9)", "Hemoptysis (R04.2)"],
          "differential": [
            "Chronic bronchitis",
            "Pneumonia",
            "Lung cancer",
            "Tuberculosis"
          ]
        },
        "procedures_ordered": ["Chest X-ray", "CBC", "BMP"],
        "referrals": [],
        "provider_note_snippet": "64M retired construction worker presents with 3-month history of persistent dry cough, now productive with blood-streaked sputum x1 week. Initially attributed to 'bronchitis' treated with course of azithromycin without improvement. Reports progressive fatigue, decreased appetite. Denies fever, night sweats, chest pain. SMOKING HISTORY: 45 pack-years (1.5 packs/day x30 years), quit 5 years ago. Former heavy smoker - HIGH RISK. Wife concerned, pushed him to come in. Exam: Decreased breath sounds right upper lobe, no wheezing. Cough suppressant prescribed but NEED chest X-ray urgently given hemoptysis and smoking history. Patient reluctant about further workup, wants to 'see if cough improves.' Educated on importance of ruling out serious causes. Lives with wife, retired 2 years ago, enjoys woodworking.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": "Former smoker, quit 5 years ago, 45 pack-year history",
          "alcohol": "Social drinker, 2-3 beers on weekends",
          "occupation": "Retired construction worker (asbestos exposure possible)",
          "living_situation": "Lives with wife, 2 adult children out of state"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-02-19",
        "visit_type": "office_visit",
        "chief_complaint": "Chest X-ray results discussion",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 138,
          "bp_diastolic": 86,
          "hr_bpm": 82,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 170.0
        },
        "labs": {},
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Benzonatate 100mg TID PRN"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Right upper lobe lung mass, suspicious for malignancy (R91.1)",
            "Hemoptysis (R04.2)"
          ],
          "differential": [
            "Lung cancer - primary concern",
            "Lung abscess",
            "Tuberculosis",
            "Fungal infection"
          ]
        },
        "procedures_ordered": [
          "CT chest with contrast - URGENT",
          "Pulmonology referral for bronchoscopy",
          "Smoking cessation counseling"
        ],
        "referrals": ["Pulmonology - urgent"],
        "provider_note_snippet": "CHEST X-RAY RESULTS (2024-02-14): 4.5cm mass right upper lobe with irregular borders, concerning for malignancy. Possible right hilar lymphadenopathy. No pleural effusion. CRITICAL FINDING called to patient 2/14, asked to come in immediately. Patient and wife present, both visibly anxious. Discussed high suspicion for lung cancer given: (1) 45 pack-year smoking history, (2) hemoptysis, (3) large mass on X-ray, (4) weight loss (2 lbs since last week). Explained need for CT chest and bronchoscopy for tissue diagnosis. Patient tearful, stating 'I knew I should have quit sooner.' Wife supportive but also tearful. Referred urgently to pulmonology - appointment scheduled for 2/23. Ordered CT chest with contrast for 2/21. Discussed prognosis depends on staging but emphasized importance of quick workup. Patient asking about treatment options - explained need diagnosis first. Construction background - possible asbestos exposure adds to risk.",
        "patient_reported_adherence": "good",
        "social_history_updates": {}
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-03-08",
        "visit_type": "office_visit",
        "chief_complaint": "Biopsy results, staging complete",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 145,
          "bp_diastolic": 90,
          "hr_bpm": 88,
          "rr_bpm": 19,
          "spo2_percent": 95.0,
          "weight_lbs": 166.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.2,
          "wbc_k_ul": 8.8,
          "platelets_k_ul": 298,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "creatinine_mg_dl": 1.1,
          "alt_u_l": 45,
          "ast_u_l": 38,
          "alk_phos_u_l": 92,
          "albumin_g_dl": 3.6,
          "calcium_mg_dl": 9.8
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily"
          ],
          "started": [
            "Dexamethasone 4mg BID",
            "Pantoprazole 40mg daily",
            "Ondansetron 8mg q8h PRN nausea"
          ],
          "stopped": ["Benzonatate"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Adenocarcinoma of lung, right upper lobe, Stage IV (C34.11)",
            "Metastatic brain lesions (C79.31)",
            "Metastatic mediastinal lymphadenopathy (C77.1)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Brain MRI with contrast",
          "PET scan",
          "Molecular testing: EGFR, ALK, ROS1, PD-L1"
        ],
        "referrals": [
          "Medical oncology - URGENT",
          "Neurosurgery consultation for brain metastases",
          "Radiation oncology"
        ],
        "provider_note_snippet": "DEVASTATING NEWS. CT CHEST (2/21): 5.2cm mass right upper lobe with spiculated margins, extensive right hilar and mediastinal lymphadenopathy (largest node 3.8cm), possible small left pleural effusion. BRONCHOSCOPY (2/28): Biopsy confirmed ADENOCARCINOMA of lung. PET SCAN (3/5): Hypermetabolic RUL mass SUV 12.8, mediastinal nodes SUV 8.2-11.4, THREE hypermetabolic brain lesions (right frontal 1.8cm SUV 6.2, left parietal 1.2cm SUV 5.8, right cerebellar 0.9cm SUV 4.9), NO other distant metastases identified. BRAIN MRI pending to better characterize lesions. STAGING: cT3N3M1c - STAGE IV NON-SMALL CELL LUNG CANCER with BRAIN METASTASES. Patient and wife devastated. Patient now asking about 'how long do I have?' - explained survival varies greatly depending on molecular markers and treatment response. Emphasized importance of molecular testing - if EGFR or ALK mutation present, targeted therapy available with better outcomes. Started dexamethasone for brain metastases (reduce cerebral edema). Urgent oncology referral - appointment 3/12. Patient reports new symptoms since last visit: mild headaches (now makes sense - brain mets), increased fatigue, weight loss continues (now 6 lbs total). Denies confusion, seizures, focal weakness. Cough improving slightly with tumor treatment. MOLECULAR TESTING ordered on biopsy tissue - results in 7-10 days. Patient asking about clinical trials. Wife asking about brain surgery vs radiation. Explained neurosurgery/radiation oncology will discuss best approach for brain lesions. Family wants adult children (California and Texas) to fly in for oncology appointment. Patient expressing regret about not quitting smoking sooner, anger at himself. Discussed: (1) This is not his 'fault,' (2) Focus on treatment options now, (3) Support resources available including oncology social work, palliative care.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "support_system": "Wife primary caregiver, adult children in California and Texas planning to visit"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-03-22",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Treatment planning, molecular results available",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 140,
          "bp_diastolic": 84,
          "hr_bpm": 80,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 164.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 11.2,
          "anc": 7.8,
          "platelets_k_ul": 285,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 42,
          "ast_u_l": 36
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Dexamethasone 4mg BID",
            "Pantoprazole 40mg daily",
            "Ondansetron 8mg q8h PRN"
          ],
          "started": [
            "Osimertinib (Tagrisso) 80mg daily",
            "Levetiracetam 500mg BID (seizure prophylaxis)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV EGFR-mutant adenocarcinoma of lung with brain metastases (C34.11, C79.31)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Whole brain radiation therapy (WBRT) - 10 fractions starting 3/25",
          "Repeat brain MRI in 6 weeks",
          "Repeat chest CT in 8 weeks",
          "Baseline EKG and echocardiogram"
        ],
        "referrals": [
          "Radiation oncology - brain metastases",
          "Palliative care consultation"
        ],
        "provider_note_snippet": "EXCELLENT NEWS ON MOLECULAR TESTING: EGFR EXON 19 DELETION MUTATION DETECTED. This is TARGETABLE mutation found in ~15% of lung adenocarcinomas, more common in never/former light smokers and Asian patients. Also found: PD-L1 expression 60% (high). ALK/ROS1 negative. BRAIN MRI (3/15): Confirmed three metastatic lesions - right frontal 2.1cm with surrounding edema, left parietal 1.4cm, right cerebellar 1.0cm. Mild mass effect from frontal lesion but no midline shift. TREATMENT PLAN: (1) OSIMERTINIB (Tagrisso) 80mg PO daily - third-generation EGFR tyrosine kinase inhibitor, excellent CNS penetration (critical for brain mets), generally well-tolerated. Expected side effects: diarrhea, rash, dry skin, nail changes, QT prolongation (need baseline EKG). (2) WHOLE BRAIN RADIATION (WBRT) 30 Gy in 10 fractions starting Monday - for brain metastases control. Neurosurgery reviewed case, recommends WBRT over surgical resection given 3 lesions and good performance status. (3) Levetiracetam for seizure prophylaxis (brain mets put at risk). (4) Continue dexamethasone, taper slowly after radiation. PROGNOSIS DISCUSSION: Stage IV NSCLC with EGFR mutation - median survival 18-24 months with osimertinib, some patients 3-5+ years. Much better than EGFR-negative (median 6-12 months). Response rates to osimertinib ~80%, including brain metastases. Patient and family relieved to have 'good mutation' and oral medication option. Adult children both present (flew in from CA and TX). Extensive discussion about goals of care - treatment is PALLIATIVE (not curative) but can provide excellent quality of life and prolonged survival. Patient wants aggressive treatment. Discussed realistic expectations: likely will respond initially, but eventually cancer will progress/develop resistance. Palliative care consult for symptom management, advance care planning. Patient asking about continuing work (does woodworking, small furniture business from home) - encouraged as tolerated. Side effects monitoring: Weekly CBC first month, then monthly. EKG at 2 weeks and periodically (QT prolongation risk). Patient started on osimertinib today.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-05-17",
        "visit_type": "office_visit",
        "chief_complaint": "Post-radiation follow-up, assess treatment response",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 132,
          "bp_diastolic": 78,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 168.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 6.4,
          "anc": 3.8,
          "platelets_k_ul": 245,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 38,
          "ast_u_l": 32
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Osimertinib 80mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily"
          ],
          "started": [
            "Loperamide 2mg PRN diarrhea",
            "Aquaphor cream for skin dryness"
          ],
          "stopped": [],
          "dose_changed": ["Dexamethasone tapered to 2mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Stage IV EGFR-mutant lung adenocarcinoma on targeted therapy (C34.11)"
          ],
          "new_acute": [
            "Radiation-induced fatigue (R53.83)",
            "Treatment-related diarrhea (K59.1)",
            "Radiation dermatitis (L58.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Brain MRI with contrast",
          "CT chest/abdomen/pelvis with contrast"
        ],
        "referrals": [],
        "provider_note_snippet": "DRAMATIC CLINICAL IMPROVEMENT. Patient reports feeling 'so much better' - cough almost completely resolved, energy improving, appetite returning, gaining weight (up 4 lbs). Completed WBRT 4/8 (10 fractions). Now 8 weeks on osimertinib. RADIATION SIDE EFFECTS: Moderate fatigue (expected, improving), mild alopecia (hair thinning, expected to regrow), some memory/concentration difficulties (discussed this is common after WBRT, may improve but could persist - 'chemo brain'). OSIMERTINIB SIDE EFFECTS: Mild diarrhea 2-3x/week (Grade 1, manageable with loperamide), dry skin/rash on trunk and arms (Grade 1, using aquaphor), some nail changes (ridging, brittleness). No QT prolongation on EKG. NEURO STATUS: No headaches, no confusion, no seizures. Dexamethasone tapered to 2mg daily, plan to discontinue in 2 weeks. IMAGING PENDING: Brain MRI scheduled today, chest CT scheduled tomorrow - will review results next visit. Physical exam: Alert, oriented, appears well. Lungs clear, improved from prior. No focal neurological deficits. Skin: Mild erythematous papular rash on chest/back, not bothersome. Family reports patient 'back to his old self' - working in woodshop again, more social. Patient and wife celebrating 40th anniversary next month, planning small family gathering. Adult son (California) staying for 2 weeks to help around house. Patient expressing gratitude for treatment response. Discussed: (1) Responses can be durable but cancer may eventually progress, (2) Continue osimertinib indefinitely until progression or intolerable toxicity, (3) Close monitoring with scans every 8-12 weeks initially.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Resumed woodworking, more socially engaged"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-05-24",
        "visit_type": "office_visit",
        "chief_complaint": "Imaging results discussion",
        "vitals": {
          "temp_f": 98.0,
          "bp_systolic": 128,
          "bp_diastolic": 76,
          "hr_bpm": 74,
          "weight_lbs": 169.0
        },
        "labs": {},
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Osimertinib 80mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily",
            "Loperamide PRN"
          ],
          "started": [],
          "stopped": ["Dexamethasone discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV EGFR-mutant lung adenocarcinoma, partial response to osimertinib (C34.11)"
          ],
          "differential": []
        },
        "procedures_ordered": ["Repeat imaging in 3 months (August 2024)"],
        "referrals": [],
        "provider_note_snippet": "EXCELLENT IMAGING RESULTS - PARTIAL RESPONSE. BRAIN MRI (5/17): All three brain metastases SIGNIFICANTLY DECREASED IN SIZE. Right frontal lesion 2.1cm  1.2cm (43% reduction), left parietal 1.4cm  0.7cm (50% reduction), right cerebellar 1.0cm  0.5cm (50% reduction). Markedly reduced surrounding edema. No new lesions. CT CHEST/ABD/PELVIS (5/18): Right upper lobe mass 5.2cm  3.1cm (40% reduction). Mediastinal lymph nodes markedly decreased, largest now 1.8cm (was 3.8cm, 53% reduction). Small pleural effusion resolved. No new metastases. Liver, adrenals, bones normal. RESPONSE ASSESSMENT: PARTIAL RESPONSE by RECIST criteria (>30% reduction in target lesions). This is EXCELLENT response to osimertinib at 8 weeks - typical of EGFR-mutant tumors. Patient and wife elated with results. Patient asking 'does this mean I'm cured?' - unfortunately had to explain this is NOT curative but is excellent disease control. Cancer will likely eventually develop resistance to osimertinib (median time to progression 18-24 months), but some patients maintain response for years. When progression occurs, second-line chemotherapy options available. PLAN: (1) Continue osimertinib 80mg daily, (2) Dexamethasone discontinued (brain mets responding well, no edema), (3) Repeat scans in 3 months, (4) Monthly labs, (5) Continue seizure prophylaxis, (6) Encouraged to maintain activities, quality of life. Patient back to baseline weight, working regularly in woodshop (building grandchild's crib currently). Anniversary celebration went well. Patient and family adjusting to 'new normal' of living with cancer.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-08-16",
        "visit_type": "office_visit",
        "chief_complaint": "3-month surveillance imaging and exam",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 130,
          "bp_diastolic": 80,
          "hr_bpm": 78,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 171.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.6,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 268,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 35,
          "ast_u_l": 30,
          "albumin_g_dl": 3.9
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Osimertinib 80mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV EGFR-mutant lung adenocarcinoma, continued response to osimertinib (C34.11)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Brain MRI with contrast",
          "CT chest/abdomen/pelvis",
          "Next surveillance in 3 months (November 2024)"
        ],
        "referrals": [],
        "provider_note_snippet": "6-MONTH FOLLOW-UP. Patient continues to do remarkably well. Minimal symptoms - occasional dry cough, well-controlled diarrhea (1-2x/week), mild skin dryness. Energy excellent, appetite good, weight stable/increasing. Working full-time in woodshop, completed multiple furniture projects. IMAGING RESULTS (8/14 and 8/15): CONTINUED RESPONSE. BRAIN MRI: All lesions stable to slightly smaller. Right frontal 1.2cm  0.9cm, left parietal 0.7cm  0.5cm, right cerebellar 0.5cm  0.4cm. No new lesions. No edema. CT CHEST: RUL mass 3.1cm  2.6cm (16% further reduction, 50% total from baseline). Mediastinal nodes continued decrease, largest 1.2cm. No pleural effusion. CT ABDOMEN/PELVIS: No metastases. Incidental note: Liver appears normal. ASSESSMENT: CONTINUED PARTIAL RESPONSE after 6 months of osimertinib. This is excellent - maintaining response without significant toxicity. Physical exam: Well-appearing, no distress. ECOG performance status 0-1 (fully active). Lungs clear. No focal neuro deficits, cognition intact. Skin changes minimal. Patient and family thrilled. First grandchild born last month (son in California), patient able to travel to meet grandson. Patient saying 'I never thought I'd see this day' given initial Stage IV diagnosis. Discussed cautious optimism - he's doing great but must continue vigilance. PLAN: Continue current regimen, repeat imaging in 3 months. Patient asking about 'how long can this last?' - explained responses vary widely, some patients years, median ~2 years before resistance develops. When/if progression occurs, have second-line options (platinum-doublet chemotherapy, clinical trials). Encouraged to enjoy current quality of life.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "family_updates": "First grandchild born, patient able to travel to California to visit"
        }
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-11-22",
        "visit_type": "urgent_office_visit",
        "chief_complaint": "Increased fatigue, mild cough returning, loss of appetite x2 weeks",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 136,
          "bp_diastolic": 82,
          "hr_bpm": 84,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 166.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 245,
          "creatinine_mg_dl": 1.1,
          "alt_u_l": 88,
          "ast_u_l": 102,
          "alk_phos_u_l": 178,
          "albumin_g_dl": 3.4,
          "total_bilirubin_mg_dl": 1.2
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Osimertinib 80mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV EGFR-mutant lung adenocarcinoma, possible disease progression (C34.11)",
            "Elevated liver enzymes (R74.0)"
          ],
          "differential": [
            "Disease progression",
            "New liver metastases",
            "Drug-induced hepatotoxicity",
            "Intercurrent illness"
          ]
        },
        "procedures_ordered": [
          "STAT CT chest/abdomen/pelvis with contrast",
          "Brain MRI",
          "Liver ultrasound or MRI"
        ],
        "referrals": ["Medical oncology - urgent consultation"],
        "provider_note_snippet": "CONCERNING SYMPTOM CHANGES. Patient reports 2-week history of increasing fatigue, decreased appetite, dry cough returning (not productive, no hemoptysis). Wife notes he's sleeping more, less interested in woodshop. Weight down 5 lbs from August. No headaches, no confusion, no focal weakness. PHYSICAL EXAM: Appears fatigued but alert. Lungs: Decreased breath sounds right upper lobe again (had improved). Abdomen: Liver edge palpable 2cm below costal margin (was not palpable before), no tenderness. LABS CONCERNING: NEW LIVER ENZYME ELEVATION - ALT 88 (was 35), AST 102 (was 30), Alk phos 178 (was normal range), albumin dropping to 3.4. This pattern suggests possible hepatic metastases vs drug toxicity. Hemoglobin also dropping 11.8 (was 12.6). CLINICAL CONCERN: After 9 months of excellent response to osimertinib, now concerning symptoms + lab changes raising suspicion for DISEASE PROGRESSION. This timeline (9 months) is within expected range for development of resistance to EGFR TKIs. Alternatively, could be osimertinib hepatotoxicity (rare but occurs). Ordered STAT imaging - CT chest/abd/pelvis today. Patient and wife very worried - 'is the cancer back?' Explained need imaging to assess. If progression, will need to discuss second-line treatment options. If drug toxicity, may need to hold osimertinib temporarily or permanently. Contacted medical oncology for urgent appointment next week pending imaging results. Patient expressing fear, stating he 'knew it was too good to last.' Wife tearful. Reassured that if progression, have additional treatment options available.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-11-29",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Imaging results - disease progression discussion",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 138,
          "bp_diastolic": 84,
          "hr_bpm": 86,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 165.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.6,
          "wbc_k_ul": 7.4,
          "platelets_k_ul": 238,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 92,
          "ast_u_l": 108,
          "alk_phos_u_l": 185
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily"
          ],
          "started": [
            "Prochlorperazine 10mg q6h PRN nausea",
            "Lorazepam 0.5mg q8h PRN anxiety"
          ],
          "stopped": ["Osimertinib discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV EGFR-mutant lung adenocarcinoma with acquired resistance, progressive disease (C34.11)",
            "Hepatic metastases (C78.7)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Port placement scheduled 12/4",
          "First chemotherapy cycle scheduled 12/6",
          "Baseline labs before chemo",
          "Repeat brain MRI in 4 weeks"
        ],
        "referrals": [
          "Palliative care - symptom management and goals of care discussion"
        ],
        "provider_note_snippet": "DISEASE PROGRESSION CONFIRMED - ACQUIRED RESISTANCE TO OSIMERTINIB. CT CHEST/ABD/PELVIS (11/23): (1) Right upper lobe mass INCREASED 2.6cm  4.8cm (85% increase from prior, though still smaller than baseline 5.2cm). (2) NEW LIVER METASTASES - at least 6 lesions ranging 0.8-2.4cm throughout both lobes, largest in segment 7. Explain elevated LFTs. (3) Mediastinal lymphadenopathy slightly increased. (4) Small right pleural effusion new. BRAIN MRI (11/24): Brain metastases STABLE - no new lesions, existing lesions unchanged from prior (good CNS control maintained). ASSESSMENT: PROGRESSIVE DISEASE after 9 months of osimertinib therapy. This represents ACQUIRED RESISTANCE to EGFR TKI - nearly universal occurrence, median time to progression 18-24 months (patient had 9 months, slightly shorter than median but within expected range). Mechanisms of resistance: T790M mutation (though patient already on 3rd-gen TKI), C797S mutation, MET amplification, BRAF mutation, small cell transformation, others. TREATMENT OPTIONS DISCUSSED: OPTION 1: Platinum-based chemotherapy doublet (Carboplatin + Pemetrexed) - standard second-line for EGFR-mutant NSCLC after TKI failure. Expected response rate 30-40%, median PFS 4-6 months. Side effects: myelosuppression, fatigue, nausea, neuropathy. OPTION 2: Clinical trial (discussed available trials, none perfect match currently). OPTION 3: Best supportive care only. PATIENT DECISION: Wants to proceed with chemotherapy - 'I want to fight, see my grandson grow up.' PLAN: (1) DISCONTINUE osimertinib (no longer effective, may contribute to liver toxicity), (2) Carboplatin AUC 5 + Pemetrexed 500mg/m IV every 3 weeks x 4-6 cycles, then pemetrexed maintenance if responding, (3) Port placement Wednesday, (4) First cycle Friday (C1D1), (5) Standard pre-meds and supportive care, (6) Restaging scans after cycle 2. PROGNOSIS DISCUSSION: Median survival after progression on EGFR TKI with chemotherapy 8-12 months. Patient understanding realistic expectations - this is for quality of life and time, not cure. Palliative care referral for symptom management, advance care planning. Patient and wife tearful but determined. Adult children planning to visit for holidays. Patient asking about immunotherapy - explained PD-L1 was 60% but immunotherapy generally less effective after EGFR TKI resistance, chemotherapy preferred. May consider later if progression.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-12-20",
        "visit_type": "chemotherapy_follow_up",
        "chief_complaint": "Post-Cycle 2 evaluation, assess tolerance and early response",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 132,
          "bp_diastolic": 78,
          "hr_bpm": 80,
          "rr_bpm": 17,
          "spo2_percent": 96.0,
          "weight_lbs": 163.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 4.2,
          "anc": 2.4,
          "platelets_k_ul": 145,
          "creatinine_mg_dl": 1.1,
          "alt_u_l": 68,
          "ast_u_l": 72,
          "alk_phos_u_l": 156
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg BID",
            "Atorvastatin 40mg daily",
            "Levetiracetam 500mg BID",
            "Pantoprazole 40mg daily",
            "Prochlorperazine PRN",
            "Lorazepam PRN"
          ],
          "started": [
            "Vitamin B12 1000mcg IM every 3 weeks (with pemetrexed)",
            "Folic acid 1mg daily (with pemetrexed)",
            "Dexamethasone 4mg BID days before and after chemo"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": [
            "Stage IV lung adenocarcinoma on second-line chemotherapy (C34.11)",
            "Chemotherapy-induced anemia (D64.81)",
            "Chemotherapy-induced thrombocytopenia (D69.59)",
            "Chemotherapy-induced fatigue (R53.83)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Restaging CT chest/abdomen/pelvis with contrast",
          "Cycle 3 scheduled 12/27",
          "Consider Neulasta if ANC drops further"
        ],
        "referrals": [],
        "provider_note_snippet": "COMPLETED 2 CYCLES OF CARBOPLATIN/PEMETREXED (C1D1: 12/6, C2D1: 12/27). TOLERANCE: Moderate side effects as expected. CHEMOTHERAPY TOXICITIES: (1) Myelosuppression - hemoglobin dropped to 10.2 (Grade 1 anemia), platelets 145 (Grade 1 thrombocytopenia), ANC 2.4 (adequate but lower than baseline). May need Neulasta if drops further. (2) Fatigue - moderate (Grade 2), limiting some activities but still functional. Napping daily. (3) Nausea - well-controlled with prochlorperazine, minimal vomiting. (4) Appetite decreased, weight down 2 lbs. (5) No significant neuropathy (carboplatin less neurotoxic than cisplatin). LFTs IMPROVING: ALT 68 (was 92), AST 72 (was 108), Alk phos 156 (was 185) - suggests liver mets may be responding. CLINICAL STATUS: Patient reports cough slightly improved, energy 'not great but okay.' Not working in woodshop much - 'too tired.' Wife reports he's sleeping 10-12 hours/night. RESTAGING SCANS ordered for next week (after cycle 2, before cycle 3) - standard timing to assess response. If responding, will complete 4 cycles then transition to pemetrexed maintenance monotherapy (less myelosuppressive). If stable disease, continue current regimen. If progression, will need to discuss third-line options (clinical trial, immunotherapy trial, hospice focus). Patient and wife anxious about scan results. Holidays difficult - patient wanted to host Christmas but too fatigued, son (TX) bringing family to them instead. Grandson now 4 months old, patient able to hold/interact but tires quickly. Palliative care has been very helpful with symptom management and emotional support. Advance directive completed - patient wants 'everything reasonable' but no CPR if cardiac arrest, no prolonged ICU care, wants quality over quantity. Patient stating 'I just want to see my grandson's first birthday in July.' Wife asking about prognosis - median 8-12 months from progression, but individual variation. Imaging results will guide next steps. Patient tolerating chemotherapy reasonably well given circumstances.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Declining - fatigue limiting activities, not working in woodshop",
          "goals_of_care": "Advance directive completed, wants reasonable treatments but focused on quality time with family"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_014",
    "patient_name": "James Mitchell",
    "patient_profile": "https://images.unsplash.com/photo-1584999734482-0361aecad844?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=880",
    "archetype": "Progressive metastatic cancer with treatment resistance",
    "age": 72,
    "sex": "M",
    "race_ethnicity": "African American",
    "allergies": [
      {
        "allergen": "Bactrim (Trimethoprim-sulfamethoxazole)",
        "reaction": "Severe skin rash, fever",
        "severity": "severe",
        "onset": "2015"
      }
    ],

    "chief_complaint": "Elevated PSA on routine screening, no symptoms",
    "first_visit_date": "2023-06-15",
    "last_visit_date": "2024-09-27",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_014_A",
        "type": "lab_trend",
        "description": "Progressive PSA elevation despite androgen deprivation therapy indicating castration resistance",
        "entities_involved": [
          "PSA",
          "Testosterone",
          "ADT",
          "Castration-resistant prostate cancer"
        ],
        "visits_involved": ["V3", "V4", "V5", "V6"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_014_B",
        "type": "symptom_lab_correlation",
        "description": "New bone pain correlating with widespread bone metastases on imaging",
        "entities_involved": [
          "Bone pain",
          "Bone scan",
          "Skeletal metastases",
          "Alkaline phosphatase elevation"
        ],
        "visits_involved": ["V5", "V6", "V7"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_014_C",
        "type": "persistent_symptom",
        "description": "Progressive bone pain and skeletal-related events requiring palliative radiation and bone-targeted therapy",
        "entities_involved": [
          "Bone pain",
          "Pathologic fracture risk",
          "Zoledronic acid",
          "Palliative radiation"
        ],
        "visits_involved": ["V6", "V7", "V8", "V9"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.9
      },
      {
        "correlation_id": "CORR_014_D",
        "type": "lab_trend",
        "description": "Rising PSA and new metastases on second-line therapy indicating disease progression",
        "entities_involved": [
          "PSA progression",
          "New liver metastases",
          "Treatment failure",
          "Chemotherapy consideration"
        ],
        "visits_involved": ["V8", "V9", "V10"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2023-06-15",
        "visit_type": "office_visit",
        "chief_complaint": "Annual physical, PSA screening",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 148,
          "bp_diastolic": 88,
          "hr_bpm": 72,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 198.0,
          "height_inches": 71.0,
          "bmi": 27.6
        },
        "labs": {
          "psa_ng_ml": 8.4,
          "hemoglobin_g_dl": 14.2,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 245,
          "creatinine_mg_dl": 1.1,
          "glucose_mg_dl": 118,
          "hba1c": 6.2,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.3,
          "calcium_mg_dl": 9.6,
          "alk_phos_u_l": 78,
          "alt_u_l": 32,
          "ast_u_l": 28
        },
        "medications": {
          "continued": ["Amlodipine 10mg daily", "Metformin 500mg BID"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Prediabetes (R73.03)",
            "Obesity (E66.9)"
          ],
          "new_acute": ["Elevated PSA (R97.2)"],
          "differential": [
            "Benign prostatic hyperplasia",
            "Prostatitis",
            "Prostate cancer"
          ]
        },
        "procedures_ordered": [
          "Repeat PSA in 6 weeks",
          "Urinalysis",
          "Urology referral if PSA remains elevated"
        ],
        "referrals": [],
        "provider_note_snippet": "72M African American male for annual physical. Patient overall feeling well, no urinary symptoms, no bone pain, no weight loss. SIGNIFICANT RISK FACTORS: (1) African American race - 2x higher prostate cancer risk, (2) Age 72, (3) Family history - father had prostate cancer diagnosed age 68. Last PSA 2 years ago was 4.2 ng/mL. TODAY'S PSA: 8.4 ng/mL - SIGNIFICANT ELEVATION from 4.2 (doubled). DRE: Prostate mildly enlarged, firm nodule right lobe, no tenderness. CONCERN: PSA doubling time concerning for malignancy, especially with abnormal DRE and risk factors. No recent UTI, no recent ejaculation (asked - last sexual activity >1 week ago). Plan: Repeat PSA in 6 weeks to confirm elevation (can have false elevations from various causes). If remains >4.0, will refer to urology for prostate biopsy. Patient aware of prostate cancer risk given family history. Retired postal worker, lives with wife of 48 years, 3 adult children. Never smoker, occasional alcohol.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "occupation": "Retired postal worker",
          "family_history": "Father had prostate cancer diagnosed age 68, died age 76 (cardiac arrest)",
          "smoking": "Never smoker",
          "alcohol": "Occasional, 1-2 drinks per week",
          "living_situation": "Lives with wife, 3 adult children in same city"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2023-08-10",
        "visit_type": "office_visit",
        "chief_complaint": "Prostate biopsy results discussion",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 142,
          "bp_diastolic": 86,
          "hr_bpm": 74,
          "weight_lbs": 196.0
        },
        "labs": {
          "psa_ng_ml": 8.8,
          "hemoglobin_g_dl": 14.0,
          "creatinine_mg_dl": 1.0
        },
        "medications": {
          "continued": ["Amlodipine 10mg daily", "Metformin 500mg BID"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Prediabetes (R73.03)"],
          "new_acute": [
            "Adenocarcinoma of prostate, Gleason 4+5=9, high-risk (C61)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Bone scan",
          "CT abdomen/pelvis",
          "Chest X-ray",
          "Urology consultation for treatment planning"
        ],
        "referrals": [
          "Urology oncology",
          "Radiation oncology consultation",
          "Medical oncology consultation"
        ],
        "provider_note_snippet": "Patient returns with wife for prostate biopsy results from urology (performed 7/28). PATHOLOGY: Adenocarcinoma identified in 8 of 12 cores. GLEASON SCORE 4+5=9 (HIGH GRADE). Right lobe: 5 cores positive, up to 80% involvement. Left lobe: 3 cores positive, up to 60% involvement. NO perineural invasion noted but extensive tumor burden. STAGING: Clinical stage at least T2c (bilateral involvement). PSA confirmed elevated 8.8. DRE: Firm nodularity bilateral, no obvious extracapsular extension. RISK STRATIFICATION: HIGH-RISK prostate cancer based on: (1) Gleason 9 (very aggressive), (2) PSA >8, (3) Bilateral disease, (4) African American race. STAGING WORKUP ordered: Bone scan (screen for bone mets - common in high-risk disease), CT abdomen/pelvis (lymph nodes, visceral mets), CXR (lung mets rare but check). Referred to multidisciplinary team: urology oncology (surgical options), radiation oncology (EBRT + ADT vs brachytherapy options), medical oncology (systemic therapy). TREATMENT OPTIONS will depend on staging: If localized (M0): Radical prostatectomy vs radiation + ADT vs ADT alone (less aggressive approach). If metastatic (M1): ADT + abiraterone or enzalutamide (systemic therapy, not curative). Patient and wife shocked - 'I had no symptoms at all.' Explained high-grade prostate cancer often asymptomatic until advanced. Good that caught on screening. Patient asking about prognosis - explained depends on whether metastatic. If localized high-risk, 5-year survival 95%+. If metastatic, median survival 4-5 years with modern therapies. Patient wants 'aggressive treatment' - still active, wants to see grandchildren grow up (has 5 grandchildren ages 2-12).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V3",
        "visit_date": "2023-09-08",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Staging results, treatment planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 138,
          "bp_diastolic": 82,
          "hr_bpm": 70,
          "weight_lbs": 195.0
        },
        "labs": {
          "psa_ng_ml": 9.2,
          "testosterone_ng_dl": 485,
          "hemoglobin_g_dl": 13.8,
          "creatinine_mg_dl": 1.0,
          "alk_phos_u_l": 82,
          "calcium_mg_dl": 9.4
        },
        "medications": {
          "continued": ["Amlodipine 10mg daily", "Metformin 500mg BID"],
          "started": [
            "Leuprolide (Lupron) 22.5mg IM every 3 months",
            "Bicalutamide 50mg daily x28 days (antiandrogen flare protection)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Prediabetes (R73.03)"],
          "new_acute": [
            "Metastatic prostate adenocarcinoma, Gleason 9, Stage IV (C61, C79.51)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "PSA and testosterone every 3 months",
          "Repeat staging scans in 6 months",
          "Baseline bone density scan (ADT causes bone loss)"
        ],
        "referrals": ["Palliative care for symptom management"],
        "provider_note_snippet": "STAGING COMPLETE - METASTATIC DISEASE. BONE SCAN (8/28): Multiple foci of increased uptake consistent with osseous metastases - bilateral ribs (4 lesions), thoracic spine (T7, T9, T11), lumbar spine (L3, L4), right iliac bone, left proximal femur. EXTENSIVE SKELETAL INVOLVEMENT. CT CHEST/ABD/PELVIS (8/30): Enlarged pelvic and retroperitoneal lymph nodes, largest 2.8cm left external iliac chain. Prostate gland enlarged, irregular. No visceral metastases (liver, lungs clear). STAGING: cT3aN1M1b - STAGE IV METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (mCSPC). TREATMENT PLAN: Androgen deprivation therapy (ADT) is BACKBONE of treatment. STARTED TODAY: (1) Leuprolide (Lupron Depot) 22.5mg IM every 3 months - LHRH agonist, suppresses testosterone production. First dose given today. (2) Bicalutamide 50mg PO daily x28 days - antiandrogen, prevents 'testosterone flare' from LHRH agonist (can temporarily worsen symptoms). Discontinue after 4 weeks. GOAL: Castrate testosterone level <50 ng/dL (ideally <20 ng/dL). Current testosterone 485 (normal range). Expect castrate levels by 4 weeks. ADDING ABIRATERONE at next visit (once castrate): Abiraterone 1000mg daily + prednisone 5mg BID - further androgen blockade. STAMPEDE trial showed ADT + abiraterone improves survival vs ADT alone in metastatic disease (median survival 5+ years vs 3.5 years). SIDE EFFECTS COUNSELED: (1) Hot flashes (very common, can use SSRI if severe), (2) Erectile dysfunction (expected, permanent), (3) Loss of libido, (4) Fatigue, (5) Muscle loss, weight gain, (6) Bone density loss (will monitor, consider bisphosphonates), (7) Cognitive changes ('chemo brain'), (8) Increased cardiovascular risk. Patient understanding this is PALLIATIVE treatment (not curative) but can provide years of disease control. PSA should drop dramatically - goal <0.2. Most patients respond initially (90-95%), median time to resistance 18-36 months with combination therapy. Patient stoic but concerned. Wife asking about quality of life - reassured most men tolerate ADT reasonably well. Discussed sexuality changes openly - patient and wife understanding. Grandchildren motivation for treatment. Bone density scan ordered (ADT accelerates osteoporosis). Will see in 6 weeks to check testosterone suppression and add abiraterone.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V4",
        "visit_date": "2023-12-15",
        "visit_type": "office_visit",
        "chief_complaint": "3-month ADT follow-up, assess response",
        "vitals": {
          "temp_f": 98.0,
          "bp_systolic": 145,
          "bp_diastolic": 88,
          "hr_bpm": 76,
          "weight_lbs": 202.0
        },
        "labs": {
          "psa_ng_ml": 0.8,
          "testosterone_ng_dl": 12,
          "hemoglobin_g_dl": 13.2,
          "creatinine_mg_dl": 1.0,
          "alk_phos_u_l": 75,
          "alt_u_l": 42,
          "ast_u_l": 35,
          "glucose_mg_dl": 128,
          "hba1c": 6.4
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "Metformin 500mg BID",
            "Leuprolide every 3 months (next dose due today)"
          ],
          "started": [
            "Abiraterone 1000mg daily (4 tablets on empty stomach)",
            "Prednisone 5mg BID",
            "Calcium 1200mg daily with Vitamin D 2000 IU",
            "Venlafaxine 37.5mg daily for hot flashes"
          ],
          "stopped": ["Bicalutamide completed 28-day course"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Metastatic prostate cancer on ADT (C61)"
          ],
          "new_acute": [
            "ADT-induced hot flashes (N95.1)",
            "ADT-related weight gain (E66.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "PSA every 3 months",
          "Testosterone every 6 months",
          "Repeat bone scan in 6 months",
          "Bone density scan in 1 year"
        ],
        "referrals": [],
        "provider_note_snippet": "EXCELLENT RESPONSE TO ADT. PSA dropped from 9.2 to 0.8 (91% reduction) - this is excellent response. Testosterone successfully suppressed to 12 ng/dL (castrate range <20). Leuprolide injection #2 given today. NOW ADDING ABIRATERONE + PREDNISONE for enhanced androgen blockade. SIDE EFFECTS: (1) Hot flashes - SEVERE, 10-15/day, disrupting sleep. Started venlafaxine today (SSRI helps 50-60% reduction in hot flashes). (2) Erectile dysfunction - complete, as expected. Patient and wife adjusted expectations. (3) Fatigue - mild, manageable. (4) Weight gain - up 7 lbs (expected with ADT - decreased muscle mass, increased fat). HbA1c rising 6.4 (was 6.2) - ADT worsens insulin resistance. May need to increase metformin. (5) Mood changes - some irritability per wife, but no depression. PHYSICAL EXAM: Gynecomastia developing (mild breast tissue enlargement - common with ADT). Muscle tone decreased. Otherwise stable. BONE HEALTH: Started calcium/vitamin D supplementation. Will check bone density in 1 year - if osteoporosis, will add zoledronic acid (bisphosphonate). ABIRATERONE EDUCATION: Take on empty stomach (1 hour before or 2 hours after food). With prednisone (prevents mineralocorticoid excess from abiraterone). Monitor LFTs monthly first 3 months (abiraterone can cause hepatotoxicity). Monitor BP (prednisone + abiraterone can cause hypertension, fluid retention, hypokalemia). Patient tolerating treatment well overall. No bone pain currently. PSA goal <0.2 - expect further decline on abiraterone. Wife reports patient more emotional ('cries at commercials now') - explained this is hormone effect. Patient appreciating extra time with grandchildren, attending school events regularly.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-04-12",
        "visit_type": "office_visit",
        "chief_complaint": "Rising PSA on treatment, new lower back pain",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 152,
          "bp_diastolic": 92,
          "hr_bpm": 78,
          "weight_lbs": 206.0
        },
        "labs": {
          "psa_ng_ml": 2.4,
          "testosterone_ng_dl": 15,
          "hemoglobin_g_dl": 12.8,
          "creatinine_mg_dl": 1.1,
          "alk_phos_u_l": 142,
          "alt_u_l": 38,
          "ast_u_l": 32,
          "calcium_mg_dl": 9.8,
          "glucose_mg_dl": 142,
          "hba1c": 6.8
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Abiraterone 1000mg daily",
            "Prednisone 5mg BID",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily"
          ],
          "started": [
            "Hydrochlorothiazide 25mg daily",
            "Tramadol 50mg q6h PRN pain"
          ],
          "stopped": [],
          "dose_changed": ["Metformin increased to 1000mg BID"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, poorly controlled (I10)",
            "Type 2 Diabetes Mellitus, worsening control (E11.9)",
            "Metastatic prostate cancer (C61)"
          ],
          "new_acute": [
            "Biochemical progression on ADT + abiraterone (C61)",
            "Lower back pain, concerning for skeletal progression (M54.5)",
            "Elevated alkaline phosphatase (R74.8)"
          ],
          "differential": [
            "Castration-resistant prostate cancer",
            "Skeletal metastases progression",
            "Musculoskeletal back pain"
          ]
        },
        "procedures_ordered": [
          "Repeat bone scan",
          "CT chest/abdomen/pelvis",
          "PSA in 4 weeks"
        ],
        "referrals": ["Medical oncology - discuss treatment escalation"],
        "provider_note_snippet": "CONCERNING DEVELOPMENTS. PSA RISING: Nadir was 0.3 at 3 months ago (1/12), now 2.4 - this is BIOCHEMICAL PROGRESSION despite castrate testosterone (T=15). PSA risen on 3 consecutive tests: 0.3  0.8  2.4. This suggests development of CASTRATION-RESISTANT PROSTATE CANCER (CRPC) - tumor growing despite very low testosterone. Median time to resistance ~18 months, patient had 7 months (faster than expected). NEW SYMPTOM: Lower back pain x3 weeks, progressively worsening, 6/10 severity, worse with standing/walking, improves with rest. No radiation to legs, no weakness, no bowel/bladder changes. PHYSICAL EXAM: Tenderness to palpation lumbar spine L3-L4 region. No focal neurological deficits, straight leg raise negative. LABS: Alkaline phosphatase ELEVATED 142 (was 75 baseline) - suggests possible bone turnover from metastases. HbA1c rising 6.8 (steroid effect, ADT effect). BP elevated 152/92 - added HCTZ. ASSESSMENT: (1) BIOCHEMICAL PROGRESSION - likely CASTRATION-RESISTANT disease developing, (2) New back pain + rising alk phos concerning for SKELETAL PROGRESSION. Ordered restaging scans urgently. Started tramadol for pain. If imaging shows progression, will need to escalate therapy. OPTIONS: (1) Enzalutamide (different antiandrogen, may work after abiraterone resistance), (2) Docetaxel chemotherapy (platinum-standard for CRPC), (3) Radium-223 if symptomatic bone mets only (bone-targeting radiopharmaceutical), (4) Clinical trial. Patient concerned - 'I thought the treatment was working.' Explained this is expected eventual resistance but happened sooner than typical. Wife worried about pain progression. Reassured have multiple treatment options available. Patient still functional, able to care for grandchildren (though back pain limiting). Weight gain continues (now +11 lbs from start) - combination of ADT, prednisone, decreased activity.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-05-10",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Imaging results - treatment plan for CRPC",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 148,
          "bp_diastolic": 88,
          "hr_bpm": 80,
          "weight_lbs": 207.0
        },
        "labs": {
          "psa_ng_ml": 4.8,
          "testosterone_ng_dl": 18,
          "hemoglobin_g_dl": 12.4,
          "creatinine_mg_dl": 1.0,
          "alk_phos_u_l": 168,
          "calcium_mg_dl": 10.2
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "HCTZ 25mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Prednisone 5mg BID",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily",
            "Tramadol 50mg q6h PRN"
          ],
          "started": [
            "Enzalutamide (Xtandi) 160mg daily (4 capsules)",
            "Zoledronic acid 4mg IV every 3 months",
            "Oxycodone 5mg q6h PRN breakthrough pain"
          ],
          "stopped": ["Abiraterone discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)"
          ],
          "new_acute": [
            "Metastatic castration-resistant prostate cancer with skeletal progression (C61, C79.51)",
            "Pathologic compression fracture T11 (M48.50XA)",
            "Hypercalcemia of malignancy (E83.52)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Palliative radiation to T11 - 8 Gy single fraction",
          "PSA monthly",
          "Repeat imaging in 3 months",
          "Orthopedic spine consultation if neurological changes"
        ],
        "referrals": [
          "Radiation oncology - urgent for T11 lesion",
          "Pain management consultation"
        ],
        "provider_note_snippet": "IMAGING CONFIRMS PROGRESSIVE METASTATIC CRPC. BONE SCAN (5/2): SIGNIFICANT PROGRESSION - new lesions throughout skeleton. Previous lesions increased uptake intensity. NEW: cervical spine (C5, C6), multiple thoracic vertebrae (T4, T6, T8, T11-HIGH INTENSITY suggesting pathologic fracture risk or early fracture), lumbar spine (all levels), sacrum, bilateral femurs, bilateral humeri, skull. DIFFUSE SKELETAL INVOLVEMENT. CT CHEST/ABD/PELVIS (5/3): (1) T11 vertebral body compression fracture - likely pathologic given increased density and known metastases. Mild spinal canal narrowing but no cord compression. (2) Pelvic/retroperitoneal lymphadenopathy stable. (3) NO visceral metastases. (4) Prostate gland enlarged. PSA CONTINUES RISING: 4.8 (doubled since last month). Alkaline phosphatase 168 (bone turnover). Calcium mildly elevated 10.2 (mild hypercalcemia from bone mets). DIAGNOSIS: METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) with symptomatic skeletal progression and pathologic fracture. TREATMENT PLAN: (1) SWITCH FROM ABIRATERONE TO ENZALUTAMIDE 160mg daily - second-generation antiandrogen, works through different mechanism, effective post-abiraterone. Expected PSA response 50-60%, median rPFS 8-10 months. Side effects: fatigue, diarrhea, hot flashes (already has), hypertension, RARE seizure risk (<1%). (2) ZOLEDRONIC ACID 4mg IV every 3 months - bisphosphonate, reduces skeletal-related events (fractures, spinal cord compression, need for radiation/surgery) by ~40%. Prevents bone loss from ADT. Side effects: flu-like symptoms first dose, rare osteonecrosis of jaw (dental exam before starting). First dose given today. (3) PALLIATIVE RADIATION to T11 - single 8 Gy fraction to prevent complete compression fracture and reduce pain. Scheduled for next week. (4) Continue ADT (leuprolide) - even in CRPC, maintain castrate testosterone. (5) PAIN MANAGEMENT: Continue tramadol, added oxycodone for breakthrough. May need long-acting opioid if pain worsens. PROGNOSIS DISCUSSION: Median survival with mCRPC ~2-3 years with sequential therapies. If enzalutamide fails, options include docetaxel chemotherapy, cabazitaxel, radium-223, lutetium-PSMA (if PSMA-positive), clinical trials. Patient understanding disease is progressing but treatable. Back pain 7/10 currently, limiting mobility. Wife concerned about fracture risk - discussed activity modifications, no heavy lifting, careful with falls. Patient wants to attend granddaughter's high school graduation in 2 weeks - reassured radiation should help pain by then.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-07-19",
        "visit_type": "office_visit",
        "chief_complaint": "Post-radiation follow-up, pain assessment",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 142,
          "bp_diastolic": 84,
          "hr_bpm": 74,
          "weight_lbs": 208.0
        },
        "labs": {
          "psa_ng_ml": 3.2,
          "testosterone_ng_dl": 16,
          "hemoglobin_g_dl": 11.8,
          "creatinine_mg_dl": 1.1,
          "alk_phos_u_l": 145,
          "calcium_mg_dl": 9.6
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "HCTZ 25mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Enzalutamide 160mg daily",
            "Prednisone 5mg BID",
            "Zoledronic acid every 3 months",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily"
          ],
          "started": [
            "Oxycodone ER 10mg q12h (long-acting)",
            "Docusate 100mg BID (stool softener)",
            "Senna 2 tablets qHS (laxative)"
          ],
          "stopped": ["Tramadol discontinued"],
          "dose_changed": ["Oxycodone IR 5mg q4h PRN breakthrough (was q6h)"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Metastatic castration-resistant prostate cancer (C61)"
          ],
          "new_acute": [
            "Chronic pain from bone metastases (G89.29)",
            "Opioid-induced constipation (K59.03)",
            "Anemia of chronic disease (D63.8)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "PSA monthly",
          "CBC monthly (monitor anemia)",
          "Next zoledronic acid infusion in August"
        ],
        "referrals": [
          "Pain management - consider interventional procedures if pain worsens"
        ],
        "provider_note_snippet": "PARTIAL RESPONSE TO ENZALUTAMIDE. PSA declined from 4.8 to 3.2 (33% reduction) - modest response, not as dramatic as initial ADT response but indicates some benefit. Testosterone remains castrate (16). Alkaline phosphatase improved 145 (was 168). Calcium normalized. RADIATION COMPLETED: T11 single fraction completed 5/17. Patient reports SIGNIFICANT PAIN IMPROVEMENT at T11 site - was 7/10, now 3/10, at rest, 5/10 with activity. Radiation very effective. Attended granddaughter's graduation pain controlled enough to sit through 2-hour ceremony. PAIN DISTRIBUTION: However, NEW PAIN developing - right hip 6/10, right shoulder 4/10, multiple rib sites 3-4/10. This is typical pattern with widespread bone mets - pain migrates as different lesions become symptomatic. Started long-acting oxycodone (extended-release) for baseline pain control, continue immediate-release for breakthrough. BOWEL REGIMEN: Aggressive bowel regimen for opioid-induced constipation - docusate (stool softener) + senna (stimulant laxative). Patient having BM every 2-3 days, manageable. ANEMIA: Hemoglobin declining 11.8 (was 12.4) - multifactorial: bone marrow infiltration by metastases, chronic disease, possible GI blood loss from NSAIDs (not using), zoledronic acid effect. Will monitor - may need erythropoietin or transfusion if drops further. FUNCTIONAL STATUS: Declining. Using cane for stability. No longer driving (safety concern with opioids + bone pain). Wife doing all driving, shopping. Patient still able to participate in family gatherings but tires easily. Granddaughter visits frequently, helps with yard work. SIDE EFFECTS: Enzalutamide causing moderate fatigue (worse than abiraterone), some dizziness with position changes. Hot flashes continue despite venlafaxine. Weight stable. Appetite fair. PLAN: Continue current regimen. If PSA continues to rise or pain becomes uncontrolled, will need to consider: (1) Docetaxel chemotherapy (most data, improves survival), (2) Radium-223 (bone-targeting, good for bone pain but doesn't help visceral disease if develops), (3) Cabazitaxel (second-line chemo), (4) Clinical trial. Patient and wife discussing advance care planning - wants quality of life prioritized. No interest in aggressive ICU care. Wants to remain at home as long as possible. Palliative care team involved, very helpful with symptom management and family support. Patient expressing gratitude for time with family, 'every day is a gift.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Declining - using cane, no longer driving, fatigues easily",
          "goals_of_care": "Quality of life prioritized, wants to remain at home, no aggressive ICU care"
        }
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-09-13",
        "visit_type": "office_visit",
        "chief_complaint": "PSA rising again, new abdominal discomfort",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 138,
          "bp_diastolic": 80,
          "hr_bpm": 82,
          "weight_lbs": 202.0
        },
        "labs": {
          "psa_ng_ml": 12.4,
          "testosterone_ng_dl": 14,
          "hemoglobin_g_dl": 10.8,
          "creatinine_mg_dl": 1.2,
          "alk_phos_u_l": 198,
          "alt_u_l": 78,
          "ast_u_l": 92,
          "ldh_u_l": 385,
          "albumin_g_dl": 3.2
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "HCTZ 25mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Enzalutamide 160mg daily",
            "Prednisone 5mg BID",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily",
            "Oxycodone ER 10mg q12h",
            "Oxycodone IR 5mg q4h PRN",
            "Docusate 100mg BID",
            "Senna 2 tablets qHS"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Metastatic castration-resistant prostate cancer (C61)"
          ],
          "new_acute": [
            "Biochemical progression on enzalutamide (C61)",
            "Elevated LFTs concerning for hepatic metastases (R74.0)",
            "Worsening anemia (D63.8)",
            "Weight loss (R63.4)"
          ],
          "differential": [
            "Hepatic metastases",
            "Drug-induced hepatotoxicity",
            "Disease progression"
          ]
        },
        "procedures_ordered": [
          "CT chest/abdomen/pelvis with contrast - URGENT",
          "Bone scan",
          "Consider liver MRI if CT equivocal"
        ],
        "referrals": ["Medical oncology - discuss chemotherapy"],
        "provider_note_snippet": "DISEASE PROGRESSION ON ENZALUTAMIDE. PSA RISING RAPIDLY: Was 3.2 in July, now 12.4 (nearly 4-fold increase in 2 months). This indicates ENZALUTAMIDE RESISTANCE developing - worked for only 4 months (shorter than expected median 8-10 months). NEW SYMPTOMS: (1) Right upper quadrant abdominal discomfort x3 weeks, dull ache, 4/10 severity, (2) Decreased appetite, (3) Increasing fatigue, (4) Weight loss - down 6 lbs since July. PHYSICAL EXAM: Liver edge palpable 4cm below costal margin (enlarged), firm, non-tender. No jaundice, no ascites. Continued bone tenderness multiple sites. LABS CONCERNING: (1) ALT 78, AST 92 - NEW ELEVATION (were normal). LDH 385 (elevated, nonspecific tumor marker). (2) Alkaline phosphatase 198 (rising - bone + possible liver source). (3) Albumin 3.2 (declining - nutritional status, liver synthesis). (4) Hemoglobin 10.8 (progressive anemia). ASSESSMENT: Highly suspicious for VISCERAL METASTASES (liver involvement) given: RUQ pain, hepatomegaly, elevated LFTs, rising PSA/alk phos/LDH. This would represent disease progression from bone-only to bone + visceral disease. Ordered urgent CT to confirm. IMPLICATIONS: If liver metastases confirmed, this changes prognosis significantly - median survival with visceral mets ~1 year vs 2-3 years with bone-only disease. TREATMENT OPTIONS: (1) DOCETAXEL CHEMOTHERAPY - platinum-standard for mCRPC, improves survival ~2-3 months, palliates symptoms. Given IV every 3 weeks, typical 6-10 cycles. Side effects: myelosuppression, neuropathy, fatigue, alopecia, fluid retention, nail changes. (2) CABAZITAXEL - second-line taxane chemo, if docetaxel fails. (3) Radium-223 - NOT appropriate if visceral mets (only works for bone). (4) Lutetium-PSMA - if PSMA-PET positive (radioligand therapy, newer option). (5) Clinical trial. (6) Best supportive care/hospice. Patient and wife somber - 'running out of options?' Explained still have chemotherapy which can help. Patient asking about quality vs quantity - wants treatment but not if it will make him 'too sick to enjoy family.' Discussed docetaxel generally tolerable, most men can maintain reasonable quality of life. Will discuss further after imaging confirms progression. Family meeting planned with all 3 children to discuss goals of care.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-10-04",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Imaging results, chemotherapy decision",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 135,
          "bp_diastolic": 78,
          "hr_bpm": 78,
          "weight_lbs": 199.0
        },
        "labs": {
          "psa_ng_ml": 18.6,
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 6.8,
          "anc": 4.2,
          "platelets_k_ul": 245,
          "creatinine_mg_dl": 1.2,
          "alt_u_l": 85,
          "ast_u_l": 98
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "HCTZ 25mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Prednisone 5mg BID",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily",
            "Oxycodone ER 15mg q12h",
            "Oxycodone IR 5-10mg q4h PRN",
            "Docusate 100mg BID",
            "Senna 2 tablets qHS"
          ],
          "started": [
            "Dexamethasone 8mg pre-chemo",
            "Ondansetron 16mg pre-chemo and q8h x2 days post-chemo",
            "Filgrastim (Neupogen) if ANC <1.0"
          ],
          "stopped": ["Enzalutamide discontinued"],
          "dose_changed": ["Oxycodone ER increased to 15mg q12h"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)"
          ],
          "new_acute": [
            "Metastatic castration-resistant prostate cancer with hepatic and skeletal metastases, progressive (C61, C78.7, C79.51)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Port placement scheduled 10/11",
          "First docetaxel cycle 10/18 (C1D1)",
          "CBC and CMP before each cycle",
          "PSA monthly"
        ],
        "referrals": [
          "Hospice consultation for advance planning (not enrolling yet)",
          "Social work for financial assistance with medications"
        ],
        "provider_note_snippet": "IMAGING CONFIRMS EXTENSIVE PROGRESSION. CT CHEST/ABD/PELVIS (9/20): (1) LIVER METASTASES - at least 12 lesions throughout both lobes, largest 3.8cm in right lobe segment 7. NEW since last imaging. (2) Skeletal metastases - progression, increased size and number. (3) Lymphadenopathy increased, largest node 4.2cm retroperitoneum. (4) NEW small pulmonary nodules x3 in lungs, largest 8mm (likely metastases). (5) NO brain metastases (head CT done given rapid progression). BONE SCAN: Superscan appearance - diffuse increased uptake throughout skeleton, so extensive the kidneys barely visible. Consistent with massive skeletal tumor burden. PSA: 18.6 (continues rapid rise despite castrate testosterone). STAGING: Progression from M1b (bone-only) to M1c (bone + visceral metastases). PROGNOSIS: Median survival with M1c disease on chemotherapy ~12-18 months from this point. FAMILY MEETING: All 3 children present with patient and wife. Extensive discussion about goals of care. Patient's goals: (1) Control pain, (2) Maintain mental clarity as long as possible, (3) Stay at home with family, (4) See Christmas with family (3 months away), (5) If possible, see youngest grandson's 3rd birthday (5 months away). Patient DECLINING aggressive chemotherapy if side effects too severe but willing to TRY docetaxel. TREATMENT PLAN: DOCETAXEL 75mg/m IV every 3 weeks x up to 10 cycles (standard regimen). Pre-medications: dexamethasone 8mg x3 days (day before, day of, day after chemo - prevents hypersensitivity reactions and fluid retention), ondansetron for nausea. Filgrastim if neutropenia. EXPECTED OUTCOMES: PSA response 50%, symptom palliation (pain, fatigue) in responders, median survival benefit 2-3 months vs no chemo. SIDE EFFECTS: (1) Myelosuppression - neutropenia (infection risk), anemia (may need transfusions), thrombocytopenia (bleeding risk), (2) Peripheral neuropathy (numbness/tingling fingers/toes, may be permanent), (3) Fatigue (significant), (4) Alopecia (hair loss, expected), (5) Fluid retention (edema, weight gain despite cancer cachexia), (6) Nail changes (onycholysis, darkening), (7) Mucositis, diarrhea. Patient understanding this is PALLIATIVE - goal is symptom control and modest survival extension, not cure. Will proceed with chemo. Port placement next week, first cycle following week. Pain increasing - increased oxycodone ER. Appetite poor - discussed nutritional supplements (Ensure, Boost). Weight loss concerning - down 3 lbs since last visit (9 lbs total since July). Hospice consultation scheduled - NOT enrolling in hospice yet, but want relationship established for smooth transition when time comes. Social work helping with medication costs (financial strain with multiple expensive medications).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "goals_of_care": "Control pain, maintain mental clarity, stay at home, see Christmas and grandson's 3rd birthday"
        }
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-12-20",
        "visit_type": "office_visit",
        "chief_complaint": "Post-Cycle 3 docetaxel, assess response and tolerance",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 128,
          "bp_diastolic": 76,
          "hr_bpm": 76,
          "weight_lbs": 194.0
        },
        "labs": {
          "psa_ng_ml": 8.2,
          "hemoglobin_g_dl": 9.4,
          "wbc_k_ul": 3.8,
          "anc": 2.1,
          "platelets_k_ul": 128,
          "creatinine_mg_dl": 1.3,
          "alt_u_l": 92,
          "ast_u_l": 105
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "HCTZ 25mg daily",
            "Metformin 1000mg BID",
            "Leuprolide every 3 months",
            "Prednisone 5mg BID",
            "Dexamethasone peri-chemo",
            "Ondansetron PRN",
            "Calcium/Vitamin D",
            "Venlafaxine 37.5mg daily",
            "Oxycodone ER 20mg q12h",
            "Oxycodone IR 10mg q4h PRN",
            "Docusate 100mg BID",
            "Senna 2 tablets qHS"
          ],
          "started": [
            "Epoetin alfa (Procrit) 40,000 units SC weekly for anemia",
            "Gabapentin 300mg TID for neuropathy"
          ],
          "stopped": [],
          "dose_changed": ["Oxycodone ER increased to 20mg q12h"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Metastatic castration-resistant prostate cancer on chemotherapy (C61)"
          ],
          "new_acute": [
            "Chemotherapy-induced anemia requiring ESA (D64.81)",
            "Chemotherapy-induced thrombocytopenia (D69.59)",
            "Chemotherapy-induced peripheral neuropathy (G62.0)",
            "Chemotherapy-induced alopecia (L65.1)",
            "Cancer cachexia (R64)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Restaging CT in 2 weeks (after Cycle 4)",
          "Blood transfusion if Hgb <8.5",
          "Next docetaxel Cycle 4 on 12/27"
        ],
        "referrals": [],
        "provider_note_snippet": "COMPLETING CYCLE 3 DOCETAXEL (C1D1: 10/18, C2D1: 11/8, C3D1: 11/29, C4D1: 12/27 planned). MODEST PSA RESPONSE: PSA declined from 18.6 to 8.2 (56% reduction) - this is good partial response. Indicates chemotherapy having some effect on tumor. TOLERANCE: Moderate-severe side effects, manageable but challenging. CHEMOTHERAPY TOXICITIES: (1) MYELOSUPPRESSION - Hemoglobin 9.4 (moderate anemia, started epoetin alfa to stimulate RBC production). Platelets 128 (Grade 1 thrombocytopenia). ANC 2.1 (adequate, no infections). (2) PERIPHERAL NEUROPATHY - Grade 2, numbness/tingling bilateral hands and feet, 'glove-stocking distribution.' Some difficulty with fine motor (buttoning shirts, writing). Started gabapentin. May need docetaxel dose reduction if worsens to Grade 3. (3) FATIGUE - Severe (Grade 3), limiting ADLs. Sleeping 12-14 hours/day. Can participate in brief family gatherings but exhausted. (4) ALOPECIA - Complete hair loss (expected, not bothering patient - wearing baseball caps). (5) EDEMA - Mild lower extremity edema despite dexamethasone (docetaxel causes fluid retention). (6) WEIGHT LOSS - Down 5 lbs since starting chemo (total 13 lbs since July) - CANCER CACHEXIA. Appetite poor despite no significant nausea. Using nutritional supplements. (7) NAIL CHANGES - Darkening, some onycholysis (nail lifting from bed). (8) No significant mucositis or diarrhea. PAIN CONTROL: Adequate with increased opioid doses. Bone pain stable, not worsening. FUNCTIONAL STATUS: Significantly declined. Bed-to-chair most of day. Needs assistance with bathing, dressing. Wife primary caregiver with help from children. No longer able to go to grandchildren's events - they come to him. QUALITY OF LIFE: Patient and wife discussing whether to continue chemotherapy. Patient made it to CHRISTMAS GOAL - family gathering planned for Christmas Day at his home, all children and grandchildren coming. Patient stating 'I don't know if I want more chemo after this cycle - it's taking a lot out of me.' PLAN: Complete Cycle 4, then restaging CT. Will discuss results and reassess goals: (1) If significant response and patient willing, could continue docetaxel (usually do 6-10 cycles), (2) If minimal/no response or patient declining further chemo, transition to hospice focus. (3) Patient may continue ADT (leuprolide) even if stopping chemo - minimal side effects, may provide some disease control. Hospice reconsulted - patient/family not ready yet but understand may transition soon. Home health involved - nurse visits 3x/week, aide daily for personal care. Palliative care managing pain/symptoms excellently. Patient expressing peace with disease trajectory, gratitude for time with family. Wife emotional but coping well with strong family support.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Significantly declined - bed-to-chair, needs assistance with ADLs",
          "support": "Wife primary caregiver with children helping, home health 3x/week, aide daily"
        }
      }
    ]
  },

  {
    "patient_name": "Haily Brown",
    "patient_profile": "data:image/jpeg;base64,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",
    "patient_id": "TEST_PT_015",
    "archetype": "Archetype_10_Preeclampsia_Trajectory",
    "demographics": {
      "age": 28,
      "sex": "F",
      "race_ethnicity": "African American"
    },
    "allergies": [
      {
        "allergen": "Penicillin",
        "reaction": "Rash, unknown details (patient report from childhood)",
        "severity": "unknown",
        "onset": "childhood per patient"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_015_A",
        "type": "lab_trend",
        "description": "Progressive BP elevation from 112/68 at baseline to 168/108, indicating preeclampsia development",
        "entities_involved": [
          "BP systolic",
          "BP diastolic",
          "Gestational age",
          "Proteinuria"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_015_B",
        "type": "symptom_lab_correlation",
        "description": "Rising proteinuria (negative to 4+ protein) correlating with BP elevation and symptoms",
        "entities_involved": [
          "Proteinuria",
          "BP",
          "Headache",
          "Visual changes",
          "Edema"
        ],
        "visits_involved": ["V2", "V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_015_C",
        "type": "lab_trend",
        "description": "Declining platelet count and elevated liver enzymes indicating HELLP syndrome development",
        "entities_involved": ["Platelets", "AST", "ALT", "LDH", "Hemoglobin"],
        "visits_involved": ["V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.95
      },
      {
        "correlation_id": "CORR_015_D",
        "type": "persistent_symptom",
        "description": "Warning symptoms (severe headache, RUQ pain, visual changes) preceding severe preeclampsia with features",
        "entities_involved": [
          "Headache",
          "RUQ pain",
          "Visual disturbance",
          "BP",
          "Labs"
        ],
        "visits_involved": ["V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.93
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-04-12",
        "visit_type": "office_visit",
        "chief_complaint": "First prenatal visit, about 10 weeks pregnant",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 112,
          "bp_diastolic": 68,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 99.0,
          "weight_lbs": 145.0,
          "height_inches": 65.0,
          "bmi": 24.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 88,
          "creatinine_mg_dl": 0.7,
          "gfr_ml_min": 125,
          "hemoglobin_g_dl": 12.6,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 245,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.1,
          "alt_u_l": 18,
          "ast_u_l": 22,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": 1.6,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": ["Prenatal vitamins daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": ["Intrauterine pregnancy, 10 weeks (Z34.00)"],
          "differential": []
        },
        "procedures_ordered": [
          "Dating ultrasound - single viable IUP, 10w3d, EDD November 22, 2024",
          "First trimester labs - all normal",
          "Urinalysis - negative protein, no infection"
        ],
        "referrals": [],
        "provider_note_snippet": "First prenatal visit. G1P0 (primigravida). 28 yo African American female. Risk factors for preeclampsia: African American race, primigravida, family history (mother had preeclampsia). Pre-pregnancy weight 142 lbs, current 145 lbs. BMI 24.1 - normal. Baseline BP 112/68. No proteinuria. Patient healthy, no chronic conditions. Discussed warning signs of preeclampsia given risk factors. Standard prenatal care plan.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "never",
          "alcohol": "none",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-06-21",
        "visit_type": "office_visit",
        "chief_complaint": "Routine visit, 20 weeks, anatomy scan completed",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 78,
          "rr_bpm": 16,
          "spo2_percent": 99.0,
          "weight_lbs": 155.0,
          "height_inches": 65.0,
          "bmi": 25.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Prenatal vitamins daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": ["Intrauterine pregnancy, 20 weeks (Z34.00)"],
          "differential": []
        },
        "procedures_ordered": [
          "Anatomy ultrasound - normal male fetus, all structures normal",
          "Urinalysis - negative protein"
        ],
        "referrals": [],
        "provider_note_snippet": "20 week visit. Weight 155 lbs (10 lb gain, appropriate). BP 118/74 (stable). Anatomy scan normal. Fundal height appropriate. Fetal movement felt. No complaints. Hemoglobin 11.8 - borderline, monitoring. Continue routine prenatal care.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-08-16",
        "visit_type": "office_visit",
        "chief_complaint": "28 week visit, noticed some swelling in hands and feet past week",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 138,
          "bp_diastolic": 86,
          "hr_bpm": 84,
          "rr_bpm": 17,
          "spo2_percent": 98.0,
          "weight_lbs": 168.0,
          "height_inches": 65.0,
          "bmi": 28.0
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 0.8,
          "gfr_ml_min": 118,
          "hemoglobin_g_dl": 11.2,
          "wbc_k_ul": 9.5,
          "platelets_k_ul": 228,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "alt_u_l": 24,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Prenatal vitamins daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Intrauterine pregnancy, 28 weeks (Z34.00)",
            "Gestational edema (O12.05)"
          ],
          "differential": ["Preeclampsia"]
        },
        "procedures_ordered": [
          "Urinalysis - trace protein (100mg)",
          "24-hour urine protein ordered",
          "Uric acid 5.2 mg/dL"
        ],
        "referrals": [],
        "provider_note_snippet": "28 weeks. Weight 168 lbs (23 lb gain, upper limit of normal). BP 138/86 - ELEVATED from baseline 112/68. 1+ pitting edema bilateral hands and feet. Patient reports rings tight. Trace proteinuria on dipstick. Concerning for early preeclampsia. Ordered 24-hour urine protein. Uric acid 5.2 (borderline). Labs otherwise normal including platelets 228, liver enzymes normal. Patient to monitor BP at home twice daily. Return in 1 week for recheck. Instructed on warning signs: severe headache, vision changes, RUQ pain, decreased fetal movement. If 24-hr protein >300mg, diagnosis of preeclampsia confirmed.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-09-06",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up visit, 31 weeks, having headaches past few days",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 152,
          "bp_diastolic": 96,
          "hr_bpm": 88,
          "rr_bpm": 18,
          "spo2_percent": 98.0,
          "weight_lbs": 173.0,
          "height_inches": 65.0,
          "bmi": 28.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 92,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 108,
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 10.2,
          "platelets_k_ul": 185,
          "sodium_meq_l": 137,
          "potassium_meq_l": 4.1,
          "alt_u_l": 42,
          "ast_u_l": 48,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Prenatal vitamins daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Intrauterine pregnancy, 31 weeks (Z34.00)",
            "Preeclampsia without severe features (O14.00)"
          ],
          "differential": ["Preeclampsia with severe features"]
        },
        "procedures_ordered": [
          "24-hour urine protein result: 450mg (ELEVATED, confirms preeclampsia)",
          "Urinalysis - 2+ protein",
          "Uric acid 6.8 mg/dL (elevated)",
          "NST - reactive",
          "Growth ultrasound - fetus 45th percentile"
        ],
        "referrals": [],
        "provider_note_snippet": "PREECLAMPSIA DIAGNOSED. 24-hr urine protein 450mg (>300 confirms diagnosis). BP 152/96. 2+ proteinuria. 2+ edema now to knees. Patient reports frontal headaches daily x3 days, responding to Tylenol. No visual changes, no RUQ pain. Platelets declining to 185 (from 228 three weeks ago). Liver enzymes mildly elevated: ALT 42, AST 48. Uric acid 6.8. This is preeclampsia without severe features currently, but trending worse. NST reactive. Fetus appropriate size. Plan: twice weekly NSTs and labs starting now. Steroids for fetal lung maturity given. Goal to reach 37 weeks if stable, but deliver earlier if severe features develop. Patient on modified bed rest. Home BP monitoring.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-09-13",
        "visit_type": "emergency",
        "chief_complaint": "Severe headache that won't go away, seeing spots, pain under right ribs",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 168,
          "bp_diastolic": 108,
          "hr_bpm": 96,
          "rr_bpm": 20,
          "spo2_percent": 97.0,
          "weight_lbs": 176.0,
          "height_inches": 65.0,
          "bmi": 29.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 9.8,
          "wbc_k_ul": 11.5,
          "platelets_k_ul": 98,
          "sodium_meq_l": 135,
          "potassium_meq_l": 4.2,
          "alt_u_l": 168,
          "ast_u_l": 242,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Prenatal vitamins daily"],
          "started": [
            "Magnesium sulfate IV for seizure prophylaxis",
            "Labetalol IV for BP control",
            "Betamethasone IM for fetal lung maturity (completed)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Intrauterine pregnancy, 32 weeks (Z34.00)",
            "Severe preeclampsia with severe features (O14.12)",
            "HELLP syndrome (O14.2)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Urinalysis - 4+ protein",
          "LDH 685 U/L (elevated)",
          "Peripheral smear - schistocytes present",
          "Coagulation panel - normal",
          "NST - reactive",
          "Emergency cesarean section performed"
        ],
        "referrals": [],
        "provider_note_snippet": "SEVERE PREECLAMPSIA WITH HELLP SYNDROME - OBSTETRIC EMERGENCY. Patient presenting at 32w1d with severe unrelenting headache, visual disturbances (scotomas), and severe RUQ/epigastric pain. BP 168/108. HELLP SYNDROME CRITERIA MET: Hemolysis (Hgb 9.8 down from 10.8, LDH 685, schistocytes on smear), Elevated Liver enzymes (AST 242, ALT 168), Low Platelets (98, down from 185). 4+ proteinuria. Creatinine rising to 1.2. This represents severe preeclampsia with severe features. Started magnesium sulfate for seizure prophylaxis. Labetalol IV for BP control. Steroids completed. IMMEDIATE DELIVERY INDICATED despite 32 weeks gestation - maternal life-threatening condition. Cesarean section performed - delivered 32w1d male infant, 3 lbs 14 oz, Apgars 7/8, admitted to NICU. Patient to ICU for monitoring. This case demonstrates rapid progression from preeclampsia to HELLP syndrome over 1 week.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-10-25",
        "visit_type": "office_visit",
        "chief_complaint": "Postpartum visit, 6 weeks after emergency delivery",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 132,
          "bp_diastolic": 82,
          "hr_bpm": 74,
          "rr_bpm": 16,
          "spo2_percent": 99.0,
          "weight_lbs": 152.0,
          "height_inches": 65.0,
          "bmi": 25.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 0.8,
          "gfr_ml_min": 118,
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 7.5,
          "platelets_k_ul": 242,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.1,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": [],
          "stopped": ["All postpartum medications discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "History of severe preeclampsia/HELLP syndrome (Z86.32)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": ["Urinalysis - no protein"],
        "referrals": [],
        "provider_note_snippet": "6 week postpartum visit. Patient recovered well from severe preeclampsia/HELLP. Spent 4 days in ICU post-delivery, platelets and liver enzymes normalized by post-op day 3. Discharged on post-op day 5. BP normalized immediately after delivery. Current BP 132/82 - borderline but acceptable. No proteinuria. Labs normalized - platelets 242, liver enzymes normal, hemoglobin recovered. Weight 152 lbs (7 lbs above pre-pregnancy). Incision healed well. Baby in NICU for 3 weeks, now home and doing well. IMPORTANT COUNSELING: Patient at HIGH RISK for preeclampsia in future pregnancies (25-50% recurrence risk). Also at increased risk for chronic hypertension and cardiovascular disease later in life. Discussed low-dose aspirin for future pregnancies starting at 12 weeks. Recommended close preconception counseling before next pregnancy. Patient choosing long-acting reversible contraception (IUD) given risks.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing the progression from normal BP to preeclampsia to severe preeclampsia with HELLP",
      "Understanding the significance of rising BP in conjunction with proteinuria",
      "Identifying warning symptoms (headache, visual changes, RUQ pain) as severe features",
      "Recognizing HELLP syndrome criteria (hemolysis, elevated liver enzymes, low platelets)",
      "Understanding the rapidity of progression requiring emergency delivery despite prematurity",
      "Appreciating long-term cardiovascular risk after preeclampsia/HELLP"
    ],
    "evaluation_notes": "This case tests ability to: (1) track progressive BP elevation across pregnancy, (2) recognize preeclampsia development through BP + proteinuria, (3) identify laboratory trends indicating worsening disease (declining platelets, rising liver enzymes), (4) connect warning symptoms with severe features requiring immediate intervention, (5) understand HELLP syndrome as life-threatening complication, (6) recognize the need for emergency delivery despite prematurity, and (7) appreciate long-term health implications. The LLM should flag concern at V3 with elevated BP and edema, recognize preeclampsia diagnosis at V4, identify rapid progression and severe features at V5 requiring emergency intervention, and understand at V6 the implications for future pregnancy and cardiovascular health. This case demonstrates how quickly preeclampsia can progress from mild to life-threatening."
  },

  {
    "patient_id": "TEST_PT_016",
    "patient_name": "Emily Rodriguez",
    "patient_profile": "https://images.unsplash.com/photo-1573497019940-1c28c88b4f3e?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=687",
    "archetype": "Young adult cancer with early relapse requiring salvage therapy",
    "age": 28,
    "sex": "F",
    "race_ethnicity": "Hispanic",
    "allergies": [
      {
        "allergen": "Erythromycin",
        "reaction": "Severe nausea, vomiting",
        "severity": "moderate",
        "onset": "childhood"
      }
    ],

    "chief_complaint": "Persistent enlarged lymph nodes in neck x6 weeks, night sweats",
    "first_visit_date": "2023-08-14",
    "last_visit_date": "2024-09-20",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_016_A",
        "type": "symptom_lab_correlation",
        "description": "Classic B symptoms (fever, night sweats, weight loss) with lymphadenopathy indicating lymphoma",
        "entities_involved": [
          "Lymphadenopathy",
          "Night sweats",
          "Fever",
          "Weight loss",
          "Lymphoma diagnosis"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_016_B",
        "type": "lab_trend",
        "description": "Complete metabolic response to chemotherapy with normalization of PET scan",
        "entities_involved": [
          "PET-CT",
          "Complete response",
          "Chemotherapy efficacy"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_016_C",
        "type": "symptom_lab_correlation",
        "description": "Early relapse within 12 months indicating high-risk disease requiring salvage therapy",
        "entities_involved": [
          "Relapsed lymphoma",
          "PET positive",
          "Refractory disease",
          "Salvage chemotherapy"
        ],
        "visits_involved": ["V6", "V7", "V8"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_016_D",
        "type": "persistent_symptom",
        "description": "Preparation for and successful autologous stem cell transplant for relapsed Hodgkin lymphoma",
        "entities_involved": [
          "Stem cell mobilization",
          "High-dose chemotherapy",
          "Autologous transplant",
          "Engraftment"
        ],
        "visits_involved": ["V8", "V9", "V10"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2023-08-14",
        "visit_type": "office_visit",
        "chief_complaint": "Enlarged lymph nodes in neck x6 weeks, night sweats",
        "vitals": {
          "temp_f": 100.8,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 88,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 132.0,
          "height_inches": 65.0,
          "bmi": 22.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 12.4,
          "platelets_k_ul": 385,
          "esr_mm_hr": 68,
          "creatinine_mg_dl": 0.8,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "ldh_u_l": 345,
          "albumin_g_dl": 3.4
        },
        "medications": {
          "continued": [],
          "started": ["Ibuprofen 400mg q6h PRN fever/discomfort"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Cervical lymphadenopathy (R59.0)",
            "Fever of unknown origin (R50.9)",
            "Night sweats (R61)"
          ],
          "differential": [
            "Lymphoma",
            "Infectious mononucleosis",
            "Tuberculosis",
            "HIV",
            "Toxoplasmosis"
          ]
        },
        "procedures_ordered": [
          "CBC with differential",
          "Comprehensive metabolic panel",
          "Monospot test",
          "HIV test",
          "Chest X-ray",
          "CT neck with contrast"
        ],
        "referrals": ["Hematology-Oncology if imaging concerning"],
        "provider_note_snippet": "28F graduate student presents with 6-week history of progressively enlarging lymph nodes in neck. Initially thought she had 'swollen glands from a cold' but nodes have grown larger. ASSOCIATED SYMPTOMS: (1) Drenching night sweats x4 weeks - soaking through sheets 3-4x/week, (2) Low-grade fevers, (3) 8 lb unintentional weight loss (was 140 lbs, now 132 lbs), (4) Generalized fatigue, (5) Occasional itching (pruritus). DENIES: cough, sore throat (initially had mild sore throat that resolved), chest pain, shortness of breath. NO sick contacts, no recent travel, no TB exposure. PHYSICAL EXAM: Multiple enlarged, firm, non-tender lymph nodes - bilateral cervical chains (largest 3cm right level II), bilateral supraclavicular nodes (1.5-2cm). No axillary or inguinal adenopathy palpated. Liver/spleen not palpably enlarged. No rashes. LABS: Mild anemia 11.8, elevated WBC 12.4, elevated ESR 68, elevated LDH 345 (nonspecific tumor marker). ASSESSMENT: CONSTELLATION OF B SYMPTOMS (fever, night sweats, weight loss) + LYMPHADENOPATHY is HIGHLY CONCERNING FOR LYMPHOMA, particularly Hodgkin lymphoma given patient's age (peak incidence 20-30s) and cervical/supraclavicular involvement. Differential includes infectious causes (EBV, HIV, TB) but clinical picture most concerning for malignancy. Ordered CT neck and chest X-ray. If imaging shows significant adenopathy, will need excisional lymph node biopsy (not FNA - need tissue architecture for lymphoma diagnosis). Patient is graduate student in psychology program, lives with roommate, no significant past medical history. No family history of cancer. Non-smoker, rare alcohol. Patient anxious about diagnosis - 'my friend's mother had lymphoma.' Reassured that if lymphoma, Hodgkin lymphoma in young adults highly curable (>80%).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "occupation": "Graduate student - psychology PhD program, 2nd year",
          "living_situation": "Lives with roommate in apartment",
          "insurance": "Student health insurance",
          "smoking": "Never smoker",
          "alcohol": "Occasional social drinking",
          "support_system": "Parents live 2 hours away, older sister nearby, close friend group"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2023-08-25",
        "visit_type": "office_visit",
        "chief_complaint": "CT results discussion, plan for biopsy",
        "vitals": {
          "temp_f": 99.8,
          "bp_systolic": 115,
          "bp_diastolic": 70,
          "hr_bpm": 82,
          "weight_lbs": 130.0
        },
        "labs": {
          "monospot": "Negative",
          "hiv_test": "Negative"
        },
        "medications": {
          "continued": ["Ibuprofen PRN"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Mediastinal mass (R91.8)",
            "Extensive lymphadenopathy, highly suspicious for lymphoma (R59.9)"
          ],
          "differential": [
            "Hodgkin lymphoma",
            "Non-Hodgkin lymphoma",
            "Thymoma",
            "Germ cell tumor"
          ]
        },
        "procedures_ordered": [
          "Excisional lymph node biopsy - scheduled 8/30",
          "PET-CT whole body (after biopsy confirms diagnosis)"
        ],
        "referrals": ["Surgery for lymph node biopsy", "Hematology-Oncology"],
        "provider_note_snippet": "CT NECK/CHEST RESULTS (8/18): EXTENSIVE LYMPHADENOPATHY throughout cervical, supraclavicular, mediastinal regions. Cervical: Multiple enlarged nodes bilaterally, largest 3.5cm right level II. Supraclavicular: Bilateral adenopathy. MEDIASTINUM: BULKY MEDIASTINAL MASS measuring 8.5 x 7.2 x 10.4cm, occupying anterior mediastinum. No airway or vascular compression. Bilateral hilar adenopathy. No pleural effusion. ABDOMEN (incidental coverage): Enlarged paraaortic lymph nodes. IMPRESSION: Findings highly suggestive of lymphoma. Chest X-ray (8/14): Widened mediastinum (explains bulky mediastinal mass on CT). MONOSPOT AND HIV: Negative. ASSESSMENT: Imaging findings essentially diagnostic of lymphoma. Most likely HODGKIN LYMPHOMA given: (1) Young age, (2) Bulky mediastinal involvement (classic for Hodgkin), (3) Contiguous nodal spread pattern, (4) B symptoms present. Could also be mediastinal large B-cell lymphoma (subtype of non-Hodgkin). PLAN: Excisional lymph node biopsy scheduled with surgery for Wednesday (8/30) - will remove entire right cervical node for pathology. Need tissue architecture, immunohistochemistry, flow cytometry for definitive diagnosis. After diagnosis confirmed, will stage with PET-CT. Patient very anxious, brought parents to appointment. Extensive discussion about likely lymphoma diagnosis and high cure rates. Explained treatment will likely be combination chemotherapy (ABVD or similar regimen) x6 months. Discussed fertility preservation - chemotherapy can affect fertility. Patient not currently in relationship, would like to preserve fertility - referred to reproductive endocrinology for urgent consultation about egg freezing before starting chemo. Patient taking semester off from graduate program - school supportive, holding her spot. Parents staying with her for biopsy and initial treatment planning.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "education": "Taking semester off from PhD program",
          "family_support": "Parents staying with her, very supportive"
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2023-09-15",
        "visit_type": "hematology_oncology_consultation",
        "chief_complaint": "Biopsy results, staging, treatment planning",
        "vitals": {
          "temp_f": 99.2,
          "bp_systolic": 110,
          "bp_diastolic": 68,
          "hr_bpm": 78,
          "weight_lbs": 128.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.2,
          "wbc_k_ul": 11.8,
          "anc": 7.2,
          "platelets_k_ul": 365,
          "esr_mm_hr": 72,
          "creatinine_mg_dl": 0.8,
          "alt_u_l": 30,
          "ast_u_l": 26,
          "ldh_u_l": 398,
          "albumin_g_dl": 3.2
        },
        "medications": {
          "continued": ["Ibuprofen PRN"],
          "started": [
            "Ondansetron 8mg q8h PRN nausea",
            "Prochlorperazine 10mg q6h PRN breakthrough nausea",
            "Compazine suppositories PRN"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Classical Hodgkin Lymphoma, Nodular Sclerosis subtype, Stage IIB with bulky mediastinal disease (C81.10)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Port placement scheduled 9/20",
          "First chemotherapy ABVD Cycle 1 Day 1 scheduled 9/22",
          "Baseline echocardiogram (doxorubicin cardiotoxicity monitoring)",
          "Baseline pulmonary function tests (bleomycin toxicity monitoring)"
        ],
        "referrals": [
          "Reproductive endocrinology - completed egg retrieval 9/8",
          "Fertility preservation - 12 eggs frozen"
        ],
        "provider_note_snippet": "PATHOLOGY RESULTS (9/5): Classical Hodgkin Lymphoma, Nodular Sclerosis subtype. Lymph node architecture effaced by nodular infiltrate with broad bands of fibrosis. REED-STERNBERG CELLS identified (diagnostic of Hodgkin lymphoma). Immunohistochemistry: CD30+, CD15+, CD20-, CD45-, PAX5 weak+. Consistent with classical Hodgkin lymphoma, nodular sclerosis (most common subtype, 60-70% of Hodgkin cases). PET-CT STAGING (9/12): FDG-avid extensive lymphadenopathy - cervical (bilateral, SUV max 8.2), supraclavicular (bilateral, SUV 7.4), mediastinal mass (SUV 12.8), bilateral hilar nodes (SUV 6.8-9.2), paraaortic nodes (SUV 5.4). Spleen appears normal size, no focal splenic lesions. Liver normal. Bone marrow shows normal FDG uptake (no marrow involvement). STAGING: Stage IIB (B = B symptoms present: fever, night sweats, weight loss >10%). Stage II = involvement of 2+ lymph node regions on same side of diaphragm. Has cervical, supraclavicular, mediastinal, hilar involvement - all above diaphragm. BULKY DISEASE: Mediastinal mass 10.4cm, ratio of mass to thoracic diameter >0.33 (bulky disease definition). This makes her UNFAVORABLE Stage II (bulky disease is poor prognostic factor). TREATMENT PLAN: ABVD CHEMOTHERAPY (Adriamycin/doxorubicin, Bleomycin, Vinblastine, Dacarbazine) every 2 weeks x 6 cycles (12 weeks total), followed by RADIATION THERAPY to bulky mediastinal mass. ABVD is standard first-line for advanced/unfavorable Hodgkin. EXPECTED OUTCOMES: 80-85% cure rate for Stage IIB bulky disease with combined modality therapy (chemo + radiation). SIDE EFFECTS COUNSELED: (1) Nausea/vomiting (well-managed with anti-emetics), (2) Myelosuppression (low blood counts, infection risk), (3) Alopecia (hair loss - will occur), (4) Fatigue, (5) Doxorubicin - cardiotoxicity (monitor with echos), (6) Bleomycin - pulmonary toxicity (monitor PFTs, stop if lung toxicity), (7) Vinblastine - neuropathy, (8) Infertility risk (patient completed egg freezing 9/8 - retrieved 12 mature eggs, all frozen). FERTILITY PRESERVATION COMPLETED: Patient underwent ovarian stimulation, egg retrieval successful with 12 eggs vitrified (frozen). This gives her excellent chance for biological children in future via IVF. Patient relieved this completed before starting chemo. BASELINE TESTING: Echo normal (EF 62%), PFTs normal (will repeat after cycle 2 and 4 to monitor for bleomycin toxicity). Port placement scheduled Wednesday, first chemo Friday. Patient anxious but ready to start treatment. Parents will alternate staying with her during treatment weeks. Sister helping with appointments. Graduate program holding her position - can return when ready. Patient asking about prognosis - emphasized 80-85% cure rate, excellent prognosis compared to many cancers. Most patients complete treatment and return to normal life.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "fertility": "Completed egg freezing - 12 eggs frozen successfully"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2023-12-08",
        "visit_type": "office_visit",
        "chief_complaint": "Mid-treatment assessment after Cycle 3 ABVD",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 108,
          "bp_diastolic": 66,
          "hr_bpm": 74,
          "weight_lbs": 125.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.4,
          "wbc_k_ul": 4.2,
          "anc": 2.1,
          "platelets_k_ul": 185,
          "creatinine_mg_dl": 0.7,
          "alt_u_l": 28,
          "ast_u_l": 24
        },
        "medications": {
          "continued": ["Ondansetron PRN", "Prochlorperazine PRN"],
          "started": [
            "Filgrastim (Neupogen) 300mcg SC day 3-10 after each chemo (for neutropenia)",
            "Lorazepam 0.5mg q8h PRN anxiety"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Classical Hodgkin Lymphoma Stage IIB on active treatment (C81.10)",
            "Chemotherapy-induced alopecia (L65.1)",
            "Chemotherapy-induced anemia (D64.81)",
            "Chemotherapy-induced neutropenia (D70.1)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Interim PET-CT after Cycle 4 (standard to assess response)",
          "Repeat echocardiogram",
          "Repeat PFTs"
        ],
        "referrals": [],
        "provider_note_snippet": "COMPLETING CYCLE 3 OF 6 (C1D1: 9/22, C2D1: 10/6, C3D1: 10/20, C4D1: 11/3, C5D1: 11/17, C6D1: 12/1, currently day 7 post-C3). CLINICAL RESPONSE: EXCELLENT. B symptoms completely resolved - no more fevers, no night sweats, weight stabilized. Palpable lymph nodes in neck have dramatically decreased in size - largest node now <1cm (was 3.5cm). Patient feeling 'almost normal' between chemo cycles. TOLERANCE: Moderate side effects, manageable. CHEMOTHERAPY TOXICITIES: (1) Nausea - well-controlled with ondansetron and prochlorperazine, minimal vomiting. (2) ALOPECIA - complete hair loss (expected with ABVD). Patient wearing scarves/hats, handling well emotionally. Hair will regrow after treatment completion. (3) MYELOSUPPRESSION - Neutropenia requiring filgrastim support (Neupogen injections days 3-10 after each cycle to boost white cells). Mild anemia 10.4 (asymptomatic). Platelets adequate. No febrile neutropenia episodes. (4) FATIGUE - moderate, worse days 3-10 post-chemo, improves by day 14. Able to maintain some activities. (5) Mild peripheral neuropathy (vinblastine effect) - fingertip numbness, not bothersome. (6) No pulmonary symptoms (bleomycin toxicity monitoring). INTERIM IMAGING: Will obtain PET-CT after Cycle 4 (mid-treatment standard practice). If showing complete metabolic response (Deauville score 1-3), excellent prognosis. If persistent FDG-avid disease, may need to escalate therapy. Echo and PFTs also due - monitor for cardiopulmonary toxicity. PSYCHOSOCIAL: Patient coping well. Parents taking turns staying with her during chemo weeks. Friends very supportive - organized meal trains, rides to appointments. Patient doing some online coursework from PhD program (not full load but staying connected). Using lorazepam PRN for anticipatory anxiety before chemo (common). Connected with young adult cancer support group - very helpful. Patient expressing optimism - 'I can feel the cancer is gone.' Physical exam: No palpable lymphadenopathy. Port site clean. Alopecia. Otherwise well-appearing. Plan: Complete remaining 3 cycles of ABVD, restaging PET after cycle 4, radiation therapy to mediastinum after cycle 6 completion.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "support": "Meal trains organized, friends very involved, parents alternating weeks"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-02-16",
        "visit_type": "post_treatment_evaluation",
        "chief_complaint": "End-of-treatment PET-CT results, radiation planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 112,
          "bp_diastolic": 70,
          "hr_bpm": 68,
          "weight_lbs": 130.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 6.2,
          "platelets_k_ul": 245,
          "esr_mm_hr": 18,
          "ldh_u_l": 180,
          "albumin_g_dl": 4.0
        },
        "medications": {
          "continued": [],
          "started": [],
          "stopped": ["All chemotherapy-related medications discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Classical Hodgkin Lymphoma, Stage IIB, in complete metabolic remission after ABVD (C81.10, Z85.71)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Radiation therapy simulation",
          "Radiation therapy 20 Gy to mediastinum in 10 fractions"
        ],
        "referrals": ["Radiation oncology", "Survivorship clinic"],
        "provider_note_snippet": "COMPLETED 6 CYCLES ABVD (last cycle 1/12/24). END-OF-TREATMENT PET-CT (2/10/24): COMPLETE METABOLIC RESPONSE (CMR). No FDG-avid disease anywhere. Deauville score 2 (uptake less than mediastinum, consistent with CMR). All previously involved lymph node stations show NO residual FDG uptake. Residual mediastinal soft tissue mass 4.2cm (decreased from 10.4cm) but NO FDG uptake - this is FIBROSIS/SCAR TISSUE, not active lymphoma. Spleen, liver, bone marrow normal. COMPARISON TO BASELINE: Baseline mediastinal mass 10.4cm SUV 12.8  now 4.2cm SUV 1.8 (background blood pool). Cervical nodes: baseline 3.5cm SUV 8.2  now not visible, SUV background. This is COMPLETE RESPONSE. INTERIM PET (after Cycle 4, 11/20/23) also showed CMR - patient has been in remission since mid-treatment. MONITORING TESTS: Echo: EF 58% (decreased from 62% but within normal range - doxorubicin causes small decrease, acceptable). No significant cardiotoxicity. PFTs: Normal, no bleomycin toxicity. ASSESSMENT: COMPLETE REMISSION. This is EXCELLENT outcome. With CMR to ABVD and planned consolidative radiation, cure probability >85-90%. PLAN: RADIATION THERAPY to mediastinal field (involved-field radiation therapy). 20 Gy in 10 fractions over 2 weeks (lower dose used when CMR achieved - reduces late effects while maintaining cure rate). Rationale: Bulky mediastinal disease at diagnosis (>10cm) requires consolidative radiation even with CMR. Reduces relapse risk. Radiation side effects: fatigue, esophagitis (difficulty swallowing), skin changes, long-term risks (secondary cancers, cardiac disease - will need lifelong cardiac surveillance). PHYSICAL EXAM: Well-appearing young woman. No lymphadenopathy. Hair regrowing (short pixie cut emerging). Port still in place (will remove after radiation completion). Patient thrilled with results, emotionally tearful with relief. Parents present, also emotional. Patient asking about returning to graduate program - cleared to return for spring semester after radiation completes (radiation won't be as debilitating as chemo). Discussed SURVIVORSHIP care: (1) Surveillance imaging every 3-6 months x2 years, then annually, (2) Cardiac surveillance (echo every 2-5 years lifelong due to doxorubicin), (3) Thyroid monitoring (radiation can cause hypothyroidism), (4) Secondary cancer screening (radiation increases breast cancer risk - need mammograms starting age 40 or 8 years after radiation, whichever first), (5) Fertility consultation when ready (has frozen eggs). Patient understanding will need lifelong medical follow-up but can resume normal life. Plans to finish PhD, career in clinical psychology. Grateful for support system that got her through treatment.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "education": "Planning to return to PhD program spring semester",
          "hair": "Regrowing - short pixie cut"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-07-12",
        "visit_type": "surveillance_visit",
        "chief_complaint": "Routine 3-month surveillance, new fatigue and mild cough",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 115,
          "bp_diastolic": 72,
          "hr_bpm": 76,
          "weight_lbs": 135.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 7.4,
          "platelets_k_ul": 285,
          "esr_mm_hr": 32,
          "ldh_u_l": 245,
          "creatinine_mg_dl": 0.8
        },
        "medications": {
          "continued": [],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "History of Hodgkin Lymphoma in remission (Z85.71)",
            "Fatigue (R53.83)",
            "Cough (R05.9)"
          ],
          "differential": [
            "Post-radiation fatigue",
            "Upper respiratory infection",
            "Relapsed lymphoma",
            "Radiation pneumonitis"
          ]
        },
        "procedures_ordered": [
          "PET-CT surveillance scan",
          "Chest X-ray",
          "CT chest if X-ray abnormal"
        ],
        "referrals": [],
        "provider_note_snippet": "3-MONTH SURVEILLANCE after completing radiation (radiation completed 3/1/24). Patient back in graduate program full-time, doing well academically. Hair fully regrown, feels 'back to normal' mostly. NEW SYMPTOMS: (1) Fatigue x3 weeks - more tired than usual, napping daily (hadn't been napping). (2) Mild dry cough x2 weeks - non-productive, worse at night. (3) No fevers, no night sweats, no weight loss. PHYSICAL EXAM: No lymphadenopathy palpable. Lungs clear to auscultation. No hepatosplenomegaly. Port removed 3/15, site healed. LABS: ESR mildly elevated 32 (was 18 in February), LDH mildly elevated 245 (was 180). These are nonspecific but can indicate lymphoma activity OR inflammation from other causes. ASSESSMENT: Symptoms could be: (1) Post-radiation effects (fatigue, cough from radiation pneumonitis), (2) Viral upper respiratory infection, (3) RELAPSED LYMPHOMA (concerning given timing - only 5 months since treatment completion, 4 months since radiation). Early relapse (<12 months) indicates more aggressive/resistant disease. Ordered surveillance PET-CT (was due anyway) and CXR. If PET shows recurrent disease, will need salvage chemotherapy + autologous stem cell transplant (standard for relapsed Hodgkin). Patient anxious - 'I thought I was done with this.' Reassured most likely post-radiation inflammation but need to investigate. Results in 1 week.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "education": "Back in PhD program full-time, doing well"
        }
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-07-19",
        "visit_type": "urgent_office_visit",
        "chief_complaint": "PET-CT results discussion",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 82,
          "weight_lbs": 134.0
        },
        "labs": {},
        "medications": {
          "continued": [],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Relapsed Hodgkin Lymphoma, early relapse (<12 months) (C81.10)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Biopsy of FDG-avid lymph node to confirm relapse",
          "Bone marrow biopsy",
          "Consultation for salvage chemotherapy and autologous stem cell transplant"
        ],
        "referrals": [
          "Hematology-Oncology - salvage therapy planning",
          "Transplant team consultation"
        ],
        "provider_note_snippet": "DEVASTATING NEWS: PET-CT (7/15/24) shows RELAPSED DISEASE. Multiple new FDG-avid lymph nodes: Right supraclavicular node 2.4cm SUV 6.8, mediastinal nodes largest 3.2cm SUV 8.4, left hilar node 1.8cm SUV 5.9. Residual mediastinal scar tissue now shows FDG uptake SUV 7.2 (was SUV 1.8 in February - indicates viable tumor within scar). No extranodal disease. CXR: Widened mediastinum again. ASSESSMENT: RELAPSED/REFRACTORY HODGKIN LYMPHOMA. Relapse at 5 months post-treatment completion (10 months from starting ABVD) = EARLY RELAPSE. This indicates chemotherapy-resistant disease. Poor prognostic factor. NEXT STEPS: (1) Biopsy to confirm relapse (could be inflammation but PET findings highly suspicious). (2) If confirmed, SALVAGE CHEMOTHERAPY followed by AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) - this is standard of care for relapsed Hodgkin. Typical salvage regimens: ICE (ifosfamide, carboplatin, etoposide) or DHAP (dexamethasone, cytarabine, cisplatin) x2-3 cycles, then if responding, proceed to ASCT. (3) ASCT involves: collecting patient's own stem cells, high-dose chemotherapy to kill all lymphoma cells (and normal bone marrow), then infusing stem cells back to rescue bone marrow. Hospitalization 3-4 weeks. (4) PR, PROGNOSIS: With salvage therapy + ASCT, 50-60% long-term disease-free survival for early relapsed Hodgkin. Without ASCT, relapsed Hodgkin is not curable. Patient and parents devastated, crying. Patient stating 'I can't believe I have to go through this again.' Explained this is setback but still curable with ASCT. Many patients successfully treated for relapsed Hodgkin go on to live normal lives. Will need more intensive therapy but goal remains cure. TREATMENT TIMELINE: Biopsy next week, salvage chemo starting late July/early August (2-3 cycles over 6-9 weeks), stem cell collection, then ASCT hospitalization likely October. Patient will need to take semester off again from graduate program. Discussed need for strong support system - this will be more intensive than first-line ABVD. Parents committed to being with her throughout. Patient asking 'why did it come back so fast?' - explained some Hodgkin lymphoma has inherent resistance to standard chemo, doesn't mean she did anything wrong. Scheduled urgent hematology-oncology and transplant consultations.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "education": "Will need to take another semester off from PhD program"
        }
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-08-16",
        "visit_type": "medical_oncology_consultation",
        "chief_complaint": "Salvage chemotherapy planning, transplant workup",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 112,
          "bp_diastolic": 68,
          "hr_bpm": 78,
          "weight_lbs": 133.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 6.8,
          "anc": 4.2,
          "platelets_k_ul": 268,
          "creatinine_mg_dl": 0.8,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "ldh_u_l": 285,
          "cd34_cells": "pending after mobilization"
        },
        "medications": {
          "continued": [],
          "started": [
            "Ondansetron 16mg IV pre-chemo and q8h PRN",
            "Dexamethasone 20mg IV pre-chemo",
            "Lorazepam 1mg q8h PRN anxiety/nausea"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Relapsed Classical Hodgkin Lymphoma, early relapse, chemotherapy-refractory (C81.10)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Port placement (new port - old one removed)",
          "ICE chemotherapy Cycle 1 starting 8/19",
          "PET-CT after Cycle 2 ICE",
          "Stem cell mobilization and collection after Cycle 2 if responding"
        ],
        "referrals": [
          "Bone Marrow Transplant team",
          "Social work for financial assistance",
          "Mental health counseling"
        ],
        "provider_note_snippet": "BIOPSY CONFIRMED: Relapsed Classical Hodgkin Lymphoma, nodular sclerosis subtype (same histology). Reed-Sternberg cells present. CD30+, CD15+. Bone marrow biopsy: NO marrow involvement (good - limits transplant complications). TRANSPLANT EVALUATION COMPLETE: Patient is excellent candidate for autologous stem cell transplant. Cardiac function normal (EF 56%), pulmonary function normal, renal function normal, liver function normal. Performance status good (ECOG 1). Dental clearance obtained. SALVAGE CHEMOTHERAPY PLAN: ICE REGIMEN (Ifosfamide, Carboplatin, Etoposide) every 2 weeks x 2 cycles, then reassess response. If achieving partial response or better, will proceed to stem cell mobilization and collection, then ASCT. ICE is more intensive than ABVD: (1) All IV, given over 3 days (Days 1-3), (2) Higher nausea/vomiting risk (aggressive pre-meds), (3) More myelosuppression (will need filgrastim support, possible transfusions), (4) Nephrotoxicity (carboplatin, ifosfamide - aggressive hydration), (5) Neurotoxicity (ifosfamide - can cause confusion/encephalopathy, rare), (6) Hearing loss (carboplatin - high-frequency hearing loss possible), (7) Hemorrhagic cystitis prevention (mesna given with ifosfamide). TREATMENT TIMELINE: ICE Cycle 1: 8/19-8/21 (Days 1-3), ICE Cycle 2: 9/2-9/4, PET-CT: 9/16, Stem cell mobilization: late September (if responding), ASCT admission: October. STEM CELL COLLECTION: After Cycle 2 ICE, will give filgrastim (G-CSF) + plerixafor to mobilize stem cells from bone marrow into bloodstream. Apheresis (similar to dialysis) to collect CD34+ stem cells over 1-2 days. Goal: collect at least 2-5 million CD34 cells/kg body weight. Cells will be frozen until transplant. AUTOLOGOUS STEM CELL TRANSPLANT: High-dose chemotherapy (usually BEAM: carmustine, etoposide, cytarabine, melphalan) or CBV (cyclophosphamide, carmustine, etoposide) to eradicate all lymphoma cells. This also destroys bone marrow. Day 0: Stem cells infused back (like blood transfusion). Days 0-14: NADIR period - no immune system, high infection risk, require hospitalization in protective isolation. Expect: severe mucositis, diarrhea, nausea, requires IV nutrition/pain control. Day +10-14: ENGRAFTMENT - stem cells start producing new blood cells. Gradual recovery over weeks-months. PROGNOSIS WITH ASCT: 50-60% long-term disease-free survival for early relapsed Hodgkin. If disease relapses after ASCT, options include: brentuximab vedotin (antibody-drug conjugate targeting CD30), checkpoint inhibitors (nivolumab/pembrolizumab), CAR-T cell therapy (investigational), allogeneic transplant (donor stem cells, higher risk). Patient understanding this is much more intensive than first treatment. Taking full year off from graduate program. Parents both taking family leave from work to be with her. Sister coordinating care. Patient connected with transplant survivor support group. Financial concerns - transplant costs significant even with insurance. Social work helping with co-pays, travel/lodging assistance (if transplant at different center). Patient tearful but determined: 'I want my life back, I'll do whatever it takes.' Mental health counseling in place - PTSD from relapse common, anticipatory anxiety about treatment.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "education": "Taking full year off from PhD program",
          "support": "Both parents taking family leave, sister coordinating care",
          "financial": "Concerns about transplant costs, social work involved"
        }
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-09-20",
        "visit_type": "post_ice_evaluation",
        "chief_complaint": "Post-ICE Cycle 2, stem cell collection planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 108,
          "bp_diastolic": 66,
          "hr_bpm": 72,
          "weight_lbs": 128.0
        },
        "labs": {
          "hemoglobin_g_dl": 9.8,
          "wbc_k_ul": 3.2,
          "anc": 1.8,
          "platelets_k_ul": 98,
          "creatinine_mg_dl": 1.1,
          "alt_u_l": 45,
          "ast_u_l": 38
        },
        "medications": {
          "continued": ["Ondansetron PRN", "Lorazepam PRN"],
          "started": [
            "Filgrastim 480mcg SC daily x10 days (for stem cell mobilization)",
            "Plerixafor 24mg SC (given night before apheresis)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Relapsed Hodgkin Lymphoma, partial response to ICE chemotherapy (C81.10)",
            "Chemotherapy-induced pancytopenia (D61.818)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Apheresis for stem cell collection - 9/23 and 9/24",
          "Admission for ASCT scheduled 10/7"
        ],
        "referrals": [],
        "provider_note_snippet": "COMPLETED 2 CYCLES ICE (Cycle 1: 8/19-8/21, Cycle 2: 9/2-9/4). TOLERANCE: ICE much more difficult than ABVD as expected. Severe nausea first 5 days each cycle (controlled with high-dose ondansetron + dexamethasone + lorazepam). Profound fatigue. Brief ifosfamide-related confusion Cycle 1 Day 2 (resolved within 24 hours with hydration). Myelosuppression significant - nadirs ANC 0.8 (required hospital admission Cycle 1 for neutropenic fever, 48 hours IV antibiotics, resolved), hemoglobin requiring 2 units RBC transfusion, platelets requiring 1 unit platelet transfusion. No hemorrhagic cystitis (mesna prophylaxis effective). Weight loss 5 lbs (poor appetite, mucositis). Hair loss again (had regrown after ABVD). RESPONSE TO ICE: PET-CT (9/16): EXCELLENT PARTIAL RESPONSE. Significant reduction in FDG-avid disease. Supraclavicular node: 2.4cm SUV 6.8  1.2cm SUV 3.4. Mediastinal nodes: largest 3.2cm SUV 8.4  largest 1.8cm SUV 4.2. Left hilar node: not visible. Deauville score 4 (uptake moderately higher than liver but lower than baseline - indicates partial response, adequate to proceed to transplant). This is GOOD NEWS - disease is chemosensitive to salvage therapy, predicts better transplant outcomes. STEM CELL MOBILIZATION: Starting filgrastim today (Day +10 post-ICE Cycle 2, counts recovering). Will give filgrastim 480mcg SC daily x10 days to mobilize stem cells from bone marrow into peripheral blood. Plerixafor 24mg SC night before apheresis (enhances mobilization). APHERESIS scheduled Monday and Tuesday (9/23-9/24) at apheresis center. Large-bore catheter will be placed, blood circulated through machine to collect CD34+ stem cells, return blood to patient. Process takes 3-4 hours each day. GOAL: Collect minimum 2 million CD34 cells/kg (for 60kg patient = 120 million cells minimum). Typically collect 2-5 million/kg over 1-2 days. Cells will be cryopreserved until transplant. TRANSPLANT ADMISSION: Scheduled 10/7 for autologous stem cell transplant. Pre-transplant conditioning: BEAM chemotherapy (Carmustine Day -6, Etoposide + Cytarabine Days -5 to -2, Melphalan Day -1), Stem cell infusion Day 0 (10/13), Expected engraftment Day +10-14 (10/23-10/27), Discharge when counts recover and eating/drinking (typically Day +14-21). PATIENT STATUS: Physically exhausted, emotionally drained but hopeful about response. Parents with her daily. Sister managing logistics. Patient asking 'am I really going to get through this?' Reassured response to ICE is encouraging sign. Most difficult part still ahead (transplant hospitalization) but she's proven she can handle difficult treatment. Support team in place. Will see her Monday for apheresis.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-10-25",
        "visit_type": "post_transplant_follow_up",
        "chief_complaint": "Post-ASCT Day +12, assessing engraftment",
        "vitals": {
          "temp_f": 99.2,
          "bp_systolic": 102,
          "bp_diastolic": 62,
          "hr_bpm": 88,
          "weight_lbs": 118.0
        },
        "labs": {
          "hemoglobin_g_dl": 8.2,
          "wbc_k_ul": 1.8,
          "anc": 0.9,
          "platelets_k_ul": 45,
          "creatinine_mg_dl": 0.9,
          "alt_u_l": 68,
          "ast_u_l": 72,
          "total_bilirubin_mg_dl": 1.8
        },
        "medications": {
          "continued": [
            "Filgrastim 480mcg SC daily until ANC >1.5",
            "Ondansetron 8mg IV q8h",
            "Morphine PCA for mucositis pain",
            "Acyclovir 400mg PO TID (viral prophylaxis)",
            "Fluconazole 400mg PO daily (fungal prophylaxis)",
            "Levofloxacin 500mg PO daily (bacterial prophylaxis)",
            "Pantoprazole 40mg IV daily"
          ],
          "started": [
            "RBC transfusion today (2 units)",
            "Platelet transfusion today (1 unit)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Relapsed Hodgkin Lymphoma status post autologous stem cell transplant (C81.10, Z94.84)",
            "Post-transplant pancytopenia (D61.818)",
            "Severe oral mucositis Grade 3 (K12.33)",
            "Post-transplant hepatotoxicity (K71.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Daily CBC",
          "Daily CMP",
          "Discharge planning when ANC >0.5 x 48hrs, platelets >20k, afebrile, tolerating PO",
          "PET-CT Day +100 (late January 2025)"
        ],
        "referrals": [],
        "provider_note_snippet": "AUTOLOGOUS STEM CELL TRANSPLANT COURSE: Admitted 10/7, BEAM conditioning Days -6 to -1 (10/7-10/12): Carmustine 300mg/m Day -6, Etoposide 100mg/m + Cytarabine 200mg/m BID Days -5 to -2, Melphalan 140mg/m Day -1. STEM CELL INFUSION DAY 0 (10/13): Infused 3.8 million CD34+ cells/kg (excellent collection, well above minimum). 'Rebirthday' celebrated with parents present. NADIR PERIOD (Days 0-12): As expected, SEVERE toxicities. (1) PANCYTOPENIA - all counts to zero by Day +3. ANC <0.1 Days +3 to +10. Now Day +12, ANC 0.9 (ENGRAFTMENT BEGINNING). Platelets requiring transfusions every 2-3 days. RBC transfusions twice weekly. (2) SEVERE MUCOSITIS - Grade 3 oral mucositis Days +5 to present. Cannot eat or drink, requires TPN (total parenteral nutrition) via central line. Severe mouth/throat pain requiring morphine PCA (patient-controlled analgesia). Using oral cryotherapy (ice chips), frequent mouth rinses. Mucositis expected to improve once engraftment occurs. (3) NAUSEA/VOMITING - controlled with ondansetron, minimal vomiting. (4) DIARRHEA - Grade 2, resolving. (5) FEVERS - low-grade fevers Days +3-7 (common during nadir, cultures negative, resolved with broad-spectrum antibiotics). No documented infections. (6) HEPATOTOXICITY - transient LFT elevation (expected with BEAM regimen), trending down. (7) WEIGHT LOSS - 10 lbs during hospitalization (fluid shifts, poor nutrition, expected). (8) FATIGUE/WEAKNESS - profound, bed-bound during nadir, now starting to ambulate with assistance. ENGRAFTMENT: ANC 0.9 today (Day +12) - first time >0.5 = ENGRAFTMENT! Expected timeline Day +10-14, right on schedule. Platelets 45k (still requiring transfusions until >50k sustained). Hemoglobin 8.2 (transfused today). INFECTION PROPHYLAXIS: Broad-spectrum coverage - levofloxacin (bacterial), fluconazole (fungal), acyclovir (viral, especially HSV reactivation). Will continue prophylaxis for 6-12 months post-transplant (immunosuppressed period). ISOLATION PRECAUTIONS: Strict protective isolation during hospitalization - private room, HEPA filter, masks for all visitors, no fresh flowers/plants, cooked food only. Will continue precautions at home for 3-6 months. DISCHARGE PLANNING: Patient eligible for discharge when: (1) ANC >0.5 x 48 hours (TODAY!), (2) Platelets >20k without transfusion x 24 hours (not yet), (3) Afebrile >48 hours (yes), (4) Tolerating adequate PO intake (not yet - still on TPN). Expect discharge in 3-5 days (Day +15-17). PATIENT STATUS: Physically debilitated but improving. Mucositis pain severe but manageable. Emotionally resilient - 'I know I'm through the worst part.' Parents at bedside daily (only 1 visitor allowed in room). Patient watching engraftment numbers closely, celebrating each ANC increase. PROGNOSIS: Successfully completing ASCT is major milestone. Post-transplant surveillance: Day +30 CBC/CMP, Day +100 PET-CT (critical scan - assesses remission status), then 3-month intervals for 2 years. Long-term risks: secondary malignancies (therapy-related MDS/AML 1-2% risk, solid tumors 5-10% risk over 20 years), infertility (likely permanent despite egg freezing - ovarian function suppressed, may not recover), cardiac toxicity (lifelong surveillance needed), pulmonary toxicity, hypothyroidism. But if Day +100 PET shows complete remission, 50-60% chance of CURE - never needing treatment again. Patient understanding this but focused on getting through immediate recovery. Planning discharge to parents' home (closer to hospital than apartment, better support).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "living_situation": "Will discharge to parents' home for initial recovery period (closer to hospital)"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_017",
    "patient_name": "David Kim",
    "patient_profile": "https://images.unsplash.com/photo-1500648767791-00dcc994a43e?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=687",
    "archetype": "Acute leukemia with life-threatening complications and molecular relapse",
    "age": 58,
    "sex": "M",
    "race_ethnicity": "Asian",
    "allergies": [
      {
        "allergen": "Penicillin",
        "reaction": "Hives, facial swelling",
        "severity": "moderate",
        "onset": "childhood"
      }
    ],

    "chief_complaint": "Severe fatigue, bruising easily x3 weeks",
    "first_visit_date": "2024-03-08",
    "last_visit_date": "2024-09-13",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_017_A",
        "type": "symptom_lab_correlation",
        "description": "Pancytopenia with circulating blasts indicating acute leukemia requiring urgent treatment",
        "entities_involved": [
          "Pancytopenia",
          "Peripheral blasts",
          "Bone marrow failure",
          "AML diagnosis"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_017_B",
        "type": "lab_trend",
        "description": "Achievement of complete remission with induction chemotherapy evidenced by bone marrow assessment",
        "entities_involved": [
          "Blast clearance",
          "Bone marrow remission",
          "Count recovery",
          "7+3 induction"
        ],
        "visits_involved": ["V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_017_C",
        "type": "persistent_symptom",
        "description": "Neutropenic fever and sepsis during induction chemotherapy requiring ICU care",
        "entities_involved": [
          "Neutropenic fever",
          "Septic shock",
          "Pseudomonas bacteremia",
          "ICU admission"
        ],
        "visits_involved": ["V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_017_D",
        "type": "lab_trend",
        "description": "Molecular relapse detected by MRD testing before clinical relapse allowing early intervention",
        "entities_involved": [
          "MRD positive",
          "Molecular relapse",
          "Rising blast percentage",
          "Salvage therapy"
        ],
        "visits_involved": ["V7", "V8", "V9"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-03-08",
        "visit_type": "office_visit",
        "chief_complaint": "Severe fatigue, easy bruising, bleeding gums x3 weeks",
        "vitals": {
          "temp_f": 99.4,
          "bp_systolic": 128,
          "bp_diastolic": 78,
          "hr_bpm": 94,
          "rr_bpm": 18,
          "spo2_percent": 97.0,
          "weight_lbs": 168.0,
          "height_inches": 69.0,
          "bmi": 24.8
        },
        "labs": {
          "hemoglobin_g_dl": 7.2,
          "wbc_k_ul": 2.8,
          "anc": 0.6,
          "platelets_k_ul": 18,
          "peripheral_blasts_percent": 15,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 42,
          "ast_u_l": 38,
          "ldh_u_l": 680,
          "uric_acid_mg_dl": 8.2
        },
        "medications": {
          "continued": ["Lisinopril 10mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)"],
          "new_acute": [
            "Pancytopenia with circulating blasts (D61.818)",
            "Severe thrombocytopenia with bleeding (D69.6)"
          ],
          "differential": [
            "Acute leukemia",
            "Aplastic anemia",
            "Myelodysplastic syndrome",
            "Severe B12/folate deficiency"
          ]
        },
        "procedures_ordered": [
          "STAT bone marrow biopsy",
          "Peripheral blood smear review",
          "Flow cytometry",
          "Cytogenetics",
          "Molecular studies",
          "Type and screen for transfusions",
          "Coagulation panel"
        ],
        "referrals": ["Hematology-Oncology URGENT"],
        "provider_note_snippet": "58M accountant presents with 3-week history of progressive fatigue, weakness, easy bruising. Reports multiple bruises on arms/legs without trauma, gums bleeding when brushing teeth, increased petechiae on lower extremities. Wife noticed increasing fatigue - 'sleeping 12 hours/night, can barely get through work day.' NO fevers, no night sweats, no bone pain, no lymphadenopathy. PAST MEDICAL HISTORY: Hypertension controlled on lisinopril, otherwise healthy. No prior cancers, no chemotherapy/radiation exposure, no toxic exposures. Family owns dry cleaning business but patient works in office (accountant), minimal chemical exposure. Never smoker, rare alcohol. PHYSICAL EXAM: Pale, fatigued-appearing but alert. Multiple ecchymoses (bruises) on extremities, petechiae on lower legs. Gingival oozing. No lymphadenopathy. Liver/spleen not palpably enlarged. No sternal tenderness. LABS CRITICAL: PANCYTOPENIA - Hemoglobin 7.2 (severe anemia), WBC 2.8 with ANC 0.6 (severe neutropenia - high infection risk), Platelets 18,000 (severe thrombocytopenia - bleeding risk). PERIPHERAL SMEAR: 15% CIRCULATING BLASTS (immature white blood cells - HIGHLY ABNORMAL, diagnostic of acute leukemia). LDH 680 (elevated - cell turnover), Uric acid 8.2 (elevated - tumor lysis risk). ASSESSMENT: ACUTE LEUKEMIA - clinical presentation + pancytopenia + circulating blasts = acute leukemia until proven otherwise. Most likely ACUTE MYELOID LEUKEMIA (AML) given age (peak incidence 60s), vs acute lymphoblastic leukemia (ALL, more common in children). This is HEMATOLOGIC EMERGENCY. Severe neutropenia puts at risk for life-threatening infections. Severe thrombocytopenia puts at risk for catastrophic bleeding (intracranial hemorrhage). IMMEDIATE ACTIONS: (1) Called hematology-oncology - patient being ADMITTED TODAY to oncology service, (2) Bone marrow biopsy scheduled for tomorrow (definitive diagnosis, identify AML subtype, cytogenetics/molecular markers guide prognosis and therapy), (3) Will need platelet transfusion (keep platelets >10-20k to prevent spontaneous bleeding), (4) May need RBC transfusion if symptomatic, (5) Urgent chemotherapy likely needed once diagnosis confirmed (AML progresses rapidly, days-weeks without treatment can be fatal). Patient and wife shocked - 'I thought I was just tired from work stress.' Explained this is serious blood cancer requiring immediate hospitalization and intensive chemotherapy, but many patients achieve remission and long-term survival with treatment. Called wife's phone as patient was being directly admitted from clinic. Lives with wife, 2 adult children (daughter in medical school, son in business). Wife very supportive, already contacting children.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "occupation": "Accountant for family dry cleaning business",
          "living_situation": "Lives with wife, 2 adult children (ages 28, 25)",
          "family_history": "Parents both deceased (father stroke age 78, mother dementia age 82), no family history of leukemia or other blood cancers",
          "smoking": "Never smoker",
          "alcohol": "Rare, occasional wine with dinner",
          "insurance": "Commercial insurance through business"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-03-10",
        "visit_type": "inpatient_consultation",
        "chief_complaint": "Hospital Day 2, bone marrow results available",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 122,
          "bp_diastolic": 76,
          "hr_bpm": 88,
          "weight_lbs": 168.0
        },
        "labs": {
          "hemoglobin_g_dl": 8.8,
          "wbc_k_ul": 3.2,
          "anc": 0.8,
          "platelets_k_ul": 32,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 38,
          "ast_u_l": 35,
          "ldh_u_l": 620,
          "uric_acid_mg_dl": 7.8,
          "fibrinogen_mg_dl": 380,
          "d_dimer_ng_ml": 680
        },
        "medications": {
          "continued": ["Lisinopril 10mg daily"],
          "started": [
            "Allopurinol 300mg daily (prevent tumor lysis syndrome)",
            "Levofloxacin 500mg daily (neutropenic prophylaxis)",
            "Fluconazole 400mg daily (antifungal prophylaxis)",
            "Acyclovir 400mg TID (antiviral prophylaxis)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)"],
          "new_acute": [
            "Acute Myeloid Leukemia with normal cytogenetics, NPM1 mutated, FLT3-ITD negative, intermediate risk (C92.00)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Central line (PICC or tunneled catheter) placement",
          "Begin induction chemotherapy 7+3 protocol",
          "Daily CBC",
          "Daily BMP",
          "Cardiac monitoring"
        ],
        "referrals": [],
        "provider_note_snippet": "BONE MARROW BIOPSY RESULTS (3/9): HYPERCELLULAR MARROW (90% cellularity, normal ~50% for age) with 68% MYELOBLASTS. Normal hematopoiesis markedly suppressed. DIAGNOSIS: ACUTE MYELOID LEUKEMIA (AML). FLOW CYTOMETRY: Blasts positive for CD34, CD117, CD33, HLA-DR, MPO - myeloid lineage confirmed. CYTOGENETICS: NORMAL KARYOTYPE 46,XY (no chromosomal abnormalities detected). MOLECULAR STUDIES: NPM1 MUTATION POSITIVE (favorable), FLT3-ITD NEGATIVE (favorable - absence of this bad mutation is good), FLT3-TKD negative, CEBPA negative. RISK STRATIFICATION: INTERMEDIATE-RISK AML based on: Normal cytogenetics + NPM1 mutated + FLT3-ITD negative = European LeukemiaNet (ELN) Favorable-Risk category. Good prognosis - 60-70% achieve complete remission with induction chemo, 40-50% long-term disease-free survival. TREATMENT PLAN: INDUCTION CHEMOTHERAPY - '7+3' protocol (standard of care for fit AML patients): Cytarabine 100mg/m continuous IV infusion x 7 days (Days 1-7), Daunorubicin 60mg/m IV push x 3 days (Days 1-3). GOAL: Eradicate leukemia, achieve COMPLETE REMISSION (CR) defined as <5% blasts in bone marrow, ANC >1000, platelets >100k. EXPECTED TIMELINE: Chemotherapy Days 1-7, Nadir Days 10-21 (severe pancytopenia, high infection/bleeding risk, most dangerous period), Bone marrow biopsy Day 14-21 to assess response, Count recovery Days 21-35 if CR achieved. Hospitalization 4-6 weeks typical. COMPLICATIONS TO EXPECT: (1) Severe myelosuppression - will need RBC/platelet transfusions, growth factors, (2) Neutropenic fever/infections (30-50% get serious infection during induction), (3) Mucositis (mouth sores, difficulty eating), (4) Nausea/vomiting, diarrhea, (5) Tumor lysis syndrome (cancer cells die rapidly, release contents - can cause kidney failure, cardiac arrhythmias), (6) Bleeding complications, (7) Prolonged hospitalization. SUPPORTIVE CARE: Allopurinol to prevent tumor lysis, antimicrobial prophylaxis (levofloxacin, fluconazole, acyclovir), aggressive transfusion support (keep platelets >10k baseline, >50k if bleeding; keep Hgb >7), IV hydration, anti-emetics. PROGNOSIS DISCUSSION: With intermediate-risk AML and favorable molecular profile (NPM1+/FLT3-ITD-), good chance of remission. If achieve CR, will need consolidation chemotherapy (high-dose cytarabine x 3-4 cycles) to maintain remission. Allogeneic stem cell transplant NOT recommended in first remission for favorable-risk AML (transplant has high mortality risk, reserved for high-risk or relapsed disease). Patient and family understanding severity - 'this is life-threatening' but also hopeful given favorable prognostic factors. Adult children both visiting daily. Daughter (medical student) asking detailed questions about treatment, prognosis. Patient stoic, stating 'I'll do whatever it takes.' Wife worried about business (patient manages finances) - assured team will help with disability paperwork. Starting 7+3 induction tomorrow after central line placed.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "Family helping manage business finances during treatment"
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-03-22",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Hospital Day 14, post-induction Day 15, neutropenic fever",
        "vitals": {
          "temp_f": 103.2,
          "bp_systolic": 98,
          "bp_diastolic": 58,
          "hr_bpm": 118,
          "rr_bpm": 24,
          "spo2_percent": 94.0,
          "weight_lbs": 162.0
        },
        "labs": {
          "hemoglobin_g_dl": 7.8,
          "wbc_k_ul": 0.3,
          "anc": 0.0,
          "platelets_k_ul": 12,
          "creatinine_mg_dl": 1.8,
          "alt_u_l": 88,
          "ast_u_l": 102,
          "total_bilirubin_mg_dl": 2.4,
          "lactate_mmol_l": 3.8,
          "procalcitonin_ng_ml": 8.4
        },
        "medications": {
          "continued": ["Allopurinol 300mg daily", "Acyclovir 400mg TID"],
          "started": [
            "Cefepime 2g IV q8h",
            "Vancomycin 1g IV q12h (adjusted for renal function)",
            "Micafungin 100mg IV daily",
            "Norepinephrine IV infusion (vasopressor)",
            "IV fluids - aggressive resuscitation",
            "Morphine PCA for pain"
          ],
          "stopped": ["Levofloxacin discontinued", "Fluconazole discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "AML on induction chemotherapy (C92.00)"
          ],
          "new_acute": [
            "Neutropenic fever (D70.1)",
            "Septic shock (R65.21)",
            "Pseudomonas aeruginosa bacteremia (A41.52)",
            "Acute kidney injury (N17.9)",
            "Severe oral mucositis Grade 4 (K12.33)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Transfer to ICU",
          "Blood cultures (drawn - positive for Pseudomonas)",
          "Chest X-ray",
          "Urine culture",
          "Central line tip culture if line removed",
          "Daily labs",
          "Bone marrow biopsy when stable (assess remission status)"
        ],
        "referrals": ["ICU team", "Infectious disease consultation"],
        "provider_note_snippet": "CRITICAL ILLNESS - SEPTIC SHOCK. Patient developed fever to 103.2F at 2am (Day 15 post-induction). Initial evaluation showed profound neutropenia (ANC 0.0 - ZERO neutrophils), hypotension BP 98/58 despite 3L IV fluid bolus, tachycardia 118, tachypnea 24, O2 sat 94% on 2L NC. TRANSFERRED TO ICU at 6am for septic shock management. CLINICAL PICTURE: This is EXPECTED complication of induction chemotherapy - nadir period with complete absence of neutrophils leaves patient vulnerable to overwhelming infection. Developed PSEUDOMONAS AERUGINOSA BACTEREMIA (blood cultures positive, Gram-negative rod, common in neutropenic patients). Source likely GI tract (translocation of gut bacteria through mucositis-damaged mucosa). SEPTIC SHOCK: Meeting criteria for septic shock - infection + hypotension requiring vasopressors + lactate >2. Aggressive management: (1) BROAD-SPECTRUM ANTIBIOTICS: Cefepime (Pseudomonas coverage) + Vancomycin (MRSA coverage, especially if central line infection). Switched from prophylactic levofloxacin to therapeutic antibiotics. Added micafungin (antifungal - neutropenic patients at risk for invasive fungal infections). (2) VASOPRESSOR SUPPORT: Norepinephrine IV drip to maintain MAP >65 mmHg. (3) IV FLUIDS: Aggressive resuscitation (already received 5L crystalloid). (4) RESPIRATORY SUPPORT: Currently on 2L NC, may need escalation if worsens. CXR shows no infiltrates currently. (5) SUPPORTIVE CARE: Transfusions (platelets, RBC), nutrition (TPN - cannot eat due to mucositis), pain control. COMPLICATIONS: (1) Acute kidney injury - Cr 1.8 (was 1.0), likely from hypotension/sepsis. Adjusting medication doses. (2) Transaminitis - LFTs elevated, likely from sepsis, medications. (3) Severe mucositis Grade 4 - entire mouth/oropharynx with ulcerations, cannot eat or drink, severe pain requiring morphine PCA. Using magic mouthwash, cryotherapy. (4) Profound pancytopenia as expected during nadir. BONE MARROW STATUS: Cannot assess remission yet given clinical instability. Will perform Day 21-28 bone marrow biopsy once patient stable and infection resolving to determine if achieved complete remission. PROGNOSIS: Septic shock in neutropenic AML patients has 20-30% mortality. However, patient young (58), no other comorbidities, appropriate aggressive management initiated. If survives this acute infection and achieves CR, still has good long-term prognosis given favorable-risk disease. FAMILY MEETING: Wife and children at bedside. Very worried - 'is he going to die?' Explained this is life-threatening complication but team doing everything possible. ICU team excellent. Infectious disease consulted. Daughter (medical student) understanding severity. Patient intubated at 2pm due to worsening respiratory status (sepsis-induced ARDS). On mechanical ventilation, sedated. Family staying at hospital 24/7.",
        "patient_reported_adherence": "n/a - intubated/sedated",
        "social_history_updates": {}
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-04-05",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Hospital Day 28, post-induction Day 29, extubated, awaiting bone marrow results",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 82,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 158.0
        },
        "labs": {
          "hemoglobin_g_dl": 9.2,
          "wbc_k_ul": 2.8,
          "anc": 1.2,
          "platelets_k_ul": 68,
          "creatinine_mg_dl": 1.1,
          "alt_u_l": 48,
          "ast_u_l": 42
        },
        "medications": {
          "continued": ["Allopurinol 300mg daily", "Acyclovir 400mg TID"],
          "started": [
            "Levofloxacin 500mg daily (restarted prophylaxis)",
            "Fluconazole 400mg daily"
          ],
          "stopped": [
            "Cefepime completed 14-day course",
            "Vancomycin completed",
            "Micafungin completed",
            "Norepinephrine discontinued",
            "Morphine PCA discontinued"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "AML, status post induction chemotherapy (C92.00)"
          ],
          "new_acute": [
            "Acute Myeloid Leukemia in complete remission (C92.01)",
            "History of Pseudomonas septic shock, resolved (Z86.19)",
            "Post-ICU weakness (M62.81)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Discharge planning",
          "Consolidation chemotherapy Cycle 1 scheduled 2 weeks after discharge"
        ],
        "referrals": [
          "Physical therapy for reconditioning",
          "Nutrition for weight restoration"
        ],
        "provider_note_snippet": "REMARKABLE RECOVERY. Patient transferred out of ICU on Day 24 (after 9 days ICU care), extubated Day 23. Pseudomonas bacteremia cleared with 14-day cefepime course (repeat blood cultures negative). Kidney function normalized. Mucositis resolved. COUNTS RECOVERING: ANC 1.2 (above 1.0 = engraftment), platelets 68 (improving, no longer transfusion-dependent), hemoglobin 9.2. This is EXCELLENT count recovery indicating bone marrow regeneration. BONE MARROW BIOPSY DAY 28 (4/4) RESULTS: <5% BLASTS (goal <5%), Normal trilineage hematopoiesis, No evidence of residual leukemia, FISH for NPM1 mutation NEGATIVE (molecular remission). DIAGNOSIS: COMPLETE REMISSION (CR). This is OUTSTANDING outcome. Patient achieved CR with first induction cycle - happens in 60-70% of favorable-risk AML, exactly as expected. MINIMAL RESIDUAL DISEASE (MRD) testing: MRD NEGATIVE by flow cytometry (no detectable leukemia cells at sensitivity of 1 in 10,000 cells). This is VERY favorable - MRD-negative CR associated with better long-term outcomes than MRD-positive CR. PHYSICAL STATUS: Patient weak from prolonged hospitalization (28 days inpatient, 9 days ICU, 5 days intubated). Lost 10 lbs (168  158 lbs). Physical therapy working on reconditioning. Able to ambulate with assistance. Appetite returning. Mucositis resolved, eating soft foods. PLAN: (1) DISCHARGE in 2-3 days once patient ambulatory independently and eating well, (2) HOME RECOVERY x2 weeks with close outpatient monitoring (CBC 2x/week to ensure counts stable), (3) CONSOLIDATION CHEMOTHERAPY: High-dose cytarabine (HiDAC) 3g/m IV q12h x 6 doses (Days 1, 3, 5) = 1 cycle. Will repeat x 3-4 cycles total (typical for favorable-risk AML in CR). Each cycle requires 5-7 day hospitalization for chemo administration + monitoring for complications (cerebellar toxicity from high-dose cytarabine - ataxia, dysarthria). (4) MRD monitoring every 3 months after consolidation completion to detect early relapse. PROGNOSIS: With favorable-risk AML achieving MRD-negative CR and completing consolidation, 40-50% chance of CURE (never needing treatment again). 50-60% will eventually relapse (median time to relapse 12-24 months), at which point would need salvage chemotherapy + allogeneic stem cell transplant. Patient and family overjoyed with remission news. Wife tearful with relief. Daughter (medical student) understanding this is 'first hurdle cleared' but needs consolidation to maintain remission. Patient stating 'I'm grateful to be alive - that sepsis almost killed me.' Motivated to complete consolidation therapy. Plans to return to work part-time after Cycle 1 consolidation (accountant work, can do from home). Family business doing okay with temp help.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "Planning to return part-time after first consolidation cycle"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-06-14",
        "visit_type": "office_visit",
        "chief_complaint": "Post-Consolidation Cycle 2, routine follow-up",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 122,
          "bp_diastolic": 76,
          "hr_bpm": 74,
          "weight_lbs": 165.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 4.8,
          "anc": 2.8,
          "platelets_k_ul": 145,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 35,
          "ast_u_l": 32
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Allopurinol 300mg daily",
            "Levofloxacin 500mg daily (during neutropenic periods)",
            "Fluconazole 400mg daily",
            "Acyclovir 400mg TID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "AML in first complete remission (C92.01)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Consolidation Cycle 3 scheduled 4 weeks",
          "Bone marrow biopsy with MRD testing in 1 month"
        ],
        "referrals": [],
        "provider_note_snippet": "CONSOLIDATION THERAPY PROGRESSING WELL. Completed Consolidation Cycle 1 (HiDAC) in late April (5 days inpatient, tolerated well, no cerebellar toxicity). Completed Consolidation Cycle 2 in late May (6 days inpatient, mild nausea but overall good tolerance). Counts recovering appropriately between cycles. CURRENT STATUS: Patient feeling well, energy good (80-90% of baseline). Working part-time from home (3-4 hours/day managing family business finances). Weight restored to near-baseline. Appetite excellent. No infections between cycles. PHYSICAL EXAM: Well-appearing, no acute distress. No lymphadenopathy. Lungs clear. No hepatosplenomegaly. CBC: All counts normal range. PLAN: Cycle 3 consolidation in 4 weeks. Will obtain bone marrow biopsy before Cycle 3 to confirm continued remission and MRD-negative status (standard practice - want to ensure no early relapse before giving more chemotherapy). If bone marrow shows continued CR and MRD-negative, will complete Cycle 3 and then Cycle 4 (final consolidation cycle). After Cycle 4 completion, will transition to SURVEILLANCE phase - bone marrow with MRD every 3 months x2 years, then every 6 months x3 years, then annually. PROGNOSIS DISCUSSION: If completes all 4 consolidation cycles and remains MRD-negative, 40-50% cure rate. Patient understanding there's also 50-60% chance of eventual relapse, but trying to stay positive. If relapse occurs, would need salvage chemotherapy to get back into remission, then allogeneic stem cell transplant (from matched sibling, matched unrelated donor, or haploidentical donor). Patient has 1 sibling (younger brother) who could be tested for HLA match if needed in future. QUALITY OF LIFE: Patient and family adjusting to 'new normal.' Patient grateful for each day. Close with grandchildren (son has 2 children ages 5 and 3), spending lots of time with them. Wife managing business operations. Daughter finishing medical school, inspired by father's illness to pursue hematology-oncology. Patient joking 'at least something good came from this cancer - my daughter found her calling.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "Working part-time from home, 3-4 hours daily",
          "family": "Close with grandchildren, spending quality time together"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-08-30",
        "visit_type": "office_visit",
        "chief_complaint": "Post-Consolidation Cycle 4 (final), end-of-treatment evaluation",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 72,
          "weight_lbs": 168.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.4,
          "wbc_k_ul": 5.2,
          "anc": 3.1,
          "platelets_k_ul": 168,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 32,
          "ast_u_l": 28
        },
        "medications": {
          "continued": ["Lisinopril 10mg daily"],
          "started": [],
          "stopped": [
            "Allopurinol discontinued",
            "Levofloxacin discontinued",
            "Fluconazole discontinued",
            "Acyclovir discontinued"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "AML in first complete remission, completed consolidation (C92.01)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Bone marrow biopsy with MRD testing in 3 months (November)",
          "CBC monthly",
          "Transition to surveillance phase"
        ],
        "referrals": ["Survivorship clinic"],
        "provider_note_snippet": "COMPLETED ALL PLANNED CONSOLIDATION THERAPY. Cycle 4 (final HiDAC) completed in early August, patient discharged Day 6, counts recovered well. END-OF-TREATMENT BONE MARROW (8/28): <5% blasts, Normal hematopoiesis, MRD NEGATIVE by flow cytometry and NPM1 molecular testing. CONTINUED COMPLETE REMISSION. This is EXCELLENT - maintained CR through entire consolidation course with persistent MRD-negative status. This is best possible outcome at this, time point. CURRENT STATUS: Patient feeling 'back to normal.' Energy 95% of baseline. Working nearly full-time hours from home office. Weight restored to pre-leukemia baseline (168 lbs). All prophylactic antimicrobials discontinued - immune system recovered, no longer immunosuppressed. PHYSICAL EXAM: Well-appearing, no acute distress. Full energy. No lymphadenopathy. No hepatosplenomegaly. CBC completely normal. SURVEILLANCE PLAN: (1) BONE MARROW with MRD testing every 3 months x 2 years (most relapses occur within first 2 years), then every 6 months x 3 years, then annually lifelong. (2) CBC with differential monthly x 1 year, then every 3 months. (3) Monitor for late effects of chemotherapy: Cardiac (anthracycline cardiotoxicity - echocardiogram every 2 years), Secondary malignancies (therapy-related MDS/AML risk 1-2%, increased solid tumor risk long-term), Neuropathy (from chemo), Cognitive changes ('chemo brain'). (4) AGE-APPROPRIATE CANCER SCREENING (colonoscopy, etc.). PROGNOSIS: With favorable-risk AML, MRD-negative CR maintained through consolidation, 40-50% chance of CURE. If stays in remission for 5 years, cure probability increases to 70-80% (most relapses by 5 years). WHAT TO WATCH FOR - SIGNS OF RELAPSE: Fatigue, easy bruising/bleeding, fevers, bone pain, new lumps (extramedullary disease), recurrent infections. If any concerning symptoms, contact immediately for evaluation. SURVIVORSHIP ISSUES: Patient asking about 'getting back to normal life.' Encouraged to resume all activities - exercise, travel (okay after immune recovery), diet (no restrictions). Return to work full-time when ready. NO DIETARY RESTRICTIONS now that immune system recovered (during chemo had to avoid raw foods, now can eat anything). Discussed: (1) It's normal to have anxiety about recurrence - 'scanxiety' before each bone marrow biopsy common. (2) PTSD from cancer experience common - available counseling if needed. (3) Some people struggle with transition from 'active treatment' to 'surveillance' - feels less safe without frequent doctor visits/treatment. This is normal. (4) Relationships may have changed during treatment - takes time to re-establish 'normal.' Patient and wife attending AML support group, finding it helpful. Daughter completed medical school, starting internal medicine residency, strongly considering hematology-oncology fellowship. Patient joking 'my cancer gave her a career path.' Family grateful for remission, treasuring time together. Patient stating 'I don't take any day for granted anymore - that's the gift cancer gave me, perspective.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "Nearly full-time from home office",
          "support": "Attending AML survivor support group with wife"
        }
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-12-06",
        "visit_type": "office_visit",
        "chief_complaint": "3-month surveillance bone marrow results",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 120,
          "bp_diastolic": 76,
          "hr_bpm": 74,
          "weight_lbs": 170.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 5.6,
          "anc": 3.4,
          "platelets_k_ul": 185,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 35,
          "ast_u_l": 30,
          "ldh_u_l": 245
        },
        "medications": {
          "continued": ["Lisinopril 10mg daily"],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of AML in remission (Z85.6)"
          ],
          "new_acute": ["Minimal residual disease detected (C92.01)"],
          "differential": ["Molecular relapse", "MRD persistence vs recurrence"]
        },
        "procedures_ordered": [
          "Repeat bone marrow biopsy in 4 weeks",
          "CBC every 2 weeks",
          "Consultation for clinical trials or preemptive therapy"
        ],
        "referrals": ["Hematology-oncology - discuss management options"],
        "provider_note_snippet": "CONCERNING FINDING ON SURVEILLANCE BONE MARROW. Bone marrow biopsy performed 11/25. RESULTS (12/5): Morphology: <5% blasts (still meets CR criteria morphologically), Normal trilineage hematopoiesis, BUT: MRD TESTING POSITIVE - NPM1 mutation DETECTED at 0.02% level by quantitative PCR (was undetectable since achieving CR). This represents MOLECULAR RELAPSE or MRD RECURRENCE. ASSESSMENT: Detection of MRD after being MRD-negative is concerning for impending hematologic relapse. Studies show patients who convert from MRD-negative to MRD-positive have 70-80% chance of overt hematologic relapse within 3-12 months. However, not all MRD-positive patients relapse - sometimes MRD can fluctuate. SIGNIFICANCE: This is EARLY WARNING SIGN. Currently patient has: (1) Morphologic CR (<5% blasts), (2) Normal blood counts, (3) No symptoms, (4) BUT molecular evidence of residual/recurrent leukemia at very low level (1 in 5,000 cells). This is called 'molecular relapse' or 'MRD relapse.' OPTIONS: (1) WATCH AND WAIT: Repeat bone marrow in 4 weeks. If MRD rising (quantitatively increasing), indicates progression toward relapse. If MRD stable or decreasing, might just be transient detection. (2) PREEMPTIVE THERAPY: Start treatment NOW before overt relapse. Options: Azacitidine (hypomethylating agent, less toxic than chemo, might clear MRD), Clinical trial (several trials for MRD-positive AML), Allogeneic stem cell transplant (curative option but high risk - typically reserved for overt relapse). (3) WAIT FOR OVERT RELAPSE: Some argue to wait until blast count rises before treating since not all MRD-positive patients relapse. However, treating at molecular relapse stage may be more effective than waiting for hematologic relapse. PATIENT IMPACT: Patient devastated. Had been feeling great, back to full activities, thinking cancer was behind him. Now faced with reality that cancer may be returning. CBC currently normal - no symptoms. This makes it harder to accept need for intervention. PLAN: (1) Repeat bone marrow in 4 weeks with quantitative MRD testing to see if MRD level rising or stable. (2) HLA-type patient and younger brother (potential stem cell donor) to know if matched sibling available if need transplant. (3) If MRD rising, recommend clinical trial or azacitidine followed by allogeneic transplant in second remission. (4) Close monitoring - CBC every 2 weeks. PROGNOSIS: If MRD-positive converts to overt relapse (likely 70-80% chance), will need salvage chemotherapy to achieve second remission, then allogeneic stem cell transplant (only curative option for relapsed AML). With second remission + transplant, 30-40% long-term survival. Without transplant, relapsed AML is fatal. Patient and wife very upset. Daughter (now intern in medicine residency) called in to discuss - she understands significance. Wife asking 'why did it come back?' Explained AML is difficult disease, even favorable-risk AML has 50-60% relapse rate. This is why we do close monitoring - caught it early at molecular stage. Patient asking if he did something wrong - absolutely not, this is biology of disease. Family meeting scheduled in 1 week after repeat bone marrow to discuss treatment plan.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {}
      },
      {
        "visit_id": "V8",
        "visit_date": "2025-01-10",
        "visit_type": "hematology_oncology_consultation",
        "chief_complaint": "Rising MRD, treatment planning",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 78,
          "weight_lbs": 169.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 5.2,
          "anc": 3.0,
          "platelets_k_ul": 168,
          "peripheral_blasts_percent": 2,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 38,
          "ast_u_l": 35,
          "ldh_u_l": 298
        },
        "medications": {
          "continued": ["Lisinopril 10mg daily"],
          "started": [
            "Azacitidine 75mg/m SC Days 1-7 every 28 days (starting today)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)"],
          "new_acute": [
            "Relapsed AML, molecular/early hematologic relapse (C92.01)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Bone marrow biopsy after Cycle 2 azacitidine",
          "CBC weekly",
          "HLA typing completed - brother is 10/10 match",
          "Allogeneic transplant evaluation"
        ],
        "referrals": [
          "Bone Marrow Transplant team - evaluation for allogeneic SCT"
        ],
        "provider_note_snippet": "REPEAT BONE MARROW (1/3/25): MRD LEVEL RISING - NPM1 mutation now detected at 0.18% (was 0.02% in November) = 9-fold increase in 6 weeks. Blasts increasing: 8% blasts on bone marrow aspirate (was <5%). PERIPHERAL BLOOD: 2% circulating blasts (new finding). LDH rising 298 (was 245). ASSESSMENT: MOLECULAR RELAPSE PROGRESSING TO HEMATOLOGIC RELAPSE. Currently in GRAY ZONE - no longer in morphologic CR (>5% blasts) but not yet overt relapse (>20% blasts). This is early relapse caught by vigilant MRD monitoring. TREATMENT PLAN: TWO-STEP APPROACH: STEP 1: BRIDGING THERAPY to achieve second remission: Azacitidine 75mg/m subcutaneous Days 1-7 every 28 days (hypomethylating agent, less toxic than intensive chemotherapy, can reduce blast burden and achieve remission in some relapsed AML patients). Will give 1-2 cycles, reassess with bone marrow. STEP 2: ALLOGENEIC STEM CELL TRANSPLANT (allotransplant): Once achieve second remission (or achieve blast count <10-20%), proceed urgently to allogeneic transplant from matched sibling donor (brother). This is ONLY curative option for relapsed AML. ALLOGENEIC TRANSPLANT EXPLAINED: Uses DONOR stem cells (brother's) instead of patient's own (autologous). Process: (1) Patient receives high-dose chemotherapy (conditioning regimen - kills leukemia cells and patient's immune system), (2) Brother's stem cells infused (like blood transfusion), (3) Brother's immune system engrafts in patient, (4) Graft-versus-leukemia effect - brother's immune cells recognize and kill any remaining leukemia cells. RISKS: Higher risk than autologous transplant. Mortality risk 15-30% (from infections during immune suppression, graft-versus-host disease, organ toxicity). Graft-versus-host disease (GVHD) - donor immune cells attack patient's normal tissues (skin, gut, liver). Can be acute (first 100 days) or chronic (lifelong). Requires immunosuppression medications for months-years. Despite risks, NECESSARY - relapsed AML without transplant is 100% fatal. HLA TYPING: Brother is 10/10 HLA MATCH (perfect match, ideal donor). Brother eager to donate, very supportive. Transplant evaluation starting - patient needs dental clearance, cardiac clearance, pulmonary clearance. Brother will undergo donor workup. PROGNOSIS: With second remission + allogeneic transplant, 30-40% long-term disease-free survival. Without transplant, median survival 6-12 months. AZACITIDINE STARTED TODAY: Cycle 1 Day 1. Subcutaneous injections Days 1-7, then 3 weeks off. Outpatient treatment (much easier than induction chemotherapy). Side effects: Injection site reactions, low blood counts (less severe than chemo), nausea (mild), fatigue. Will check CBC weekly, bone marrow after Cycle 2 (8 weeks). If blasts decreasing and MRD improving, will proceed to transplant. If not responding or worsening, may need intensive salvage chemotherapy (FLAG-IDA or similar regimen) to achieve remission before transplant. Patient and family understanding gravity of situation. This is life-threatening relapse. Transplant is only cure option. Patient stating 'I'll do whatever it takes, I'm not giving up.' Brother already meeting with transplant team for donor evaluation. Daughter helping coordinate care. Wife managing business, will need to close or hire manager during transplant hospitalization (patient hospitalized 4-6 weeks for transplant). Financial concerns - transplant very expensive even with insurance. Social work helping with financial assistance applications.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "May need to close business temporarily or hire manager during transplant",
          "support": "Brother committed to being stem cell donor, daughter coordinating care"
        }
      },
      {
        "visit_id": "V9",
        "visit_date": "2025-03-14",
        "visit_type": "office_visit",
        "chief_complaint": "Post-Cycle 2 azacitidine, assess response, transplant planning",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 115,
          "bp_diastolic": 70,
          "hr_bpm": 76,
          "weight_lbs": 167.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 3.8,
          "anc": 2.1,
          "platelets_k_ul": 95,
          "peripheral_blasts_percent": 0,
          "creatinine_mg_dl": 1.0,
          "alt_u_l": 35,
          "ast_u_l": 32,
          "ldh_u_l": 210
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Azacitidine 75mg/m Days 1-7 q28 days"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)"],
          "new_acute": ["Relapsed AML in second complete remission (C92.02)"],
          "differential": []
        },
        "procedures_ordered": [
          "Allogeneic stem cell transplant admission scheduled 3/25",
          "Pre-transplant donor collection from brother scheduled 3/23-3/24"
        ],
        "referrals": [
          "Transplant team - final pre-transplant evaluation completed"
        ],
        "provider_note_snippet": "EXCELLENT RESPONSE TO AZACITIDINE. Completed Cycle 2 (Days 1-7 of February cycle). Tolerated well - mild injection site reactions, mild fatigue, counts stable. BONE MARROW (3/10): <5% BLASTS (2% blasts), Normal trilineage hematopoiesis, MRD BY NPM1 PCR: NEGATIVE (undetectable), Flow cytometry MRD: NEGATIVE. ACHIEVED SECOND COMPLETE REMISSION (CR2). This is EXCELLENT - azacitidine successfully reduced blast burden and cleared MRD. Patient achieved second remission with relatively gentle therapy (avoided intensive chemotherapy). PERIPHERAL BLOOD: No circulating blasts, LDH normalized to 210. TRANSPLANT PLANNING: ALL SYSTEMS GO. Pre-transplant evaluation completed: Cardiac clearance (echo EF 58%), Pulmonary clearance (PFTs normal), Dental clearance (all dental work completed), Infectious disease clearance (all vaccinations updated, no active infections), Social work (financial assistance secured, housing near hospital arranged for wife during recovery). DONOR (BROTHER) EVALUATION COMPLETED: Brother is healthy, cleared for donation, HLA 10/10 match confirmed. STEM CELL COLLECTION from brother scheduled 3/23-3/24 (peripheral blood stem cell collection via apheresis after mobilization with filgrastim). TRANSPLANT TIMELINE: 3/25: Hospital admission, 3/25-3/30: Conditioning chemotherapy (Fludarabine + Busulfan = 'FluBu' regimen, reduced-intensity conditioning given age 58), 3/31 (Day 0): STEM CELL INFUSION from brother, Days 0-14: Nadir/aplasia period (no immune system, high infection risk, requires protective isolation), Days +10-21: Engraftment expected (brother's cells start producing new blood cells), Days +14-100: Early post-transplant period (acute GVHD risk, infection risk, multiple medications), Discharge: typically Day +21-28 if engrafted and stable, then frequent outpatient monitoring. CONDITIONING REGIMEN: Fludarabine + Busulfan = reduced-intensity conditioning (RIC). Less toxic than full myeloablative conditioning, appropriate for age 58. Still kills patient's bone marrow and leukemia cells, but relies more on graft-versus-leukemia effect for cure rather than just chemotherapy intensity. GVHD PROPHYLAXIS: Tacrolimus + Methotrexate (standard regimen to prevent acute graft-versus-host disease). RISKS REVIEWED: (1) Treatment-related mortality 15-20% (from infections during immune suppression, conditioning regimen toxicity, GVHD), (2) Acute GVHD 30-50% risk (donor immune cells attack patient's gut, liver, skin - can be life-threatening), (3) Chronic GVHD 40-60% risk if survive past Day +100 (can affect any organ, requires long-term immunosuppression), (4) Infections (bacterial, viral, fungal - especially CMV, EBV, aspergillus), (5) Organ toxicity (liver veno-occlusive disease, lung injury, etc.), (6) Relapse (even after transplant, 30-40% relapse risk). BENEFITS: Only curative option for relapsed AML. If successful, 30-40% long-term disease-free survival. Some transplant survivors live 20+ years cancer-free. PATIENT/FAMILY PREPAREDNESS: Entire family understands risks and committed to process. Brother excited and honored to be donor, stating 'I'm giving my brother a second chance at life.' Daughter took leave from residency to be present during hospitalization. Wife closing business temporarily, staying in housing near hospital. Patient completed advance directive, designated wife as healthcare proxy. Patient emotional but determined: 'I've come this far, I'm going to fight through this transplant.' Family preparing for potentially 3-6 month recovery period (hospitalization 3-4 weeks, then close outpatient monitoring for 100 days, then gradual return to activities over 6-12 months).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "work": "Business closed temporarily during transplant",
          "support": "Daughter taking leave from residency, wife staying near hospital, brother donating stem cells"
        }
      },
      {
        "visit_id": "V10",
        "visit_date": "2025-05-16",
        "visit_type": "post_transplant_follow_up",
        "chief_complaint": "Post-allogeneic transplant Day +46, assess engraftment and GVHD",
        "vitals": {
          "temp_f": 99.0,
          "bp_systolic": 108,
          "bp_diastolic": 66,
          "hr_bpm": 82,
          "weight_lbs": 155.0
        },
        "labs": {
          "hemoglobin_g_dl": 9.8,
          "wbc_k_ul": 3.2,
          "anc": 2.4,
          "platelets_k_ul": 68,
          "creatinine_mg_dl": 1.2,
          "alt_u_l": 125,
          "ast_u_l": 148,
          "total_bilirubin_mg_dl": 2.8,
          "chimerism_percent": 98
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Tacrolimus (adjusted to therapeutic levels)",
            "Mycophenolate mofetil 1000mg BID",
            "Acyclovir 400mg TID",
            "Fluconazole 400mg daily",
            "Levofloxacin 500mg daily",
            "Ursodiol 300mg TID"
          ],
          "started": [
            "Prednisone 1mg/kg daily (for acute GVHD)",
            "Budesonide 9mg daily (gut GVHD)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Relapsed AML status post allogeneic stem cell transplant in CR2 (C92.02, Z94.84)"
          ],
          "new_acute": [
            "Acute graft-versus-host disease, Grade II (D89.813)",
            "Post-transplant hepatotoxicity (K71.9)",
            "Post-transplant thrombocytopenia (D69.59)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Bone marrow biopsy Day +60 (assess remission status)",
          "CBC twice weekly",
          "CMP twice weekly",
          "Tacrolimus levels twice weekly",
          "CMV PCR weekly"
        ],
        "referrals": [],
        "provider_note_snippet": "POST-ALLOGENEIC TRANSPLANT DAY +46. TRANSPLANT COURSE: Admitted 3/25, Conditioning FluBu Days -6 to -2, Stem cell infusion Day 0 (3/31) - infused 6.2 x 10^6 CD34+ cells/kg from brother, Nadir period Days 0-14 - severe pancytopenia as expected, neutropenic fever Day +8 (treated with meropenem, resolved), ENGRAFTMENT Day +16 (ANC >0.5 x 3 days) - excellent timeline, DISCHARGE Day +24 to nearby housing, frequent outpatient visits. ENGRAFTMENT STATUS: ANC 2.4 (engrafted), Platelets 68 (slow recovery, common), Hemoglobin 9.8 (transfusion-dependent still, 2 units/week). CHIMERISM 98% DONOR (excellent - indicates brother's cells have taken over, only 2% patient's own cells remaining). This is what we want - full donor chimerism. ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD): Developed Grade II acute GVHD starting Day +28. SKIN: Maculopapular rash on trunk, arms, legs - Stage 2 skin GVHD (25-50% BSA involved). GUT: Diarrhea 800-1000 mL/day, crampy abdominal pain - Stage 2 gut GVHD. LIVER: Transaminitis (ALT 125, AST 148), hyperbilirubinemia (total bili 2.8) - Stage 1-2 liver GVHD vs drug toxicity vs veno-occlusive disease (less likely given timeline). OVERALL GRADE: II acute GVHD (organ involvement but not life-threatening). GVHD TREATMENT: Increased immunosuppression - prednisone 1mg/kg daily added (60mg daily), continue tacrolimus, continue mycophenolate. Added budesonide (topical steroid for gut GVHD). Rash improving, diarrhea decreased to 400-500mL/day. INFECTIOUS COMPLICATIONS: CMV reactivation Day +35 (CMV PCR 2,400 copies/mL) - treated with valganciclovir, now undetectable. BK virus cystitis (hemorrhagic cystitis) Days +20-30 - resolved with hydration, bladder irrigation. No invasive fungal infections (thankfully). WEIGHT LOSS: Down 13 lbs from pre-transplant (167  155 lbs). Poor appetite due to GVHD, nausea from medications, altered taste. Using nutritional supplements. FUNCTIONAL STATUS: Weak, fatigued. Able to perform basic ADLs but limited. Walking 10-15 minutes daily. Brother visiting regularly (donors often feel protective of recipients). Wife at bedside daily. Daughter visiting on days off from residency. DISEASE STATUS: Will perform Day +60 bone marrow biopsy to assess: (1) Remission status (looking for <5% blasts, no MRD), (2) Chimerism (want to maintain >95% donor). Early bone marrow post-transplant critical to ensure leukemia hasn't relapsed. PROGNOSIS: Successfully engrafted, but Grade II GVHD complicates recovery. GVHD is double-edged sword - indicates donor immune system is active (good for graft-versus-leukemia effect to prevent relapse) but causes morbidity. If can control GVHD with steroids while maintaining graft-versus-leukemia effect AND if remains in remission, then has good chance of long-term survival. Critical period is first 100 days post-transplant (acute GVHD, infections). If survives past Day +100 in remission, long-term survival probability improves significantly. Patient's attitude remarkable - 'This is hard, but I'm alive, and my brother's cells are fighting my cancer.' Brother feeling emotional about being donor: 'I'm literally living inside my brother now, keeping him alive.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "living_situation": "Staying in housing near hospital with wife, frequent outpatient visits",
          "support": "Brother visiting regularly, daughter visiting on days off"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_018",
    "patient_name": "Patricia Johnson",
    "patient_profile": "https://plus.unsplash.com/premium_photo-1688350808212-4e6908a03925?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=1169",
    "archetype": "End-stage heart failure requiring mechanical circulatory support",
    "age": 67,
    "sex": "F",
    "race_ethnicity": "African American",
    "allergies": [
      {
        "allergen": "ACE inhibitors (Lisinopril, Enalapril)",
        "reaction": "Angioedema - severe facial and tongue swelling",
        "severity": "severe",
        "onset": "2019"
      },
      {
        "allergen": "Shellfish",
        "reaction": "Hives, throat tightness",
        "severity": "moderate",
        "onset": "childhood"
      }
    ],

    "chief_complaint": "Worsening shortness of breath, can't lie flat, feet very swollen x2 weeks",
    "first_visit_date": "2024-01-15",
    "last_visit_date": "2024-09-27",
    "total_visits": 10,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_018_A",
        "type": "symptom_lab_correlation",
        "description": "Progressive volume overload with declining cardiac function indicating decompensated heart failure",
        "entities_involved": [
          "Orthopnea",
          "Edema",
          "Weight gain",
          "BNP elevation",
          "Low EF"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_018_B",
        "type": "persistent_symptom",
        "description": "Cardiogenic shock requiring inotropic support and mechanical circulatory support",
        "entities_involved": [
          "Hypotension",
          "End-organ hypoperfusion",
          "Inotropes",
          "Impella device"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_018_C",
        "type": "lab_trend",
        "description": "Progressive renal dysfunction from cardiorenal syndrome complicating heart failure management",
        "entities_involved": [
          "Rising creatinine",
          "Decreased GFR",
          "Fluid retention",
          "Diuretic resistance"
        ],
        "visits_involved": ["V2", "V3", "V4", "V5", "V6"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_018_D",
        "type": "persistent_symptom",
        "description": "End-stage heart failure requiring LVAD placement as destination therapy",
        "entities_involved": [
          "Stage D heart failure",
          "LVAD candidacy",
          "Mechanical support",
          "Quality of life improvement"
        ],
        "visits_involved": ["V6", "V7", "V8", "V9", "V10"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-01-15",
        "visit_type": "office_visit",
        "chief_complaint": "Worsening shortness of breath, orthopnea, bilateral lower extremity edema x2 weeks",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 108,
          "bp_diastolic": 68,
          "hr_bpm": 92,
          "rr_bpm": 22,
          "spo2_percent": 93.0,
          "weight_lbs": 198.0,
          "height_inches": 64.0,
          "bmi": 34.0
        },
        "labs": {
          "bnp_pg_ml": 2840,
          "hemoglobin_g_dl": 11.2,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 185,
          "sodium_meq_l": 132,
          "potassium_meq_l": 4.8,
          "creatinine_mg_dl": 1.6,
          "bun_mg_dl": 42,
          "gfr_ml_min": 34,
          "albumin_g_dl": 3.2,
          "tsh_miu_l": 2.8
        },
        "medications": {
          "continued": [
            "Carvedilol 25mg BID",
            "Losartan 100mg daily",
            "Furosemide 40mg BID",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [
            "Furosemide increased to 80mg BID",
            "Metolazone 5mg daily (added thiazide for synergistic diuresis)"
          ],
          "stopped": [],
          "dose_changed": ["Furosemide 40mg BID  80mg BID"]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, NYHA Class III (I50.22)",
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3b (N18.32)",
            "Obesity (E66.9)"
          ],
          "new_acute": [
            "Acute decompensated heart failure (I50.23)",
            "Volume overload (E87.70)",
            "Cardiorenal syndrome type 2 (N17.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Chest X-ray",
          "Echocardiogram",
          "BNP",
          "Daily weights at home",
          "Recheck in 5 days"
        ],
        "referrals": [],
        "provider_note_snippet": "67F African American woman with long-standing heart failure (ischemic cardiomyopathy from MI 2018, EF last known 25-30%) presents with 2-week history of progressive dyspnea. SYMPTOMS: Can no longer lie flat - sleeps in recliner on 3 pillows (orthopnea), wakes up gasping for air 2-3x/night (paroxysmal nocturnal dyspnea), severe bilateral lower extremity edema 'up to knees,' weight gain 14 lbs over 2 weeks (184  198 lbs), severe fatigue limiting all activities. DENIES: Chest pain, palpitations, syncope, cough productive of frothy sputum (though has dry cough). PAST MEDICAL HISTORY: MI 2018 with stent to LAD, subsequent development of ischemic cardiomyopathy, EF declined from 45% post-MI to 25-30% over past 5 years despite optimal medical therapy. FAMILY HISTORY: Mother died age 62 from 'heart problems,' brother age 70 with heart failure. Strong family history cardiovascular disease. Lives with husband (primary caregiver), retired teacher, 3 adult children. PHYSICAL EXAM: Appears dyspneic at rest, using accessory muscles. JVP elevated 12cm. Lungs: bilateral crackles to mid-lung fields. Cardiac: S3 gallop, displaced PMI, 2/6 systolic murmur at apex (mitral regurgitation). Abdomen: soft, liver edge palpable 3cm below costal margin (hepatomegaly from congestion). Extremities: 3+ pitting edema bilateral lower extremities to knees, cool extremities. LABS: BNP 2840 (very elevated, was 650 three months ago), Creatinine 1.6 (baseline 1.2-1.3, worsening renal function), GFR 34 (Stage 3b CKD, was 45), Hyponatremia 132 (dilutional from volume overload). ASSESSMENT: ACUTE DECOMPENSATED HEART FAILURE on CHRONIC SYSTOLIC HF. This is classic presentation: orthopnea, PND, weight gain, edema, elevated JVP, pulmonary crackles, S3 gallop, dramatically elevated BNP. Volume overload overwhelming current diuretic regimen. Worsening renal function (cardiorenal syndrome) complicates management - kidneys failing due to poor cardiac output and venous congestion. PLAN: AGGRESSIVE DIURESIS - doubled furosemide to 80mg BID, added metolazone 5mg daily (thiazide + loop diuretic synergy for diuretic-resistant patients). Goal: net negative 1-2 liters daily, lose 2-4 lbs by this weekend. SODIUM/FLUID RESTRICTION: <2g sodium diet, fluid restriction <2L daily. Daily weights - call if gain >3 lbs. Ordered echo to assess current EF. CXR to assess pulmonary edema. CONCERN: Patient declining despite optimal medical therapy (GDMT - guideline-directed medical therapy: beta-blocker, ARB, aldosterone antagonist, diuretics). May be approaching advanced/refractory heart failure. If doesn't respond to escalated diuretics, will need hospital admission for IV diuretics, possibly inotropes. Patient and husband very worried. Patient stating 'I can't live like this, I can barely function.' Discussed this is serious but will try aggressive outpatient management first.",
        "patient_reported_adherence": "good - but difficulty affording medications, sometimes skips doses to stretch prescriptions",
        "social_history_updates": {
          "occupation": "Retired elementary school teacher",
          "living_situation": "Lives with husband (age 69, retired), 3 adult children nearby",
          "insurance": "Medicare with Part D, some medication co-pay challenges",
          "smoking": "Never smoker",
          "alcohol": "None",
          "diet": "Admits to high sodium diet - eats a lot of canned soups, frozen meals",
          "functional_status": "NYHA Class III - marked limitation, comfortable only at rest"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-01-22",
        "visit_type": "urgent_office_visit",
        "chief_complaint": "Not improving with increased diuretics, worsening shortness of breath",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 96,
          "bp_diastolic": 62,
          "hr_bpm": 98,
          "rr_bpm": 24,
          "spo2_percent": 91.0,
          "weight_lbs": 196.0
        },
        "labs": {
          "bnp_pg_ml": 3280,
          "hemoglobin_g_dl": 10.8,
          "sodium_meq_l": 128,
          "potassium_meq_l": 5.2,
          "creatinine_mg_dl": 2.1,
          "bun_mg_dl": 58,
          "gfr_ml_min": 24
        },
        "medications": {
          "continued": [
            "Carvedilol 25mg BID",
            "Losartan 100mg daily",
            "Furosemide 80mg BID",
            "Metolazone 5mg daily",
            "Spironolactone 25mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction (I50.22)",
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 4 (N18.4)"
          ],
          "new_acute": [
            "Acute decompensated heart failure, refractory (I50.23)",
            "Cardiorenal syndrome type 2, worsening (N17.9)",
            "Hyponatremia (E87.1)",
            "Hyperkalemia (E87.5)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Hospital admission - acute decompensated heart failure",
          "Chest X-ray",
          "Echocardiogram",
          "Right heart catheterization",
          "Cardiology consultation"
        ],
        "referrals": ["Cardiology - advanced heart failure evaluation"],
        "provider_note_snippet": "Patient returns after 7 days of escalated diuretic therapy - MINIMAL IMPROVEMENT. Lost only 2 lbs (198  196 lbs, goal was 10-15 lbs). Still severely dyspneic, orthopneic, edematous. Husband reports patient sleeping in recliner, can barely walk to bathroom without severe shortness of breath. PHYSICAL EXAM UNCHANGED: JVP elevated, crackles bilateral, S3 gallop, 3+ edema. O2 sat 91% on room air (hypoxemic). LABS CONCERNING: (1) BNP RISING 2840  3280 despite diuretics (worsening heart failure), (2) RENAL FUNCTION DECLINING - Creatinine 1.6  2.1 (Stage 3b  Stage 4 CKD), GFR 34  24. This is CARDIORENAL SYNDROME - kidneys failing due to poor cardiac output and venous congestion. Creates vicious cycle: worse renal function  worse diuresis  more volume overload  worse cardiac output  worse renal function. (3) HYPONATREMIA WORSENING 132  128 (dilutional, indicates severe heart failure), (4) HYPERKALEMIA 5.2 (from reduced GFR + spironolactone). ECHO RESULTS (1/18): EF 15-20% (severely reduced, was 25-30% six months ago - PROGRESSIVE DECLINE), Severe global hypokinesis, Moderate-severe mitral regurgitation (functional MR from dilated ventricle), LV end-diastolic diameter 6.8cm (severely dilated), Moderate right ventricular dysfunction. CXR: Severe pulmonary vascular congestion, bilateral pleural effusions, cardiomegaly. ASSESSMENT: REFRACTORY ACUTE DECOMPENSATED HEART FAILURE. Patient is DIURETIC-RESISTANT - not responding adequately to high-dose oral loop diuretic + thiazide. This is Stage D heart failure (refractory symptoms despite optimal medical therapy, recurrent hospitalizations). REQUIRES HOSPITAL ADMISSION for: (1) IV DIURETICS - furosemide IV continuous infusion for more effective diuresis, (2) Consider INOTROPES (dobutamine, milrinone) to improve cardiac output and renal perfusion, (3) RIGHT HEART CATHETERIZATION - measure hemodynamics (cardiac output, filling pressures, pulmonary artery pressures) to guide therapy, (4) ADVANCED HEART FAILURE EVALUATION - patient may be candidate for: LVAD (left ventricular assist device), Heart transplant evaluation (though age 67 makes transplant less likely), Palliative care/hospice discussion if not candidate for advanced therapies. PROGNOSIS: EF 15-20% + BNP >3000 + refractory symptoms + declining renal function = very poor prognosis. Without advanced interventions (LVAD/transplant), median survival 6-12 months. WITH interventions, can potentially improve quality of life and prolong survival. Patient and husband understanding gravity. Patient tearful: 'Am I dying?' Explained heart is very weak, need hospital for intensive treatment and evaluation for advanced therapies. Calling EMS for ambulance transport to hospital (patient too unstable to have husband drive). Will admit to CCU (cardiac care unit) under cardiology service.",
        "patient_reported_adherence": "good",
        "social_history_updates": {}
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-01-25",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Hospital Day 3, CCU, worsening despite IV diuretics",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 82,
          "bp_diastolic": 54,
          "hr_bpm": 108,
          "rr_bpm": 26,
          "spo2_percent": 89.0,
          "weight_lbs": 194.0
        },
        "labs": {
          "bnp_pg_ml": 4120,
          "hemoglobin_g_dl": 10.2,
          "sodium_meq_l": 126,
          "potassium_meq_l": 5.4,
          "creatinine_mg_dl": 2.8,
          "bun_mg_dl": 72,
          "lactate_mmol_l": 3.2,
          "alt_u_l": 185,
          "ast_u_l": 245,
          "total_bilirubin_mg_dl": 2.8
        },
        "medications": {
          "continued": [
            "Carvedilol held (hypotension)",
            "Losartan held (hypotension, renal dysfunction)",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [
            "Furosemide 10mg/hour IV continuous infusion",
            "Metolazone 10mg IV daily",
            "Dobutamine 5mcg/kg/min IV infusion",
            "Milrinone 0.375mcg/kg/min IV infusion",
            "Heparin drip (anticoagulation for low cardiac output)"
          ],
          "stopped": [
            "Spironolactone (hyperkalemia, renal dysfunction)",
            "All oral diuretics"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction (I50.22)",
            "Type 2 Diabetes Mellitus (E11.9)"
          ],
          "new_acute": [
            "Cardiogenic shock (R57.0)",
            "Acute kidney injury on CKD Stage 4 (N17.9, N18.4)",
            "Congestive hepatopathy (K76.1)",
            "Severe hyponatremia (E87.1)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Impella placement consultation",
          "Advanced heart failure team consultation",
          "LVAD evaluation",
          "Family meeting"
        ],
        "referrals": [
          "Advanced heart failure/transplant cardiology",
          "Cardiac surgery",
          "Palliative care"
        ],
        "provider_note_snippet": "PATIENT IN CARDIOGENIC SHOCK. Admitted to CCU 1/22, started on IV furosemide continuous infusion 10mg/hour + IV metolazone. Initial modest diuresis (lost 2 lbs), but now CLINICAL DETERIORATION. HEMODYNAMICS: RIGHT HEART CATHETERIZATION (1/23): Cardiac index 1.8 L/min/m (severely reduced, normal >2.5), Cardiac output 3.2 L/min (severely reduced), PCWP (pulmonary capillary wedge pressure) 28 mmHg (markedly elevated, normal <12), RAP 18 mmHg (elevated), PA pressure 58/32 mmHg (pulmonary hypertension), SVR 1850 dynes (elevated). Interpretation: CARDIOGENIC SHOCK - severely reduced cardiac output, elevated filling pressures ('wet and cold' hemodynamic profile). CLINICAL STATUS: BP 82/54 (hypotensive - unable to tolerate beta-blocker or ARB), HR 108 (compensatory tachycardia), O2 sat 89% on 4L NC, RR 26 (tachypneic), Cool extremities (poor perfusion), Altered mental status - lethargic, confused (hypoperfusion to brain), Oliguria - urine output <15mL/hour despite IV diuretics (renal hypoperfusion). LABS: (1) RISING BNP 4120 (worsening despite therapy), (2) WORSENING RENAL FAILURE - Creatinine 2.8 (was 2.1), GFR dropping, BUN 72. Kidneys shutting down from poor perfusion. (3) SEVERE HYPONATREMIA 126 (critical - risk of seizures), (4) LACTATE 3.2 (tissue hypoperfusion, anaerobic metabolism), (5) TRANSAMINITIS - ALT 185, AST 245, Tbili 2.8 (congestive hepatopathy - liver failing from venous congestion and hypoperfusion). MULTI-ORGAN FAILURE from cardiogenic shock. INOTROPE THERAPY: Started dobutamine 5mcg/kg/min (beta-agonist, increases cardiac contractility) + milrinone 0.375mcg/kg/min (phosphodiesterase inhibitor, inotrope + vasodilator). Goal: improve cardiac output, improve end-organ perfusion. RESPONSE: Minimal improvement. Cardiac output increased slightly (3.2  3.8 L/min) but still severely reduced. BP remains low, kidneys not responding. MECHANICAL CIRCULATORY SUPPORT NEEDED: This is STAGE D, INOTROPE-DEPENDENT HEART FAILURE. Options: (1) IMPELLA device - percutaneous left ventricular assist device, inserted via femoral artery, pumps blood from LV to aorta, can provide 2.5-5 liters/min support. Used as 'bridge to decision' or 'bridge to recovery.' (2) LVAD (durable left ventricular assist device) - surgically implanted pump, provides long-term support. Can be 'destination therapy' (permanent) or 'bridge to transplant.' (3) HEART TRANSPLANT - definitive treatment but patient age 67 makes her borderline candidate (most centers prefer <65-70 years). Also need to assess other organ function. (4) PALLIATIVE CARE/HOSPICE - if not candidate for above interventions, focus on comfort. FAMILY MEETING held this morning with patient (somewhat confused but able to participate), husband, 3 children, advanced heart failure team, cardiac surgery. OPTIONS DISCUSSED: Team recommends LVAD evaluation - likely as destination therapy given age. Patient hesitant about 'living with machine' but understands without intervention, prognosis is days-weeks. Impella placement planned for tomorrow as temporary bridge while completing LVAD workup. Patient and family need time to process. Social work involved, chaplain involved.",
        "patient_reported_adherence": "n/a - critically ill",
        "social_history_updates": {
          "support": "Husband and all 3 children present daily, very involved in decision-making"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-02-02",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Hospital Day 11, post-Impella placement Day 7, awaiting LVAD",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 98,
          "bp_diastolic": 62,
          "hr_bpm": 88,
          "rr_bpm": 18,
          "spo2_percent": 95.0,
          "weight_lbs": 182.0
        },
        "labs": {
          "bnp_pg_ml": 1850,
          "hemoglobin_g_dl": 9.8,
          "sodium_meq_l": 134,
          "potassium_meq_l": 4.2,
          "creatinine_mg_dl": 1.8,
          "bun_mg_dl": 38,
          "lactate_mmol_l": 1.4,
          "alt_u_l": 68,
          "ast_u_l": 72,
          "total_bilirubin_mg_dl": 1.4
        },
        "medications": {
          "continued": [
            "Dobutamine 3mcg/kg/min IV (weaning)",
            "Heparin drip",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [
            "Furosemide 40mg IV BID",
            "Carvedilol 6.25mg BID (low dose restarted)",
            "Losartan 25mg daily (low dose restarted)"
          ],
          "stopped": [
            "Furosemide continuous infusion",
            "Milrinone discontinued",
            "Metolazone discontinued"
          ],
          "dose_changed": ["Dobutamine weaned from 5 to 3mcg/kg/min"]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction (I50.22)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3b (N18.32)"
          ],
          "new_acute": [
            "Status post Impella placement (Z95.818)",
            "History of cardiogenic shock, stabilized (R57.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "LVAD surgery scheduled 2/6",
          "Continue Impella support until LVAD",
          "Daily labs",
          "Echocardiogram"
        ],
        "referrals": [],
        "provider_note_snippet": "SIGNIFICANT IMPROVEMENT WITH MECHANICAL SUPPORT. IMPELLA CP device placed 1/26 via right femoral artery. Device positioned across aortic valve, pumps blood from LV to aorta at 2.5-3.5 L/min (P-level 8-9). Provides mechanical circulatory support to unload failing left ventricle. RESPONSE TO IMPELLA: DRAMATIC IMPROVEMENT. Cardiac output improved from 3.2 L/min (pre-Impella, on inotropes) to estimated 5.5-6 L/min (Impella support + native cardiac output). BP stabilized 98/62 (improved from 82/54). End-organ perfusion restored: Mental status cleared - alert, oriented, conversing normally. Urine output improved to 30-50mL/hour (adequate renal perfusion). Extremities warm, capillary refill normal. Lactate normalized 1.4 (was 3.2 - no longer in shock). Liver function improving - transaminases and bilirubin declining. RENAL FUNCTION IMPROVING: Creatinine 1.8 (was 2.8 peak), BUN 38 (was 72). Responding to diuretics now that cardiac output adequate. Diuresed 14 lbs since Impella placement (196  182 lbs). Sodium improving 134 (was 126). INOTROPE WEANING: Successfully weaned from milrinone (discontinued 1/30). Weaning dobutamine 5  3mcg/kg/min, goal to discontinue in 2-3 days. Patient now supported primarily by Impella, not inotropes. LVAD EVALUATION COMPLETE: Advanced heart failure team completed full evaluation. Patient is ACCEPTABLE LVAD CANDIDATE: (1) Age 67 - upper limit but acceptable for destination therapy, (2) Body size adequate (BMI 34 - can accommodate LVAD), (3) Other organs recovering with mechanical support (kidneys, liver improving), (4) No active infection, (5) Adequate social support (husband, children committed), (6) Psychosocial evaluation cleared (patient understands commitment, lifestyle changes), (7) Nutrition evaluation - will need weight loss post-LVAD for optimal outcomes. DECISION: LVAD as DESTINATION THERAPY (permanent support, not bridge to transplant given age). Considered for HeartMate 3 LVAD (newest generation, continuous flow pump, durable, best outcomes). LVAD SURGERY SCHEDULED 2/6 (4 days from now). Will keep Impella in place as bridge until surgery. Impella typical duration <14 days (device-related complications increase after 2 weeks - hemolysis, bleeding, infection, vascular complications). Current plan optimal timing. PATIENT UNDERSTANDING: Patient and family extensive education over past week about LVAD. What is LVAD: Surgically implanted pump (size of small flashlight) in chest, connected to heart. Takes blood from left ventricle, pumps to aorta. Powered by external controller (wear around waist) connected to batteries or electrical outlet. Driveline (cable) exits abdomen connecting internal pump to external controller. Lifestyle with LVAD: Must keep driveline site clean (infection risk). Cannot swim, bathe (shower only with waterproof covers). Must always be connected to power (carry 2 batteries, each lasts 8-12 hours). Cannot have MRI. Need frequent clinic visits, monthly for first 6 months. Alarm system on controller - must respond to alarms. Support person training required (husband trained as backup). Benefits: Improve symptoms, increase functional capacity, prolong survival. Median survival with destination therapy LVAD: 5-7 years (much better than predicted survival without LVAD of 6-12 months). Risks: Bleeding, infection, stroke, device malfunction, right heart failure post-LVAD. Patient decided to proceed: 'I want to live, I want to see my grandchildren grow up. I'll do whatever it takes.' Husband and children supportive. Understanding this is major life change but beats the alternative (dying from heart failure).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "support": "Husband completed LVAD caregiver training, children also trained"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-02-16",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "Post-LVAD Day 10, preparing for discharge",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 105,
          "bp_diastolic": 68,
          "hr_bpm": 78,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 175.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 9.2,
          "platelets_k_ul": 168,
          "inr": 2.3,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "creatinine_mg_dl": 1.4,
          "bun_mg_dl": 28,
          "alt_u_l": 42,
          "ast_u_l": 38
        },
        "medications": {
          "continued": [
            "Carvedilol 6.25mg BID",
            "Losartan 50mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 40mg daily"
          ],
          "started": [
            "Warfarin 5mg daily (goal INR 2-3 for LVAD thrombosis prophylaxis)",
            "Omeprazole 40mg daily (GI prophylaxis on anticoagulation)",
            "Trimethoprim-sulfamethoxazole DS 3x/week (PCP prophylaxis on immunosuppression)"
          ],
          "stopped": [
            "Heparin drip (transitioned to warfarin)",
            "Dobutamine discontinued",
            "Impella removed"
          ],
          "dose_changed": ["Losartan increased from 25mg to 50mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, status post LVAD (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3a (N18.31)",
            "Obesity (E66.9)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Discharge home with LVAD",
          "Home health nursing 3x/week",
          "LVAD clinic follow-up in 1 week",
          "INR checks twice weekly",
          "Echocardiogram in 1 month"
        ],
        "referrals": [
          "LVAD coordinator",
          "Home health agency",
          "Cardiac rehabilitation"
        ],
        "provider_note_snippet": "LVAD SURGERY SUCCESSFUL - EXCELLENT RECOVERY. HeartMate 3 LVAD implanted 2/6 via median sternotomy. Surgery duration 6 hours, on cardiopulmonary bypass 3 hours. Pump positioned in LV apex, outflow graft anastomose, d to ascending aorta. Driveline exits through right upper quadrant of abdomen. POST-OPERATIVE COURSE: Uncomplicated. Extubated POD#1 (post-operative day 1), out of bed POD#2, driveline site clean and dry, no bleeding complications, no arrhythmias, no right heart failure (common complication post-LVAD - right ventricle must work harder without LV to help). LVAD PARAMETERS: Flow: 5.2 L/min (excellent), Speed: 5400 RPM (revolutions per minute - typical range 5000-6000), Power: 5.8 watts, Pulsatility Index: 4.2 (indicates some native heart contribution). Controller functioning perfectly, no alarms. CLINICAL STATUS: Patient feels 'like a new person.' No shortness of breath at rest or with activity. Able to walk hallways without dyspnea. No orthopnea - can lie flat (first time in months). No edema. Weight down to 175 lbs (lost 23 lbs from peak of 198 lbs - all excess fluid). Energy improving daily. PHYSICAL EXAM: Alert, comfortable, ambulating independently. No JVP elevation. Lungs clear. Cardiac: Continuous hum from LVAD (normal), no S3 gallop. Abdomen: Driveline exit site clean, well-healed, no erythema or drainage. Extremities: No edema, warm, well-perfused. LABS: Renal function improved - Creatinine 1.4 (back near baseline), Liver function normalized, Electrolytes normal, INR 2.3 (therapeutic range 2-3 for LVAD anticoagulation - prevents pump thrombosis), Hemoglobin 10.2 (acceptable, mild anemia expected with LVAD from mechanical hemolysis). LVAD EDUCATION COMPLETED: Patient and husband completed extensive education: (1) Controller management - recognizing alarms, responding appropriately, (2) Battery changes - practiced multiple times, (3) Driveline care - daily inspection, weekly dressing changes with sterile technique, (4) Showering technique - waterproof covers for controller and driveline site, (5) Emergency procedures - what to do if alarm sounds, backup equipment, (6) Activity restrictions - no swimming, no contact sports, no MRI, (7) Signs of complications - fever (infection), dizziness/syncope (low flow), dark urine (hemolysis), stroke symptoms. ANTICOAGULATION: Warfarin for thrombosis prevention. Goal INR 2-3 (tighter range than typical AFib, lower bleeding risk than mechanical valve). INR checks 2x/week initially, then weekly once stable. Diet education about vitamin K intake (consistent, not restricted). DISCHARGE PLAN: Home with husband (primary caregiver). Home health nursing 3x/week initially for: vital signs, driveline assessment, medication management, INR checks (can do at home with point-of-care device). LVAD clinic follow-up in 1 week, then every 2 weeks x3 months, then monthly. LVAD coordinator available 24/7 for questions/concerns. Cardiac rehab starting in 2 weeks - supervised exercise program for LVAD patients, goal to improve functional capacity and quality of life. PATIENT PERSPECTIVE: Patient tearful with gratitude: 'I thought I was dying a month ago. Now I feel better than I have in years. This machine saved my life.' Husband emotional: 'I was preparing to lose my wife. Now we get more time together.' Children visited daily during hospitalization, expressing amazement at mother's transformation. Patient understanding LVAD is permanent (destination therapy), not bridge to transplant. Accepting of lifestyle changes - 'I'd rather live with this machine than die without it.' Already planning activities - wants to attend grandson's Little League games this spring (couldn't do last year due to heart failure symptoms).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "Dramatically improved - NYHA Class I-II, can perform most ADLs and light activities",
          "support": "Home health arranged, husband trained as primary caregiver"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-03-22",
        "visit_type": "lvad_clinic_visit",
        "chief_complaint": "5-week post-LVAD, routine follow-up",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 108,
          "bp_diastolic": 70,
          "hr_bpm": 74,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 172.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.2,
          "wbc_k_ul": 7.4,
          "platelets_k_ul": 185,
          "inr": 2.4,
          "creatinine_mg_dl": 1.3,
          "bun_mg_dl": 24,
          "ldh_u_l": 385,
          "albumin_g_dl": 3.8
        },
        "medications": {
          "continued": [
            "Carvedilol 12.5mg BID",
            "Losartan 100mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 20mg daily",
            "Warfarin (dose adjusted to INR)",
            "Omeprazole 40mg daily",
            "Trimethoprim-sulfamethoxazole DS 3x/week"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": [
            "Carvedilol increased from 6.25mg to 12.5mg BID",
            "Losartan increased from 50mg to 100mg daily",
            "Furosemide decreased from 40mg to 20mg daily"
          ]
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure with reduced ejection fraction, status post LVAD destination therapy (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3a (N18.31)",
            "Obesity (E66.9)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Echocardiogram with LVAD assessment",
          "Continue current medications",
          "LVAD clinic monthly",
          "INR weekly"
        ],
        "referrals": [
          "Nutrition - weight loss program",
          "Physical therapy - continued strengthening"
        ],
        "provider_note_snippet": "THRIVING ON LVAD - 5 WEEKS POST-IMPLANT. Patient doing exceptionally well. Reports feeling 'better than I have in 10 years.' No shortness of breath, no chest pain, no edema, no dizziness. Able to perform all ADLs independently. Walking 30 minutes daily. Attending cardiac rehab 3x/week. Attending grandson's Little League games (major quality of life milestone). LVAD FUNCTION: Device interrogation: Flow 5.4 L/min, Speed 5400 RPM (unchanged), Power 5.9 watts, PI 4.5, No alarms, No power interruptions. PERFECT LVAD FUNCTION. Driveline site: Clean, well-healed, no erythema, no drainage, no tenderness. Patient and husband performing dressing changes perfectly with sterile technique. PHYSICAL EXAM: Well-appearing, no distress. BP 108/70 (MAP ~82, adequate for LVAD - don't need high BP with continuous flow device). No JVP elevation. Lungs clear. Cardiac: Continuous LVAD hum, regular. Abdomen: Driveline exit site pristine. Extremities: No edema, warm. ECHO WITH LVAD (3/20): LVAD inflow cannula well-positioned in LV apex, LVAD outflow graft patent, Aortic valve closed (expected - LVAD does all the work, native valve doesn't open), LV severely dilated but decompressed with LVAD support, RV function adequate (no RV failure post-LVAD - good sign), Trace mitral regurgitation (improved from moderate-severe pre-LVAD). LABS: Renal function stable/improved, INR therapeutic, Hemoglobin 11.2 (improved - mild hemolysis is expected with LVAD, LDH 385 mildly elevated confirms low-level hemolysis but clinically insignificant). MEDICATION OPTIMIZATION: UP-TITRATING HEART FAILURE MEDICATIONS - now that patient hemodynamically stable with LVAD support, can optimize medical therapy. Increased carvedilol and losartan to target doses. These medications may allow some native heart recovery (rare but possible). Decreased furosemide - minimal fluid retention now that cardiac output adequate. QUALITY OF LIFE: Patient reports dramatic improvement. Using SF-36 quality of life questionnaire: scores improved in all domains (physical function, role limitations, energy, emotional well-being, social function, pain). Patient resuming hobbies - gardening (limited heavy lifting), reading, time with grandchildren. Husband reports 'having his wife back.' Marriage strengthened through this experience. COMPLICATIONS: None. NO infections (most common complication - driveline infections, pump pocket infections), NO thrombotic events (stroke, pump thrombosis), NO bleeding (GI bleeding common with LVAD due to acquired von Willebrand deficiency from high shear stress), NO hemolysis requiring transfusion, NO right heart failure, NO arrhythmias. This is IDEAL LVAD course. NUTRITION: Referred to dietitian for weight loss program. Patient BMI 34 (obese). Goal: lose 30-40 lbs over next year. Weight loss will improve diabetes control, reduce cardiac workload, improve mobility. Patient motivated. LOOKING AHEAD: Patient asking about future. Explained LVAD is permanent (destination therapy). Device expected to last 5-10+ years with proper maintenance. Will need lifelong LVAD clinic follow-up, anticoagulation, driveline care. If device fails, can be replaced (though second LVAD surgery higher risk). Patient accepting: 'This machine gave me my life back. I'm grateful for every day.'",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "functional_status": "NYHA Class I - no limitation of physical activity, can perform most activities without symptoms",
          "activities": "Walking daily, cardiac rehab 3x/week, attending grandson's baseball games, gardening",
          "quality_of_life": "Dramatically improved per SF-36 questionnaire"
        }
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-05-31",
        "visit_type": "lvad_clinic_visit",
        "chief_complaint": "3.5 months post-LVAD, fever and chills x2 days",
        "vitals": {
          "temp_f": 101.8,
          "bp_systolic": 102,
          "bp_diastolic": 64,
          "hr_bpm": 98,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 168.0
        },
        "labs": {
          "hemoglobin_g_dl": 10.8,
          "wbc_k_ul": 15.2,
          "platelets_k_ul": 168,
          "inr": 2.6,
          "creatinine_mg_dl": 1.4,
          "bun_mg_dl": 28,
          "blood_cultures": "Pending",
          "crp_mg_l": 85,
          "esr_mm_hr": 68
        },
        "medications": {
          "continued": [
            "Carvedilol 12.5mg BID",
            "Losartan 100mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 20mg daily",
            "Warfarin",
            "Omeprazole 40mg daily"
          ],
          "started": [
            "Vancomycin 1g IV q12h (empiric for driveline infection)",
            "Ceftriaxone 2g IV daily",
            "Acetaminophen 650mg q6h PRN fever"
          ],
          "stopped": [
            "Trimethoprim-sulfamethoxazole (will restart after acute infection treated)"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure status post LVAD (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3a (N18.31)"
          ],
          "new_acute": [
            "LVAD driveline infection, suspected (T85.79XA)",
            "Bacteremia, organism pending (A41.9)"
          ],
          "differential": [
            "Driveline infection",
            "Pump pocket infection",
            "Endocarditis",
            "Unrelated infection"
          ]
        },
        "procedures_ordered": [
          "Hospital admission",
          "Blood cultures x2 sets",
          "Wound culture from driveline site",
          "CT chest/abdomen (assess pump pocket)",
          "Echocardiogram (rule out endocarditis)",
          "Infectious disease consultation"
        ],
        "referrals": ["Infectious Disease", "LVAD surgery team"],
        "provider_note_snippet": "FIRST COMPLICATION - SUSPECTED DRIVELINE INFECTION. Patient presented to urgent LVAD clinic with 2-day history of fever (Tmax 102.4F at home), chills, malaise. No chest pain, no shortness of breath, no change in LVAD parameters or alarms. DRIVELINE ASSESSMENT: Erythema surrounding driveline exit site - 3cm area of redness, warm to touch, tender. Small amount purulent drainage noted on dressing. Exit site had been clean at last visit 6 weeks ago. This is CLASSIC DRIVELINE INFECTION. PHYSICAL EXAM: Febrile 101.8F, tachycardic 98 bpm. LVAD functioning normally (hum present, controller parameters normal). Driveline exit site: Erythema 3cm around exit, purulent drainage, tenderness. Tunneled portion: Mild tenderness along tunnel tract. No obvious abscess. Remainder exam unremarkable. LABS: WBC 15.2 with left shift (infection), Elevated inflammatory markers (CRP 85, ESR 68), Blood cultures drawn x2 sets (results pending 24-48 hours). IMAGING ORDERED: CT chest/abdomen to assess for: Pump pocket infection (fluid/abscess around pump), Deep driveline infection (along tunnel tract), Mediastinitis (rare but serious). Echo to rule out endocarditis on LVAD components. ASSESSMENT: LVAD DRIVELINE INFECTION. This is MOST COMMON LVAD COMPLICATION - occurs in 20-40% of LVAD patients at some point. Infections range from superficial (exit site only) to deep (pump pocket, bloodstream). Risk factors: Diabetes (impaired healing), Obesity (creates deep tunnel), Moisture/friction at exit site. MANAGEMENT: HOSPITAL ADMISSION for IV antibiotics. Started empiric broad-spectrum: Vancomycin (MRSA coverage - common skin pathogen) + Ceftriaxone (Gram-negative coverage). Will tailor antibiotics once cultures result. Duration: Minimum 4-6 weeks IV antibiotics for driveline infections (often require long-term suppressive oral antibiotics after IV course). Some driveline infections can be managed with chronic suppressive antibiotics without clearing infection completely. SURGICAL CONSIDERATIONS: If superficial infection, may respond to antibiotics alone. If deep infection or pump pocket involvement, may need: Driveline revision surgery (externalize new driveline exit site), Pump pocket washout, In rare cases, LVAD removal/replacement (only if device-associated endocarditis or uncontrolled sepsis). PROGNOSIS: Most driveline infections manageable with prolonged antibiotics. Major concern is progression to pump pocket infection or bloodstream infection with sepsis. Close monitoring required. PATIENT IMPACT: Patient very disappointed. Had been doing so well. Now facing prolonged hospitalization and IV antibiotics. Worried about losing independence. Explained this is known complication, caught early, treatable. Will do everything possible to preserve LVAD function and avoid need for device replacement.",
        "patient_reported_adherence": "excellent - patient and husband performed driveline care exactly as instructed, infection not due to non-compliance",
        "social_history_updates": {}
      },
      {
        "visit_id": "V8",
        "visit_date": "2024-07-12",
        "visit_type": "lvad_clinic_visit",
        "chief_complaint": "Post-driveline infection treatment, 6-week IV antibiotics completed",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 105,
          "bp_diastolic": 68,
          "hr_bpm": 76,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 165.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.4,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 195,
          "inr": 2.2,
          "creatinine_mg_dl": 1.3,
          "bun_mg_dl": 22,
          "crp_mg_l": 12,
          "esr_mm_hr": 25
        },
        "medications": {
          "continued": [
            "Carvedilol 12.5mg BID",
            "Losartan 100mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 20mg daily",
            "Warfarin",
            "Omeprazole 40mg daily"
          ],
          "started": [
            "Doxycycline 100mg BID (chronic suppressive antibiotic)",
            "Rifampin 300mg BID (chronic suppressive antibiotic)"
          ],
          "stopped": [
            "Vancomycin completed 6-week course",
            "Ceftriaxone completed 6-week course"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure status post LVAD (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 3a (N18.31)",
            "History of LVAD driveline infection, resolved (Z87.440)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Continue chronic suppressive antibiotics indefinitely",
          "Monthly driveline assessment",
          "Weekly dressing changes",
          "LVAD clinic every 6 weeks"
        ],
        "referrals": [],
        "provider_note_snippet": "INFECTION SUCCESSFULLY TREATED. BLOOD CULTURES from 5/31: Staphylococcus epidermidis (coagulase-negative staph - common skin flora, common cause of device infections). Sensitive to vancomycin. CT IMAGING: Superficial driveline infection only, no pump pocket involvement, no deep abscess. GOOD NEWS - caught early, limited to exit site. TREATMENT COURSE: Admitted 5/31, IV vancomycin x 6 weeks (completed 7/8), Ceftriaxone discontinued after cultures showed Staph (not needed). PICC line placed for outpatient IV antibiotics. Patient discharged after 1 week inpatient, completed remaining 5 weeks as outpatient with home IV antibiotics (visiting nurse administered daily). CURRENT STATUS: Driveline exit site HEALED - no erythema, no drainage, well-approximated. WBC normalized, inflammatory markers near normal. No fevers, no signs of recurrent infection. CHRONIC SUPPRESSIVE ANTIBIOTICS: Started oral doxycycline + rifampin for INDEFINITE duration. This is common practice for LVAD driveline infections - even after treating acute infection, maintain chronic suppressive antibiotics to prevent recurrence. Biofilms form on driveline surface, impossible to completely eradicate bacteria. Chronic antibiotics keep bacterial load low, prevent clinical infection. LVAD FUNCTION: Device functioning perfectly throughout infection. Flow 5.3 L/min, Speed 5400 RPM, Power 5.8 watts. No compromise to device function. PATIENT STATUS: Back to baseline functional status. Walking daily, attending cardiac rehab resumed. Weight loss progressing (down 7 lbs since starting nutrition program). HbA1c improved with weight loss and increased activity. Patient relieved infection resolved. Understanding need for lifelong suppressive antibiotics - 'small price to pay to keep this machine working.' QUALITY OF LIFE: Returned to pre-infection quality of life. Back to attending grandson's games, gardening, social activities. Husband reports 'she's back to herself.' Overall, despite infection complication, patient has done remarkably well with LVAD. It's been 5.5 months post-implant. Transformed from Stage D heart failure, cardiogenic shock, near death  functional, independent, excellent quality of life.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "activities": "Resumed all previous activities after infection resolved",
          "weight_loss": "Down 7 lbs through nutrition program and increased activity"
        }
      },
      {
        "visit_id": "V9",
        "visit_date": "2024-08-30",
        "visit_type": "lvad_clinic_visit",
        "chief_complaint": "7 months post-LVAD, routine follow-up, discuss alarm overnight",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 110,
          "bp_diastolic": 72,
          "hr_bpm": 74,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 162.0
        },
        "labs": {
          "hemoglobin_g_dl": 11.6,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 205,
          "inr": 2.3,
          "creatinine_mg_dl": 1.2,
          "bun_mg_dl": 20,
          "ldh_u_l": 420
        },
        "medications": {
          "continued": [
            "Carvedilol 12.5mg BID",
            "Losartan 100mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 20mg daily",
            "Warfarin",
            "Omeprazole 40mg daily",
            "Doxycycline 100mg BID",
            "Rifampin 300mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure status post LVAD destination therapy (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Chronic kidney disease Stage 2 (N18.2)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Continue current regimen",
          "LVAD clinic in 2 months",
          "Battery replacement scheduled (routine)"
        ],
        "referrals": [],
        "provider_note_snippet": "7 MONTHS POST-LVAD - DOING EXCELLENT. Patient reports alarm sounded at 2am last night - 'Low Battery' alarm. Patient and husband responded appropriately: checked connections, switched to backup battery, plugged controller into electrical outlet. Alarm resolved. This was APPROPRIATE ALARM - primary battery depleted overnight (battery life 8-12 hours, patient had been on same battery for 14 hours). Patient responded correctly - this is exactly what training prepared for. No actual device problem. LVAD FUNCTION: Device interrogation shows perfect function. Flow 5.5 L/min, Speed 5400 RPM, Power 5.9 watts, PI 4.8, Event log: Shows low battery warning 2:14am, resolved 2:16am (2-minute response time - excellent). No other alarms, no power interruptions. Driveline: Clean, healed, no signs of infection recurrence. CLINICAL STATUS: Patient continues to do remarkably well. Reports feeling 'great.' No dyspnea, no chest pain, no edema, no fatigue. Walking 45 minutes daily. Lost 13 lbs since starting nutrition program (now 162 lbs, down from 175 at discharge). HbA1c 6.8 (improved from 8.2 pre-LVAD - better diabetes control with weight loss, exercise, improved perfusion). PHYSICAL EXAM: Well-appearing. BP 110/72. No JVP elevation. Lungs clear. Cardiac: LVAD hum continuous, regular. Abdomen: driveline site pristine. Extremities: no edema. LABS: All stable. Renal function actually IMPROVED - creatinine 1.2 (was 1.6 pre-LVAD, now Stage 2 CKD instead of Stage 3b). This is benefit of improved cardiac output - better renal perfusion. Mild LDH elevation 420 (expected low-level hemolysis with LVAD, clinically insignificant). QUALITY OF LIFE ASSESSMENT: Using Kansas City Cardiomyopathy Questionnaire (disease-specific QOL tool): Score 85/100 (excellent - indicates minimal impact of heart disease on daily life). Patient reports: Can do all household tasks, Can walk as far as desired without dyspnea, Sleeping well (no orthopnea, no PND), Social life restored - visiting friends, attending church, Social life restored - visiting friends, attending church, Active with grandchildren, Emotional well-being good - 'grateful to be alive.' BATTERY REPLACEMENT: Controller batteries last 2-3 years with regular use. Patient's batteries now 7 months old, functioning well. Will need replacement eventually. Keep spare batteries always (patient has 6 batteries total - rotates them). LONG-TERM OUTLOOK: Patient is POSTER CHILD for LVAD destination therapy. Transformed from dying in cardiogenic shock  thriving 7 months later. This is what LVAD is designed to do. Patient stating: 'This machine gave me my life back. I was dying in January, now I'm living in August. I can't believe how good I feel.' Husband agrees: 'It's like getting my wife back after watching her slowly die for years.' Patient planning trip to see daughter who lives out of state (first travel since LVAD - requires planning but doable with spare batteries, LVAD center contact info at destination, TSA notification card). LVAD team very pleased with patient's progress.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "weight": "162 lbs (down from 198 lbs at presentation, 13 lbs lost through nutrition program)",
          "activities": "Walking 45 minutes daily, active with grandchildren, planning travel",
          "diabetes_control": "HbA1c improved to 6.8 from 8.2"
        }
      },
      {
        "visit_id": "V10",
        "visit_date": "2024-09-27",
        "visit_type": "lvad_clinic_visit",
        "chief_complaint": "8 months post-LVAD, routine follow-up",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 108,
          "bp_diastolic": 70,
          "hr_bpm": 72,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 159.0
        },
        "labs": {
          "hemoglobin_g_dl": 12.0,
          "wbc_k_ul": 6.5,
          "platelets_k_ul": 215,
          "inr": 2.4,
          "creatinine_mg_dl": 1.1,
          "bun_mg_dl": 18,
          "ldh_u_l": 395,
          "hba1c": 6.4
        },
        "medications": {
          "continued": [
            "Carvedilol 12.5mg BID",
            "Losartan 100mg daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily",
            "Furosemide 20mg daily",
            "Warfarin",
            "Omeprazole 40mg daily",
            "Doxycycline 100mg BID",
            "Rifampin 300mg BID"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Heart failure status post LVAD destination therapy (I50.22, Z95.811)",
            "Type 2 Diabetes Mellitus, well-controlled (E11.9)",
            "Chronic kidney disease Stage 2 (N18.2)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Echocardiogram - annual post-LVAD assessment",
          "Continue current regimen",
          "LVAD clinic every 2 months"
        ],
        "referrals": [],
        "provider_note_snippet": "8 MONTHS POST-LVAD - EXCELLENT SUSTAINED OUTCOMES. Patient continues to thrive on LVAD support. No complaints, no symptoms, no device issues. LVAD FUNCTION: Flow 5.6 L/min, Speed 5400 RPM, Power 5.9 watts, PI 5.0 (stable), No alarms, no events. PERFECT DEVICE FUNCTION for 8 consecutive months. CLINICAL STATUS: Patient reports highest quality of life in over a decade. Able to perform all desired activities. Completed trip to visit daughter (traveled by car with spare batteries, visited LVAD center in daughter's city for routine check - went smoothly). Walking 60 minutes daily now. Weight loss total 39 lbs (198  159 lbs, BMI decreased from 34 to 27 - now just overweight, no longer obese). HbA1c 6.4 (pre-diabetic range, excellent control). PHYSICAL EXAM: Appears younger than stated age, vibrant, energetic. BP 108/70. Cardiovascular: LVAD hum. Driveline site: Completely healed, no issues. Extremities: Trace edema only (minimal). ECHO (9/25): LVAD inflow/outflow well-positioned, LV severely dilated but well-decompressed with LVAD, RV function adequate, Aortic valve remains closed (LVAD doing all work), Trace mitral regurgitation. NO NATIVE HEART RECOVERY (this is expected - with EF 15-20%, destination therapy, unlikely to recover enough function to explant LVAD). LABS: All improved or stable. Creatinine 1.1 (best since before heart failure diagnosis years ago). Hemoglobin 12.0 (normal - no longer anemic). LDH mildly elevated (expected low-level hemolysis, clinically insignificant). COMPLICATIONS: Zero since driveline infection in May/June. No: Infections, Thrombotic events (stroke, pump thrombosis), Bleeding episodes, Device malfunctions, Right heart failure, Arrhythmias. This is IDEAL LVAD COURSE. PATIENT PERSPECTIVE: 'In January I thought I was dying. I was in cardiogenic shock, my organs were failing, I couldn't breathe, couldn't function. I made peace with dying. Then I got this LVAD, and it literally saved my life. Now, 8 months later, I feel better than I've felt in 10 years. I can do everything I want to do. Yes, I live with a machine - I have a driveline coming out of my belly, I carry batteries everywhere, I can't swim or get in a hot tub. But I'm ALIVE. I'm living, not just surviving. I see my grandchildren, I travel, I garden, I enjoy my life. This machine is a miracle.' CAREGIVER PERSPECTIVE: Husband states: 'The LVAD saved both our lives. It saved her physically, and it saved me from losing her. Learning to live with the LVAD was an adjustment - the alarms in the middle of the night, the constant vigilance, helping with dressing changes. But it's our new normal, and we've adapted. I'd do it all over again in a heartbeat. My wife is alive and thriving.' LONG-TERM PLAN: Patient will live with LVAD indefinitely (destination therapy). Device expected to last 5-10+ years. Will require: Lifelong LVAD clinic follow-up (every 2-3 months), Lifelong anticoagulation (warfarin), Lifelong driveline care (infection prevention), Chronic suppressive antibiotics (prevent infection recurrence), Potential future procedures (battery replacements, controller upgrades, possible device replacement if fails). Patient accepting of this. 'This is my life now, and I'm grateful for it.' Patient advocates in LVAD support group, mentoring newly implanted patients, sharing her success story. SURVIVORSHIP: Patient is now LVAD SURVIVOR, not just heart failure patient. Embraced identity. Wears medical alert bracelet. Carries LVAD emergency card. Educated all family members on device basics. Has backup equipment at home (spare controller, spare batteries, hand pump for absolute emergency). FUTURE GOALS: Patient wants to see youngest grandchild (age 2) start kindergarten in 3 years, attend oldest grandchild's high school graduation in 4 years, celebrate 50th wedding anniversary with husband in 6 years. All realistic goals with LVAD. TEAM ASSESSMENT: This patient represents LVAD SUCCESS STORY. Appropriate candidate selection (Stage D heart failure, refractory symptoms, failed medical therapy, good social support, motivated patient), Excellent surgical outcome, Proactive complication management (driveline infection caught early, treated successfully), Outstanding adherence and self-management, Dramatic quality of life improvement, Prolonged survival (from predicted 6-12 months without LVAD to expected 5-10+ years with LVAD). This is why we do what we do.",
        "patient_reported_adherence": "excellent - exemplary patient, now mentoring others",
        "social_history_updates": {
          "weight": "159 lbs (total weight loss 39 lbs)",
          "activities": "Walking 60 min daily, traveling, gardening, active with grandchildren, mentoring new LVAD patients",
          "functional_status": "NYHA Class I - no limitations, excellent quality of life",
          "future_goals": "See grandchildren's milestones, 50th wedding anniversary in 6 years"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_019",
    "patient_name": "Michael Torres",
    "patient_profile": "https://images.unsplash.com/photo-1535713875002-d1d0cf377fde?ixlib=rb-4.1.0&ixid=M3wxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8fA%3D%3D&auto=format&fit=crop&q=80&w=880",
    "archetype": "STEMI with complications and complete lifestyle transformation",
    "age": 52,
    "sex": "M",
    "race_ethnicity": "Hispanic",
    "allergies": [
      {
        "allergen": "No known drug allergies",
        "reaction": "None",
        "severity": "none",
        "onset": "n/a"
      }
    ],

    "chief_complaint": "Severe chest pain radiating to left arm x2 hours, diaphoresis, nausea",
    "first_visit_date": "2024-06-15",
    "last_visit_date": "2024-09-06",
    "total_visits": 7,

    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_019_A",
        "type": "symptom_lab_correlation",
        "description": "Classic STEMI presentation with ECG changes and troponin elevation requiring urgent revascularization",
        "entities_involved": [
          "Chest pain",
          "ST elevation",
          "Troponin elevation",
          "STEMI",
          "Emergent catheterization"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_019_B",
        "type": "persistent_symptom",
        "description": "Development of cardiogenic shock during PCI requiring mechanical circulatory support",
        "entities_involved": [
          "Hypotension",
          "Pulmonary edema",
          "Low cardiac output",
          "IABP placement",
          "Cardiogenic shock"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_019_C",
        "type": "lab_trend",
        "description": "Post-MI heart failure with reduced ejection fraction requiring medical optimization",
        "entities_involved": [
          "Low EF",
          "Ventricular dysfunction",
          "Heart failure medications",
          "Cardiac rehabilitation"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_019_D",
        "type": "persistent_symptom",
        "description": "Successful cardiac rehabilitation with functional improvement and medication adherence",
        "entities_involved": [
          "Exercise capacity",
          "Symptom improvement",
          "Medication adherence",
          "Risk factor modification"
        ],
        "visits_involved": ["V5", "V6", "V7"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.88
      }
    ],

    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-06-15",
        "visit_type": "emergency_department",
        "chief_complaint": "Severe crushing chest pain x2 hours, radiating to left arm and jaw",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 102,
          "rr_bpm": 22,
          "spo2_percent": 94.0,
          "weight_lbs": 215.0,
          "height_inches": 70.0,
          "bmi": 30.8
        },
        "labs": {
          "troponin_i_ng_ml": 0.08,
          "ck_mb_ng_ml": 8.2,
          "hemoglobin_g_dl": 14.8,
          "wbc_k_ul": 11.2,
          "platelets_k_ul": 265,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.2,
          "creatinine_mg_dl": 1.1,
          "glucose_mg_dl": 245,
          "total_cholesterol_mg_dl": 285,
          "ldl_mg_dl": 189,
          "hdl_mg_dl": 32,
          "triglycerides_mg_dl": 320
        },
        "medications": {
          "continued": [],
          "started": [
            "Aspirin 325mg chewed in ED",
            "Ticagrelor 180mg loading dose",
            "Heparin IV bolus and infusion",
            "Nitroglycerin sublingual 0.4mg x3 doses",
            "Morphine 4mg IV x1 for pain",
            "Metoprolol 5mg IV x1"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "ST-elevation myocardial infarction, anterior wall (I21.09)",
            "Acute coronary syndrome (I24.9)",
            "Hyperglycemia (R73.9)",
            "Hyperlipidemia (E78.5)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "STAT ECG",
          "Troponin serial x3",
          "CK-MB",
          "Lipid panel",
          "Chest X-ray",
          "STAT cardiology consultation",
          "Emergency cardiac catheterization"
        ],
        "referrals": [
          "Cardiology - STEMI activation",
          "Interventional cardiology - emergent PCI"
        ],
        "provider_note_snippet": "52M Hispanic male presents via EMS with acute onset severe substernal chest pain starting 2 hours ago while mowing lawn. CHEST PAIN CHARACTERISTICS: 10/10 severity, crushing/pressure quality, substernal, radiating to left arm and jaw, associated with diaphoresis (drenched in sweat), nausea, shortness of breath. NO relief with rest. Wife called 911. PAST MEDICAL HISTORY: NO prior cardiac history, NO prior hospitalizations, Never seen cardiologist. RISK FACTORS: (1) Type 2 diabetes - undiagnosed until today, not on treatment, (2) Hypertension - undiagnosed, never checked BP regularly, (3) Hyperlipidemia - never checked, (4) Current smoker - 1 pack/day x30 years (30 pack-years), (5) Family history - father MI age 48 (died), brother CABG age 50, (6) Obesity BMI 30.8, (7) Sedentary lifestyle. Multiple HIGH-RISK factors, no medical care, no primary care physician. Works in construction, no health insurance until recently (Medicaid expansion). PHYSICAL EXAM: Acute distress, diaphoretic, clutching chest. BP 142/88, HR 102, RR 22, O2 sat 94% on RA. Cardiovascular: Tachycardic, regular, no murmurs. Lungs: Clear bilaterally. ECG (12:34pm): SINUS TACHYCARDIA 102 bpm, ST-SEGMENT ELEVATION 3-4mm in leads V1-V4 (anterior leads), ST elevation 2mm in leads I, aVL (lateral leads), Reciprocal ST depression in inferior leads (II, III, aVF). INTERPRETATION: ACUTE ANTERIOR WALL ST-ELEVATION MYOCARDIAL INFARCTION (STEMI). This is LEFT ANTERIOR DESCENDING (LAD) artery occlusion - 'widow-maker' - most dangerous coronary occlusion, large territory at risk. TROPONIN: 0.08 (elevated, normal <0.04) - will continue to rise. CK-MB elevated. CHEST X-RAY: Clear lung fields, normal cardiac silhouette. ASSESSMENT: ACUTE STEMI - ANTERIOR WALL. This is TIME-SENSITIVE EMERGENCY. 'Time is muscle' - every minute of delay = more myocardium dies. DOOR-TO-BALLOON TIME goal <90 minutes. Patient arrived ED 12:32pm. STEMI PROTOCOL ACTIVATED: (1) Aspirin 325mg chewed (antiplatelet), (2) Ticagrelor 180mg loading dose (P2Y12 inhibitor, dual antiplatelet therapy), (3) Heparin bolus + infusion (anticoagulation), (4) Nitroglycerin sublingual (coronary vasodilation, preload reduction) - gave 3 doses, chest pain improved from 10/10 to 6/10, (5) Morphine for pain/anxiety, (6) Metoprolol IV (reduce myocardial oxygen demand). EMERGENT CARDIAC CATHETERIZATION: Cath lab activated 12:40pm (8 minutes from arrival - excellent door-to-activation time). Patient to cath lab 12:55pm. INTERVENTIONAL CARDIOLOGY TAKING OVER. Explained to patient and wife: Heart attack from blocked artery, need emergency procedure to open artery with balloon/stent, high-risk procedure but necessary to save heart muscle, risks include bleeding, stroke, arrhythmias, death. Patient consented. Wife terrified - 'Is he going to die?' Explained doing everything possible, caught relatively early (2 hours from symptom onset), best chance is emergency intervention now.",
        "patient_reported_adherence": "n/a - no prior medications",
        "social_history_updates": {
          "occupation": "Construction worker - roofing",
          "living_situation": "Lives with wife and 3 teenage children (ages 14, 16, 18)",
          "insurance": "Recently obtained Medicaid (expansion), previously uninsured x 10+ years",
          "smoking": "Current smoker - 1 PPD x 30 years",
          "alcohol": "Social drinking, 2-3 beers on weekends",
          "exercise": "Sedentary outside of physical labor at work",
          "diet": "Poor - high fat, high salt, fast food frequently",
          "family_history": "Father MI age 48 (died), brother CABG age 50, mother stroke age 65"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-06-15",
        "visit_type": "cardiac_catheterization_report",
        "chief_complaint": "Emergency PCI for STEMI",
        "vitals": {
          "temp_f": 99.2,
          "bp_systolic": 92,
          "bp_diastolic": 58,
          "hr_bpm": 118,
          "rr_bpm": 26,
          "spo2_percent": 91.0,
          "weight_lbs": 215.0
        },
        "labs": {
          "troponin_i_ng_ml": 28.5,
          "ck_mb_ng_ml": 185,
          "lactate_mmol_l": 2.8,
          "bnp_pg_ml": 680
        },
        "medications": {
          "continued": ["Aspirin", "Ticagrelor", "Heparin infusion"],
          "started": [
            "Dopamine 5mcg/kg/min IV (vasopressor for cardiogenic shock)",
            "Lasix 40mg IV (pulmonary edema)",
            "Atorvastatin 80mg daily"
          ],
          "stopped": ["Nitroglycerin held (hypotension)"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Acute anterior STEMI status post emergent PCI with DES to LAD (I21.09)",
            "Cardiogenic shock (R57.0)",
            "Acute systolic heart failure (I50.21)",
            "Status post IABP placement (Z95.811)",
            "Ventricular tachycardia, sustained (I47.2)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Transfer to CCU",
          "IABP 1:1 counterpulsation",
          "Continuous cardiac monitoring",
          "Serial troponins",
          "Echocardiogram in AM",
          "Hemodynamic monitoring"
        ],
        "referrals": ["Critical Care Cardiology"],
        "provider_note_snippet": "CARDIAC CATHETERIZATION REPORT (Attending: Dr. Martinez, Interventional Cardiology): INDICATION: Acute anterior STEMI. PROCEDURE START: 1:05pm. ACCESS: Right femoral artery, 6 French sheath. CORONARY ANGIOGRAPHY FINDINGS: LEFT MAIN: Patent, no disease. LAD (LEFT ANTERIOR DESCENDING): 100% OCCLUSION in proximal LAD just after first diagonal branch. TIMI 0 flow (complete occlusion, no flow beyond blockage). Large thrombus burden visible. This is the CULPRIT LESION. LCX (LEFT CIRCUMFLEX): 40% stenosis mid-vessel (moderate disease, not flow-limiting). RCA (RIGHT CORONARY ARTERY): 30% stenosis proximal (mild disease). IMPRESSION: Acute thrombotic occlusion of proximal LAD - explains anterior STEMI. INTERVENTION: Manual aspiration thrombectomy performed - removed large thrombus. Balloon angioplasty with 2.5mm balloon to cross lesion. Drug-eluting stent (DES) 3.0 x 24mm deployed in proximal LAD. Post-stent balloon inflation with 3.25mm NC balloon to 18 ATM. FINAL RESULT: TIMI 3 flow restored (normal flow), 0% residual stenosis, Excellent angiographic result. COMPLICATIONS DURING PROCEDURE: At 1:42pm (during balloon inflation), patient developed SUSTAINED VENTRICULAR TACHYCARDIA - wide complex tachycardia 180 bpm, patient became unresponsive, BP dropped to 70s systolic. Immediate synchronized cardioversion 200J - converted to sinus rhythm. Patient regained consciousness. HEMODYNAMIC INSTABILITY: Despite successful LAD opening, patient remained hypotensive (BP 85-95 systolic), tachycardic (HR 110-120), Started dopamine 5mcg/kg/min (inadequate response). Patient developing CARDIOGENIC SHOCK - low cardiac output from large anterior MI with stunned/dead myocardium. DECISION: INTRA-AORTIC BALLOON PUMP (IABP) PLACEMENT via left femoral artery. 40cc balloon positioned in descending thoracic aorta, 1:1 counterpulsation started (inflates during diastole to augment coronary perfusion, deflates during systole to reduce afterload). RESPONSE TO IABP: BP improved to 92/58 (MAP 69) with IABP + dopamine. Patient mentating, following commands. TRANSFERRED TO CCU on IABP support, dopamine infusion, ventilator support (intubated in cath lab during code). TOTAL DOOR-TO-BALLOON TIME: 93 minutes (goal <90, slightly over but acceptable given complexity). ASSESSMENT: (1) Successfully opened LAD with stent - vessel patent with excellent flow. (2) However, developed CARDIOGENIC SHOCK from extensive anterior wall injury - myocardium stunned, not contracting well. (3) Ventricular arrhythmia during procedure (reperfusion arrhythmia - common after opening occluded vessel). (4) Requiring mechanical circulatory support (IABP) + inotropes to maintain adequate perfusion. PROGNOSIS: Critical. Large anterior MI with cardiogenic shock carries 40-50% mortality. Next 24-48 hours critical. Will assess LV function with echo in AM. May develop mechanical complications (VSD, papillary muscle rupture, free wall rupture - rare but catastrophic). Close monitoring in CCU. Family updated: Procedure successful in opening artery, but patient very sick from heart damage, requiring life support machines, next 48 hours critical.",
        "patient_reported_adherence": "n/a - intubated/sedated",
        "social_history_updates": {}
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-20",
        "visit_type": "inpatient_progress_note",
        "chief_complaint": "CCU Day 5, post-STEMI, weaning mechanical support",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 105,
          "bp_diastolic": 68,
          "hr_bpm": 88,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 218.0
        },
        "labs": {
          "troponin_i_ng_ml": 12.4,
          "ck_mb_ng_ml": 45,
          "bnp_pg_ml": 1250,
          "hemoglobin_g_dl": 12.8,
          "creatinine_mg_dl": 1.3,
          "potassium_meq_l": 4.0,
          "magnesium_mg_dl": 2.0
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg BID",
            "Atorvastatin 80mg daily",
            "Heparin infusion (transitioning to oral)"
          ],
          "started": [
            "Metoprolol 25mg BID",
            "Lisinopril 5mg daily",
            "Furosemide 20mg daily",
            "Spironolactone 25mg daily",
            "Insulin glargine 20 units qHS",
            "Insulin lispro sliding scale",
            "Nicotine patch 21mg daily"
          ],
          "stopped": ["Dopamine discontinued Day 3", "IABP removed Day 4"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Ischemic cardiomyopathy, acute (I25.5)",
            "Type 2 Diabetes Mellitus, newly diagnosed (E11.9)",
            "Hypertension, newly diagnosed (I10)",
            "Hyperlipidemia (E78.5)",
            "Tobacco use disorder (F17.210)"
          ],
          "new_acute": [
            "Acute anterior STEMI, status post PCI with DES to LAD (I21.09)",
            "Heart failure with reduced ejection fraction, acute (I50.21)",
            "History of cardiogenic shock, resolved (R57.0)",
            "History of ventricular tachycardia (I47.2)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Transfer to step-down unit",
          "Cardiac rehabilitation referral",
          "Nutrition consultation",
          "Diabetes education",
          "Smoking cessation program",
          "Discharge planning"
        ],
        "referrals": [
          "Cardiac rehabilitation",
          "Endocrinology",
          "Primary care establishment"
        ],
        "provider_note_snippet": "REMARKABLE RECOVERY FROM CARDIOGENIC SHOCK. Patient extubated POD#2 (Day 3), IABP removed POD#4 (Day 5), weaned from dopamine POD#3. Now hemodynamically stable without mechanical support or inotropes. ECHOCARDIOGRAM (6/17, Day 3): LV severely dilated, Severe hypokinesis of entire anterior wall, apex, and anterior septum (LAD territory), Hyperkinesis of inferior/posterior walls (compensatory), EJECTION FRACTION 25-30% (severely reduced, normal 55-65%), Moderate mitral regurgitation (functional MR from LV dilatation), No VSD, no free wall rupture, no LV thrombus. INTERPRETATION: Large anterior MI with severely reduced systolic function. Expected given extent of infarction. EF may improve somewhat over weeks-months as stunned myocardium recovers ('hibernating myocardium'), but significant portion is likely permanent scar. CURRENT CLINICAL STATUS: Alert, oriented, conversational. Chest pain resolved. No dyspnea at rest but becomes short of breath with minimal activity (walking to bathroom). Orthopnea - needs 2 pillows to sleep. Trace lower extremity edema. These are HEART FAILURE symptoms from reduced EF. PEAK TROPONIN: 28.5 ng/mL (very elevated, reflects large infarct size). Now trending down (12.4 today). BNP elevated 1250 (heart failure marker). HEART FAILURE MEDICAL THERAPY INITIATED: 'Guideline-directed medical therapy' (GDMT) for HFrEF: (1) Beta-blocker: Metoprolol 25mg BID (reduces mortality post-MI, improves EF over time), (2) ACE-inhibitor: Lisinopril 5mg daily (remodeling prevention, mortality benefit), (3) Mineralocorticoid receptor antagonist: Spironolactone 25mg daily (mortality benefit in HFrEF), (4) Diuretic: Furosemide 20mg daily (symptom management, fluid balance). Will up-titrate these medications as tolerated over weeks-months to target doses. DUAL ANTIPLATELET THERAPY (DAPT): Aspirin 81mg + Ticagrelor 90mg BID. Must continue for MINIMUM 12 months post-stent (reduces stent thrombosis risk). STATIN: Atorvastatin 80mg (high-intensity statin for secondary prevention post-MI). NEWLY DIAGNOSED CONDITIONS: (1) TYPE 2 DIABETES: Glucose 245 on admission, HbA1c pending. Started on insulin (basal-bolus regimen). Endocrine consult, diabetes education. (2) HYPERTENSION: BP elevated on admission. Now on ACE-inhibitor + beta-blocker. (3) HYPERLIPIDEMIA: LDL 189, HDL 32 (very low), Triglycerides 320 (very high). On high-dose statin, will recheck in 6 weeks. SMOKING CESSATION: Patient had MI WHILE SMOKING (1 PPD x 30 years). Continuing to smoke would be catastrophic - doubles risk of recurrent MI. Started nicotine patch, referred to smoking cessation program. Patient motivated - 'I almost died, I'm done with cigarettes.' CARDIAC REHABILITATION: Referred to outpatient cardiac rehab - supervised exercise program, risk factor modification, education. Critical for recovery and secondary prevention. DISCHARGE PLANNING: Medically stable for discharge in 2-3 days. Need to establish: (1) Primary care physician (never had one), (2) Cardiologist follow-up, (3) Medication assistance (multiple expensive medications, Medicaid should cover), (4) Cardiac rehab enrollment, (5) Home care (possible VNA for medication teaching, diabetes teaching). PROGNOSIS DISCUSSION: Patient asking 'Will I be okay?' Explained: (1) Survived large heart attack and cardiogenic shock - already beat the worst odds. (2) Heart muscle is damaged (EF 25-30%), unlikely to return to normal, but may improve to 35-40% with time and medication. (3) With medications, lifestyle changes, cardiac rehab - can live many years with good quality of life. (4) However, HIGH RISK for recurrent cardiac events if doesn't address risk factors. (5) CRITICAL: Stop smoking, control diabetes, control cholesterol, take all medications, attend cardiac rehab. (6) Will need ICD (implantable cardioverter-defibrillator) evaluation in 3 months if EF remains 35% (protects against sudden cardiac death from arrhythmias). Patient tearful, overwhelmed. Wife at bedside daily, very supportive. Children visited - shocked to see father in ICU. Family dynamics changed overnight. Patient was 'healthy' worker, now cardiac cripple. Adjusting to new reality. Social work involved for coping, financial concerns (can't work construction in near future, disability application).",
        "patient_reported_adherence": "excellent - motivated by near-death experience",
        "social_history_updates": {
          "smoking": "Quit Day 1 (in hospital), using nicotine patch, committed to cessation",
          "work": "Unable to work currently, applying for short-term disability",
          "insurance": "Medicaid active, covering hospitalizations and medications"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-07-15",
        "visit_type": "cardiology_office_visit",
        "chief_complaint": "1-month post-MI follow-up, assess recovery and medication tolerance",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 68,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 212.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.2,
          "creatinine_mg_dl": 1.2,
          "potassium_meq_l": 4.2,
          "hba1c": 8.9,
          "lipid_panel": {
            "total_cholesterol_mg_dl": 162,
            "ldl_mg_dl": 78,
            "hdl_mg_dl": 38,
            "triglycerides_mg_dl": 230
          }
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg BID",
            "Atorvastatin 80mg daily",
            "Metoprolol 25mg BID",
            "Lisinopril 5mg daily",
            "Furosemide 20mg daily",
            "Spironolactone 25mg daily",
            "Insulin glargine 24 units qHS",
            "Insulin lispro with meals",
            "Nicotine patch 14mg daily"
          ],
          "started": ["Metformin 500mg BID"],
          "stopped": [],
          "dose_changed": [
            "Nicotine patch decreased from 21mg to 14mg (step-down)",
            "Insulin glargine increased from 20 to 24 units"
          ]
        },
        "diagnoses": {
          "active_chronic": [
            "Ischemic cardiomyopathy (I25.5)",
            "Heart failure with reduced ejection fraction (I50.22)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Tobacco dependence, in remission (Z87.891)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Repeat echocardiogram in 2 months (assess for EF improvement)",
          "Cardiac rehab continuation",
          "Holter monitor (assess for arrhythmias)",
          "ICD evaluation if EF 35% at 3 months"
        ],
        "referrals": [
          "Continuing cardiac rehab",
          "Endocrinology for diabetes management"
        ],
        "provider_note_snippet": "1-MONTH POST-STEMI FOLLOW-UP. Patient doing remarkably well given severity of initial presentation. SYMPTOM REVIEW: Chest pain: None since discharge, no angina. Shortness of breath: Improved significantly. Can walk 2-3 blocks before dyspnea (was unable to walk to bathroom initially). Still has dyspnea with stairs. Orthopnea: Resolved - sleeps flat now. Edema: Minimal ankle swelling end of day. Exercise tolerance: Attending cardiac rehab 3x/week, tolerating well, no chest pain or excessive dyspnea during exercise. PHYSICAL EXAM: Appears well. BP 118/74 (excellent control), HR 68 (good beta-blockade). No JVP elevation. Lungs clear. Cardiac: Regular rate/rhythm, no murmurs. Extremities: Trace edema. MEDICATIONS: Tolerating all heart failure medications well. No dizziness, fatigue, or other side effects. ADHERENCE: Excellent - taking all medications as prescribed. Wife helping with pill organizer. LIPIDS: LDL decreased from 189 to 78 (excellent response to high-dose statin, goal LDL <70 post-MI, achieved). HDL still low 38 (goal >40), Triglycerides still elevated 230 (goal <150). Added metformin (helps with diabetes AND triglycerides). DIABETES: HbA1c 8.9% (elevated, goal <7%). On insulin + metformin. Endocrine following, titrating insulin doses. Patient learning carb counting, checking blood sugars 4x/day. SMOKING CESSATION: Patient has not smoked since MI (5 weeks smoke-free). Using nicotine patch (step-down from 21mg to 14mg). Attending smoking cessation support group. Wife reports patient threw away all cigarettes, ashtrays, lighters. No cravings currently. This is CRITICAL for secondary prevention. WEIGHT: Lost 6 lbs (218  212) since discharge through cardiac rehab and dietary changes. Goal: lose another 25-30 lbs (target weight ~180 lbs, BMI 25-26). CARDIAC REHABILITATION: Completed 8 sessions so far. Exercise capacity improving - can walk on treadmill 15 minutes at moderate pace. Blood pressure and heart rate responses appropriate. No arrhythmias on telemetry during exercise. Attending nutrition and education classes. Patient very engaged. PLAN: (1) Continue current medications. (2) Will up-titrate beta-blocker and ACE-inhibitor over next 2 months to target doses (metoprolol up to 200mg/day, lisinopril up to 40mg/day) to maximize mortality benefit and cardiac remodeling prevention. (3) REPEAT ECHO in 2 months (8/15) - assess for EF improvement. If EF improved to >35%, excellent. If EF remains 35%, will need ICD (implantable cardioverter-defibrillator) for primary prevention of sudden cardiac death. (4) Holter monitor ordered - 48-hour ambulatory ECG monitoring to assess for arrhythmias (patient had VT during cath, at risk for recurrent arrhythmias with low EF). (5) Continue cardiac rehab - goal 36 sessions over 12 weeks. (6) Diabetes optimization with endocrine. (7) Follow-up in 6 weeks. PROGNOSIS: Doing well. No recurrent angina, no heart failure decompensation. Excellent medication adherence, lifestyle modification, smoking cessation. If continues on this trajectory, has good long-term prognosis despite low EF. Patient motivated, engaged, grateful to be alive.",
        "patient_reported_adherence": "excellent - wife helping with medication management, using pill organizer",
        "social_history_updates": {
          "smoking": "5 weeks smoke-free, no cigarettes since MI, attending support group",
          "weight": "212 lbs (down 6 lbs), actively working on weight loss",
          "work": "Still on disability, hoping to return to light-duty work in 2-3 months",
          "exercise": "Cardiac rehab 3x/week, walking at home on non-rehab days"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-08-20",
        "visit_type": "cardiology_office_visit",
        "chief_complaint": "2-month post-MI follow-up, repeat echo results",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 115,
          "bp_diastolic": 72,
          "hr_bpm": 64,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 205.0
        },
        "labs": {
          "hemoglobin_g_dl": 13.8,
          "creatinine_mg_dl": 1.1,
          "potassium_meq_l": 4.0,
          "hba1c": 7.8,
          "bnp_pg_ml": 385
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg BID",
            "Atorvastatin 80mg daily",
            "Furosemide 20mg daily",
            "Spironolactone 25mg daily",
            "Metformin 1000mg BID",
            "Insulin glargine 28 units qHS",
            "Nicotine patch 7mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": [
            "Metoprolol increased from 25mg to 50mg BID",
            "Lisinopril increased from 5mg to 10mg daily",
            "Metformin increased from 500mg to 1000mg BID"
          ]
        },
        "diagnoses": {
          "active_chronic": [
            "Ischemic cardiomyopathy with improving ej, 'ection fraction (I25.5)', 'Heart failure with reduced ejection fraction, NYHA Class II (I50.22)', 'Type 2 Diabetes Mellitus (E11.9)', 'Hypertension (I10)', 'Hyperlipidemia (E78.5)', 'Former smoker (Z87.891)'"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Holter monitor review",
          "Continue cardiac rehab",
          "Recheck echo in 1 month",
          "ICD discussion if EF remains 35%"
        ],
        "referrals": [],
        "provider_note_snippet": "2-MONTH POST-STEMI - CONTINUED IMPROVEMENT. Patient doing very well. Highly motivated, excellent adherence, engaged in recovery. ECHOCARDIOGRAM (8/15): LV size: Mildly dilated (improved from severely dilated), Anterior wall: Moderate hypokinesis (improved from severe), Septum: Mild hypokinesis, Inferior/lateral walls: Normal, EJECTION FRACTION: 35-40% (IMPROVED from 25-30%). This is EXCELLENT improvement. 10-15% absolute increase in EF. Indicates stunned myocardium has recovered, less permanent scar than feared. Mitral regurgitation: Mild (improved from moderate). INTERPRETATION: Significant improvement in LV systolic function. This is best-case scenario - shows substantial myocardial recovery. SYMPTOMS: Chest pain: None, no angina with activity. Dyspnea: Minimal - only with vigorous exertion (climbing 2 flights stairs, brisk walking >10 minutes). Can perform all ADLs without dyspnea. NYHA Class II (slight limitation with strenuous activity). Orthopnea: None. Edema: None. Energy level: 'Feel almost back to normal.' CARDIAC REHABILITATION: Completed 24 of 36 sessions. Exercise tolerance dramatically improved: Treadmill: 30 minutes at moderate pace (3.0 mph, 2% grade) without symptoms. Peak heart rate 110 bpm (appropriate, 70% of max). Blood pressure response: Normal. No chest pain, no dyspnea, no arrhythmias during exercise. Functional capacity improved from <4 METs (unable to walk) to ~7-8 METs (can do most moderate activities). RISK FACTOR MODIFICATION: (1) SMOKING: 9 weeks smoke-free. No cigarettes, no relapses. Using 7mg nicotine patch (lowest dose, will discontinue in 2 weeks). Patient stating 'cigarettes almost killed me, I'll never touch them again.' (2) WEIGHT: 205 lbs (down 13 lbs from 218 at discharge, down 10 lbs from admission weight 215 after fluid loss). BMI decreased from 30.8 to 29.4 (still overweight but improving). Goal: lose another 20-25 lbs. (3) DIABETES: HbA1c improved from 8.9% to 7.8% (still above goal <7% but trending right direction). On metformin + insulin. Blood sugars better controlled. (4) LIPIDS: On high-dose statin, LDL at goal <70. (5) BLOOD PRESSURE: Well-controlled 115/72. MEDICATIONS: Tolerating well, no side effects. Up-titrated metoprolol to 50mg BID (target 200mg/day total, currently 100mg/day). Up-titrated lisinopril to 10mg (target 40mg). Will continue gradual up-titration to target doses over next 2 months. HOLTER MONITOR (48 hours, 8/10-8/12): Sinus rhythm throughout, No sustained ventricular arrhythmias, Rare PVCs (<100/day), No significant pauses or bradycardia. EXCELLENT - no concerning arrhythmias. ICD EVALUATION: With EF 35-40%, patient is in BORDERLINE zone for ICD. Guidelines: EF 35% at 3 months post-MI = ICD indicated (primary prevention sudden cardiac death). EF >35% = medical therapy, no ICD needed. Patient's EF 35-40% (improved). PLAN: Recheck echo in 1 month (3-month mark from MI). If EF 40%, NO ICD needed. If EF 35-40%, shared decision-making with patient. If EF 35%, ICD recommended. Given trend of improvement, expect EF will be >35% and ICD won't be needed. RETURN TO WORK: Patient asking about returning to work (construction, roofing). Discussed: (1) Cannot return to heavy physical labor (roofing) given cardiac status. (2) May be able to do light-duty construction work (supervisory role, light carpentry) after completing cardiac rehab. (3) Will need cardiac clearance after 3-month echo. (4) May need vocational rehabilitation for job retraining if cannot return to construction. (5) Disability/workers comp issues - social work helping navigate. Patient understanding may not be able to return to previous job. Family adjusting financially - wife increased work hours, oldest child (age 18) working to help family. PATIENT PERSPECTIVE: 'I can't believe how much better I feel. Two months ago I was dying in the ICU on machines. Now I can walk, exercise, do things with my kids. I know I got lucky - the doctors saved my life. I'm not taking it for granted. I take every pill, I go to every rehab session, I haven't touched a cigarette. This heart attack was a wake-up call.'",
        "patient_reported_adherence": "excellent - exemplary patient",
        "social_history_updates": {
          "smoking": "9 weeks smoke-free, nearly finished with nicotine replacement therapy",
          "weight": "205 lbs (down 13 lbs)",
          "work": "On disability, discussing light-duty work options vs. vocational rehab",
          "family": "Wife increased work hours, oldest child working to help financially"
        }
      },
      {
        "visit_id": "V6",
        "visit_date": "2024-09-06",
        "visit_type": "cardiology_office_visit",
        "chief_complaint": "3-month post-MI follow-up, repeat echo, ICD decision",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 112,
          "bp_diastolic": 70,
          "hr_bpm": 62,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 198.0
        },
        "labs": {
          "hemoglobin_g_dl": 14.2,
          "creatinine_mg_dl": 1.0,
          "potassium_meq_l": 4.1,
          "hba1c": 7.2,
          "lipid_panel": {
            "total_cholesterol_mg_dl": 148,
            "ldl_mg_dl": 62,
            "hdl_mg_dl": 42,
            "triglycerides_mg_dl": 180
          },
          "bnp_pg_ml": 245
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg BID (will continue for 12 months total post-stent)",
            "Atorvastatin 80mg daily",
            "Furosemide 20mg daily",
            "Spironolactone 25mg daily",
            "Metformin 1000mg BID",
            "Insulin glargine 28 units qHS"
          ],
          "started": [],
          "stopped": ["Nicotine patch discontinued (completed taper)"],
          "dose_changed": [
            "Metoprolol increased to 75mg BID (target dose approaching)",
            "Lisinopril increased to 20mg daily"
          ]
        },
        "diagnoses": {
          "active_chronic": [
            "Ischemic cardiomyopathy with recovered ejection fraction (I25.5)",
            "Heart failure with mildly reduced ejection fraction, NYHA Class I (I50.23)",
            "Type 2 Diabetes Mellitus, improving control (E11.9)",
            "Hypertension, controlled (I10)",
            "Hyperlipidemia, controlled (E78.5)",
            "Former smoker (Z87.891)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Cardiac rehab graduation (completed 36 sessions)",
          "Cardiac clearance for light-duty work",
          "Annual follow-up with cardiology",
          "Primary care establishment",
          "Continue all medications indefinitely"
        ],
        "referrals": [
          "Primary care physician",
          "Vocational rehabilitation services"
        ],
        "provider_note_snippet": "3-MONTH POST-STEMI - REMARKABLE RECOVERY. ECHOCARDIOGRAM (9/3): LV size: Normal, Anterior wall: Mild hypokinesis (continued improvement), Septum: Normal, Inferior/lateral walls: Normal, EJECTION FRACTION: 45-50% (EXCELLENT - near-normal range). This is DRAMATIC improvement from initial EF 25-30%. 20% absolute improvement in EF over 3 months. Mitral regurgitation: Trace (essentially resolved). NO ICD NEEDED: With EF 45-50%, patient does NOT meet criteria for ICD (would need EF 35%). No ICD implantation necessary. Will continue medical therapy. SYMPTOMS: Essentially ASYMPTOMATIC. No chest pain, no dyspnea except with very strenuous exertion, no orthopnea, no edema, full energy. NYHA Class I (no limitation of physical activity, ordinary activity does not cause symptoms). Patient feels 'back to normal.' CARDIAC REHABILITATION: COMPLETED 36 sessions (graduated yesterday). Final stress test: 9 minutes on Bruce protocol (9-10 METs), No chest pain, no significant dyspnea, no arrhythmias, Appropriate heart rate and blood pressure response. This is EXCELLENT functional capacity - able to perform most activities without limitation. RISK FACTORS - ALL OPTIMIZED: (1) SMOKING: 12 weeks (3 months) smoke-free. No nicotine replacement therapy (completed taper). Patient confident in cessation. (2) WEIGHT: 198 lbs (down 20 lbs from admission, down 17 lbs from discharge). BMI 28.4 (overweight but approaching normal range). Patient continuing weight loss efforts - goal 185 lbs. (3) DIABETES: HbA1c 7.2% (nearly at goal <7%, dramatic improvement from 8.9%). Blood sugars well-controlled on metformin + insulin. (4) LIPIDS: LDL 62 (well below goal <70), HDL 42 (improved from 32), Triglycerides 180 (improved from 320). All improving. (5) BLOOD PRESSURE: 112/70 (excellent control). (6) EXERCISE: Walking 30-45 minutes daily, staying active. MEDICATIONS: Optimal medical therapy for ischemic cardiomyopathy: Beta-blocker (metoprolol 75mg BID, nearly at target dose), ACE-inhibitor (lisinopril 20mg, will increase to target 40mg), Aldosterone antagonist (spironolactone 25mg), Diuretic (low-dose furosemide for minimal residual symptoms), High-intensity statin (atorvastatin 80mg), Dual antiplatelet therapy (aspirin + ticagrelor, will continue ticagrelor through June 2025 = 12 months post-stent, then aspirin only), Diabetes medications. BNP: 245 (continued decline from 1250, indicates well-compensated heart failure). RETURN TO WORK: Cardiac clearance provided for LIGHT-DUTY work. Cannot return to roofing (too strenuous, risk of falls with cardiac history). Referred to vocational rehab services. Patient exploring options: light construction supervision, warehouse work, potentially retraining for different career. Patient accepting he cannot do heavy labor anymore. LONG-TERM PLAN: (1) Continue all cardiac medications indefinitely (these are LIFELONG medications post-MI with heart failure). (2) Cardiology follow-up annually (or sooner if symptoms develop). (3) Primary care physician: Patient establishing care with PCP (first PCP in adult life) for ongoing management of diabetes, hypertension, preventive care. (4) Lifestyle: Maintain smoking cessation, continue weight loss to goal, maintain physical activity, heart-healthy diet. (5) Monitor for symptoms: Chest pain, dyspnea, edema - call immediately if develop. (6) Dual antiplatelet therapy through June 2025 (absolutely critical - cannot stop early, risk of stent thrombosis). PROGNOSIS: Excellent recovery. Went from cardiogenic shock with EF 25% and 40-50% mortality risk  EF 45-50%, NYHA Class I, excellent functional capacity, all risk factors optimized. With continued medication adherence and lifestyle modification, excellent long-term prognosis. Risk of recurrent MI exists but substantially reduced with current management. Patient may live many years with good quality of life. PATIENT REFLECTION: 'Three months ago I was dying. They told my wife I might not make it. I had a massive heart attack, I was on life support, I thought my life was over. But here I am - I feel better than I've felt in years. I lost weight, I quit smoking, I'm exercising, I'm controlling my diabetes. This heart attack was the worst and best thing that happened to me. Worst because I almost died. Best because it forced me to change my life. I was killing myself slowly - smoking, eating poorly, never seeing doctors. Now I take care of myself. I take my pills, I see my doctors, I'm around for my kids. I got a second chance and I'm not wasting it.' TEAM ASSESSMENT: This patient represents IDEAL post-MI recovery: Timely reperfusion (door-to-balloon <95 minutes), Survived cardiogenic shock with mechanical support, Excellent myocardial recovery (EF 25%  45-50%), Complete risk factor modification (smoking cessation, weight loss, diabetes control, lipid control), Excellent medication adherence, Completed cardiac rehabilitation, Strong family support, Highly motivated patient. This is what guideline-directed therapy can achieve.",
        "patient_reported_adherence": "excellent - continues to be exemplary patient",
        "social_history_updates": {
          "smoking": "3 months smoke-free, off nicotine replacement therapy, confident in cessation",
          "weight": "198 lbs (20 lbs weight loss from admission, goal 185 lbs)",
          "work": "Medically cleared for light-duty work, pursuing vocational rehab and job retraining",
          "exercise": "Walking 30-45 min daily, graduated from cardiac rehab",
          "primary_care": "Establishing with PCP for first time in adult life"
        }
      },
      {
        "visit_id": "V7",
        "visit_date": "2024-09-27",
        "visit_type": "primary_care_visit",
        "chief_complaint": "Establishing primary care, post-MI follow-up, chronic disease management",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 64,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 195.0
        },
        "labs": {
          "cbc": "Normal",
          "cmp": "Normal except glucose 145 (fasting)",
          "hba1c": 7.0,
          "lipid_panel": "Optimal on current therapy",
          "tsh": 2.4
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg BID",
            "Atorvastatin 80mg daily",
            "Metoprolol 75mg BID",
            "Lisinopril 20mg daily",
            "Furosemide 20mg daily",
            "Spironolactone 25mg daily",
            "Metformin 1000mg BID",
            "Insulin glargine 28 units qHS"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Ischemic cardiomyopathy, stable (I25.5)",
            "Heart failure with mildly reduced ejection fraction, NYHA Class I (I50.23)",
            "Type 2 Diabetes Mellitus, well-controlled (E11.9)",
            "Hypertension, controlled (I10)",
            "Hyperlipidemia, controlled (E78.5)",
            "Obesity (E66.9)",
            "Former smoker (Z87.891)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Age-appropriate cancer screening (colonoscopy - never had one, now age 52)",
          "Annual influenza vaccine given today",
          "Pneumococcal vaccine given today",
          "HbA1c every 3 months",
          "Lipid panel annually",
          "Diabetic eye exam referral",
          "Diabetic foot exam"
        ],
        "referrals": [
          "Ophthalmology - diabetic retinopathy screening",
          "Gastroenterology - colonoscopy screening"
        ],
        "provider_note_snippet": "52M establishing primary care for FIRST TIME IN ADULT LIFE. Patient never had PCP, avoided medical care for decades. Cardiac event (massive MI 3.5 months ago) served as 'wake-up call.' Now highly engaged in health. CURRENT STATUS: Post-STEMI with recovered EF (45-50%), completing cardiac rehab, multiple chronic conditions (CAD, HF, DM, HTN, HLD) all well-controlled on medications. Cardiology managing cardiac issues - PCP role is coordinating care, managing non-cardiac chronic diseases, preventive care, medication refills. DIABETES: HbA1c 7.0% (AT GOAL <7%, down from 8.9% at diagnosis 3 months ago). Excellent improvement. On metformin + insulin. Checking blood sugars at home. Understanding carb counting. Referred for diabetic eye exam (never had one, important for retinopathy screening). Will perform diabetic foot exam at each visit. HYPERTENSION: Well-controlled on ACE-inhibitor + beta-blocker (also serving cardiac function). BP 118/74 (goal <130/80, achieved). HYPERLIPIDEMIA: On high-intensity statin (atorvastatin 80mg). LDL well below goal. Continue current therapy. OBESITY: BMI 28 (down from 30.8). Lost 20 lbs since MI through diet and exercise. Patient continuing weight loss efforts. Provided dietary counseling, encouraged continued exercise. SMOKING CESSATION: 3+ months smoke-free. Patient adamant about not relapsing. Discussed triggers, coping strategies. PREVENTIVE CARE: Patient is 52 years old. Never had age-appropriate screening. Today administered: Influenza vaccine, Pneumococcal vaccine (important for cardiac patients). Ordered: Colonoscopy (age 50+ screening, patient never had), Diabetic eye exam, Reviewed testicular self-exam, Discussed prostate cancer screening (shared decision-making, will discuss at next visit). MEDICATION MANAGEMENT: Reviewed all 9 daily medications. Patient taking all as prescribed, using pill organizer, wife helping with reminders. All medications appropriate, no interactions. Will continue indefinitely. Discussed importance of NEVER stopping cardiac medications (especially aspirin + ticagrelor) without discussing with cardiologist (stent thrombosis risk). SOCIAL DETERMINANTS: Medicaid active, covering all medications and appointments. Exploring light-duty work through vocational rehab. Financial stressors improved somewhat with disability payments. Wife working, oldest child contributing. Family adjusting to 'new normal.' MENTAL HEALTH SCREENING: Patient screening negative for depression (PHQ-9 score 3). Some anxiety about recurrent cardiac events ('will I have another heart attack?'). Provided reassurance - with current medication adherence and lifestyle changes, risk substantially reduced. Encouraged continued engagement with care. PATIENT ENGAGEMENT: This patient's transformation remarkable. Went from: NO medical care x decades  highly engaged in health. Smoker 30 years  3+ months smoke-free. Obese, sedentary  lost 20 lbs, exercising daily. Uncontrolled diabetes/hypertension/cholesterol  all at goal. Near-death from MI  thriving 3 months later. Patient attributing change to 'second chance at life.' Motivated to 'be around for my kids, see my grandkids someday.' PLAN: (1) Continue all current medications. (2) HbA1c recheck in 3 months. (3) Follow-up in 3 months for chronic disease management. (4) Complete recommended screening (colonoscopy, eye exam). (5) Continue lifestyle modifications. (6) Open-door policy - call with any concerns. (7) Coordinate with cardiology for cardiac care. PROGNOSIS: With excellent adherence, risk factor control, and engaged patient, excellent long-term outlook despite significant cardiac disease.",
        "patient_reported_adherence": "excellent - continues exemplary adherence",
        "social_history_updates": {
          "weight": "195 lbs (total 23 lbs lost from admission)",
          "preventive_care": "First time receiving age-appropriate screening and vaccinations",
          "patient_engagement": "Transformed from avoiding medical care to highly engaged in health management"
        }
      }
    ]
  },

  {
    "patient_id": "TEST_PT_020",
    "patient_profile": "https://thumbs.dreamstime.com/b/passport-photo-african-american-businessman-passport-photo-african-american-businessman-isolated-white-background-cut-168920819.jpg",
    "patient_name": "John Doe",
    "archetype": "Cardiovascular_Acute_MI_STEMI",
    "demographics": {
      "age": 58,
      "sex": "M",
      "race_ethnicity": "Caucasian"
    },
    "allergies": [
      {
        "allergen": "Contrast dye (iodinated)",
        "reaction": "Hives, mild bronchospasm during prior CT scan",
        "severity": "moderate",
        "onset": "2019"
      },
      {
        "allergen": "Clopidogrel",
        "reaction": "Severe rash, discontinued after prior stent",
        "severity": "moderate",
        "onset": "2020"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_020_A",
        "type": "symptom_lab_correlation",
        "description": "Acute chest pain with ST-segment elevation and troponin rise indicating STEMI",
        "entities_involved": [
          "Chest pain",
          "EKG changes",
          "Troponin elevation",
          "ST elevation"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_020_B",
        "type": "lab_trend",
        "description": "Progressive troponin elevation from 0.05 to peak 45.2 ng/mL indicating large MI with myocardial necrosis",
        "entities_involved": ["Troponin I", "CK-MB", "Time from symptom onset"],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_020_C",
        "type": "symptom_lab_correlation",
        "description": "Post-MI heart failure development with declining EF and rising BNP",
        "entities_involved": ["Ejection fraction", "BNP", "Dyspnea", "Edema"],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.9
      },
      {
        "correlation_id": "CORR_020_D",
        "type": "persistent_symptom",
        "description": "Delayed presentation (12 hours from symptom onset) resulting in larger infarct and worse outcomes",
        "entities_involved": [
          "Time to treatment",
          "Troponin peak",
          "EF",
          "Complications"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.88
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-06-15",
        "visit_type": "emergency",
        "chief_complaint": "Severe crushing chest pain since yesterday evening, pain radiating to left arm and jaw",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 168,
          "bp_diastolic": 98,
          "hr_bpm": 102,
          "rr_bpm": 22,
          "spo2_percent": 94.0,
          "weight_lbs": 215.0,
          "height_inches": 70.0,
          "bmi": 30.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 185,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 72,
          "hemoglobin_g_dl": 14.8,
          "wbc_k_ul": 12.5,
          "platelets_k_ul": 285,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.5,
          "alt_u_l": 38,
          "ast_u_l": 52,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 485
        },
        "medications": {
          "continued": [
            "Atorvastatin 20mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": [
            "Aspirin 325mg chewed immediately",
            "Nitroglycerin sublingual 0.4mg x3 doses",
            "Morphine 4mg IV for pain",
            "Heparin IV bolus then infusion",
            "Metoprolol 5mg IV"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Hypertension (I10)"
          ],
          "new_acute": [
            "ST-elevation myocardial infarction, inferior wall (I21.19)",
            "Acute coronary syndrome (I24.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "EKG - ST elevation in leads II, III, aVF (inferior STEMI)",
          "Troponin I: 8.5 ng/mL (elevated, normal <0.04)",
          "CK-MB: 85 ng/mL (elevated)",
          "Chest X-ray - clear lung fields, normal cardiac silhouette",
          "STAT cardiology consult for cardiac catheterization"
        ],
        "referrals": [
          "Interventional cardiology - emergency cardiac catheterization"
        ],
        "provider_note_snippet": "ACUTE STEMI - EMERGENCY. 58 yo male presenting with 12 hours of severe substernal chest pain, radiating to left arm and jaw, associated with diaphoresis, nausea. Pain started at 8pm yesterday while watching TV. Patient delayed seeking care, hoping it would resolve. EKG shows classic inferior STEMI with ST elevation in II, III, aVF. Troponin significantly elevated at 8.5. DELAYED PRESENTATION - symptom onset 12 hours ago. Activated cardiac cath lab. Given aspirin, heparin, beta-blocker, morphine. Patient to cath lab emergently. Risk factors: diabetes, hyperlipidemia, obesity, hypertension, family history (father MI at age 52). Pre-treated with IV fluids and antihistamine due to contrast allergy history.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": "current (1 pack per day x 35 years)",
          "alcohol": "moderate (2-3 beers daily)",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-06-16",
        "visit_type": "office_visit",
        "chief_complaint": "Post-catheterization day 1, CCU admission",
        "vitals": {
          "temp_f": 99.2,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 78,
          "rr_bpm": 18,
          "spo2_percent": 96.0,
          "weight_lbs": 213.0,
          "height_inches": 70.0,
          "bmi": 30.6
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 168,
          "creatinine_mg_dl": 1.4,
          "gfr_ml_min": 65,
          "hemoglobin_g_dl": 13.8,
          "wbc_k_ul": 14.2,
          "platelets_k_ul": 275,
          "sodium_meq_l": 137,
          "potassium_meq_l": 4.2,
          "alt_u_l": 45,
          "ast_u_l": 128,
          "crp_mg_l": 85.4,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 248,
          "ldl_mg_dl": 168,
          "hdl_mg_dl": 32,
          "triglycerides_mg_dl": 240,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 2850
        },
        "medications": {
          "continued": [
            "Atorvastatin 20mg daily",
            "Metformin 1000mg twice daily",
            "Heparin infusion"
          ],
          "started": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg twice daily (alternative to clopidogrel due to allergy)",
            "Metoprolol succinate 50mg daily",
            "Lisinopril 5mg daily",
            "Insulin sliding scale for hyperglycemia"
          ],
          "stopped": [],
          "dose_changed": ["Atorvastatin increased to 80mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Hypertension (I10)"
          ],
          "new_acute": [
            "ST-elevation myocardial infarction, inferior wall, acute (I21.19)",
            "Right coronary artery occlusion, status post PCI with stent (I25.10)",
            "Acute systolic heart failure (I50.21)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Cardiac catheterization report: 100% occlusion of RCA, successful PCI with drug-eluting stent placement",
          "Troponin I peak: 45.2 ng/mL (massive elevation)",
          "Echocardiogram: EF 35%, inferior wall akinesis, mild mitral regurgitation",
          "Telemetry monitoring"
        ],
        "referrals": [],
        "provider_note_snippet": "Post-cath day 1. Successful PCI to RCA with single drug-eluting stent for 100% occlusion. TIMI 3 flow achieved. However, LARGE MI - troponin peaked at 45.2 (very high), CK 2850. Delayed presentation (12 hours) resulted in significant myocardial necrosis before reperfusion. Echo shows EF 35% with inferior wall akinesis. Now has systolic heart failure. Started GDMT: aspirin, ticagrelor (can't use clopidogrel due to allergy history), beta-blocker, ACE-I, high-dose statin. Creatinine slightly elevated at 1.4 (contrast-induced nephropathy vs cardiorenal). Patient hemodynamically stable, chest pain resolved. Will monitor for complications - arrhythmias, heart failure, free wall rupture. Cardiac rehab referral. Smoking cessation critical.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "current - counseled extensively on cessation",
          "alcohol": "none during hospitalization",
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-20",
        "visit_type": "office_visit",
        "chief_complaint": "Hospital day 5, transfer to step-down unit, some shortness of breath",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 108,
          "bp_diastolic": 68,
          "hr_bpm": 82,
          "rr_bpm": 20,
          "spo2_percent": 94.0,
          "weight_lbs": 218.0,
          "height_inches": 70.0,
          "bmi": 31.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 142,
          "creatinine_mg_dl": 1.3,
          "gfr_ml_min": 68,
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 10.5,
          "platelets_k_ul": 268,
          "sodium_meq_l": 136,
          "potassium_meq_l": 4.6,
          "alt_u_l": 42,
          "ast_u_l": 68,
          "crp_mg_l": 52.3,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 485
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg twice daily",
            "Metoprolol succinate 50mg daily",
            "Lisinopril 5mg daily",
            "Atorvastatin 80mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": ["Furosemide 40mg daily", "Spironolactone 25mg daily"],
          "stopped": [
            "Heparin discontinued",
            "Insulin sliding scale discontinued"
          ],
          "dose_changed": ["Lisinopril increased to 10mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Hypertension (I10)"
          ],
          "new_acute": [
            "Acute myocardial infarction, healing (I21.19)",
            "Coronary artery disease with stent (I25.10, Z95.5)",
            "Systolic heart failure, acute (I50.21)",
            "Post-MI volume overload (E87.70)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "BNP: 1250 pg/mL (elevated)",
          "Chest X-ray: mild pulmonary vascular congestion",
          "Repeat echo: EF 32% (slightly worse), inferior/inferolateral akinesis"
        ],
        "referrals": ["Cardiac rehabilitation"],
        "provider_note_snippet": "Hospital day 5. Patient developing post-MI heart failure symptoms - mild dyspnea on exertion, 5 lb weight gain, mild crackles at bases. BNP elevated at 1250. Repeat echo shows EF declined to 32%. Started diuretic therapy with furosemide and spironolactone. Uptitrated ACE-I. Patient hemodynamically stable. No arrhythmias on telemetry. CK trending down (was 2850, now 485). Discharge planning - will go home in 1-2 days. Extensive education on dual antiplatelet therapy (must take aspirin AND ticagrelor for minimum 1 year - cannot stop), heart failure medications, lifestyle modifications. Smoking cessation critical - provided resources. Cardiac rehab enrolled.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-07-12",
        "visit_type": "office_visit",
        "chief_complaint": "Post-MI follow-up, 4 weeks after discharge, feeling weak and tired",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 102,
          "bp_diastolic": 64,
          "hr_bpm": 68,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 208.0,
          "height_inches": 70.0,
          "bmi": 29.9
        },
        "labs": {
          "hba1c": 7.8,
          "glucose_mg_dl": 138,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 72,
          "hemoglobin_g_dl": 12.2,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 242,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.4,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "crp_mg_l": 8.5,
          "esr_mm_hr": null,
          "tsh_miu_l": 2.4,
          "cholesterol_total_mg_dl": 142,
          "ldl_mg_dl": 68,
          "hdl_mg_dl": 38,
          "triglycerides_mg_dl": 180,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg twice daily",
            "Metoprolol succinate 50mg daily",
            "Lisinopril 10mg daily",
            "Atorvastatin 80mg daily",
            "Metformin 1000mg twice daily",
            "Furosemide 40mg daily",
            "Spironolactone 25mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Hypertension (I10)",
            "Coronary artery disease with history of MI and stent (I25.10, Z95.5)",
            "Systolic heart failure (I50.22)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "BNP: 680 pg/mL (improved from 1250)",
          "Echocardiogram: EF 38% (improved from 32%)"
        ],
        "referrals": [],
        "provider_note_snippet": "4 week post-MI follow-up. Patient doing reasonably well. Enrolled in cardiac rehab, attending 3x per week. 7 lb weight loss (intentional diet modification). Reports fatigue and weakness - likely deconditioning from MI and beta-blocker effect. No chest pain, no dyspnea at rest. Some dyspnea with exertion but improving. Echo shows EF improved to 38%. BNP down to 680. LDL excellent at 68 on high-dose statin. A1c 7.8 - needs better diabetes control. CRITICAL: Patient MUST continue dual antiplatelet therapy (aspirin + ticagrelor) for minimum 1 year - reinforced multiple times. Patient quit smoking 2 weeks ago - using nicotine patches. Excellent progress. Continue all medications. Gradual return to activities as tolerated through cardiac rehab.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": "quit 2 weeks ago (using nicotine replacement)",
          "alcohol": "none since MI",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-10-18",
        "visit_type": "office_visit",
        "chief_complaint": "6-month post-MI follow-up, doing well overall",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 64,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 195.0,
          "height_inches": 70.0,
          "bmi": 28.0
        },
        "labs": {
          "hba1c": 6.8,
          "glucose_mg_dl": 118,
          "creatinine_mg_dl": 1.1,
          "gfr_ml_min": 78,
          "hemoglobin_g_dl": 13.4,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 248,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": 2.8,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 138,
          "ldl_mg_dl": 62,
          "hdl_mg_dl": 42,
          "triglycerides_mg_dl": 170,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Aspirin 81mg daily",
            "Ticagrelor 90mg twice daily",
            "Metoprolol succinate 50mg daily",
            "Lisinopril 10mg daily",
            "Atorvastatin 80mg daily",
            "Metformin 1000mg twice daily",
            "Furosemide 40mg daily",
            "Spironolactone 25mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Type 2 Diabetes Mellitus, improved control (E11.9)",
            "Hyperlipidemia (E78.5)",
            "Obesity (E66.9)",
            "Hypertension (I10)",
            "Coronary artery disease with history of MI and stent (I25.10, Z95.5)",
            "Systolic heart failure (I50.22)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Echocardiogram: EF 42% (continued improvement)",
          "BNP: 385 pg/mL (near normal)",
          "Stress test at 1 year if no symptoms"
        ],
        "referrals": [],
        "provider_note_snippet": "Excellent 6-month post-MI progress. Patient lost 20 lbs total (215 to 195), completed cardiac rehab, remains smoke-free (6 months!), exercising regularly. EF improved to 42%. BNP near normal at 385. Diabetes control improved (A1c 6.8). LDL at goal (<70). No angina, no heart failure symptoms. Functionally independent, back to work. Will continue dual antiplatelet therapy for full year, then transition to aspirin monotherapy after discussion with cardiology. Patient understands importance of lifelong risk factor modification - diet, exercise, smoking cessation, medication adherence. This case demonstrates: (1) Consequences of delayed presentation in STEMI, (2) Development of post-MI heart failure, (3) Importance of comprehensive cardiac rehab and lifestyle modification, (4) Recovery potential with optimal medical therapy.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": "quit (6 months smoke-free)",
          "alcohol": "none",
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing the significance of delayed presentation (12 hours) on infarct size",
      "Understanding the relationship between troponin elevation magnitude and myocardial damage",
      "Connecting acute MI with development of post-MI heart failure (EF decline)",
      "Recognizing the importance of dual antiplatelet therapy after stent placement",
      "Understanding contrast allergy management in emergency cardiac catheterization",
      "Tracking recovery trajectory through serial EF measurements"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize acute STEMI presentation and need for emergency intervention, (2) understand impact of time-to-treatment on outcomes, (3) track troponin kinetics and correlation with infarct size, (4) recognize post-MI complications (heart failure development), (5) understand importance of secondary prevention medications, (6) appreciate role of lifestyle modifications and cardiac rehabilitation in recovery, and (7) recognize allergy considerations affecting treatment choices (clopidogrel allergy requiring ticagrelor, contrast allergy requiring premedication). The LLM should identify the critical nature of delayed presentation at V1, recognize massive MI with high troponin at V2, identify post-MI heart failure at V3, and track positive recovery trajectory through V4-V5 with lifestyle modifications."
  },

  {
    "patient_name": "Alan Miller",
    "patient_profile": "https://img.freepik.com/free-photo/worldface-american-man-white-background_53876-139742.jpg",
    "patient_id": "TEST_PT_003",
    "archetype": "Archetype_3_Medication_Induced_Statin_Myopathy",
    "demographics": {
      "age": 67,
      "sex": "M",
      "race_ethnicity": "Caucasian"
    },
    "allergies": [
      {
        "allergen": "Atorvastatin",
        "reaction": "Severe myopathy, CK elevation >1800, muscle weakness",
        "severity": "severe",
        "onset": "documented 2024 (this case)"
      },
      {
        "allergen": "Penicillin",
        "reaction": "Hives - childhood reaction",
        "severity": "moderate",
        "onset": "childhood"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_003_A",
        "type": "symptom_lab_correlation",
        "description": "New onset muscle pain and weakness temporally associated with atorvastatin initiation and dose escalation",
        "entities_involved": [
          "Muscle pain",
          "Weakness",
          "Atorvastatin",
          "CK elevation"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.9
      },
      {
        "correlation_id": "CORR_003_B",
        "type": "lab_trend",
        "description": "Progressive CK elevation from normal baseline to 1850 U/L correlating with statin use",
        "entities_involved": ["CK", "Atorvastatin dose"],
        "visits_involved": ["V1", "V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_003_C",
        "type": "symptom_lab_correlation",
        "description": "Symptom and lab improvement after statin discontinuation, confirming causal relationship",
        "entities_involved": [
          "Muscle pain",
          "CK",
          "Atorvastatin discontinuation"
        ],
        "visits_involved": ["V4", "V5"],
        "expected_severity": "medium",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_003_D",
        "type": "medication_nonresponse",
        "description": "Continued symptom escalation despite dose adjustments, requiring drug class change",
        "entities_involved": [
          "Atorvastatin",
          "Rosuvastatin",
          "Muscle symptoms"
        ],
        "visits_involved": ["V2", "V3", "V4", "V5"],
        "expected_severity": "medium",
        "minimum_confidence_threshold": 0.85
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-03-22",
        "visit_type": "office_visit",
        "chief_complaint": "Annual physical, discussing cholesterol results",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 132,
          "bp_diastolic": 82,
          "hr_bpm": 68,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 185.0,
          "height_inches": 70.0,
          "bmi": 26.5
        },
        "labs": {
          "hba1c": 5.6,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.2,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 225,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.3,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": 2.4,
          "cholesterol_total_mg_dl": 268,
          "ldl_mg_dl": 175,
          "hdl_mg_dl": 48,
          "triglycerides_mg_dl": 225,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 125
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Aspirin 81mg daily",
            "Metoprolol 25mg twice daily"
          ],
          "started": ["Atorvastatin 40mg daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of MI 2018 (I25.2)",
            "Coronary artery disease (I25.10)"
          ],
          "new_acute": ["Hyperlipidemia (E78.5)"],
          "differential": []
        },
        "procedures_ordered": ["Lipid panel recheck in 6 weeks"],
        "referrals": [],
        "provider_note_snippet": "Annual exam. Patient doing well overall. LDL significantly elevated at 175. Given CAD history, starting atorvastatin 40mg. Discussed diet and exercise. Baseline CK normal at 125. Patient reports no muscle symptoms currently.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "former",
          "alcohol": "social",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-05-10",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up cholesterol, also some muscle aches in thighs and shoulders past few weeks",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 128,
          "bp_diastolic": 78,
          "hr_bpm": 66,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 183.5,
          "height_inches": 70.0,
          "bmi": 26.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": 32,
          "ast_u_l": 35,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 188,
          "ldl_mg_dl": 105,
          "hdl_mg_dl": 52,
          "triglycerides_mg_dl": 155,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 385
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Aspirin 81mg daily",
            "Metoprolol 25mg twice daily",
            "Atorvastatin 40mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of MI 2018 (I25.2)",
            "Coronary artery disease (I25.10)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": ["Myalgia (M79.1)"],
          "differential": []
        },
        "procedures_ordered": [],
        "referrals": [],
        "provider_note_snippet": "Excellent lipid response to atorvastatin - LDL down from 175 to 105. Patient reports mild muscle aches in thighs and shoulders for past 3-4 weeks. CK mildly elevated at 385 (was 125 baseline). Discussed that mild CK elevation can occur with statins. Will monitor. Advised patient to report worsening symptoms.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-28",
        "visit_type": "office_visit",
        "chief_complaint": "Muscle pain getting worse, now having trouble climbing stairs and lifting things",
        "vitals": {
          "temp_f": 98.1,
          "bp_systolic": 130,
          "bp_diastolic": 80,
          "hr_bpm": 70,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 182.0,
          "height_inches": 70.0,
          "bmi": 26.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.1,
          "gfr_ml_min": 85,
          "hemoglobin_g_dl": 14.0,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 218,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.2,
          "alt_u_l": 45,
          "ast_u_l": 52,
          "crp_mg_l": 8.2,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 892
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Aspirin 81mg daily",
            "Metoprolol 25mg twice daily"
          ],
          "started": ["Coenzyme Q10 200mg daily"],
          "stopped": [],
          "dose_changed": ["Atorvastatin reduced to 20mg daily"]
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of MI 2018 (I25.2)",
            "Coronary artery disease (I25.10)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": ["Statin-induced myopathy, suspected (G72.0)"],
          "differential": []
        },
        "procedures_ordered": ["Repeat CK in 2 weeks"],
        "referrals": [],
        "provider_note_snippet": "Patient with worsening myalgias and now functional impairment - difficulty with stairs and lifting. CK further elevated to 892 (>7x baseline). ALT/AST also elevated. Strong suspicion for statin-induced myopathy. Reduced atorvastatin to 20mg and added CoQ10. Will recheck CK in 2 weeks. If no improvement, will need to discontinue statin and consider alternative agent.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-07-15",
        "visit_type": "office_visit",
        "chief_complaint": "Muscle pain and weakness even worse, now affecting daily activities",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 126,
          "bp_diastolic": 78,
          "hr_bpm": 68,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 180.5,
          "height_inches": 70.0,
          "bmi": 25.9
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 1.2,
          "gfr_ml_min": 82,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": 58,
          "ast_u_l": 68,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 1850
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Aspirin 81mg daily",
            "Metoprolol 25mg twice daily",
            "Coenzyme Q10 200mg daily"
          ],
          "started": [],
          "stopped": ["Atorvastatin discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of MI 2018 (I25.2)",
            "Coronary artery disease (I25.10)",
            "Hyperlipidemia (E78.5)"
          ],
          "new_acute": ["Statin-induced myopathy (G72.0)"],
          "differential": []
        },
        "procedures_ordered": [
          "CK recheck in 3 weeks",
          "Lipid panel in 6 weeks"
        ],
        "referrals": [],
        "provider_note_snippet": "No improvement with dose reduction - CK now 1850, nearly 15x baseline. Patient reports significant weakness affecting ADLs, unable to get up from chair without using arms. This is moderate-severe statin myopathy. DISCONTINUED atorvastatin immediately. Will allow 4-6 week washout period then reassess lipid management options. May trial low-dose rosuvastatin or ezetimibe. Patient counseled on symptoms to watch for rhabdomyolysis.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-08-30",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up after stopping statin, muscle symptoms much improved",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 128,
          "bp_diastolic": 80,
          "hr_bpm": 66,
          "rr_bpm": 14,
          "spo2_percent": 98.0,
          "weight_lbs": 182.0,
          "height_inches": 70.0,
          "bmi": 26.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 102,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.1,
          "wbc_k_ul": 6.9,
          "platelets_k_ul": 222,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.3,
          "alt_u_l": 26,
          "ast_u_l": 28,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 242,
          "ldl_mg_dl": 158,
          "hdl_mg_dl": 50,
          "triglycerides_mg_dl": 170,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": 165
        },
        "medications": {
          "continued": [
            "Lisinopril 10mg daily",
            "Aspirin 81mg daily",
            "Metoprolol 25mg twice daily",
            "Coenzyme Q10 200mg daily"
          ],
          "started": ["Ezetimibe 10mg daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "History of MI 2018 (I25.2)",
            "Coronary artery disease (I25.10)",
            "Hyperlipidemia (E78.5)",
            "Statin intolerance (Z88.6)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Lipid panel in 8 weeks",
          "Consider PCSK9 inhibitor if ezetimibe insufficient"
        ],
        "referrals": ["Cardiology for lipid management discussion"],
        "provider_note_snippet": "Excellent improvement after statin discontinuation. Patient reports muscle pain nearly resolved, strength back to baseline. CK normalized at 165, liver enzymes normalized. LDL rebounded to 158 off statin. Given CAD history, need aggressive lipid management but patient is statin-intolerant. Started ezetimibe. Referred to cardiology to discuss PCSK9 inhibitor options given high CV risk.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing the temporal relationship between statin initiation and symptom onset",
      "Connecting progressive CK elevation with worsening clinical symptoms",
      "Distinguishing statin myopathy from other causes of muscle pain in elderly patient",
      "Recognizing that dose reduction was insufficient and discontinuation was necessary",
      "Understanding the confirmatory pattern of symptom/lab resolution after drug discontinuation"
    ],
    "evaluation_notes": "This case tests ability to: (1) detect temporal associations between medication starts and new symptoms, (2) track progressive laboratory abnormalities correlating with drug exposure, (3) recognize medication non-response to dose adjustment, (4) identify causal relationships through drug discontinuation and symptom resolution, and (5) understand severity grading of adverse drug reactions. The LLM should recognize statin myopathy by Visit 2-3 based on CK elevation and myalgias, and should flag the need for discontinuation by Visit 3 when CK exceeded 5x normal with functional impairment."
  },

  {
    "patient_id": "TEST_PT_021",
    "patient_profile": "https://media.istockphoto.com/id/2180600273/photo/smiling-mature-hispanic-woman-looking-at-the-camera-on-a-gray-background.jpg?s=612x612&w=0&k=20&c=qYoF_P2nrtPm9CyUOtgxM7OpS5BTqL664lYiy0vv00Y=",
    "patient_name": "Hillory Williams",
    "archetype": "Cardiovascular_Atrial_Fibrillation_Stroke_Risk",
    "demographics": {
      "age": 68,
      "sex": "F",
      "race_ethnicity": "Asian"
    },
    "allergies": [],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_021_A",
        "type": "symptom_lab_correlation",
        "description": "New onset atrial fibrillation with palpitations and irregular heart rhythm",
        "entities_involved": [
          "Palpitations",
          "Irregular pulse",
          "EKG showing AFib",
          "Heart rate"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_021_B",
        "type": "lab_trend",
        "description": "Progressive decline in heart rate control despite medication escalation",
        "entities_involved": [
          "Heart rate",
          "Beta-blocker doses",
          "Calcium channel blocker",
          "AFib burden"
        ],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_021_C",
        "type": "care_gap",
        "description": "Delayed anticoagulation initiation despite high stroke risk (CHA2DS2-VASc score 5)",
        "entities_involved": [
          "CHA2DS2-VASc score",
          "Anticoagulation",
          "Stroke risk",
          "Time to treatment"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_021_D",
        "type": "symptom_lab_correlation",
        "description": "Transient ischemic attack (TIA) occurring while on inadequate anticoagulation",
        "entities_involved": [
          "TIA symptoms",
          "INR subtherapeutic",
          "Atrial fibrillation",
          "Stroke"
        ],
        "visits_involved": ["V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-04-05",
        "visit_type": "office_visit",
        "chief_complaint": "Heart racing and fluttering sensation in chest for past week",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 118,
          "rr_bpm": 16,
          "spo2_percent": 97.0,
          "weight_lbs": 138.0,
          "height_inches": 62.0,
          "bmi": 25.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 108,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 78,
          "hemoglobin_g_dl": 13.2,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 245,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": 2.8,
          "cholesterol_total_mg_dl": 208,
          "ldl_mg_dl": 132,
          "hdl_mg_dl": 58,
          "triglycerides_mg_dl": 90,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Hydrochlorothiazide 25mg daily"
          ],
          "started": ["Metoprolol tartrate 25mg twice daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Hyperlipidemia (E78.5)"],
          "new_acute": ["Palpitations (R00.2)", "Sinus tachycardia (R00.0)"],
          "differential": ["Atrial fibrillation", "Anxiety", "Hyperthyroidism"]
        },
        "procedures_ordered": [
          "EKG - sinus rhythm, rate 118, no acute changes",
          "TSH ordered",
          "24-hour Holter monitor ordered"
        ],
        "referrals": [],
        "provider_note_snippet": "68 yo female with 1 week of palpitations and racing heart. Heart rate 118 in office. EKG today shows sinus tachycardia. Pulse irregular on exam. No chest pain, no dyspnea. Patient anxious about symptoms. Started low-dose beta-blocker. Ordered Holter monitor to capture rhythm during symptoms. TSH to rule out hyperthyroidism. RTC in 2 weeks for Holter results.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "never",
          "alcohol": "social (wine with dinner)",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-04-22",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up for Holter monitor results, still having episodes of rapid heartbeat",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 138,
          "bp_diastolic": 84,
          "hr_bpm": 96,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 137.0,
          "height_inches": 62.0,
          "bmi": 25.1
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": 2.6,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Hydrochlorothiazide 25mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": ["Metoprolol tartrate increased to 50mg twice daily"]
        },
        "diagnoses": {
          "active_chronic": ["Hypertension (I10)", "Hyperlipidemia (E78.5)"],
          "new_acute": ["Atrial fibrillation, paroxysmal (I48.0)"],
          "differential": []
        },
        "procedures_ordered": [
          "Holter monitor results: Multiple episodes of atrial fibrillation, longest 4 hours, heart rates 110-145 during AFib",
          "Echocardiogram ordered",
          "EKG today - atrial fibrillation with rapid ventricular response, rate 96"
        ],
        "referrals": ["Cardiology"],
        "provider_note_snippet": "ATRIAL FIBRILLATION diagnosed on Holter monitor. Multiple paroxysmal AFib episodes over 24 hours. EKG today also shows AFib. TSH normal. Patient has multiple stroke risk factors: age 68, female, hypertension. CHA2DS2-VASc score = 4 (age, female, hypertension) - HIGH RISK for stroke, anticoagulation indicated. However, patient very anxious about 'blood thinners' after reading online. Spent significant time discussing stroke risk (annual risk ~4% without anticoagulation). Patient wants to 'think about it' before starting anticoagulation. Increased beta-blocker for rate control. Ordered echo to assess heart structure. Cardiology referral for AFib management and discussion of anticoagulation vs cardioversion options. CRITICAL: Patient needs anticoagulation but declining currently.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-05-24",
        "visit_type": "office_visit",
        "chief_complaint": "Cardiology follow-up completed, still having palpitations, agreed to start blood thinner",
        "vitals": {
          "temp_f": 98.3,
          "bp_systolic": 144,
          "bp_diastolic": 86,
          "hr_bpm": 88,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 136.0,
          "height_inches": 62.0,
          "bmi": 24.9
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 102,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 78,
          "hemoglobin_g_dl": 13.4,
          "wbc_k_ul": 6.5,
          "platelets_k_ul": 242,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.1,
          "alt_u_l": 26,
          "ast_u_l": 24,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Hydrochlorothiazide 25mg daily",
            "Metoprolol tartrate 50mg twice daily"
          ],
          "started": ["Warfarin 5mg daily (target INR 2-3)"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Atrial fibrillation, paroxysmal (I48.0)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Echocardiogram results: Normal LV function, EF 60%, mild LA enlargement, no valvular disease",
          "Baseline INR: 1.0",
          "INR recheck in 3 days"
        ],
        "referrals": [],
        "provider_note_snippet": "Saw cardiology. Echo shows preserved EF 60%, mild LA enlargement. Cardiologist discussed rate vs rhythm control, anticoagulation options. Patient finally agreed to anticoagulation after cardiologist reinforced stroke risk. Started warfarin (patient preferred over DOACs due to cost/insurance coverage). Explained INR monitoring, dietary vitamin K considerations, drug interactions. Patient understanding seems good. Will need frequent INR checks initially. CHA2DS2-VASc score actually 5 (rereviewed - age, female, hypertension, vascular disease history - patient had DVT 10 years ago, forgot to mention initially). VERY HIGH stroke risk. Critical that INR maintained in therapeutic range 2-3.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": "stopped drinking wine on warfarin",
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-06-28",
        "visit_type": "emergency",
        "chief_complaint": "Sudden onset of slurred speech and right arm weakness this morning, resolved after 20 minutes",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 168,
          "bp_diastolic": 94,
          "hr_bpm": 102,
          "rr_bpm": 18,
          "spo2_percent": 97.0,
          "weight_lbs": 135.0,
          "height_inches": 62.0,
          "bmi": 24.7
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 118,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 78,
          "hemoglobin_g_dl": 13.2,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 238,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Hydrochlorothiazide 25mg daily",
            "Metoprolol tartrate 50mg twice daily",
            "Warfarin 5mg daily"
          ],
          "started": ["Atorvastatin 80mg daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Atrial fibrillation, paroxysmal (I48.0)"
          ],
          "new_acute": [
            "Transient ischemic attack (G45.9)",
            "Cerebrovascular disease (I67.9)"
          ],
          "differential": ["Stroke"]
        },
        "procedures_ordered": [
          "CT head - no acute hemorrhage or infarct",
          "MRI brain - small acute infarct in left MCA territory",
          "Carotid ultrasound - <30% stenosis bilaterally",
          "EKG - atrial fibrillation, rate 102",
          "INR: 1.4 (SUBTHERAPEUTIC - should be 2-3)"
        ],
        "referrals": ["Neurology", "Admitted for observation"],
        "provider_note_snippet": "TRANSIENT ISCHEMIC ATTACK / SMALL STROKE. Patient presented with sudden slurred speech and right arm weakness at 9am, resolved by 9:20am. By ED arrival at 10am, neurologically intact. CT negative for hemorrhage. MRI shows small acute infarct in left MCA territory consistent with cardioembolic stroke from atrial fibrillation. CRITICAL FINDING: INR only 1.4, SUBTHERAPEUTIC (should be 2-3). Patient on warfarin only 5 weeks. Reviewed INR records - has been erratic: 1.2, 2.8, 1.6, 1.4. Patient admits inconsistent warfarin dosing - sometimes forgets, sometimes takes double dose when remembers she forgot. Also eating large amounts of leafy greens inconsistently. This stroke was PREVENTABLE with adequate anticoagulation. Started high-dose statin. Admitted for observation, telemetry monitoring. Neurology recommends switching to DOAC (direct oral anticoagulant) - more predictable, no monitoring needed, better for non-adherent patients. Discussed with patient - will transition to apixaban.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-07-26",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up after TIA, now on apixaban, feeling well",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 132,
          "bp_diastolic": 78,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 134.0,
          "height_inches": 62.0,
          "bmi": 24.5
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": 78,
          "hemoglobin_g_dl": 13.0,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 245,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.2,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 162,
          "ldl_mg_dl": 78,
          "hdl_mg_dl": 62,
          "triglycerides_mg_dl": 110,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 5mg daily",
            "Hydrochlorothiazide 25mg daily",
            "Metoprolol tartrate 50mg twice daily",
            "Atorvastatin 80mg daily"
          ],
          "started": ["Apixaban 5mg twice daily"],
          "stopped": ["Warfarin discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Hyperlipidemia (E78.5)",
            "Atrial fibrillation, paroxysmal (I48.0)",
            "History of TIA/stroke (Z86.73)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Repeat MRI brain in 3 months",
          "Neurology follow-up scheduled"
        ],
        "referrals": [],
        "provider_note_snippet": "1 month post-TIA. Patient doing well, no neurologic deficits. No recurrent symptoms. Switched from warfarin to apixaban - much easier for patient (no INR monitoring, no dietary restrictions, twice daily dosing). Patient reports excellent adherence with apixaban - using pill organizer and phone alarms. Heart rate better controlled on metoprolol. Still in paroxysmal AFib. LDL excellent at 78 on high-dose statin. BP improved. Patient very motivated after stroke scare. This case demonstrates: (1) Importance of CHA2DS2-VASc scoring and early anticoagulation, (2) Consequences of subtherapeutic anticoagulation, (3) Impact of medication non-adherence on stroke risk, (4) Advantages of DOACs over warfarin for certain patients, (5) Stroke as preventable complication of untreated/undertreated AFib. Patient's stroke was PREVENTABLE - either earlier anticoagulation or better warfarin adherence would have prevented this.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing delayed anticoagulation as a critical care gap despite high stroke risk",
      "Understanding CHA2DS2-VASc scoring and its implications for anticoagulation decisions",
      "Connecting subtherapeutic INR with TIA/stroke occurrence",
      "Identifying medication non-adherence as contributing factor to adverse outcome",
      "Understanding the difference between rate control and anticoagulation in AFib",
      "Recognizing preventable nature of the stroke with earlier/better anticoagulation"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize new-onset atrial fibrillation and its clinical significance, (2) calculate stroke risk using CHA2DS2-VASc score, (3) identify delayed anticoagulation as a care gap despite clear indications, (4) understand the relationship between subtherapeutic anticoagulation and stroke risk, (5) recognize medication non-adherence and its consequences, (6) understand advantages of DOACs over warfarin for certain patient populations, and (7) identify the preventable nature of complications when guideline-directed therapy is not followed. The LLM should flag high stroke risk at V2 when AFib is diagnosed, identify the care gap of delayed anticoagulation at V2-V3, recognize subtherapeutic INR as critical finding at V4, connect poor adherence with stroke occurrence, and understand the improved safety/adherence profile with DOAC switch at V5. This case emphasizes that strokes from AFib are largely preventable with appropriate anticoagulation."
  },

  {
    "patient_id": "TEST_PT_022",
    "patient_profile": "data:image/jpeg;base64,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",
    "patient_name": "Rebecca Barber",
    "archetype": "ENT_Chronic_Sinusitis_Complications",
    "demographics": {
      "age": 42,
      "sex": "F",
      "race_ethnicity": "Caucasian"
    },
    "allergies": [
      {
        "allergen": "Penicillin",
        "reaction": "Hives, facial swelling",
        "severity": "moderate",
        "onset": "childhood"
      },
      {
        "allergen": "Dust mites",
        "reaction": "Nasal congestion, sneezing, itchy eyes",
        "severity": "moderate",
        "onset": "adult"
      },
      {
        "allergen": "Ragweed pollen",
        "reaction": "Allergic rhinitis symptoms",
        "severity": "moderate",
        "onset": "teenage years"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_022_A",
        "type": "persistent_symptom",
        "description": "Recurrent sinus infections (5 episodes in 8 months) despite multiple antibiotic courses indicating chronic sinusitis",
        "entities_involved": [
          "Sinus infections",
          "Facial pain",
          "Nasal discharge",
          "Antibiotic treatments"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_022_B",
        "type": "symptom_lab_correlation",
        "description": "Nasal polyps and chronic inflammation on CT correlating with persistent symptoms and allergic history",
        "entities_involved": [
          "Nasal polyps",
          "CT findings",
          "Allergies",
          "Eosinophilia"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_022_C",
        "type": "medication_nonresponse",
        "description": "Failure of medical management (antibiotics, steroids, nasal sprays) requiring surgical intervention",
        "entities_involved": [
          "Multiple antibiotics",
          "Nasal steroids",
          "Oral steroids",
          "Symptom persistence"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.85
      },
      {
        "correlation_id": "CORR_022_D",
        "type": "care_gap",
        "description": "Delayed ENT referral despite recurrent infections and inadequate response to medical therapy",
        "entities_involved": [
          "ENT referral timing",
          "Number of infections",
          "Treatment failures"
        ],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "moderate",
        "minimum_confidence_threshold": 0.82
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-02-10",
        "visit_type": "office_visit",
        "chief_complaint": "Sinus infection, facial pain and pressure, thick yellow nasal discharge x1 week",
        "vitals": {
          "temp_f": 99.8,
          "bp_systolic": 118,
          "bp_diastolic": 74,
          "hr_bpm": 78,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 152.0,
          "height_inches": 65.0,
          "bmi": 25.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": 11.2,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Fluticasone nasal spray 2 sprays each nostril daily (for allergies)"
          ],
          "started": [
            "Azithromycin 500mg day 1, then 250mg daily x4 days (Z-pack)",
            "Pseudoephedrine 30mg as needed for congestion"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Allergic rhinitis (J30.1)",
            "Environmental allergies (Z91.040)"
          ],
          "new_acute": ["Acute sinusitis (J01.90)"],
          "differential": []
        },
        "procedures_ordered": [],
        "referrals": [],
        "provider_note_snippet": "42 yo female with 1 week of facial pain, pressure over maxillary sinuses, thick purulent nasal discharge, post-nasal drip, mild headache. Low-grade fever 99.8. Exam: tenderness over maxillary and frontal sinuses, purulent discharge in nares, pharynx mildly erythematous from post-nasal drip. Diagnosed acute bacterial sinusitis. Started azithromycin (penicillin allergy documented). Patient has history of seasonal allergies, already on fluticasone nasal spray. This is her third sinus infection in past 6 months per patient report.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "never",
          "alcohol": "social",
          "housing_status": "stable (owns home)",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-04-18",
        "visit_type": "office_visit",
        "chief_complaint": "Another sinus infection, same symptoms as before, not getting better with antibiotics",
        "vitals": {
          "temp_f": 100.2,
          "bp_systolic": 122,
          "bp_diastolic": 76,
          "hr_bpm": 82,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 153.0,
          "height_inches": 65.0,
          "bmi": 25.5
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": 12.8,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Fluticasone nasal spray 2 sprays each nostril daily"],
          "started": [
            "Levofloxacin 500mg daily x10 days",
            "Prednisone 40mg daily x5 days"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Allergic rhinitis (J30.1)",
            "Environmental allergies (Z91.040)"
          ],
          "new_acute": [
            "Acute sinusitis, recurrent (J01.91)",
            "Treatment-resistant sinusitis (J32.9)"
          ],
          "differential": ["Chronic sinusitis"]
        },
        "procedures_ordered": [],
        "referrals": [],
        "provider_note_snippet": "Fourth sinus infection in 6 months. Patient completed azithromycin in February with initial improvement, but symptoms returned within 3 weeks. Presents now with fever 100.2, severe facial pain, thick green nasal discharge. Exam: significant tenderness over all sinuses, purulent drainage, nasal mucosa edematous and inflamed. This is becoming recurrent/chronic pattern. Started fluoroquinolone (levofloxacin) for broader coverage and oral steroids for inflammation. Discussed possibility of chronic sinusitis. Should consider ENT referral if this doesn't resolve or recurs again.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-25",
        "visit_type": "office_visit",
        "chief_complaint": "Sinus symptoms never really went away, now worse again, can't breathe through nose, constant pressure",
        "vitals": {
          "temp_f": 98.8,
          "bp_systolic": 126,
          "bp_diastolic": 78,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 154.0,
          "height_inches": 65.0,
          "bmi": 25.6
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": 9.5,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Fluticasone nasal spray 2 sprays each nostril daily"],
          "started": [
            "Amoxicillin-clavulanate 875mg twice daily x14 days",
            "Prednisone 20mg daily x7 days",
            "Montelukast 10mg daily"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Allergic rhinitis (J30.1)",
            "Environmental allergies (Z91.040)",
            "Chronic rhinosinusitis (J32.9)"
          ],
          "new_acute": ["Acute exacerbation of chronic sinusitis (J01.90)"],
          "differential": ["Nasal polyps", "Deviated septum"]
        },
        "procedures_ordered": [
          "CT sinuses ordered",
          "CBC with differential - eosinophils 8% (mildly elevated)"
        ],
        "referrals": ["ENT referral placed"],
        "provider_note_snippet": "CHRONIC SINUSITIS - fifth episode in 8 months. Patient reports symptoms never fully resolved after last infection. Now with complete nasal obstruction, can't breathe through nose, constant facial pressure, thick post-nasal drip, reduced sense of smell. No fever today. Exam: nasal passages almost completely obstructed with boggy, inflamed mucosa bilaterally. Visualized what appears to be polyps in left naris. Sinuses very tender. This is CHRONIC RHINOSINUSITIS. Started augmentin (amoxicillin-clavulanate works for penicillin allergy when true allergy is just rash/hives, not anaphylaxis), oral steroids, added montelukast for anti-inflammatory effect and allergic component. Ordered CT sinuses. ENT REFERRAL - patient needs specialist evaluation, likely needs functional endoscopic sinus surgery (FESS) if medical management continues to fail.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-08-09",
        "visit_type": "office_visit",
        "chief_complaint": "ENT follow-up completed, discussing CT results and surgery options",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 120,
          "bp_diastolic": 74,
          "hr_bpm": 74,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 152.0,
          "height_inches": 65.0,
          "bmi": 25.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 12.8,
          "wbc_k_ul": 8.2,
          "platelets_k_ul": 245,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": 22,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Fluticasone nasal spray 2 sprays each nostril daily",
            "Montelukast 10mg daily"
          ],
          "started": [
            "Budesonide nasal rinse (0.5mg in 240mL saline) twice daily"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Allergic rhinitis (J30.1)",
            "Environmental allergies (Z91.040)",
            "Chronic rhinosinusitis with nasal polyps (J33.1)",
            "Pansinusitis (J32.4)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "CT sinuses results: Complete opacification of maxillary sinuses bilaterally, near-complete opacification of ethmoid and frontal sinuses, nasal polyps throughout nasal cavity and ethmoid sinuses, deviated nasal septum to right, ostiomeatal complex obstruction bilaterally",
          "Allergy testing scheduled"
        ],
        "referrals": ["Allergy/Immunology", "ENT surgery scheduled"],
        "provider_note_snippet": "Saw ENT specialist. CT shows severe chronic pansinusitis with extensive nasal polyposis - explains recurrent infections and treatment failures. ENT recommends functional endoscopic sinus surgery (FESS) with polypectomy and septoplasty. Patient scheduled for surgery in 4 weeks. In meantime, started on budesonide sinus rinses (steroid irrigation) to reduce inflammation. Will also see allergist for comprehensive testing and potential immunotherapy - environmental allergies are contributing factor to polyp formation. ENT explained surgery will open blocked sinuses, remove polyps, improve drainage. Patient understanding and agreeable to surgical plan. This case shows progression from recurrent acute sinusitis to chronic sinusitis with polyposis requiring surgical intervention when medical management fails.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-10-25",
        "visit_type": "office_visit",
        "chief_complaint": "Post-op follow-up, 6 weeks after sinus surgery, doing much better",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 70,
          "rr_bpm": 14,
          "spo2_percent": 99.0,
          "weight_lbs": 149.0,
          "height_inches": 65.0,
          "bmi": 24.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Fluticasone nasal spray 2 sprays each nostril daily",
            "Montelukast 10mg daily",
            "Budesonide nasal rinse twice daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Allergic rhinitis (J30.1)",
            "Environmental allergies (Z91.040)",
            "Chronic rhinosinusitis with nasal polyps, status post FESS (J33.1, Z98.89)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Allergy testing results: Strongly positive to dust mites, mold, ragweed, tree pollen"
        ],
        "referrals": ["Starting sublingual immunotherapy (allergy drops)"],
        "provider_note_snippet": "6 weeks post-FESS with polypectomy and septoplasty. Surgery successful per ENT - all polyps removed, sinuses opened, septum corrected. Patient reports DRAMATIC improvement - can breathe through nose for first time in years, no facial pressure, sense of smell returning. No infections since surgery. Continuing nasal steroid spray and budesonide rinses to prevent polyp recurrence. Allergy testing showed multiple strong environmental allergies. Starting sublingual immunotherapy (allergy drops) - proven to reduce polyp recurrence and improve long-term control. Patient very satisfied with surgical outcome. Will need ongoing ENT surveillance for polyp recurrence. This case demonstrates: (1) Natural history of chronic sinusitis with polyposis, (2) Failure of medical management alone in severe disease, (3) Role of surgery in refractory cases, (4) Importance of addressing underlying allergies to prevent recurrence, (5) Need for long-term maintenance therapy post-surgery.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing the pattern of recurrent acute sinusitis progressing to chronic sinusitis",
      "Understanding when medical management has failed and surgical referral is indicated",
      "Identifying nasal polyps as a complication of chronic inflammation and allergies",
      "Recognizing the role of environmental allergies in chronic sinusitis pathophysiology",
      "Understanding the importance of post-surgical maintenance therapy to prevent recurrence",
      "Identifying the care gap of delayed ENT referral despite multiple treatment failures"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize recurrent sinusitis pattern (5 episodes in 8 months) indicating chronic disease, (2) identify treatment failure with multiple antibiotic courses, (3) understand the progression from acute recurrent to chronic sinusitis with complications, (4) recognize nasal polyps on exam and imaging as structural cause of symptoms, (5) understand when surgical intervention is indicated after medical management failure, (6) appreciate the role of allergies in chronic sinusitis, (7) identify delayed specialist referral as a care gap, and (8) understand importance of post-surgical maintenance and immunotherapy. The LLM should flag recurrent pattern by V2, recognize inadequate response to medical therapy by V3, identify need for imaging and ENT referral, understand CT findings showing severe disease at V4, and appreciate successful surgical outcome and prevention strategies at V5. This case emphasizes that chronic sinusitis often requires multimodal treatment including surgery and allergy management, not just antibiotics."
  },

  {
    "patient_id": "TEST_PT_023",
    "patient_profile": "data:image/jpeg;base64,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",
    "patient_name": "David Kimmel",
    "archetype": "ENT_Sudden_Sensorineural_Hearing_Loss",
    "demographics": {
      "age": 55,
      "sex": "M",
      "race_ethnicity": "African American"
    },
    "allergies": [
      {
        "allergen": "Sulfa drugs (Sulfamethoxazole)",
        "reaction": "Severe rash, Stevens-Johnson syndrome risk per patient",
        "severity": "severe",
        "onset": "1998"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_023_A",
        "type": "symptom_lab_correlation",
        "description": "Sudden unilateral hearing loss with tinnitus and vertigo indicating inner ear pathology (SSHL)",
        "entities_involved": [
          "Hearing loss",
          "Tinnitus",
          "Vertigo",
          "Audiogram findings"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_023_B",
        "type": "care_gap",
        "description": "Critical delay in treatment - patient waited 5 days before seeking care, missing optimal treatment window",
        "entities_involved": [
          "Symptom onset",
          "Time to treatment",
          "Steroid efficacy",
          "Hearing recovery"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_023_C",
        "type": "medication_nonresponse",
        "description": "Incomplete hearing recovery despite high-dose steroids due to delayed treatment initiation",
        "entities_involved": [
          "Oral prednisone",
          "Intratympanic dexamethasone",
          "Audiogram results",
          "Hearing thresholds"
        ],
        "visits_involved": ["V2", "V3", "V4"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_023_D",
        "type": "persistent_symptom",
        "description": "Permanent hearing loss and persistent tinnitus resulting in significant functional impairment",
        "entities_involved": [
          "Hearing loss",
          "Tinnitus",
          "Quality of life",
          "Work difficulties"
        ],
        "visits_involved": ["V3", "V4", "V5"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.9
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-05-23",
        "visit_type": "office_visit",
        "chief_complaint": "Can't hear out of left ear for past 5 days, ringing in ear, some dizziness",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 198.0,
          "height_inches": 70.0,
          "bmi": 28.4
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 118,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.5,
          "wbc_k_ul": 7.2,
          "platelets_k_ul": 252,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.1,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": 18,
          "tsh_miu_l": 2.4,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Obesity (E66.9)"
          ],
          "new_acute": [
            "Hearing loss, left ear (H91.90)",
            "Tinnitus (H93.1)",
            "Vertigo (R42)"
          ],
          "differential": [
            "Cerumen impaction",
            "Ear infection",
            "Sudden sensorineural hearing loss"
          ]
        },
        "procedures_ordered": [
          "Otoscopic exam - bilateral TMs clear, no effusion, no cerumen impaction",
          "Weber test - lateralizes to RIGHT ear (away from affected left ear)",
          "Rinne test - LEFT ear: bone conduction > air conduction (abnormal); RIGHT ear: air > bone (normal)"
        ],
        "referrals": ["STAT ENT referral placed"],
        "provider_note_snippet": "55 yo male with SUDDEN onset left-sided hearing loss 5 days ago. Woke up on May 18th and noticed couldn't hear out of left ear. Associated with loud ringing (tinnitus) and episodes of dizziness/vertigo. NO ear pain, no discharge, no recent URI, no trauma. Exam: TMs normal bilaterally, no obvious cause. Weber lateralizes to RIGHT (good ear) - suggests sensorineural loss on left. Rinne shows bone > air on left (abnormal). This is CONCERNING for sudden sensorineural hearing loss (SSHL) - ENT EMERGENCY requiring urgent treatment. CRITICAL: Patient waited 5 days before coming in - optimal treatment window is within 72 hours of onset. Placed STAT ENT referral. Patient has diabetes and hypertension - risk factors for vascular causes of SSHL.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "former (quit 10 years ago)",
          "alcohol": "moderate (2-3 drinks per week)",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-05-24",
        "visit_type": "office_visit",
        "chief_complaint": "ENT urgent appointment, sudden hearing loss evaluation",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 138,
          "bp_diastolic": 84,
          "hr_bpm": 74,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 198.0,
          "height_inches": 70.0,
          "bmi": 28.4
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": [
            "Prednisone 60mg daily x7 days, then taper over 2 weeks",
            "Meclizine 25mg three times daily as needed for vertigo",
            "Omeprazole 20mg daily (GI prophylaxis with steroids)"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Obesity (E66.9)"
          ],
          "new_acute": [
            "Sudden sensorineural hearing loss, left ear (H91.21)",
            "Tinnitus, left ear (H93.11)",
            "Vestibular dysfunction (H81.9)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Audiogram: LEFT ear - severe-to-profound sensorineural hearing loss across all frequencies (70-90 dB loss); RIGHT ear - normal hearing",
          "Tympanometry - normal bilaterally (middle ear function intact)",
          "MRI brain/IAC with contrast ordered to rule out acoustic neuroma",
          "Labs: CBC, CMP, ESR, ANA, RPR - to rule out autoimmune, infectious, or vascular causes"
        ],
        "referrals": [],
        "provider_note_snippet": "ENT EVALUATION: Confirmed SUDDEN SENSORINEURAL HEARING LOSS (SSHL) - idiopathic. Audiogram shows severe-to-profound hearing loss in left ear (70-90 dB across all frequencies). RIGHT ear normal. This is a TRUE ENT EMERGENCY. Unfortunately, patient delayed seeking care for 5 DAYS - optimal treatment window is <72 hours from onset. Prognosis for recovery is significantly worse with delayed treatment. Started high-dose oral prednisone immediately - may help reduce inflammation in inner ear. Will also consider intratympanic steroid injections if no improvement in 1 week. Ordered MRI to rule out retrocochlear pathology (acoustic neuroma, though typically causes gradual hearing loss). Most cases of SSHL are idiopathic (unknown cause). Patient has vascular risk factors (diabetes, hypertension) which may contribute. Educated patient that recovery is uncertain given delay in presentation.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-06-07",
        "visit_type": "office_visit",
        "chief_complaint": "2 week follow-up, completed steroid course, minimal improvement in hearing",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 152,
          "bp_diastolic": 92,
          "hr_bpm": 82,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 202.0,
          "height_inches": 70.0,
          "bmi": 29.0
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 168,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.2,
          "wbc_k_ul": 7.8,
          "platelets_k_ul": 248,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.3,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": 16,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": 385,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg twice daily",
            "Meclizine 25mg as needed (using less frequently)"
          ],
          "started": [
            "Intratympanic dexamethasone injections scheduled (series of 3)"
          ],
          "stopped": ["Prednisone completed taper", "Omeprazole discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Obesity (E66.9)",
            "Sudden sensorineural hearing loss, left ear (H91.21)",
            "Tinnitus, left ear (H93.11)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Repeat audiogram: LEFT ear - severe sensorineural hearing loss, minimal improvement (65-85 dB loss, improved 5-10 dB from baseline); RIGHT ear - remains normal",
          "MRI brain/IAC - negative for acoustic neuroma, no structural abnormalities",
          "First intratympanic steroid injection performed"
        ],
        "referrals": [],
        "provider_note_snippet": "2 weeks post-treatment initiation. Completed oral steroid course. Repeat audiogram shows MINIMAL improvement - only 5-10 dB recovery. Still has severe hearing loss in left ear. MRI negative for tumor or structural cause. Vertigo has resolved. Tinnitus persists - very bothersome to patient. Started intratympanic steroid injections (dexamethasone injected directly through eardrum into middle ear space) - can deliver higher steroid concentration to inner ear. Will do series of 3 injections over 2 weeks. However, prognosis is guarded - delayed treatment (5 days from onset) significantly reduces likelihood of recovery. Most recovery occurs in first 2-4 weeks; if no improvement by 6-8 weeks, hearing loss is likely permanent. Patient very distressed - hearing loss affecting work (he's a high school teacher, can't hear students on left side), social situations difficult. Side effects from steroids: BP elevated to 152/92 (was 138/84), glucose elevated to 168 (was 118), weight gain 4 lbs.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-07-19",
        "visit_type": "office_visit",
        "chief_complaint": "8 week follow-up, completed all treatments, some improvement but still significant hearing loss",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 146,
          "bp_diastolic": 86,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 200.0,
          "height_inches": 70.0,
          "bmi": 28.7
        },
        "labs": {
          "hba1c": 7.2,
          "glucose_mg_dl": 142,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.0,
          "wbc_k_ul": 7.0,
          "platelets_k_ul": 245,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.2,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": [],
          "stopped": ["Meclizine discontinued (vertigo resolved)"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Obesity (E66.9)",
            "Sensorineural hearing loss, left ear, permanent (H90.42)",
            "Tinnitus, left ear, chronic (H93.11)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Final audiogram: LEFT ear - moderate-to-severe sensorineural hearing loss (50-70 dB loss across frequencies); RIGHT ear - normal",
          "Hearing aid evaluation scheduled"
        ],
        "referrals": [
          "Audiology for hearing aid fitting",
          "Tinnitus management program"
        ],
        "provider_note_snippet": "8 weeks from onset. Completed all treatments: oral prednisone and intratympanic steroid injections (3 sessions). Final audiogram shows PARTIAL recovery - improved from 70-90 dB loss to 50-70 dB loss. This represents moderate-to-severe hearing loss. Patient regained some hearing (about 20-30 dB improvement overall) but has PERMANENT significant hearing loss. Vertigo completely resolved. Tinnitus persists - constant ringing/buzzing in left ear, very distressing to patient. Discussed prognosis: unlikely to see further spontaneous improvement at this point. Referred to audiology for hearing aid - will need amplification. Also enrolled in tinnitus management program (sound therapy, cognitive behavioral techniques). Patient disappointed with outcome - understandably frustrated that delay in seeking care may have affected recovery. Reviewed that SSHL is a medical emergency requiring treatment within 72 hours for best outcomes. Even with prompt treatment, only 50-60% of patients achieve good recovery; delayed treatment significantly worsens prognosis. This case will result in permanent disability.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-10-11",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up with hearing aid, adjusting to new reality of hearing loss",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 138,
          "bp_diastolic": 82,
          "hr_bpm": 72,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 195.0,
          "height_inches": 70.0,
          "bmi": 28.0
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 128,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": 88,
          "hemoglobin_g_dl": 14.2,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 242,
          "sodium_meq_l": 140,
          "potassium_meq_l": 4.1,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Lisinopril 20mg daily",
            "Metformin 1000mg twice daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension (I10)",
            "Type 2 Diabetes Mellitus (E11.9)",
            "Obesity (E66.9)",
            "Sensorineural hearing loss, left ear, permanent (H90.42)",
            "Tinnitus, left ear, chronic (H93.11)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [],
        "referrals": [],
        "provider_note_snippet": "5 months from initial presentation. Patient fitted with hearing aid in left ear - reports significant improvement in ability to function. Hearing aid helps amplify sounds but doesn't restore normal hearing. Still struggles in noisy environments, group conversations. Tinnitus remains constant but patient learning coping strategies through tinnitus management program - using white noise at night, CBT techniques. Patient reports some depression and social isolation related to hearing loss - may benefit from counseling. Lost 5 lbs through diet/exercise. BP and glucose better controlled. This case demonstrates: (1) SSHL is a true ENT emergency requiring immediate treatment, (2) Delayed presentation (>72 hours) significantly worsens prognosis, (3) Even with aggressive treatment, recovery may be incomplete, (4) Permanent hearing loss has significant functional and psychological impact, (5) Importance of patient education about red flag symptoms requiring urgent care, (6) Role of rehabilitation (hearing aids, tinnitus management) when recovery incomplete. Patient's outcome could have been better with immediate presentation - critical teaching point.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing sudden sensorineural hearing loss as a medical emergency requiring urgent treatment",
      "Understanding the critical importance of time-to-treatment (<72 hours) on prognosis",
      "Identifying the 5-day delay as a major factor in poor outcome",
      "Correlating delayed treatment with incomplete hearing recovery",
      "Understanding the difference between conductive and sensorineural hearing loss",
      "Recognizing permanent functional impairment despite maximal medical therapy"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize sudden sensorineural hearing loss (SSHL) as an ENT emergency requiring immediate intervention, (2) understand the critical time-window for treatment (optimal <72 hours), (3) identify patient delay in seeking care as a major factor affecting outcome, (4) track partial hearing recovery through serial audiograms, (5) understand that even with aggressive treatment (oral and intratympanic steroids), delayed presentation results in worse outcomes, (6) recognize permanent disability and need for rehabilitation, and (7) appreciate psychological and functional impacts of sudden hearing loss. The LLM should flag the 5-day delay at V1 as critical, recognize SSHL diagnosis and urgent treatment initiation at V2, identify minimal improvement despite treatment at V3, understand permanent hearing loss by V4, and appreciate long-term disability and rehabilitation needs at V5. This case emphasizes that SSHL is a 'stroke of the ear' requiring emergency treatment, and patient education about urgent symptoms is crucial."
  },

  {
    "patient_id": "TEST_PT_024",
    "patient_profile": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS1xuk09PwZkyLFNPQB2r-lvTucu--kfNMy6Q&s",
    "patient_name": "Richard Nelson",
    "archetype": "ENT_Peritonsillar_Abscess_Emergency",
    "demographics": {
      "age": 28,
      "sex": "M",
      "race_ethnicity": "Hispanic/Latino"
    },
    "allergies": [
      {
        "allergen": "Codeine",
        "reaction": "Severe nausea and vomiting",
        "severity": "moderate",
        "onset": "2018"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_024_A",
        "type": "symptom_lab_correlation",
        "description": "Progressive worsening from pharyngitis to peritonsillar abscess with airway compromise",
        "entities_involved": [
          "Sore throat",
          "Fever",
          "Dysphagia",
          "Trismus",
          "Airway obstruction"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.96
      },
      {
        "correlation_id": "CORR_024_B",
        "type": "lab_trend",
        "description": "Progressive leukocytosis and inflammatory markers indicating worsening bacterial infection",
        "entities_involved": ["WBC count", "CRP", "ESR", "Fever curve"],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.92
      },
      {
        "correlation_id": "CORR_024_C",
        "type": "medication_nonresponse",
        "description": "Failure of oral antibiotics for pharyngitis leading to abscess formation requiring surgical drainage",
        "entities_involved": [
          "Amoxicillin",
          "Symptom progression",
          "Abscess formation"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.88
      },
      {
        "correlation_id": "CORR_024_D",
        "type": "care_gap",
        "description": "Patient delay in follow-up despite worsening symptoms and inadequate initial antibiotic coverage",
        "entities_involved": [
          "Follow-up compliance",
          "Symptom progression",
          "Time to intervention"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "high",
        "minimum_confidence_threshold": 0.85
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2024-07-08",
        "visit_type": "urgent_care",
        "chief_complaint": "Severe sore throat x3 days, fever, hard to swallow",
        "vitals": {
          "temp_f": 101.8,
          "bp_systolic": 128,
          "bp_diastolic": 78,
          "hr_bpm": 92,
          "rr_bpm": 18,
          "spo2_percent": 98.0,
          "weight_lbs": 182.0,
          "height_inches": 69.0,
          "bmi": 26.9
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": 13.5,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": [
            "Amoxicillin 500mg three times daily x10 days",
            "Ibuprofen 600mg every 6 hours as needed for pain/fever",
            "Acetaminophen 650mg every 6 hours alternating with ibuprofen"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Acute pharyngitis (J02.9)",
            "Acute tonsillitis (J03.90)"
          ],
          "differential": ["Strep throat", "Viral pharyngitis", "Mononucleosis"]
        },
        "procedures_ordered": [
          "Rapid strep test - negative",
          "Throat culture sent"
        ],
        "referrals": [],
        "provider_note_snippet": "28 yo male with 3 days severe sore throat, fever to 101.8, odynophagia (painful swallowing). Denies cough, congestion. Exam: pharynx markedly erythematous, tonsils 3+ enlarged with white exudate bilaterally, tender anterior cervical lymphadenopathy. Rapid strep negative but sent culture. WBC 13.5 (elevated). Started amoxicillin empirically for bacterial pharyngitis/tonsillitis. Advised fluids, rest, pain control. Return if worse or not improving in 48-72 hours.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": "never",
          "alcohol": "social (weekends)",
          "housing_status": "stable (apartment with roommates)",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-07-14",
        "visit_type": "emergency",
        "chief_complaint": "Sore throat much worse, can barely swallow or open mouth, voice sounds different, drooling",
        "vitals": {
          "temp_f": 103.2,
          "bp_systolic": 138,
          "bp_diastolic": 84,
          "hr_bpm": 108,
          "rr_bpm": 20,
          "spo2_percent": 97.0,
          "weight_lbs": 178.0,
          "height_inches": 69.0,
          "bmi": 26.3
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 118,
          "creatinine_mg_dl": 1.0,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 14.2,
          "wbc_k_ul": 18.5,
          "platelets_k_ul": 385,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.0,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": 125.6,
          "esr_mm_hr": 48,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amoxicillin 500mg three times daily (patient reports taking as prescribed)",
            "Ibuprofen 600mg as needed",
            "Acetaminophen 650mg as needed"
          ],
          "started": [
            "Morphine 4mg IV for pain",
            "IV fluids (normal saline) - patient dehydrated",
            "Dexamethasone 10mg IV"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Peritonsillar abscess, suspected (J36)",
            "Severe odynophagia (R13.12)",
            "Trismus (M26.62)",
            "Dehydration (E86.0)"
          ],
          "differential": ["Retropharyngeal abscess", "Epiglottitis"]
        },
        "procedures_ordered": [
          "CT neck with contrast - LEFT peritonsillar abscess 3.2cm x 2.8cm with mass effect displacing airway medially",
          "Throat culture from 7/8 resulted: Group A Streptococcus positive (came back after patient already started amoxicillin)"
        ],
        "referrals": ["ENT emergency consult"],
        "provider_note_snippet": "PERITONSILLAR ABSCESS - ENT EMERGENCY. Patient took amoxicillin as prescribed but symptoms WORSENED dramatically. Now with high fever 103.2, severe dysphagia (can't swallow even saliva - drooling), trismus (can barely open mouth), 'hot potato' muffled voice, deviation of uvula to RIGHT side. Exam very limited due to trismus but visible bulging of left soft palate with uvular deviation. WBC 18.5 (was 13.5 six days ago). CRP markedly elevated 125.6. CT confirms LARGE left peritonsillar abscess 3.2cm with airway displacement. This is AIRWAY EMERGENCY - abscess could rupture and cause aspiration or cause complete airway obstruction. Started IV steroids, IV fluids (patient hasn't eaten/drunk in 2 days due to pain), morphine for pain. STAT ENT consult for incision and drainage. Patient admitted. Retrospective review: throat culture from initial visit came back positive for Group A Strep - amoxicillin SHOULD have been effective, but patient progressed to abscess despite treatment. Suggests either resistant organism, inadequate drug penetration, or abscess was already forming at initial presentation.",
        "patient_reported_adherence": "good",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-07-15",
        "visit_type": "office_visit",
        "chief_complaint": "Hospital day 2, status post I&D of peritonsillar abscess",
        "vitals": {
          "temp_f": 99.8,
          "bp_systolic": 122,
          "bp_diastolic": 76,
          "hr_bpm": 88,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 180.0,
          "height_inches": 69.0,
          "bmi": 26.6
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": 0.9,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": 13.8,
          "wbc_k_ul": 12.2,
          "platelets_k_ul": 358,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.1,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": 68.4,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Morphine IV as needed for pain (using less)",
            "IV fluids continued",
            "Dexamethasone IV"
          ],
          "started": [
            "Clindamycin 600mg IV every 8 hours",
            "Ampicillin-sulbactam 3g IV every 6 hours"
          ],
          "stopped": ["Amoxicillin discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Peritonsillar abscess, left, status post I&D (J36)",
            "Bacteremia (A49.9)",
            "Dehydration, improving (E86.0)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "I&D performed by ENT in OR under general anesthesia - drained 15mL purulent material",
          "Abscess culture: Group A Streptococcus and Fusobacterium necrophorum (anaerobe)",
          "Blood cultures x2 - positive for Group A Streptococcus (BACTEREMIA)"
        ],
        "referrals": [],
        "provider_note_snippet": "Post-op day 1 from I&D of peritonsillar abscess. ENT drained 15mL of purulent material in OR. Pathology CRITICAL: abscess grew Group A Strep (as expected from throat culture) PLUS Fusobacterium necrophorum (anaerobic bacteria). This polymicrobial infection explains why amoxicillin alone was insufficient - amoxicillin doesn't cover anaerobes well. Blood cultures POSITIVE for Group A Strep - patient had BACTEREMIA (bacteria in bloodstream), which is serious complication. Now on IV clindamycin (covers both strep and anaerobes) and ampicillin-sulbactam for broad coverage. Patient significantly improved after drainage - fever down to 99.8, WBC improving (18.5 to 12.2), CRP trending down, able to swallow liquids and soft foods, trismus resolved, pain much better. Will continue IV antibiotics x48 hours then transition to oral if continued improvement. Minimum 2 week total antibiotic course. ENT recommends elective tonsillectomy in 6-8 weeks to prevent recurrence (30% recurrence rate of peritonsillar abscess without tonsillectomy).",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": null,
          "housing_status": null,
          "food_security": null
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-07-18",
        "visit_type": "office_visit",
        "chief_complaint": "Hospital discharge, feeling much better, able to eat soft foods",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 118,
          "bp_diastolic": 72,
          "hr_bpm": 76,
          "rr_bpm": 16,
          "spo2_percent": 99.0,
          "weight_lbs": 181.0,
          "height_inches": 69.0,
          "bmi": 26.7
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": 9.2,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": 24.5,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": [
            "Clindamycin 450mg by mouth four times daily x10 more days (total 14 days)",
            "Ibuprofen 600mg every 6 hours as needed",
            "Hydrocodone-acetaminophen 5-325mg every 6 hours as needed for pain (avoiding codeine due to allergy)"
          ],
          "stopped": [
            "All IV medications discontinued",
            "IV fluids discontinued"
          ],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": [
            "Peritonsillar abscess, left, treated (J36)",
            "History of bacteremia (Z86.19)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "ENT follow-up in 2 weeks",
          "Tonsillectomy consultation scheduled for 6 weeks"
        ],
        "referrals": ["ENT for tonsillectomy consultation"],
        "provider_note_snippet": "Discharged after 4 days hospitalization. Completed 72 hours IV antibiotics with excellent response. WBC normalized to 9.2, CRP down to 24.5 (was 125.6). Blood cultures cleared after 48 hours of treatment. Patient able to swallow, eating soft diet, pain controlled. Transitioned to oral clindamycin to complete 14-day course. Educated on warning signs: difficulty breathing, worsening swallowing, high fever, neck stiffness - return to ED immediately. CRITICAL TEACHING: This was life-threatening infection that could have obstructed airway. ENT strongly recommends tonsillectomy in 6-8 weeks once acute infection fully resolved - will prevent recurrence. Without tonsillectomy, 30% chance of another peritonsillar abscess. Patient agrees to surgery. This case demonstrates: (1) Progression from simple pharyngitis to life-threatening abscess, (2) Polymicrobial nature of deep space neck infections requiring broad-spectrum antibiotics, (3) Serious complications including bacteremia, (4) Need for surgical drainage when abscess forms, (5) Importance of follow-up and definitive treatment (tonsillectomy) to prevent recurrence.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": "none until fully recovered",
          "housing_status": "stable",
          "food_security": "secure"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-09-06",
        "visit_type": "office_visit",
        "chief_complaint": "Post-tonsillectomy follow-up, 2 weeks after surgery, doing well",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 122,
          "bp_diastolic": 74,
          "hr_bpm": 72,
          "rr_bpm": 16,
          "spo2_percent": 99.0,
          "weight_lbs": 176.0,
          "height_inches": 69.0,
          "bmi": 26.0
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": null,
          "creatinine_mg_dl": null,
          "gfr_ml_min": null,
          "hemoglobin_g_dl": null,
          "wbc_k_ul": null,
          "platelets_k_ul": null,
          "sodium_meq_l": null,
          "potassium_meq_l": null,
          "alt_u_l": null,
          "ast_u_l": null,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": [],
          "stopped": ["All pain medications discontinued"],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [],
          "new_acute": ["Status post bilateral tonsillectomy (Z90.02)"],
          "differential": []
        },
        "procedures_ordered": [
          "Tonsillectomy performed 8/22 - bilateral tonsillectomy without complications"
        ],
        "referrals": [],
        "provider_note_snippet": "2 weeks post-tonsillectomy. Surgery performed without complications. Post-op course typical - 7-10 days of throat pain, difficulty swallowing, managed with pain medications and soft diet. Throat now healed, tonsillar fossae well-granulated, no signs of infection or bleeding. Patient back to normal diet, no pain, back to work. Lost 6 lbs during recovery period (expected). This definitive treatment eliminates risk of recurrent peritonsillar abscess. Patient very relieved to have this behind him - was frightening experience with the abscess. Final teaching points: (1) Peritonsillar abscess is serious, potentially life-threatening infection, (2) Early recognition and treatment critical, (3) Don't delay seeking care for severe or worsening sore throat, (4) Polymicrobial infections may require broader antibiotic coverage than simple pharyngitis, (5) Surgical drainage necessary for abscess, (6) Tonsillectomy prevents recurrence in high-risk patients. Complete resolution of case.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": null,
          "alcohol": "resumed social drinking",
          "housing_status": "stable",
          "food_security": "secure"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing progression from simple pharyngitis to life-threatening peritonsillar abscess",
      "Understanding why initial antibiotic (amoxicillin) failed despite Group A Strep sensitivity",
      "Identifying polymicrobial infection (strep + anaerobe) as cause of treatment failure",
      "Recognizing airway emergency and need for urgent surgical intervention",
      "Understanding complications including bacteremia from deep space infection",
      "Appreciating need for tonsillectomy to prevent recurrence"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize progression from acute pharyngitis to peritonsillar abscess, (2) identify red flag symptoms (trismus, drooling, uvular deviation, muffled voice) indicating abscess formation, (3) understand polymicrobial nature of deep space infections requiring anaerobic coverage, (4) recognize treatment failure despite appropriate initial antibiotic, (5) identify life-threatening complications including airway compromise and bacteremia, (6) understand need for surgical drainage when abscess forms, (7) appreciate role of definitive treatment (tonsillectomy) in preventing recurrence, and (8) recognize this as an ENT emergency requiring immediate specialist involvement. The LLM should flag initial pharyngitis treatment at V1, recognize dramatic worsening and airway emergency at V2, understand polymicrobial infection and bacteremia at V3, identify successful treatment response at V4, and appreciate complete resolution with tonsillectomy at V5. This case emphasizes that seemingly simple throat infections can rapidly progress to life-threatening conditions requiring emergency intervention."
  },

  {
    "patient_id": "TEST_PT_025",
    "patient_profile": "data:image/jpeg;base64,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",
    "patient_name": "Shallan Davar",
    "archetype": "Cardiovascular_Hypertensive_Emergency",
    "demographics": {
      "age": 52,
      "sex": "M",
      "race_ethnicity": "African American"
    },
    "allergies": [
      {
        "allergen": "Hydrochlorothiazide",
        "reaction": "Severe hyponatremia requiring hospitalization",
        "severity": "severe",
        "onset": "2022"
      }
    ],
    "ground_truth_correlations": [
      {
        "correlation_id": "CORR_025_A",
        "type": "symptom_lab_correlation",
        "description": "Severe hypertension (BP 220/128) with acute end-organ damage (kidney injury, hypertensive encephalopathy, retinopathy)",
        "entities_involved": [
          "Blood pressure",
          "Creatinine",
          "Neurologic symptoms",
          "Retinal changes"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.98
      },
      {
        "correlation_id": "CORR_025_B",
        "type": "lab_trend",
        "description": "Progressive worsening of renal function from baseline CKD to acute kidney injury during hypertensive crisis",
        "entities_involved": [
          "Creatinine",
          "GFR",
          "Blood pressure",
          "Proteinuria"
        ],
        "visits_involved": ["V1", "V2", "V3", "V4"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.94
      },
      {
        "correlation_id": "CORR_025_C",
        "type": "medication_nonresponse",
        "description": "Medication non-adherence leading to uncontrolled hypertension and hypertensive emergency",
        "entities_involved": [
          "Medication adherence",
          "BP control",
          "ER visits",
          "Cost barriers"
        ],
        "visits_involved": ["V1", "V2", "V3"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.9
      },
      {
        "correlation_id": "CORR_025_D",
        "type": "care_gap",
        "description": "Lost to follow-up for 18 months despite severe hypertension and CKD, lack of medication access",
        "entities_involved": [
          "Appointment adherence",
          "Medication access",
          "Insurance status",
          "Time gap"
        ],
        "visits_involved": ["V1", "V2"],
        "expected_severity": "critical",
        "minimum_confidence_threshold": 0.88
      }
    ],
    "clinical_timeline": [
      {
        "visit_id": "V1",
        "visit_date": "2023-01-20",
        "visit_type": "office_visit",
        "chief_complaint": "Follow-up for high blood pressure and kidney disease",
        "vitals": {
          "temp_f": 98.6,
          "bp_systolic": 168,
          "bp_diastolic": 102,
          "hr_bpm": 84,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 245.0,
          "height_inches": 71.0,
          "bmi": 34.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 105,
          "creatinine_mg_dl": 2.1,
          "gfr_ml_min": 38,
          "hemoglobin_g_dl": 11.8,
          "wbc_k_ul": 7.5,
          "platelets_k_ul": 238,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.8,
          "alt_u_l": 32,
          "ast_u_l": 28,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 218,
          "ldl_mg_dl": 142,
          "hdl_mg_dl": 38,
          "triglycerides_mg_dl": 190,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "Lisinopril 40mg daily",
            "Metoprolol 100mg twice daily"
          ],
          "started": ["Hydralazine 50mg three times daily"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, severe (I10)",
            "Chronic kidney disease Stage 3b (N18.32)",
            "Obesity (E66.9)",
            "Hypertensive nephrosclerosis (I12.9)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Urinalysis: 2+ protein, trace blood",
          "Urine protein/creatinine ratio: 850 mg/g (elevated)"
        ],
        "referrals": ["Nephrology referral placed"],
        "provider_note_snippet": "52 yo African American male with long-standing hypertension and CKD Stage 3b. BP today 168/102 - UNCONTROLLED despite triple therapy. Creatinine 2.1 (baseline ~1.8-2.0), GFR 38. Significant proteinuria. Added hydralazine as fourth agent. Patient admits inconsistent medication adherence - sometimes skips doses, ran out of medications last month and didn't refill for 2 weeks due to cost. Lost insurance 6 months ago, now paying out of pocket. Discussed patient assistance programs. Nephrology referral for CKD management. CRITICAL: Patient at very high risk for cardiovascular events and progression to ESRD. Stressed importance of medication adherence and BP control. RTC 4 weeks.",
        "patient_reported_adherence": "fair",
        "social_history_updates": {
          "smoking": "current (1/2 pack per day)",
          "alcohol": "moderate (3-4 beers daily)",
          "housing_status": "stable (rents apartment)",
          "food_security": "insecure (high sodium diet, fast food frequent)"
        }
      },
      {
        "visit_id": "V2",
        "visit_date": "2024-07-25",
        "visit_type": "emergency",
        "chief_complaint": "Severe headache, confusion, blurry vision, chest pressure x2 days",
        "vitals": {
          "temp_f": 99.2,
          "bp_systolic": 220,
          "bp_diastolic": 128,
          "hr_bpm": 102,
          "rr_bpm": 22,
          "spo2_percent": 96.0,
          "weight_lbs": 252.0,
          "height_inches": 71.0,
          "bmi": 35.2
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 118,
          "creatinine_mg_dl": 3.8,
          "gfr_ml_min": 18,
          "hemoglobin_g_dl": 10.2,
          "wbc_k_ul": 9.8,
          "platelets_k_ul": 225,
          "sodium_meq_l": 136,
          "potassium_meq_l": 5.4,
          "alt_u_l": 42,
          "ast_u_l": 38,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [],
          "started": [
            "Nicardipine IV infusion for BP control",
            "Labetalol 20mg IV boluses",
            "Aspirin 325mg"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, severe (I10)",
            "Chronic kidney disease Stage 3b (N18.32)",
            "Obesity (E66.9)",
            "Hypertensive nephrosclerosis (I12.9)"
          ],
          "new_acute": [
            "Hypertensive emergency (I16.1)",
            "Hypertensive encephalopathy (I67.4)",
            "Acute kidney injury on CKD (N17.9, N18.32)",
            "Hypertensive retinopathy (H35.03)"
          ],
          "differential": ["Stroke", "Acute coronary syndrome"]
        },
        "procedures_ordered": [
          "CT head - no acute hemorrhage or infarct, mild cerebral edema",
          "Chest X-ray - cardiomegaly, no pulmonary edema",
          "EKG - LVH with strain pattern, no acute STEMI",
          "Troponin - mildly elevated 0.12 ng/mL (likely demand ischemia)",
          "BNP - 850 pg/mL (elevated)",
          "Urinalysis - 3+ protein, 2+ blood, RBC casts",
          "Fundoscopic exam - bilateral papilledema, flame hemorrhages, cotton-wool spots (Grade IV hypertensive retinopathy)"
        ],
        "referrals": [
          "ICU admission",
          "Nephrology consult",
          "Ophthalmology consult"
        ],
        "provider_note_snippet": "HYPERTENSIVE EMERGENCY - LIFE-THREATENING. 52 yo male presenting with BP 220/128, severe headache, confusion, visual changes, chest pressure. LOST TO FOLLOW-UP for 18 MONTHS since last visit. Patient admits stopped taking ALL blood pressure medications 6 months ago - couldn't afford them, lost insurance, felt 'fine' so didn't think he needed them. Now with ACUTE END-ORGAN DAMAGE: (1) Hypertensive encephalopathy - confusion, severe headache, CT shows cerebral edema, (2) Acute kidney injury - creatinine 3.8 (was 2.1 in Jan 2023), GFR 18 (was 38), now Stage 4 CKD, (3) Hypertensive retinopathy Grade IV - papilledema, hemorrhages, at risk for vision loss, (4) Possible cardiac ischemia - troponin 0.12, chest pressure, EKG shows LVH with strain. Started IV nicardipine for controlled BP reduction - goal to lower MAP by 10-20% in first hour, 25% in first 24 hours (too rapid reduction can cause stroke). ADMITTED TO ICU. This is PREVENTABLE emergency caused by medication non-adherence.",
        "patient_reported_adherence": "poor",
        "social_history_updates": {
          "smoking": "current (increased to 1 pack per day)",
          "alcohol": "moderate to heavy (5-6 beers daily)",
          "housing_status": "stable but financial stress",
          "food_security": "insecure"
        }
      },
      {
        "visit_id": "V3",
        "visit_date": "2024-07-28",
        "visit_type": "office_visit",
        "chief_complaint": "ICU day 3, BP improving, mental status clearing",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 168,
          "bp_diastolic": 96,
          "hr_bpm": 82,
          "rr_bpm": 18,
          "spo2_percent": 97.0,
          "weight_lbs": 248.0,
          "height_inches": 71.0,
          "bmi": 34.6
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 108,
          "creatinine_mg_dl": 3.2,
          "gfr_ml_min": 22,
          "hemoglobin_g_dl": 9.8,
          "wbc_k_ul": 8.2,
          "platelets_k_ul": 232,
          "sodium_meq_l": 137,
          "potassium_meq_l": 5.1,
          "alt_u_l": 38,
          "ast_u_l": 32,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": null,
          "ldl_mg_dl": null,
          "hdl_mg_dl": null,
          "triglycerides_mg_dl": null,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": ["Nicardipine IV (being weaned)", "Aspirin 81mg daily"],
          "started": [
            "Amlodipine 10mg daily",
            "Lisinopril 40mg daily",
            "Carvedilol 25mg twice daily (switched from metoprolol)",
            "Hydralazine 100mg three times daily (increased dose)",
            "Atorvastatin 80mg daily"
          ],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, severe (I10)",
            "Chronic kidney disease Stage 4 (N18.4)",
            "Obesity (E66.9)",
            "Hypertensive nephrosclerosis (I12.9)"
          ],
          "new_acute": [
            "Hypertensive emergency, resolving (I16.1)",
            "Hypertensive encephalopathy, resolved (I67.4)",
            "Acute kidney injury on CKD, improving (N17.9, N18.4)",
            "Hypertensive retinopathy Grade IV (H35.03)"
          ],
          "differential": []
        },
        "procedures_ordered": [
          "Repeat fundoscopic exam - papilledema improving, hemorrhages stable",
          "Echocardiogram - severe LVH, EF 45% (reduced), diastolic dysfunction"
        ],
        "referrals": [
          "Nephrology following",
          "Social work for medication assistance",
          "Case management for insurance enrollment"
        ],
        "provider_note_snippet": "ICU day 3. BP controlled with IV nicardipine, now weaning to oral medications. BP down to 168/96 (from 220/128). Mental status completely cleared - patient alert, oriented, no longer confused. Headache resolved. Vision improving but still some blurriness. Creatinine improved from 3.8 to 3.2 but still much worse than baseline 2.1 - now has Stage 4 CKD (was Stage 3b). Some kidney damage may be permanent. Restarted oral antihypertensives at MAXIMUM doses - four-drug regimen. Echo shows severe LVH and reduced EF 45% (hypertensive cardiomyopathy). EXTENSIVE COUNSELING: This was life-threatening, preventable emergency. Could have died or had permanent stroke/blindness/kidney failure. Social work involved - enrolled patient in medication assistance programs, all BP meds now FREE. Helping with insurance enrollment. Patient very shaken by this experience, now understands severity. Transfer to step-down unit, discharge tomorrow if BP stable.",
        "patient_reported_adherence": "excellent (motivated after near-death experience)",
        "social_history_updates": {
          "smoking": "quit in hospital (using nicotine patch)",
          "alcohol": "none since admission",
          "housing_status": "stable",
          "food_security": "working with social work"
        }
      },
      {
        "visit_id": "V4",
        "visit_date": "2024-08-22",
        "visit_type": "office_visit",
        "chief_complaint": "1-month post-discharge follow-up, adhering to all medications",
        "vitals": {
          "temp_f": 98.2,
          "bp_systolic": 142,
          "bp_diastolic": 88,
          "hr_bpm": 74,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 242.0,
          "height_inches": 71.0,
          "bmi": 33.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 102,
          "creatinine_mg_dl": 2.8,
          "gfr_ml_min": 26,
          "hemoglobin_g_dl": 10.4,
          "wbc_k_ul": 7.0,
          "platelets_k_ul": 242,
          "sodium_meq_l": 138,
          "potassium_meq_l": 4.9,
          "alt_u_l": 28,
          "ast_u_l": 26,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 168,
          "ldl_mg_dl": 92,
          "hdl_mg_dl": 42,
          "triglycerides_mg_dl": 170,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "Lisinopril 40mg daily",
            "Carvedilol 25mg twice daily",
            "Hydralazine 100mg three times daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": [],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, severe (I10)",
            "Chronic kidney disease Stage 4 (N18.4)",
            "Obesity (E66.9)",
            "Hypertensive nephrosclerosis (I12.9)",
            "Hypertensive cardiomyopathy (I11.0)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "Urinalysis - 2+ protein, no blood",
          "Home BP monitoring log reviewed - BPs 135-155/85-95"
        ],
        "referrals": ["Nephrology - discussing preparation for dialysis"],
        "provider_note_snippet": "Excellent 1-month follow-up. Patient 100% adherent to medications (verified with pharmacy records, patient using pill organizer). BP much improved at 142/88 (goal <130/80 but this is significant improvement). Creatinine stabilized at 2.8 (was 3.8 at worst, baseline 2.1). GFR 26 - Stage 4 CKD, likely some permanent kidney damage from hypertensive crisis. Nephrology discussing preparation for eventual dialysis - may need within 1-2 years. Patient lost 6 lbs, quit smoking (3 weeks smoke-free), stopped alcohol, working with dietitian on low-sodium diet. Vision fully recovered. No headaches. Medication assistance programs working well - all meds free. Re-enrolled in Medicaid. Patient attending all appointments. This case demonstrates: (1) Catastrophic consequences of medication non-adherence, (2) Social determinants (insurance, cost) as barriers to care, (3) Hypertensive emergency with multi-organ damage, (4) Some damage (kidney, heart) may be permanent despite treatment, (5) Importance of addressing barriers to medication access, (6) Behavior change after serious health scare. Patient's life was saved but long-term complications remain.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": "quit (1 month smoke-free)",
          "alcohol": "none",
          "housing_status": "stable, Medicaid approved",
          "food_security": "improved with food assistance"
        }
      },
      {
        "visit_id": "V5",
        "visit_date": "2024-10-25",
        "visit_type": "office_visit",
        "chief_complaint": "3-month follow-up, BP well-controlled, preparing for dialysis",
        "vitals": {
          "temp_f": 98.4,
          "bp_systolic": 136,
          "bp_diastolic": 82,
          "hr_bpm": 70,
          "rr_bpm": 16,
          "spo2_percent": 98.0,
          "weight_lbs": 235.0,
          "height_inches": 71.0,
          "bmi": 32.8
        },
        "labs": {
          "hba1c": null,
          "glucose_mg_dl": 98,
          "creatinine_mg_dl": 3.1,
          "gfr_ml_min": 23,
          "hemoglobin_g_dl": 10.6,
          "wbc_k_ul": 6.8,
          "platelets_k_ul": 248,
          "sodium_meq_l": 139,
          "potassium_meq_l": 4.7,
          "alt_u_l": 26,
          "ast_u_l": 24,
          "crp_mg_l": null,
          "esr_mm_hr": null,
          "tsh_miu_l": null,
          "cholesterol_total_mg_dl": 158,
          "ldl_mg_dl": 82,
          "hdl_mg_dl": 48,
          "triglycerides_mg_dl": 140,
          "b12_pg_ml": null,
          "folate_ng_ml": null,
          "ferritin_ng_ml": null,
          "ck_u_l": null
        },
        "medications": {
          "continued": [
            "Amlodipine 10mg daily",
            "Lisinopril 40mg daily",
            "Carvedilol 25mg twice daily",
            "Hydralazine 100mg three times daily",
            "Atorvastatin 80mg daily",
            "Aspirin 81mg daily"
          ],
          "started": ["Erythropoietin injections for anemia of CKD"],
          "stopped": [],
          "dose_changed": []
        },
        "diagnoses": {
          "active_chronic": [
            "Hypertension, controlled (I10)",
            "Chronic kidney disease Stage 4 (N18.4)",
            "Obesity (E66.9)",
            "Hypertensive nephrosclerosis (I12.9)",
            "Hypertensive cardiomyopathy (I11.0)",
            "Anemia of chronic kidney disease (D63.1)"
          ],
          "new_acute": [],
          "differential": []
        },
        "procedures_ordered": [
          "AV fistula placement scheduled for dialysis access"
        ],
        "referrals": [
          "Vascular surgery for AV fistula",
          "Dialysis center tour"
        ],
        "provider_note_snippet": "3 months post-hypertensive emergency. Patient doing remarkably well. BP excellent at 136/82 on four-drug regimen. 100% medication adherent. Lost total 17 lbs through diet changes. Smoke-free for 3.5 months. No alcohol. Creatinine stable 3.1, GFR 23 (Stage 4 CKD approaching Stage 5). Nephrology preparing for dialysis - AV fistula surgery scheduled next month, estimated need for dialysis in 6-9 months when GFR <15. Patient has accepted this reality - understands permanent kidney damage from years of uncontrolled hypertension culminating in hypertensive crisis. Started erythropoietin for anemia. On transplant waiting list. This case illustrates: (1) Hypertensive emergency is medical catastrophe with multi-organ damage, (2) Medication non-adherence due to cost/access is major public health issue, (3) Some end-organ damage is irreversible even with subsequent excellent control, (4) Addressing social determinants is critical for long-term management, (5) Near-death experience can be powerful motivator for behavior change, (6) Comprehensive support (medication assistance, insurance, dietitian, social work) improves outcomes. Patient's life was saved but faces dialysis - sobering reminder of consequences of untreated hypertension.",
        "patient_reported_adherence": "excellent",
        "social_history_updates": {
          "smoking": "quit (3.5 months smoke-free)",
          "alcohol": "none",
          "housing_status": "stable with Medicaid",
          "food_security": "stable with assistance programs"
        }
      }
    ],
    "expected_llm_challenges": [
      "Recognizing hypertensive emergency vs hypertensive urgency (presence of end-organ damage)",
      "Understanding the progression from uncontrolled hypertension to multi-organ failure",
      "Identifying medication non-adherence as root cause of preventable emergency",
      "Recognizing social determinants (insurance, cost) as barriers to medication access",
      "Understanding irreversible end-organ damage despite subsequent control",
      "Appreciating the role of comprehensive social support in long-term management"
    ],
    "evaluation_notes": "This case tests ability to: (1) recognize hypertensive emergency (BP >180/120 WITH acute end-organ damage) vs urgency (elevated BP without damage), (2) identify multiple end-organ injuries (brain, kidney, eye, heart), (3) understand medication non-adherence as root cause, (4) recognize 18-month care gap and its consequences, (5) identify social determinants as critical barriers to care, (6) understand that some organ damage is permanent despite later excellent control, (7) track progression from Stage 3b to Stage 4 CKD approaching dialysis, (8) appreciate need for comprehensive support addressing insurance, medication access, and social needs, and (9) understand this as preventable catastrophe. The LLM should flag uncontrolled hypertension and medication non-adherence at V1, identify 18-month gap and recognize life-threatening emergency with multi-organ damage at V2, understand ICU management and partial recovery at V3, track improved control but permanent damage at V4, and recognize long-term consequences (approaching dialysis) despite excellent subsequent adherence at V5. This case emphasizes that hypertension is 'silent killer' until catastrophic complications occur, and addressing social barriers is essential for management."
  }
]
